fact_id,Location_id,Country,Indicator Name,IndicatorId,Year,CategoryId,CategoryOption,measuremethod_id,measure type,DatasourceId,DataSource,Value
90847,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1975,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,26.5
90882,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1975,9,Female,1,Percentage,3,WHO / GHO,25.4
90917,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1975,8,Male,1,Percentage,3,WHO / GHO,27.5
90848,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1976,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,26.7
90883,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1976,9,Female,1,Percentage,3,WHO / GHO,25.6
90918,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1976,8,Male,1,Percentage,3,WHO / GHO,27.6
90849,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1977,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,26.8
90884,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1977,9,Female,1,Percentage,3,WHO / GHO,25.8
90919,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1977,8,Male,1,Percentage,3,WHO / GHO,27.7
90850,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1978,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27
90885,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1978,9,Female,1,Percentage,3,WHO / GHO,26
90920,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1978,8,Male,1,Percentage,3,WHO / GHO,27.9
90851,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1979,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.2
90886,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1979,9,Female,1,Percentage,3,WHO / GHO,26.2
90921,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1979,8,Male,1,Percentage,3,WHO / GHO,28
90852,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1980,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.3
90887,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1980,9,Female,1,Percentage,3,WHO / GHO,26.4
90922,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1980,8,Male,1,Percentage,3,WHO / GHO,28.1
90853,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1981,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.5
90888,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1981,9,Female,1,Percentage,3,WHO / GHO,26.6
90923,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1981,8,Male,1,Percentage,3,WHO / GHO,28.3
90854,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1982,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.7
90889,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1982,9,Female,1,Percentage,3,WHO / GHO,26.8
90924,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1982,8,Male,1,Percentage,3,WHO / GHO,28.4
90855,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.8
90890,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,9,Female,1,Percentage,3,WHO / GHO,27
90925,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,8,Male,1,Percentage,3,WHO / GHO,28.5
90856,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28
90891,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,9,Female,1,Percentage,3,WHO / GHO,27.1
90926,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,8,Male,1,Percentage,3,WHO / GHO,28.7
90857,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.1
90892,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,9,Female,1,Percentage,3,WHO / GHO,27.3
90927,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,8,Male,1,Percentage,3,WHO / GHO,28.8
90858,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.3
90893,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,9,Female,1,Percentage,3,WHO / GHO,27.5
90928,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,8,Male,1,Percentage,3,WHO / GHO,28.9
90859,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.4
90894,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,9,Female,1,Percentage,3,WHO / GHO,27.7
90929,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,8,Male,1,Percentage,3,WHO / GHO,28.9
90860,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.5
90895,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,9,Female,1,Percentage,3,WHO / GHO,27.8
90930,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,8,Male,1,Percentage,3,WHO / GHO,29
90861,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.6
90896,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,9,Female,1,Percentage,3,WHO / GHO,28
90931,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,8,Male,1,Percentage,3,WHO / GHO,29.1
11439,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,1990,9,Female,1,Percentage,3,WHO / GHO,965
90862,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1990,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.7
90897,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1990,9,Female,1,Percentage,3,WHO / GHO,28.1
90932,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1990,8,Male,1,Percentage,3,WHO / GHO,29.1
123017,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1990,28,Both sexes (male and female),1,Percentage,35,IHME,0.96
124457,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1990,8,Male,1,Percentage,35,IHME,0.97
125897,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1990,9,Female,1,Percentage,35,IHME,0.94
135993,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1990,29,Total,1,Percentage,36,WHO/UNICEF,57
13762,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1990,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,45
47439,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1990,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,177
95309,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1990,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,177
137390,1,AFRO Region,Number of cancer cases (all cause),AFR0321,1990,29,Total,5,Count (Numeric Integer),35,IHME,1218542
144695,1,AFRO Region,Number of people living with HIV,AFR0019,1990,29,Total,5,Count (Numeric Integer),16,UNAIDS,5700000
142652,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1990,29,Total,6,Per 1000 population,16,UNAIDS,2.92
143972,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1990,8,Male,6,Per 1000 population,16,UNAIDS,2.65
122126,1,AFRO Region,Life expectancy at age 60 years,AFR0003,1990-1995,28,Both sexes (male and female),1,Percentage,17,UN Population,15.27
122414,1,AFRO Region,Life expectancy at age 60 years,AFR0003,1990-1995,8,Male,1,Percentage,17,UN Population,14.43
122702,1,AFRO Region,Life expectancy at age 60 years,AFR0003,1990-1995,9,Female,1,Percentage,17,UN Population,16.05
90863,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1991,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.8
90898,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1991,9,Female,1,Percentage,3,WHO / GHO,28.3
90933,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1991,8,Male,1,Percentage,3,WHO / GHO,29.2
123065,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1991,28,Both sexes (male and female),1,Percentage,35,IHME,0.96
124505,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1991,8,Male,1,Percentage,35,IHME,0.98
125945,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1991,9,Female,1,Percentage,35,IHME,0.94
136036,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1991,29,Total,1,Percentage,36,WHO/UNICEF,50
13763,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1991,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,45.2
47440,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1991,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,176.3
95310,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1991,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,176.3
137438,1,AFRO Region,Number of cancer cases (all cause),AFR0321,1991,29,Total,5,Count (Numeric Integer),35,IHME,1252289
144696,1,AFRO Region,Number of people living with HIV,AFR0019,1991,29,Total,5,Count (Numeric Integer),16,UNAIDS,7000000
142696,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1991,29,Total,6,Per 1000 population,16,UNAIDS,3.21
144016,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1991,8,Male,6,Per 1000 population,16,UNAIDS,2.87
90864,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1992,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.9
90899,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1992,9,Female,1,Percentage,3,WHO / GHO,28.4
90934,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1992,8,Male,1,Percentage,3,WHO / GHO,29.2
123113,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1992,28,Both sexes (male and female),1,Percentage,35,IHME,0.96
124553,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1992,8,Male,1,Percentage,35,IHME,0.98
125993,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1992,9,Female,1,Percentage,35,IHME,0.95
136080,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1992,29,Total,1,Percentage,36,WHO/UNICEF,50
13764,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1992,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,44.9
47441,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1992,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,175
95311,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1992,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,175
137486,1,AFRO Region,Number of cancer cases (all cause),AFR0321,1992,29,Total,5,Count (Numeric Integer),35,IHME,1294161
144697,1,AFRO Region,Number of people living with HIV,AFR0019,1992,29,Total,5,Count (Numeric Integer),16,UNAIDS,8300000
142740,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1992,29,Total,6,Per 1000 population,16,UNAIDS,3.42
144060,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1992,8,Male,6,Per 1000 population,16,UNAIDS,3.02
90865,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1993,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.9
90900,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1993,9,Female,1,Percentage,3,WHO / GHO,28.5
90935,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1993,8,Male,1,Percentage,3,WHO / GHO,29.2
123161,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1993,28,Both sexes (male and female),1,Percentage,35,IHME,0.97
124601,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1993,8,Male,1,Percentage,35,IHME,0.99
126041,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1993,9,Female,1,Percentage,35,IHME,0.95
136124,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1993,29,Total,1,Percentage,36,WHO/UNICEF,50
13765,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1993,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,44.6
47442,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1993,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,173.8
95312,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1993,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,173.8
137534,1,AFRO Region,Number of cancer cases (all cause),AFR0321,1993,29,Total,5,Count (Numeric Integer),35,IHME,1324105
144698,1,AFRO Region,Number of people living with HIV,AFR0019,1993,29,Total,5,Count (Numeric Integer),16,UNAIDS,9700000
142784,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1993,29,Total,6,Per 1000 population,16,UNAIDS,3.54
144104,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1993,8,Male,6,Per 1000 population,16,UNAIDS,3.09
90866,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1994,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.9
90901,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1994,9,Female,1,Percentage,3,WHO / GHO,28.6
90936,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1994,8,Male,1,Percentage,3,WHO / GHO,29.2
123209,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1994,28,Both sexes (male and female),1,Percentage,35,IHME,0.97
124649,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1994,8,Male,1,Percentage,35,IHME,0.99
126089,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1994,9,Female,1,Percentage,35,IHME,0.95
136169,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1994,29,Total,1,Percentage,36,WHO/UNICEF,55
13766,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1994,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,44.3
47443,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1994,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,173.5
95313,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1994,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,173.5
137582,1,AFRO Region,Number of cancer cases (all cause),AFR0321,1994,29,Total,5,Count (Numeric Integer),35,IHME,1360733
144699,1,AFRO Region,Number of people living with HIV,AFR0019,1994,29,Total,5,Count (Numeric Integer),16,UNAIDS,11000000
142828,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1994,29,Total,6,Per 1000 population,16,UNAIDS,3.59
144148,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1994,8,Male,6,Per 1000 population,16,UNAIDS,3.1
11440,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,1995,9,Female,1,Percentage,3,WHO / GHO,914
90867,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1995,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.9
90902,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1995,9,Female,1,Percentage,3,WHO / GHO,28.6
90937,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1995,8,Male,1,Percentage,3,WHO / GHO,29.1
123257,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1995,28,Both sexes (male and female),1,Percentage,35,IHME,0.97
124697,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1995,8,Male,1,Percentage,35,IHME,0.99
126137,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1995,9,Female,1,Percentage,35,IHME,0.95
136214,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1995,29,Total,1,Percentage,36,WHO/UNICEF,54
13767,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1995,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,44
47444,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1995,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,171.2
95314,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1995,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,171.2
137630,1,AFRO Region,Number of cancer cases (all cause),AFR0321,1995,29,Total,5,Count (Numeric Integer),35,IHME,1394212
144700,1,AFRO Region,Number of people living with HIV,AFR0019,1995,29,Total,5,Count (Numeric Integer),16,UNAIDS,12300000
47468,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,1995,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,15.5
142872,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1995,29,Total,6,Per 1000 population,16,UNAIDS,3.57
144192,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1995,8,Male,6,Per 1000 population,16,UNAIDS,3.06
74705,1,AFRO Region,Gender development index score,AFR0347,1995,28,Both sexes (male and female),12,Index,14,UNDP,0.83
122174,1,AFRO Region,Life expectancy at age 60 years,AFR0003,1995-2000,28,Both sexes (male and female),1,Percentage,17,UN Population,15.19
122462,1,AFRO Region,Life expectancy at age 60 years,AFR0003,1995-2000,8,Male,1,Percentage,17,UN Population,14.3
122750,1,AFRO Region,Life expectancy at age 60 years,AFR0003,1995-2000,9,Female,1,Percentage,17,UN Population,16.02
90868,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1996,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.9
90903,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1996,9,Female,1,Percentage,3,WHO / GHO,28.7
90938,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1996,8,Male,1,Percentage,3,WHO / GHO,29.1
123305,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1996,28,Both sexes (male and female),1,Percentage,35,IHME,0.97
124745,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1996,8,Male,1,Percentage,35,IHME,0.99
126185,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1996,9,Female,1,Percentage,35,IHME,0.95
136259,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1996,29,Total,1,Percentage,36,WHO/UNICEF,51
13768,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1996,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,43.6
47445,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1996,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,168.3
95315,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1996,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,168.3
137678,1,AFRO Region,Number of cancer cases (all cause),AFR0321,1996,29,Total,5,Count (Numeric Integer),35,IHME,1431953
144701,1,AFRO Region,Number of people living with HIV,AFR0019,1996,29,Total,5,Count (Numeric Integer),16,UNAIDS,13400000
142916,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1996,29,Total,6,Per 1000 population,16,UNAIDS,3.51
144236,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1996,8,Male,6,Per 1000 population,16,UNAIDS,2.99
90869,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1997,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.9
90904,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1997,9,Female,1,Percentage,3,WHO / GHO,28.7
90939,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1997,8,Male,1,Percentage,3,WHO / GHO,29
123353,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1997,28,Both sexes (male and female),1,Percentage,35,IHME,0.97
124793,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1997,8,Male,1,Percentage,35,IHME,1
126233,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1997,9,Female,1,Percentage,35,IHME,0.95
136304,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1997,29,Total,1,Percentage,36,WHO/UNICEF,50
13769,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1997,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,43.1
47446,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1997,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,165.9
95316,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1997,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,165.9
137726,1,AFRO Region,Number of cancer cases (all cause),AFR0321,1997,29,Total,5,Count (Numeric Integer),35,IHME,1482467
144702,1,AFRO Region,Number of people living with HIV,AFR0019,1997,29,Total,5,Count (Numeric Integer),16,UNAIDS,14500000
142960,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1997,29,Total,6,Per 1000 population,16,UNAIDS,3.44
144280,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1997,8,Male,6,Per 1000 population,16,UNAIDS,2.92
90870,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1998,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.9
90905,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1998,9,Female,1,Percentage,3,WHO / GHO,28.7
90940,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1998,8,Male,1,Percentage,3,WHO / GHO,28.9
123401,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1998,28,Both sexes (male and female),1,Percentage,35,IHME,0.97
124841,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1998,8,Male,1,Percentage,35,IHME,1
126281,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1998,9,Female,1,Percentage,35,IHME,0.95
136349,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1998,29,Total,1,Percentage,36,WHO/UNICEF,51
13770,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1998,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,42.5
47447,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1998,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,162.9
95317,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1998,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,162.9
137774,1,AFRO Region,Number of cancer cases (all cause),AFR0321,1998,29,Total,5,Count (Numeric Integer),35,IHME,1527617
144703,1,AFRO Region,Number of people living with HIV,AFR0019,1998,29,Total,5,Count (Numeric Integer),16,UNAIDS,15500000
143004,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1998,29,Total,6,Per 1000 population,16,UNAIDS,3.34
144324,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1998,8,Male,6,Per 1000 population,16,UNAIDS,2.84
90871,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1999,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.8
90906,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1999,9,Female,1,Percentage,3,WHO / GHO,28.7
90941,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1999,8,Male,1,Percentage,3,WHO / GHO,28.8
123449,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1999,28,Both sexes (male and female),1,Percentage,35,IHME,0.97
124889,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1999,8,Male,1,Percentage,35,IHME,1
126329,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,1999,9,Female,1,Percentage,35,IHME,0.95
136394,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1999,29,Total,1,Percentage,36,WHO/UNICEF,49
13771,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1999,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,41.8
47448,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1999,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,158.7
95318,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1999,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,158.7
137822,1,AFRO Region,Number of cancer cases (all cause),AFR0321,1999,29,Total,5,Count (Numeric Integer),35,IHME,1573433
144704,1,AFRO Region,Number of people living with HIV,AFR0019,1999,29,Total,5,Count (Numeric Integer),16,UNAIDS,16300000
143048,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1999,29,Total,6,Per 1000 population,16,UNAIDS,3.22
144368,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1999,8,Male,6,Per 1000 population,16,UNAIDS,2.74
11441,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2000,9,Female,1,Percentage,3,WHO / GHO,857
67529,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2000,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,56
68403,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2000,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,11
72734,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2000,9,Female,1,Percentage,18,Inter-Parliamentary Union,10.27
72968,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2000,28,Both sexes (male and female),1,Percentage,5,UNICEF,7.8
73525,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2000,28,Both sexes (male and female),1,Percentage,15,UNESCO,18
73545,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2000,9,Female,1,Percentage,15,UNESCO,15.15
73565,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2000,8,Male,1,Percentage,15,UNESCO,21.47
75348,1,AFRO Region,GDP growth (annual %),AFR0388,2000,999,Not Applicable,1,Percentage,22,UN DESA,0.44
75561,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2000,9,Female,1,Percentage,1,WHO/AFRO,26
90872,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.8
90907,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2000,9,Female,1,Percentage,3,WHO / GHO,28.7
90942,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2000,8,Male,1,Percentage,3,WHO / GHO,28.7
90974,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2000,28,Both sexes (male and female),1,Percentage,15,UNESCO,37.02
90997,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2000,9,Female,1,Percentage,15,UNESCO,35.57
91020,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2000,8,Male,1,Percentage,15,UNESCO,38.45
92029,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2000,28,Both sexes (male and female),1,Percentage,5,UNICEF,7.8
112761,1,AFRO Region,TB treatment coverage,AFR0173,2000,29,Total,1,Percentage,3,WHO / GHO,36
123497,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2000,28,Both sexes (male and female),1,Percentage,35,IHME,0.97
124937,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2000,8,Male,1,Percentage,35,IHME,1
126377,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2000,9,Female,1,Percentage,35,IHME,0.95
136441,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2000,29,Total,1,Percentage,36,WHO/UNICEF,52
147087,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2000,29,Total,1,Percentage,36,WHO/UNICEF,5
2317,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,46.19
2333,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.18
10104,1,AFRO Region,Life expectancy at birth (years),AFR0381,2000,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,50.8
10109,1,AFRO Region,Life expectancy at birth (years),AFR0381,2000,8,Male,2,Per 1000 live births,1,WHO/AFRO,49.6
10114,1,AFRO Region,Life expectancy at birth (years),AFR0381,2000,9,Female,2,Per 1000 live births,1,WHO/AFRO,52.1
10119,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2000,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,15
10124,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2000,8,Male,2,Per 1000 live births,1,WHO/AFRO,14.3
10129,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2000,9,Female,2,Per 1000 live births,1,WHO/AFRO,15.6
10134,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,44.4
10139,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2000,8,Male,2,Per 1000 live births,3,WHO / GHO,43.5
10144,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2000,9,Female,2,Per 1000 live births,3,WHO / GHO,45.3
10149,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,11
10154,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2000,8,Male,2,Per 1000 live births,3,WHO / GHO,10.5
10159,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2000,9,Female,2,Per 1000 live births,3,WHO / GHO,11.4
13772,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,40.9
15924,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,8.3
16164,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,8,Male,2,Per 1000 live births,3,WHO / GHO,10.8
16404,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,9,Female,2,Per 1000 live births,3,WHO / GHO,5.8
16644,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,8.3
18178,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,50.8
18183,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2000,8,Male,2,Per 1000 live births,3,WHO / GHO,49.6
18188,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2000,9,Female,2,Per 1000 live births,3,WHO / GHO,52.1
18290,1,AFRO Region,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,24.1
18521,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2000,9,Female,2,Per 1000 live births,3,WHO / GHO,283.48
18522,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2000,8,Male,2,Per 1000 live births,3,WHO / GHO,289.78
21272,1,AFRO Region,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,327.69
24826,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2000,9,Female,2,Per 1000 live births,3,WHO / GHO,26
32648,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2000,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,40.59
32886,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2000,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,8.84
37226,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2000,11,Rural,2,Per 1000 live births,3,WHO / GHO,21.3
37227,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2000,29,Total,2,Per 1000 live births,3,WHO / GHO,29.3
37228,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2000,12,Urban,2,Per 1000 live births,3,WHO / GHO,39.9
37439,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2000,11,Rural,2,Per 1000 live births,5,UNICEF,42.56
37440,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2000,29,Total,2,Per 1000 live births,5,UNICEF,31.71
37441,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2000,12,Urban,2,Per 1000 live births,5,UNICEF,11.63
38502,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2000,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.88
40614,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2000,999,Not Applicable,2,Per 1000 live births,19,OECD,4421.64
47111,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,0
47112,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,4038
47113,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,46,Measles,2,Per 1000 live births,1,WHO/AFRO,520102
47114,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,38713
47115,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,5175
47116,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,52008
47117,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,51,Polio,2,Per 1000 live births,1,WHO/AFRO,1863
47118,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,865
47119,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,5835
47120,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,593
47449,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2000,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,154
95319,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,154
82929,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2000,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,0
82930,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2000,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,4038
82931,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2000,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,520102
82932,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2000,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,38713
82933,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2000,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,5175
82934,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2000,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,52008
82935,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2000,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,1863
82936,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2000,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,865
82937,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2000,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,5835
82938,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2000,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,593
137870,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2000,29,Total,5,Count (Numeric Integer),35,IHME,1624312
144705,1,AFRO Region,Number of people living with HIV,AFR0019,2000,29,Total,5,Count (Numeric Integer),16,UNAIDS,17000000
47469,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2000,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,14.5
143092,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2000,29,Total,6,Per 1000 population,16,UNAIDS,3.09
144412,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2000,8,Male,6,Per 1000 population,16,UNAIDS,2.62
62229,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2000,9,Female,7,per 100 000 live births,23,MMEIG,857
120746,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2000,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,24.1
120986,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2000,8,Male,8,Per 100 000 population,3,WHO / GHO,24.1
121226,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2000,9,Female,8,Per 100 000 population,3,WHO / GHO,24.1
92929,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2000,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,4421.64
74742,1,AFRO Region,Gender development index score,AFR0347,2000,28,Both sexes (male and female),12,Index,14,UNDP,0.84
122222,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2000-2005,28,Both sexes (male and female),1,Percentage,17,UN Population,15.28
122510,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2000-2005,8,Male,1,Percentage,17,UN Population,14.37
122798,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2000-2005,9,Female,1,Percentage,17,UN Population,16.12
25695,1,AFRO Region,Adolescent birth rate [SDG 3.7.2],AFR0293,2000-2005,9,Female,2,Per 1000 live births,1,WHO/AFRO,120.9
70467,1,AFRO Region,Adolescent birth rate [SDG 3.7.2],AFR0293,2000-2005,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,120.9
11442,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2001,9,Female,1,Percentage,3,WHO / GHO,837
67575,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2001,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,56
68430,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2001,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,11
72735,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2001,9,Female,1,Percentage,18,Inter-Parliamentary Union,10.59
72969,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2001,28,Both sexes (male and female),1,Percentage,5,UNICEF,5.4
73571,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2001,28,Both sexes (male and female),1,Percentage,15,UNESCO,17.92
73577,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2001,9,Female,1,Percentage,15,UNESCO,14.31
73583,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2001,8,Male,1,Percentage,15,UNESCO,22.34
75349,1,AFRO Region,GDP growth (annual %),AFR0388,2001,999,Not Applicable,1,Percentage,22,UN DESA,2.74
75560,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2001,9,Female,1,Percentage,1,WHO/AFRO,21
90873,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.7
90908,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2001,9,Female,1,Percentage,3,WHO / GHO,28.6
90943,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2001,8,Male,1,Percentage,3,WHO / GHO,28.6
92030,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2001,28,Both sexes (male and female),1,Percentage,5,UNICEF,5.4
112798,1,AFRO Region,TB treatment coverage,AFR0173,2001,29,Total,1,Percentage,3,WHO / GHO,38
123545,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2001,28,Both sexes (male and female),1,Percentage,35,IHME,0.98
124985,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2001,8,Male,1,Percentage,35,IHME,1.01
126425,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2001,9,Female,1,Percentage,35,IHME,0.95
136488,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2001,29,Total,1,Percentage,36,WHO/UNICEF,52
147090,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2001,29,Total,1,Percentage,36,WHO/UNICEF,5
2318,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2001,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,46.1
2334,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.36
13773,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2001,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,40
18523,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2001,9,Female,2,Per 1000 live births,3,WHO / GHO,273.19
18524,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2001,8,Male,2,Per 1000 live births,3,WHO / GHO,276.91
24825,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2001,9,Female,2,Per 1000 live births,3,WHO / GHO,21
32649,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2001,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,43.75
32887,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2001,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,11.39
37229,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2001,11,Rural,2,Per 1000 live births,3,WHO / GHO,21.67
37230,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2001,29,Total,2,Per 1000 live births,3,WHO / GHO,29.78
37231,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2001,12,Urban,2,Per 1000 live births,3,WHO / GHO,40.33
37442,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2001,11,Rural,2,Per 1000 live births,5,UNICEF,41.98
37443,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2001,29,Total,2,Per 1000 live births,5,UNICEF,31.12
37444,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2001,12,Urban,2,Per 1000 live births,5,UNICEF,11.39
38503,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2001,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,1.19
40615,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2001,999,Not Applicable,2,Per 1000 live births,19,OECD,3464.35
46890,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,0
46891,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,2587
46892,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,46,Measles,2,Per 1000 live births,1,WHO/AFRO,491989
46893,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,15731
46894,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,5160
46895,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,50386
46896,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,51,Polio,2,Per 1000 live births,1,WHO/AFRO,70
46897,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,1572
46898,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,6482
46899,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,572
47450,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2001,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,148.7
95320,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2001,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,148.7
82708,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2001,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,0
82709,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2001,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,2587
82710,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2001,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,491989
82711,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2001,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,15731
82712,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2001,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,5160
82713,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2001,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,50386
82714,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2001,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,70
82715,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2001,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,1572
82716,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2001,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,6482
82717,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2001,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,572
137918,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2001,29,Total,5,Count (Numeric Integer),35,IHME,1675238
144751,1,AFRO Region,Number of people living with HIV,AFR0019,2001,29,Total,5,Count (Numeric Integer),16,UNAIDS,17600000
143136,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2001,29,Total,6,Per 1000 population,16,UNAIDS,2.94
144456,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2001,8,Male,6,Per 1000 population,16,UNAIDS,2.49
62230,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2001,9,Female,7,per 100 000 live births,23,MMEIG,837
92930,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2001,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,3464.35
11443,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2002,9,Female,1,Percentage,3,WHO / GHO,822
67621,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2002,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,57
68457,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2002,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,11
72736,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2002,9,Female,1,Percentage,18,Inter-Parliamentary Union,11.32
72970,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2002,28,Both sexes (male and female),1,Percentage,5,UNICEF,8.1
73588,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2002,28,Both sexes (male and female),1,Percentage,15,UNESCO,11
73593,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2002,9,Female,1,Percentage,15,UNESCO,9.52
73598,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2002,8,Male,1,Percentage,15,UNESCO,12.69
75350,1,AFRO Region,GDP growth (annual %),AFR0388,2002,999,Not Applicable,1,Percentage,22,UN DESA,2.02
90874,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.6
90909,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2002,9,Female,1,Percentage,3,WHO / GHO,28.6
90944,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2002,8,Male,1,Percentage,3,WHO / GHO,28.5
91021,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2002,28,Both sexes (male and female),1,Percentage,15,UNESCO,27.48
91022,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2002,9,Female,1,Percentage,15,UNESCO,25.27
91023,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2002,8,Male,1,Percentage,15,UNESCO,29.87
92031,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2002,28,Both sexes (male and female),1,Percentage,5,UNICEF,8.1
112840,1,AFRO Region,TB treatment coverage,AFR0173,2002,29,Total,1,Percentage,3,WHO / GHO,42
123593,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2002,28,Both sexes (male and female),1,Percentage,35,IHME,0.98
125033,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2002,8,Male,1,Percentage,35,IHME,1.01
126473,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2002,9,Female,1,Percentage,35,IHME,0.95
136535,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2002,29,Total,1,Percentage,36,WHO/UNICEF,54
147095,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2002,29,Total,1,Percentage,36,WHO/UNICEF,5
2319,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2002,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,44.67
2335,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.28
13774,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2002,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,39
18525,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2002,9,Female,2,Per 1000 live births,3,WHO / GHO,268.35
18526,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2002,8,Male,2,Per 1000 live births,3,WHO / GHO,274.7
32650,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2002,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,44.46
32888,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2002,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,9.28
37232,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2002,11,Rural,2,Per 1000 live births,3,WHO / GHO,22.05
37233,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2002,29,Total,2,Per 1000 live births,3,WHO / GHO,30.28
37234,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2002,12,Urban,2,Per 1000 live births,3,WHO / GHO,40.76
37445,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2002,11,Rural,2,Per 1000 live births,5,UNICEF,41.37
37446,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2002,29,Total,2,Per 1000 live births,5,UNICEF,30.48
37447,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2002,12,Urban,2,Per 1000 live births,5,UNICEF,11.15
38504,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2002,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,1.53
40616,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2002,999,Not Applicable,2,Per 1000 live births,19,OECD,2871.87
46613,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,0
46614,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,941
46615,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,46,Measles,2,Per 1000 live births,1,WHO/AFRO,288340
46616,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,18023
46617,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,4693
46618,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,19452
46619,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,51,Polio,2,Per 1000 live births,1,WHO/AFRO,212
46620,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,2265
46621,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,10872
46622,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,610
47451,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2002,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,143
95321,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2002,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,143
82431,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2002,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,0
82432,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2002,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,941
82433,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2002,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,288340
82434,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2002,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,18023
82435,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2002,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,4693
82436,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2002,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,19452
82437,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2002,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,212
82438,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2002,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,2265
82439,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2002,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,10872
82440,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2002,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,610
137966,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2002,29,Total,5,Count (Numeric Integer),35,IHME,1737070
144797,1,AFRO Region,Number of people living with HIV,AFR0019,2002,29,Total,5,Count (Numeric Integer),16,UNAIDS,18000000
143180,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2002,29,Total,6,Per 1000 population,16,UNAIDS,2.8
144500,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2002,8,Male,6,Per 1000 population,16,UNAIDS,2.36
62231,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2002,9,Female,7,per 100 000 live births,23,MMEIG,822
92931,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2002,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,2871.87
11444,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2003,9,Female,1,Percentage,3,WHO / GHO,801
67667,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2003,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,60
68484,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2003,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,11
72737,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2003,9,Female,1,Percentage,18,Inter-Parliamentary Union,12.42
72971,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2003,28,Both sexes (male and female),1,Percentage,5,UNICEF,5.7
73604,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2003,28,Both sexes (male and female),1,Percentage,15,UNESCO,27.98
73610,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2003,9,Female,1,Percentage,15,UNESCO,26.73
73616,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2003,8,Male,1,Percentage,15,UNESCO,29.74
75351,1,AFRO Region,GDP growth (annual %),AFR0388,2003,999,Not Applicable,1,Percentage,22,UN DESA,0.94
75559,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2003,9,Female,1,Percentage,1,WHO/AFRO,25
90875,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.6
90910,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2003,9,Female,1,Percentage,3,WHO / GHO,28.6
90945,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2003,8,Male,1,Percentage,3,WHO / GHO,28.4
91027,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2003,28,Both sexes (male and female),1,Percentage,15,UNESCO,55.18
91028,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2003,9,Female,1,Percentage,15,UNESCO,58.6
91029,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2003,8,Male,1,Percentage,15,UNESCO,52.15
92032,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2003,28,Both sexes (male and female),1,Percentage,5,UNICEF,5.7
112884,1,AFRO Region,TB treatment coverage,AFR0173,2003,29,Total,1,Percentage,3,WHO / GHO,43
123641,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2003,28,Both sexes (male and female),1,Percentage,35,IHME,0.98
125081,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2003,8,Male,1,Percentage,35,IHME,1.02
126521,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2003,9,Female,1,Percentage,35,IHME,0.95
136582,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2003,29,Total,1,Percentage,36,WHO/UNICEF,56
147101,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2003,29,Total,1,Percentage,36,WHO/UNICEF,5
2320,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2003,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,58.3
2336,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.57
13775,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2003,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,38
18527,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2003,9,Female,2,Per 1000 live births,3,WHO / GHO,263.41
18528,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2003,8,Male,2,Per 1000 live births,3,WHO / GHO,270.61
24824,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2003,9,Female,2,Per 1000 live births,3,WHO / GHO,25
32651,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2003,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,40.78
32889,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2003,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,10.49
37235,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2003,11,Rural,2,Per 1000 live births,3,WHO / GHO,22.42
37236,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2003,29,Total,2,Per 1000 live births,3,WHO / GHO,30.77
37237,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2003,12,Urban,2,Per 1000 live births,3,WHO / GHO,41.2
37448,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2003,11,Rural,2,Per 1000 live births,5,UNICEF,40.76
37449,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2003,29,Total,2,Per 1000 live births,5,UNICEF,29.85
37450,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2003,12,Urban,2,Per 1000 live births,5,UNICEF,10.9
38505,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2003,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,1.96
40617,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2003,999,Not Applicable,2,Per 1000 live births,19,OECD,2956.14
46334,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,9
46335,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,216
46336,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,46,Measles,2,Per 1000 live births,1,WHO/AFRO,403016
46337,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,11550
46338,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,2364
46339,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,16418
46340,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,51,Polio,2,Per 1000 live births,1,WHO/AFRO,446
46341,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,4835
46342,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,2017
46343,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,498
47452,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2003,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,137.1
95322,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2003,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,137.1
82152,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2003,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,9
82153,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2003,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,216
82154,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2003,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,403016
82155,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2003,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,11550
82156,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2003,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,2364
82157,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2003,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,16418
82158,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2003,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,446
82159,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2003,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,4835
82160,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2003,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,2017
82161,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2003,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,498
138014,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2003,29,Total,5,Count (Numeric Integer),35,IHME,1804147
144843,1,AFRO Region,Number of people living with HIV,AFR0019,2003,29,Total,5,Count (Numeric Integer),16,UNAIDS,18400000
143224,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2003,29,Total,6,Per 1000 population,16,UNAIDS,2.66
144544,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2003,8,Male,6,Per 1000 population,16,UNAIDS,2.24
62232,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2003,9,Female,7,per 100 000 live births,23,MMEIG,801
92932,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2003,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,2956.13
11445,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2004,9,Female,1,Percentage,3,WHO / GHO,771
67713,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2004,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,62
68511,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2004,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,13
72738,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2004,9,Female,1,Percentage,18,Inter-Parliamentary Union,13.41
72972,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2004,28,Both sexes (male and female),1,Percentage,5,UNICEF,8.3
73623,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2004,28,Both sexes (male and female),1,Percentage,15,UNESCO,14.72
73630,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2004,9,Female,1,Percentage,15,UNESCO,12.38
73637,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2004,8,Male,1,Percentage,15,UNESCO,17.54
75352,1,AFRO Region,GDP growth (annual %),AFR0388,2004,999,Not Applicable,1,Percentage,22,UN DESA,2.8
75558,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2004,9,Female,1,Percentage,1,WHO/AFRO,27.8
90876,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.5
90911,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2004,9,Female,1,Percentage,3,WHO / GHO,28.5
90946,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2004,8,Male,1,Percentage,3,WHO / GHO,28.3
91035,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2004,28,Both sexes (male and female),1,Percentage,15,UNESCO,37.19
91041,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2004,9,Female,1,Percentage,15,UNESCO,36.86
91047,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2004,8,Male,1,Percentage,15,UNESCO,37.8
92033,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2004,28,Both sexes (male and female),1,Percentage,5,UNICEF,8.3
112929,1,AFRO Region,TB treatment coverage,AFR0173,2004,29,Total,1,Percentage,3,WHO / GHO,45
123689,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2004,28,Both sexes (male and female),1,Percentage,35,IHME,0.99
125129,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2004,8,Male,1,Percentage,35,IHME,1.02
126569,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2004,9,Female,1,Percentage,35,IHME,0.95
136629,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2004,29,Total,1,Percentage,36,WHO/UNICEF,60
147107,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2004,29,Total,1,Percentage,36,WHO/UNICEF,5
2321,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2004,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,69.27
2337,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.75
13776,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2004,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,37
18529,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2004,9,Female,2,Per 1000 live births,3,WHO / GHO,256.8
18530,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2004,8,Male,2,Per 1000 live births,3,WHO / GHO,264.44
24823,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2004,9,Female,2,Per 1000 live births,3,WHO / GHO,27.8
32652,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2004,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,43.1
32890,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2004,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,7.95
37238,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2004,11,Rural,2,Per 1000 live births,3,WHO / GHO,22.8
37239,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2004,29,Total,2,Per 1000 live births,3,WHO / GHO,31.27
37240,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2004,12,Urban,2,Per 1000 live births,3,WHO / GHO,41.63
37451,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2004,11,Rural,2,Per 1000 live births,5,UNICEF,40.15
37452,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2004,29,Total,2,Per 1000 live births,5,UNICEF,29.22
37453,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2004,12,Urban,2,Per 1000 live births,5,UNICEF,10.65
38506,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2004,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,2.67
40618,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2004,999,Not Applicable,2,Per 1000 live births,19,OECD,3342.23
46050,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,4
46051,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,23
46052,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,46,Measles,2,Per 1000 live births,1,WHO/AFRO,220180
46053,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,19266
46054,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,2693
46055,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,26335
46056,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,51,Polio,2,Per 1000 live births,1,WHO/AFRO,934
46057,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,4452
46058,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,2417
46059,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,1253
47453,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2004,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,131.1
95323,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2004,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,131.1
81868,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2004,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,4
81869,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2004,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,23
81870,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2004,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,220180
81871,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2004,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,19266
81872,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2004,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,2693
81873,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2004,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,26335
81874,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2004,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,934
81875,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2004,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,4452
81876,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2004,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,2417
81877,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2004,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,1253
138062,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2004,29,Total,5,Count (Numeric Integer),35,IHME,1873919
144889,1,AFRO Region,Number of people living with HIV,AFR0019,2004,29,Total,5,Count (Numeric Integer),16,UNAIDS,18700000
143268,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2004,29,Total,6,Per 1000 population,16,UNAIDS,2.53
144588,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2004,8,Male,6,Per 1000 population,16,UNAIDS,2.14
62233,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2004,9,Female,7,per 100 000 live births,23,MMEIG,771
92933,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2004,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,3342.23
11446,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2005,9,Female,1,Percentage,3,WHO / GHO,735
67759,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2005,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,65
68538,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2005,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,12
72739,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2005,9,Female,1,Percentage,18,Inter-Parliamentary Union,13.82
72973,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2005,28,Both sexes (male and female),1,Percentage,5,UNICEF,6.3
73647,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2005,28,Both sexes (male and female),1,Percentage,15,UNESCO,20.37
73658,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2005,9,Female,1,Percentage,15,UNESCO,18.17
73669,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2005,8,Male,1,Percentage,15,UNESCO,22.89
75353,1,AFRO Region,GDP growth (annual %),AFR0388,2005,999,Not Applicable,1,Percentage,22,UN DESA,2.62
75557,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2005,9,Female,1,Percentage,1,WHO/AFRO,22.1
90877,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.4
90912,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2005,9,Female,1,Percentage,3,WHO / GHO,28.5
90947,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2005,8,Male,1,Percentage,3,WHO / GHO,28.2
91054,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2005,28,Both sexes (male and female),1,Percentage,15,UNESCO,29.95
91061,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2005,9,Female,1,Percentage,15,UNESCO,27.57
91068,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2005,8,Male,1,Percentage,15,UNESCO,32.15
92034,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2005,28,Both sexes (male and female),1,Percentage,5,UNICEF,6.3
112975,1,AFRO Region,TB treatment coverage,AFR0173,2005,29,Total,1,Percentage,3,WHO / GHO,45
123737,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2005,28,Both sexes (male and female),1,Percentage,35,IHME,0.99
125177,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2005,8,Male,1,Percentage,35,IHME,1.02
126617,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2005,9,Female,1,Percentage,35,IHME,0.96
136676,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2005,29,Total,1,Percentage,36,WHO/UNICEF,63
147114,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2005,29,Total,1,Percentage,36,WHO/UNICEF,4
2322,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2005,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,74.84
2338,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.8
10103,1,AFRO Region,Life expectancy at birth (years),AFR0381,2005,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,53.4
10108,1,AFRO Region,Life expectancy at birth (years),AFR0381,2005,8,Male,2,Per 1000 live births,1,WHO/AFRO,52.3
10113,1,AFRO Region,Life expectancy at birth (years),AFR0381,2005,9,Female,2,Per 1000 live births,1,WHO/AFRO,54.4
10118,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2005,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,15.4
10123,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2005,8,Male,2,Per 1000 live births,1,WHO/AFRO,14.7
10128,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2005,9,Female,2,Per 1000 live births,1,WHO/AFRO,16.1
10133,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,46.7
10138,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2005,8,Male,2,Per 1000 live births,3,WHO / GHO,46
10143,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2005,9,Female,2,Per 1000 live births,3,WHO / GHO,47.4
10148,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,11.4
10153,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2005,8,Male,2,Per 1000 live births,3,WHO / GHO,10.9
10158,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2005,9,Female,2,Per 1000 live births,3,WHO / GHO,11.8
13777,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,36
15972,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2005,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,7.9
16212,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2005,8,Male,2,Per 1000 live births,3,WHO / GHO,10.4
16452,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2005,9,Female,2,Per 1000 live births,3,WHO / GHO,5.4
16692,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,7.9
18177,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,53.4
18182,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2005,8,Male,2,Per 1000 live births,3,WHO / GHO,52.3
18187,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2005,9,Female,2,Per 1000 live births,3,WHO / GHO,54.4
18289,1,AFRO Region,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,22.8
18531,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2005,9,Female,2,Per 1000 live births,3,WHO / GHO,249.21
18532,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2005,8,Male,2,Per 1000 live births,3,WHO / GHO,257.62
21227,1,AFRO Region,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,323.47
24822,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2005,9,Female,2,Per 1000 live births,3,WHO / GHO,22.1
32653,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2005,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,41.17
32891,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2005,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,8.7
37241,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2005,11,Rural,2,Per 1000 live births,3,WHO / GHO,23.18
37242,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2005,29,Total,2,Per 1000 live births,3,WHO / GHO,31.76
37243,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2005,12,Urban,2,Per 1000 live births,3,WHO / GHO,42.06
37454,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2005,11,Rural,2,Per 1000 live births,5,UNICEF,39.55
37455,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2005,29,Total,2,Per 1000 live births,5,UNICEF,28.59
37456,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2005,12,Urban,2,Per 1000 live births,5,UNICEF,10.4
38507,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2005,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,3.12
40619,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2005,999,Not Applicable,2,Per 1000 live births,19,OECD,3592.63
45770,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,3
45771,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,54
45772,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,46,Measles,2,Per 1000 live births,1,WHO/AFRO,316219
45773,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,18215
45774,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,4415
45775,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,22139
45776,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,51,Polio,2,Per 1000 live births,1,WHO/AFRO,885
45777,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,2868
45778,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,2861
45779,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,474
47454,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2005,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,125.1
95324,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,125.1
81588,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2005,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,3
81589,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2005,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,54
81590,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2005,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,316219
81591,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2005,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,18215
81592,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2005,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,4415
81593,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2005,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,22139
81594,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2005,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,885
81595,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2005,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,2868
81596,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2005,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,2861
81597,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2005,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,474
138110,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2005,29,Total,5,Count (Numeric Integer),35,IHME,1944366
144935,1,AFRO Region,Number of people living with HIV,AFR0019,2005,29,Total,5,Count (Numeric Integer),16,UNAIDS,19000000
47470,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2005,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,12.2
143312,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2005,29,Total,6,Per 1000 population,16,UNAIDS,2.41
144632,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2005,8,Male,6,Per 1000 population,16,UNAIDS,2.03
62234,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2005,9,Female,7,per 100 000 live births,23,MMEIG,735
120794,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2005,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,22.8
121034,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2005,8,Male,8,Per 100 000 population,3,WHO / GHO,22.9
121274,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2005,9,Female,8,Per 100 000 population,3,WHO / GHO,22.8
92934,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2005,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,3592.62
74783,1,AFRO Region,Gender development index score,AFR0347,2005,28,Both sexes (male and female),12,Index,14,UNDP,0.85
122270,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2005-2010,28,Both sexes (male and female),1,Percentage,17,UN Population,15.8
122558,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2005-2010,8,Male,1,Percentage,17,UN Population,14.9
122846,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2005-2010,9,Female,1,Percentage,17,UN Population,16.62
25694,1,AFRO Region,Adolescent birth rate [SDG 3.7.2],AFR0293,2005-2010,9,Female,2,Per 1000 live births,1,WHO/AFRO,115.6
70466,1,AFRO Region,Adolescent birth rate [SDG 3.7.2],AFR0293,2005-2010,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,115.6
11447,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2006,9,Female,1,Percentage,3,WHO / GHO,701
67805,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2006,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,67
68565,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2006,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,12
72740,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2006,9,Female,1,Percentage,18,Inter-Parliamentary Union,15.5
72974,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2006,28,Both sexes (male and female),1,Percentage,5,UNICEF,8.5
73684,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2006,28,Both sexes (male and female),1,Percentage,15,UNESCO,23.12
73699,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2006,9,Female,1,Percentage,15,UNESCO,19.42
73714,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2006,8,Male,1,Percentage,15,UNESCO,27.34
75354,1,AFRO Region,GDP growth (annual %),AFR0388,2006,999,Not Applicable,1,Percentage,22,UN DESA,3.06
75556,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2006,9,Female,1,Percentage,1,WHO/AFRO,24.1
90878,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.3
90913,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2006,9,Female,1,Percentage,3,WHO / GHO,28.4
90948,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2006,8,Male,1,Percentage,3,WHO / GHO,28
91077,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2006,28,Both sexes (male and female),1,Percentage,15,UNESCO,41.74
91086,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2006,9,Female,1,Percentage,15,UNESCO,39.92
91095,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2006,8,Male,1,Percentage,15,UNESCO,43.58
92035,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2006,28,Both sexes (male and female),1,Percentage,5,UNICEF,8.5
113019,1,AFRO Region,TB treatment coverage,AFR0173,2006,29,Total,1,Percentage,3,WHO / GHO,46
123785,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2006,28,Both sexes (male and female),1,Percentage,35,IHME,0.99
125225,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2006,8,Male,1,Percentage,35,IHME,1.03
126665,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2006,9,Female,1,Percentage,35,IHME,0.96
136723,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2006,29,Total,1,Percentage,36,WHO/UNICEF,65
147121,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2006,29,Total,1,Percentage,36,WHO/UNICEF,5
2323,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2006,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,81.53
2339,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.76
13778,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2006,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,35
18533,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2006,9,Female,2,Per 1000 live births,3,WHO / GHO,242.67
18534,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2006,8,Male,2,Per 1000 live births,3,WHO / GHO,252.31
24821,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2006,9,Female,2,Per 1000 live births,3,WHO / GHO,24.1
32654,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2006,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,36.78
32892,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2006,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,9.67
37244,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2006,11,Rural,2,Per 1000 live births,3,WHO / GHO,23.56
37245,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2006,29,Total,2,Per 1000 live births,3,WHO / GHO,32.26
37246,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2006,12,Urban,2,Per 1000 live births,3,WHO / GHO,42.5
37457,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2006,11,Rural,2,Per 1000 live births,5,UNICEF,38.94
37458,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2006,29,Total,2,Per 1000 live births,5,UNICEF,27.96
37459,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2006,12,Urban,2,Per 1000 live births,5,UNICEF,10.15
38508,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2006,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,3.84
40620,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2006,999,Not Applicable,2,Per 1000 live births,19,OECD,3642.7
45456,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,8
45457,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,351
45458,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,7
45459,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,46,Measles,2,Per 1000 live births,1,WHO/AFRO,99420
45460,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,9303
45461,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,3468
45462,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,18399
45463,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,51,Polio,2,Per 1000 live births,1,WHO/AFRO,1213
45464,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,2457
45465,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,5825
45466,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,272
47455,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2006,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,119.4
95325,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2006,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,119.4
81274,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2006,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,8
81275,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2006,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,351
81276,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2006,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,7
81277,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2006,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,99420
81278,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2006,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,9303
81279,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2006,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,3468
81280,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2006,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,18399
81281,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2006,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,1213
81282,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2006,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,2457
81283,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2006,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,5825
81284,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2006,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,272
138158,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2006,29,Total,5,Count (Numeric Integer),35,IHME,2017457
144981,1,AFRO Region,Number of people living with HIV,AFR0019,2006,29,Total,5,Count (Numeric Integer),16,UNAIDS,19300000
143356,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2006,29,Total,6,Per 1000 population,16,UNAIDS,2.3
144676,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2006,8,Male,6,Per 1000 population,16,UNAIDS,1.94
62235,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2006,9,Female,7,per 100 000 live births,23,MMEIG,701
92935,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2006,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,3642.7
11448,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2007,9,Female,1,Percentage,3,WHO / GHO,673
67851,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2007,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,70
68592,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2007,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,12
72741,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2007,9,Female,1,Percentage,18,Inter-Parliamentary Union,15.64
72975,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2007,28,Both sexes (male and female),1,Percentage,5,UNICEF,6.8
73722,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2007,28,Both sexes (male and female),1,Percentage,15,UNESCO,31.51
73730,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2007,9,Female,1,Percentage,15,UNESCO,30.28
73738,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2007,8,Male,1,Percentage,15,UNESCO,32.88
75355,1,AFRO Region,GDP growth (annual %),AFR0388,2007,999,Not Applicable,1,Percentage,22,UN DESA,3.42
75555,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2007,9,Female,1,Percentage,1,WHO/AFRO,20
90879,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.3
90914,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2007,9,Female,1,Percentage,3,WHO / GHO,28.4
90949,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2007,8,Male,1,Percentage,3,WHO / GHO,27.9
91098,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2007,28,Both sexes (male and female),1,Percentage,15,UNESCO,53.84
91101,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2007,9,Female,1,Percentage,15,UNESCO,55.05
91104,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2007,8,Male,1,Percentage,15,UNESCO,50.23
92036,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2007,28,Both sexes (male and female),1,Percentage,5,UNICEF,6.8
113060,1,AFRO Region,TB treatment coverage,AFR0173,2007,29,Total,1,Percentage,3,WHO / GHO,46
123833,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2007,28,Both sexes (male and female),1,Percentage,35,IHME,0.99
125273,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2007,8,Male,1,Percentage,35,IHME,1.03
126713,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2007,9,Female,1,Percentage,35,IHME,0.96
136770,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2007,29,Total,1,Percentage,36,WHO/UNICEF,67
147128,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2007,29,Total,1,Percentage,36,WHO/UNICEF,4
2324,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2007,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,88.68
2340,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.77
13779,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2007,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,34.1
18535,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2007,9,Female,2,Per 1000 live births,3,WHO / GHO,236.99
18536,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2007,8,Male,2,Per 1000 live births,3,WHO / GHO,247.18
24820,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2007,9,Female,2,Per 1000 live births,3,WHO / GHO,20
32426,1,AFRO Region,Coverage (%) - All Social Assistance,AFR0153,2007,999,Not Applicable,2,Per 1000 live births,4,WB Database,24.96
32655,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2007,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,37.41
32893,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2007,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,9.61
37247,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2007,11,Rural,2,Per 1000 live births,3,WHO / GHO,23.94
37248,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2007,29,Total,2,Per 1000 live births,3,WHO / GHO,32.76
37249,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2007,12,Urban,2,Per 1000 live births,3,WHO / GHO,42.93
37460,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2007,11,Rural,2,Per 1000 live births,5,UNICEF,38.33
37461,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2007,29,Total,2,Per 1000 live births,5,UNICEF,27.34
37462,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2007,12,Urban,2,Per 1000 live births,5,UNICEF,9.9
38509,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2007,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,4.26
40621,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2007,999,Not Applicable,2,Per 1000 live births,19,OECD,4199.48
45127,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,1
45128,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,17
45129,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
45130,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,46,Measles,2,Per 1000 live births,1,WHO/AFRO,76410
45131,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,9097
45132,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,1346
45133,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,21197
45134,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,51,Polio,2,Per 1000 live births,1,WHO/AFRO,438
45135,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,3993
45136,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,5157
45137,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,212
47456,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2007,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,113.8
95326,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2007,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,113.8
80945,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2007,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,1
80946,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2007,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,17
80947,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2007,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
80948,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2007,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,76410
80949,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2007,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,9097
80950,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2007,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,1346
80951,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2007,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,21197
80952,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2007,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,438
80953,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2007,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,3993
80954,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2007,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,5157
80955,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2007,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,212
138206,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2007,29,Total,5,Count (Numeric Integer),35,IHME,2087886
145027,1,AFRO Region,Number of people living with HIV,AFR0019,2007,29,Total,5,Count (Numeric Integer),16,UNAIDS,19700000
143400,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2007,29,Total,6,Per 1000 population,16,UNAIDS,2.18
62236,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2007,9,Female,7,per 100 000 live births,23,MMEIG,673
92936,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2007,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,4199.48
11449,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2008,9,Female,1,Percentage,3,WHO / GHO,653
67897,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2008,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,72
68619,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2008,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,10
68916,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2008,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,0
72742,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2008,9,Female,1,Percentage,18,Inter-Parliamentary Union,16.31
72976,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2008,28,Both sexes (male and female),1,Percentage,5,UNICEF,7.5
73745,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2008,28,Both sexes (male and female),1,Percentage,15,UNESCO,30.1
73752,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2008,9,Female,1,Percentage,15,UNESCO,27.24
73759,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2008,8,Male,1,Percentage,15,UNESCO,33.29
75356,1,AFRO Region,GDP growth (annual %),AFR0388,2008,999,Not Applicable,1,Percentage,22,UN DESA,2.42
75554,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2008,9,Female,1,Percentage,1,WHO/AFRO,27.5
90880,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.2
90915,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2008,9,Female,1,Percentage,3,WHO / GHO,28.3
90950,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2008,8,Male,1,Percentage,3,WHO / GHO,27.8
91108,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2008,28,Both sexes (male and female),1,Percentage,15,UNESCO,58.66
91112,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2008,9,Female,1,Percentage,15,UNESCO,60.27
91116,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2008,8,Male,1,Percentage,15,UNESCO,56.94
92037,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2008,28,Both sexes (male and female),1,Percentage,5,UNICEF,7.5
113104,1,AFRO Region,TB treatment coverage,AFR0173,2008,29,Total,1,Percentage,3,WHO / GHO,49
123881,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2008,28,Both sexes (male and female),1,Percentage,35,IHME,0.99
125321,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2008,8,Male,1,Percentage,35,IHME,1.03
126761,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2008,9,Female,1,Percentage,35,IHME,0.96
136817,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2008,29,Total,1,Percentage,36,WHO/UNICEF,70
147135,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2008,29,Total,1,Percentage,36,WHO/UNICEF,4
2325,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2008,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,95.5
2341,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.56
13780,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2008,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,33.2
18537,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2008,9,Female,2,Per 1000 live births,3,WHO / GHO,232.81
18538,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2008,8,Male,2,Per 1000 live births,3,WHO / GHO,243.82
24819,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2008,9,Female,2,Per 1000 live births,3,WHO / GHO,27.5
32427,1,AFRO Region,Coverage (%) - All Social Assistance,AFR0153,2008,999,Not Applicable,2,Per 1000 live births,4,WB Database,18.55
32656,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2008,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,34.26
32894,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2008,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,7.95
37250,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2008,11,Rural,2,Per 1000 live births,3,WHO / GHO,24.32
37251,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2008,29,Total,2,Per 1000 live births,3,WHO / GHO,33.26
37252,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2008,12,Urban,2,Per 1000 live births,3,WHO / GHO,43.37
37463,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2008,11,Rural,2,Per 1000 live births,5,UNICEF,37.72
37464,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2008,29,Total,2,Per 1000 live births,5,UNICEF,26.71
37465,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2008,12,Urban,2,Per 1000 live births,5,UNICEF,9.65
38510,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2008,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,5.06
40622,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2008,999,Not Applicable,2,Per 1000 live births,19,OECD,4532.96
44802,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,0
44803,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,72
44804,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
44805,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,46,Measles,2,Per 1000 live births,1,WHO/AFRO,37012
44806,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,16944
44807,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,2182
44808,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,19429
44809,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,51,Polio,2,Per 1000 live births,1,WHO/AFRO,996
44810,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,16297
44811,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,5505
44812,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,270
47457,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2008,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,108.4
95327,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2008,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,108.4
80620,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2008,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,0
80621,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2008,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,72
80622,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2008,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
80623,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2008,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,37012
80624,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2008,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,16944
80625,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2008,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,2182
80626,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2008,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,19429
80627,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2008,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,996
80628,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2008,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,16297
80629,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2008,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,5505
80630,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2008,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,270
138254,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2008,29,Total,5,Count (Numeric Integer),35,IHME,2166062
145073,1,AFRO Region,Number of people living with HIV,AFR0019,2008,29,Total,5,Count (Numeric Integer),16,UNAIDS,20200000
102364,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2008,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,11.91
143444,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2008,29,Total,6,Per 1000 population,16,UNAIDS,2.06
62237,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2008,9,Female,7,per 100 000 live births,23,MMEIG,653
92937,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2008,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,4532.95
11450,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2009,9,Female,1,Percentage,3,WHO / GHO,634
67943,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2009,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,75
68646,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2009,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,11
68957,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2009,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,0
72743,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2009,9,Female,1,Percentage,18,Inter-Parliamentary Union,16.72
72977,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2009,28,Both sexes (male and female),1,Percentage,5,UNICEF,4.7
73767,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2009,28,Both sexes (male and female),1,Percentage,15,UNESCO,36
73774,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2009,9,Female,1,Percentage,15,UNESCO,36.7
73782,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2009,8,Male,1,Percentage,15,UNESCO,35.4
75357,1,AFRO Region,GDP growth (annual %),AFR0388,2009,999,Not Applicable,1,Percentage,22,UN DESA,1.98
75553,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2009,9,Female,1,Percentage,1,WHO/AFRO,42
90881,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.1
90916,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2009,9,Female,1,Percentage,3,WHO / GHO,28.2
90951,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2009,8,Male,1,Percentage,3,WHO / GHO,27.7
91120,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2009,28,Both sexes (male and female),1,Percentage,15,UNESCO,55.16
91124,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2009,9,Female,1,Percentage,15,UNESCO,59.6
92038,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2009,28,Both sexes (male and female),1,Percentage,5,UNICEF,4.7
113150,1,AFRO Region,TB treatment coverage,AFR0173,2009,29,Total,1,Percentage,3,WHO / GHO,50
123929,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2009,28,Both sexes (male and female),1,Percentage,35,IHME,1
125369,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2009,8,Male,1,Percentage,35,IHME,1.04
126809,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2009,9,Female,1,Percentage,35,IHME,0.96
136864,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2009,29,Total,1,Percentage,36,WHO/UNICEF,73
147142,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2009,29,Total,1,Percentage,36,WHO/UNICEF,5
2326,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2009,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,94.15
2342,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.77
13781,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2009,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,32.3
18539,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2009,9,Female,2,Per 1000 live births,3,WHO / GHO,228.6
18540,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2009,8,Male,2,Per 1000 live births,3,WHO / GHO,240.33
24818,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2009,9,Female,2,Per 1000 live births,3,WHO / GHO,42
32428,1,AFRO Region,Coverage (%) - All Social Assistance,AFR0153,2009,999,Not Applicable,2,Per 1000 live births,4,WB Database,30.66
32657,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2009,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,42.63
32895,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2009,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,4.47
37253,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2009,11,Rural,2,Per 1000 live births,3,WHO / GHO,24.7
37254,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2009,29,Total,2,Per 1000 live births,3,WHO / GHO,33.76
37255,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2009,12,Urban,2,Per 1000 live births,3,WHO / GHO,43.8
37466,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2009,11,Rural,2,Per 1000 live births,5,UNICEF,37.11
37467,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2009,29,Total,2,Per 1000 live births,5,UNICEF,26.08
37468,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2009,12,Urban,2,Per 1000 live births,5,UNICEF,9.41
38511,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2009,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,5.07
40623,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2009,999,Not Applicable,2,Per 1000 live births,19,OECD,5568.82
44476,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,47
44477,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,10
44478,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
44479,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,46,Measles,2,Per 1000 live births,1,WHO/AFRO,83479
44480,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,1698
44481,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,1517
44482,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,15768
44483,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,51,Polio,2,Per 1000 live births,1,WHO/AFRO,855
44484,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,17422
44485,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,4607
44486,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,76
47458,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2009,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,103.4
95328,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2009,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,103.4
80294,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2009,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,47
80295,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2009,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,10
80296,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2009,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
80297,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2009,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,83479
80298,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2009,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,1698
80299,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2009,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,1517
80300,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2009,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,15768
80301,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2009,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,855
80302,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2009,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,17422
80303,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2009,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,4607
80304,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2009,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,76
138302,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2009,29,Total,5,Count (Numeric Integer),35,IHME,2254961
145119,1,AFRO Region,Number of people living with HIV,AFR0019,2009,29,Total,5,Count (Numeric Integer),16,UNAIDS,20700000
102365,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2009,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,11.45
143488,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2009,29,Total,6,Per 1000 population,16,UNAIDS,1.94
62238,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2009,9,Female,7,per 100 000 live births,23,MMEIG,634
92938,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2009,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,5568.81
10990,1,AFRO Region,Number of people living with HIV,AFR0019,2010,28,Both sexes (male and female),1,Percentage,16,UNAIDS,22914800
11451,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2010,9,Female,1,Percentage,3,WHO / GHO,615
67989,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2010,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,74
68673,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2010,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,10
68998,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2010,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,3
72744,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2010,9,Female,1,Percentage,18,Inter-Parliamentary Union,17.35
72978,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2010,28,Both sexes (male and female),1,Percentage,5,UNICEF,4.5
73457,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,84
73801,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2010,28,Both sexes (male and female),1,Percentage,15,UNESCO,30.28
73820,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2010,9,Female,1,Percentage,15,UNESCO,27.4
73839,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2010,8,Male,1,Percentage,15,UNESCO,33.64
74234,1,AFRO Region,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2010,999,Not Applicable,1,Percentage,3,WHO / GHO,40
75197,1,AFRO Region,"Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting, by age (%)",AFR0103,2010,9,Female,1,Percentage,5,UNICEF,61
75225,1,AFRO Region,Prevalence of female genital mutilation/cutting [SDG 5.3.2],AFR0298,2010,9,Female,1,Percentage,5,UNICEF,61
75358,1,AFRO Region,GDP growth (annual %),AFR0388,2010,999,Not Applicable,1,Percentage,22,UN DESA,3.45
75552,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2010,9,Female,1,Percentage,1,WHO/AFRO,26.5
76074,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,94.6
86008,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,51
91134,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2010,28,Both sexes (male and female),1,Percentage,15,UNESCO,44.92
91144,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2010,9,Female,1,Percentage,15,UNESCO,42.83
91154,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2010,8,Male,1,Percentage,15,UNESCO,47.11
91442,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,85
91482,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,94
91913,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,85
92039,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2010,28,Both sexes (male and female),1,Percentage,5,UNICEF,4.5
95742,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,85
96001,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,48
112339,1,AFRO Region,Pneumococcal vaccination coverage,AFR0186,2010,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,3
113195,1,AFRO Region,TB treatment coverage,AFR0173,2010,29,Total,1,Percentage,3,WHO / GHO,50
123977,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2010,28,Both sexes (male and female),1,Percentage,35,IHME,1
125417,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2010,8,Male,1,Percentage,35,IHME,1.04
126857,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2010,9,Female,1,Percentage,35,IHME,0.96
136911,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2010,29,Total,1,Percentage,36,WHO/UNICEF,71
147049,1,AFRO Region,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",AFR0442,2010,29,Total,1,Percentage,13,UNStat,0
147149,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2010,29,Total,1,Percentage,36,WHO/UNICEF,4
147341,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2010,29,Total,1,Percentage,36,WHO/UNICEF,3
148162,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2010,107,Female (10-14 years),1,Percentage,35,IHME,46.05
150904,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2010,66,Female (15-49 years),1,Percentage,35,IHME,26.66
207897,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2010,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,73
2327,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2010,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,107.2
2343,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.86
6277,1,AFRO Region,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,324
10102,1,AFRO Region,Life expectancy at birth (years),AFR0381,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,57.6
10107,1,AFRO Region,Life expectancy at birth (years),AFR0381,2010,8,Male,2,Per 1000 live births,1,WHO/AFRO,56.4
10112,1,AFRO Region,Life expectancy at birth (years),AFR0381,2010,9,Female,2,Per 1000 live births,1,WHO/AFRO,58.8
10117,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,16.1
10122,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2010,8,Male,2,Per 1000 live births,1,WHO/AFRO,15.4
10127,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2010,9,Female,2,Per 1000 live births,1,WHO/AFRO,16.7
10132,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,50.4
10137,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,49.6
10142,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,51.3
10147,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,12
10152,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,11.5
10157,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,12.4
11004,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,356
11056,1,AFRO Region,Population size (in thousands) total,AFR0004,2010,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,858892.99
13782,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,31.5
16020,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2010,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,7.6
16260,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,9.9
16500,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,5.3
16740,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,7.6
18176,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,57.6
18181,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,56.4
18186,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,58.8
18284,1,AFRO Region,TB mortality rate (per 100 000 population),AFR0013,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,44
18288,1,AFRO Region,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,21.4
18541,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,223.42
18542,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,235
20248,1,AFRO Region,HIV incidence rate per 1000 uninfected population [SDG 3.3.1],AFR0395,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.77
20814,1,AFRO Region,TB incidence rate [SDG 3.3.2],AFR0334,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,312.16
21182,1,AFRO Region,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,275.13
22150,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,28
22156,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,28.2
22162,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,27.5
23291,1,AFRO Region,Anaemia prevalence in children,AFR0300,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,62.9
24817,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,26.5
25249,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,94.6
25423,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,51
26899,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,84
27660,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,85
28091,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,94
32429,1,AFRO Region,Coverage (%) - All Social Assistance,AFR0153,2010,999,Not Applicable,2,Per 1000 live births,4,WB Database,16.39
32658,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2010,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,39.51
32896,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2010,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,7.38
37256,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2010,11,Rural,2,Per 1000 live births,3,WHO / GHO,25.08
37257,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2010,29,Total,2,Per 1000 live births,3,WHO / GHO,34.26
37258,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2010,12,Urban,2,Per 1000 live births,3,WHO / GHO,44.23
37469,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2010,11,Rural,2,Per 1000 live births,5,UNICEF,36.5
37470,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2010,29,Total,2,Per 1000 live births,5,UNICEF,25.46
37471,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2010,12,Urban,2,Per 1000 live births,5,UNICEF,9.16
38512,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2010,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,7.52
39577,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2010,8,Male,2,Per 1000 live births,20,ITU,17.27
39586,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2010,9,Female,2,Per 1000 live births,20,ITU,3.48
39703,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2010,28,Both sexes (male and female),2,Per 1000 live births,21,ILO,23.56
39713,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2010,8,Male,2,Per 1000 live births,21,ILO,23.97
39723,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2010,9,Female,2,Per 1000 live births,21,ILO,23.04
40624,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2010,999,Not Applicable,2,Per 1000 live births,19,OECD,4664.41
41103,1,AFRO Region,DTP dropout rate (DTP1 -DPT3),AFR0226,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,8.4
44155,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,16
44156,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,50
44157,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
44158,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,46,Measles,2,Per 1000 live births,1,WHO/AFRO,199174
44159,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,13836
44160,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,1937
44161,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,4929
44162,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,51,Polio,2,Per 1000 live births,1,WHO/AFRO,709
44163,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,2754
44164,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,4311
44165,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,714
47459,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2010,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,98.6
95329,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,98.6
118683,1,AFRO Region,Top 10 Causes of death,AFR0431,2010,999,Not Applicable,3,String,3,WHO / GHO,\N
79973,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2010,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,16
79974,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2010,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,50
79975,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2010,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
79976,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2010,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,199174
79977,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2010,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,13836
79978,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2010,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,1937
79979,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2010,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,4929
79980,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2010,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,709
79981,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2010,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,2754
79982,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2010,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,4311
79983,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2010,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,714
138350,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2010,29,Total,5,Count (Numeric Integer),35,IHME,2345580
145165,1,AFRO Region,Number of people living with HIV,AFR0019,2010,29,Total,5,Count (Numeric Integer),16,UNAIDS,21300000
47471,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2010,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,10.1
103025,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2010,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,11.01
143532,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2010,29,Total,6,Per 1000 population,16,UNAIDS,1.83
62239,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2010,9,Female,7,per 100 000 live births,23,MMEIG,615
47518,1,AFRO Region,AIDS-related mortality rate (per 100 000 population),AFR0014,2010,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,89.66
74193,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2010,8,Male,8,Per 100 000 population,13,UNStat,17.27
74202,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2010,9,Female,8,Per 100 000 population,13,UNStat,3.48
120842,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2010,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,21.4
121082,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2010,8,Male,8,Per 100 000 population,3,WHO / GHO,21.8
121322,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2010,9,Female,8,Per 100 000 population,3,WHO / GHO,21.1
92939,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2010,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,4664.4
74825,1,AFRO Region,Gender development index score,AFR0347,2010,28,Both sexes (male and female),12,Index,14,UNDP,0.87
122318,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2010-2015,28,Both sexes (male and female),1,Percentage,17,UN Population,16.39
122606,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2010-2015,8,Male,1,Percentage,17,UN Population,15.52
122894,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2010-2015,9,Female,1,Percentage,17,UN Population,17.19
25693,1,AFRO Region,Adolescent birth rate [SDG 3.7.2],AFR0293,2010-2015,9,Female,2,Per 1000 live births,1,WHO/AFRO,110
70465,1,AFRO Region,Adolescent birth rate [SDG 3.7.2],AFR0293,2010-2015,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,110
135512,1,AFRO Region,"Proportion of ever-partnered women and girls subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months, by age (%)",AFR0101,2010-2017,9,Female,1,Percentage,3,WHO / GHO,\N
130091,1,AFRO Region,Proportion of population with large household expenditures on health (greater than 10%) as a share of total household expenditure or income (%),AFR0107,2010-2018,999,Not Applicable,1,Percentage,3,WHO / GHO,7.3
130139,1,AFRO Region,Proportion of the population with large household expenditure on health as a share of total household consumption or income [SDG 3.8.2],AFR0052,2010-2018,999,Not Applicable,1,Percentage,3,WHO / GHO,1.8
22768,1,AFRO Region,Prevalence of exclusive breastfeeding in infants aged six months or less (Exclusive BF),AFR0306,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,45.7
22814,1,AFRO Region,Early initiation of breastfeeding (%),AFR0305,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,52.9
22862,1,AFRO Region,Children under 5 years who are stunted [SDG 2.2.1],AFR0303,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,33.1
22909,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,3.5
22955,1,AFRO Region,Incidence of low birth weight among newborns,AFR0304,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,11.7
130555,1,AFRO Region,Nursing and midwifery personnel density (per 1000 population),AFR0286,2010-2018,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,1.01
129995,1,AFRO Region,"Adolescent birth rate (per 1,000 women aged 15-19 years)",AFR0106,2010-2018,28,Both sexes (male and female),9,Per 1000 women aged 15-19 years,3,WHO / GHO,102.1
130507,1,AFRO Region,Density of medical doctors (per 10 000 population),AFR0434,2010-2018,28,Both sexes (male and female),13,Per 10 000 population,3,WHO / GHO,3
135267,1,AFRO Region,"Pharmacists (per 10,000 population)",AFR0253,2010-2018,28,Both sexes (male and female),13,Per 10 000 population,3,WHO / GHO,\N
75606,1,AFRO Region,Completeness of birth registration (%),AFR0245,2010-2019,28,Both sexes (male and female),1,Percentage,13,UNStat,59.8
75651,1,AFRO Region,Civil registration coverage of births (%),AFR0062,2010-2019,28,Both sexes (male and female),1,Percentage,13,UNStat,59.8
129842,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010-2019,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,\N
129947,1,AFRO Region,Proportion of women married or in a union of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (% of women aged 15-49 years),AFR0105,2010-2019,9,Female,1,Percentage,3,WHO / GHO,56.5
130459,1,AFRO Region,Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis [SDG 3.b.3],AFR0399,2010-2019,999,Not Applicable,1,Percentage,3,WHO / GHO,\N
135320,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2010-2019,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.4
135368,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2010-2019,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.1
135416,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2010-2019,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,32.5
135257,1,AFRO Region,Density of dentists (per 10 000 population ),AFR0435,2010-2019,28,Both sexes (male and female),13,Per 10 000 population,3,WHO / GHO,\N
10991,1,AFRO Region,Number of people living with HIV,AFR0019,2011,28,Both sexes (male and female),1,Percentage,16,UNAIDS,23271500
11452,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2011,9,Female,1,Percentage,3,WHO / GHO,599
68035,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2011,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,74
68700,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2011,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,10
69039,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2011,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,11
72745,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2011,9,Female,1,Percentage,18,Inter-Parliamentary Union,18.1
72979,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2011,28,Both sexes (male and female),1,Percentage,5,UNICEF,4.1
73458,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,83
73850,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2011,28,Both sexes (male and female),1,Percentage,15,UNESCO,35.67
73861,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2011,9,Female,1,Percentage,15,UNESCO,33.39
73872,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2011,8,Male,1,Percentage,15,UNESCO,38.42
74272,1,AFRO Region,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2011,999,Not Applicable,1,Percentage,3,WHO / GHO,43
75359,1,AFRO Region,GDP growth (annual %),AFR0388,2011,999,Not Applicable,1,Percentage,22,UN DESA,2.55
75551,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2011,9,Female,1,Percentage,1,WHO/AFRO,23.9
76075,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,96.6
86009,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,59
91158,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2011,28,Both sexes (male and female),1,Percentage,15,UNESCO,49.05
91162,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2011,9,Female,1,Percentage,15,UNESCO,48.77
91166,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2011,8,Male,1,Percentage,15,UNESCO,49.27
91443,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,86
91483,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,93
91914,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,86
92040,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2011,28,Both sexes (male and female),1,Percentage,5,UNICEF,4.1
95743,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,86
96002,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,58
112343,1,AFRO Region,Pneumococcal vaccination coverage,AFR0186,2011,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,12
113240,1,AFRO Region,TB treatment coverage,AFR0173,2011,29,Total,1,Percentage,3,WHO / GHO,50
124025,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2011,28,Both sexes (male and female),1,Percentage,35,IHME,1.01
125465,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2011,8,Male,1,Percentage,35,IHME,1.05
126905,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2011,9,Female,1,Percentage,35,IHME,0.96
136958,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2011,29,Total,1,Percentage,36,WHO/UNICEF,72
147050,1,AFRO Region,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",AFR0442,2011,29,Total,1,Percentage,13,UNStat,1
147156,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2011,29,Total,1,Percentage,36,WHO/UNICEF,4
147342,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2011,29,Total,1,Percentage,36,WHO/UNICEF,12
148163,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2011,107,Female (10-14 years),1,Percentage,35,IHME,45.06
150905,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2011,66,Female (15-49 years),1,Percentage,35,IHME,25.69
207898,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2011,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,71
2328,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2011,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,119.09
2344,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.7
6276,1,AFRO Region,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,314
11005,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,345
11104,1,AFRO Region,Population size (in thousands) total,AFR0004,2011,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,882472.08
13783,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,30.7
15547,1,AFRO Region,AIDS-related mortality rate (per 100 000 population),AFR0014,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,79.74
18283,1,AFRO Region,TB mortality rate (per 100 000 population),AFR0013,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,43
18543,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2011,9,Female,2,Per 1000 live births,3,WHO / GHO,219.02
18544,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2011,8,Male,2,Per 1000 live births,3,WHO / GHO,231.47
20249,1,AFRO Region,HIV incidence rate per 1000 uninfected population [SDG 3.3.1],AFR0395,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.59
20815,1,AFRO Region,TB incidence rate [SDG 3.3.2],AFR0334,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,301.07
21137,1,AFRO Region,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,260.38
22151,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,27.9
22157,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2011,9,Female,2,Per 1000 live births,3,WHO / GHO,28.1
22163,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2011,8,Male,2,Per 1000 live births,3,WHO / GHO,27.4
23290,1,AFRO Region,Anaemia prevalence in children,AFR0300,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,62.1
24816,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2011,9,Female,2,Per 1000 live births,3,WHO / GHO,23.9
25250,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,96.6
25424,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,59
26900,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,83
27661,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,86
28092,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,93
32430,1,AFRO Region,Coverage (%) - All Social Assistance,AFR0153,2011,999,Not Applicable,2,Per 1000 live births,4,WB Database,13.89
32659,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2011,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,32.78
32897,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2011,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,7.48
37259,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2011,11,Rural,2,Per 1000 live births,3,WHO / GHO,25
37260,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2011,29,Total,2,Per 1000 live births,3,WHO / GHO,34.76
37261,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2011,12,Urban,2,Per 1000 live births,3,WHO / GHO,44.11
37472,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2011,11,Rural,2,Per 1000 live births,5,UNICEF,36.84
37473,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2011,29,Total,2,Per 1000 live births,5,UNICEF,25.88
37474,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2011,12,Urban,2,Per 1000 live births,5,UNICEF,9.62
38513,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2011,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,9.05
39578,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2011,8,Male,2,Per 1000 live births,20,ITU,18.65
39587,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2011,9,Female,2,Per 1000 live births,20,ITU,4.5
39704,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2011,28,Both sexes (male and female),2,Per 1000 live births,21,ILO,48.56
39714,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2011,8,Male,2,Per 1000 live births,21,ILO,50.5
39724,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2011,9,Female,2,Per 1000 live births,21,ILO,46.49
40625,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2011,999,Not Applicable,2,Per 1000 live births,19,OECD,4580.42
41104,1,AFRO Region,DTP dropout rate (DTP1 -DPT3),AFR0226,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,7.7
43822,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,0
43823,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,13
43824,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
43825,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,46,Measles,2,Per 1000 live births,1,WHO/AFRO,195620
43826,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,10808
43827,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,1908
43828,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,5816
43829,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,51,Polio,2,Per 1000 live births,1,WHO/AFRO,398
43830,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,16190
43831,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,4355
43832,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,2574
47460,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2011,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,94.1
95330,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,94.1
79640,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2011,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,0
79641,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2011,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,13
79642,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2011,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
79643,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2011,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,195620
79644,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2011,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,10808
79645,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2011,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,1908
79646,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2011,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,5816
79647,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2011,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,398
79648,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2011,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,16190
79649,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2011,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,4355
79650,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2011,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,2574
139668,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2011,29,Total,5,Count (Numeric Integer),35,IHME,2443288
145211,1,AFRO Region,Number of people living with HIV,AFR0019,2011,29,Total,5,Count (Numeric Integer),16,UNAIDS,21800000
102366,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2011,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,10.6
143576,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2011,29,Total,6,Per 1000 population,16,UNAIDS,1.7
62240,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2011,9,Female,7,per 100 000 live births,23,MMEIG,599
74194,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2011,8,Male,8,Per 100 000 population,13,UNStat,18.65
74203,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2011,9,Female,8,Per 100 000 population,13,UNStat,4.5
92940,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2011,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,4580.41
74867,1,AFRO Region,Gender development index score,AFR0347,2011,28,Both sexes (male and female),12,Index,14,UNDP,0.88
37679,1,AFRO Region,Average death rate due to natural disasters y (per 100 000 population),AFR0027,2011-2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,0.05
39416,1,AFRO Region,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2011-2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.4
73034,1,AFRO Region,Average death rate due to natural disasters y (per 100 000 population),AFR0027,2011-2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,0.05
13884,1,AFRO Region,Demand for family planning satisfied with modern methods [SDG 3.7.1],AFR0207,2011-2017,9,Female,1,Percentage,3,WHO / GHO,56
76128,1,AFRO Region,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2011-2017,9,Female,1,Percentage,1,WHO/AFRO,53
140988,1,AFRO Region,Proportion of women married or in a union of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (% of women aged 15-49 years),AFR0105,2011-2017,9,Female,1,Percentage,3,WHO / GHO,56
24061,1,AFRO Region,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2011-2017,9,Female,2,Per 1000 live births,3,WHO / GHO,53
10992,1,AFRO Region,Number of people living with HIV,AFR0019,2012,28,Both sexes (male and female),1,Percentage,16,UNAIDS,23670300
11453,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2012,9,Female,1,Percentage,3,WHO / GHO,585
68081,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2012,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,73
68727,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2012,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,12
69080,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2012,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,19
72746,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2012,9,Female,1,Percentage,18,Inter-Parliamentary Union,18.76
72980,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2012,28,Both sexes (male and female),1,Percentage,5,UNICEF,5.1
73459,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,86
73879,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2012,28,Both sexes (male and female),1,Percentage,15,UNESCO,27.8
73886,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2012,9,Female,1,Percentage,15,UNESCO,25
73893,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2012,8,Male,1,Percentage,15,UNESCO,31.33
74294,1,AFRO Region,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2012,999,Not Applicable,1,Percentage,3,WHO / GHO,49
75360,1,AFRO Region,GDP growth (annual %),AFR0388,2012,999,Not Applicable,1,Percentage,22,UN DESA,2.61
75550,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2012,9,Female,1,Percentage,1,WHO/AFRO,22.7
76076,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,96.2
86010,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,60
91171,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2012,28,Both sexes (male and female),1,Percentage,15,UNESCO,55.05
91176,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2012,9,Female,1,Percentage,15,UNESCO,53.4
91181,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2012,8,Male,1,Percentage,15,UNESCO,56.69
91444,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,84
91484,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,94
91915,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,86
92041,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2012,28,Both sexes (male and female),1,Percentage,5,UNICEF,5.1
95744,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,86
96003,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,62
112356,1,AFRO Region,Pneumococcal vaccination coverage,AFR0186,2012,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,21
113286,1,AFRO Region,TB treatment coverage,AFR0173,2012,29,Total,1,Percentage,3,WHO / GHO,49
124073,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2012,28,Both sexes (male and female),1,Percentage,35,IHME,1.01
125513,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2012,8,Male,1,Percentage,35,IHME,1.06
126953,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2012,9,Female,1,Percentage,35,IHME,0.97
137006,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2012,29,Total,1,Percentage,36,WHO/UNICEF,71
147052,1,AFRO Region,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",AFR0442,2012,29,Total,1,Percentage,13,UNStat,1
147164,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2012,29,Total,1,Percentage,36,WHO/UNICEF,6
147343,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2012,29,Total,1,Percentage,36,WHO/UNICEF,21
148164,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2012,107,Female (10-14 years),1,Percentage,35,IHME,44.42
150906,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2012,66,Female (15-49 years),1,Percentage,35,IHME,24.87
207899,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2012,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,71
2329,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2012,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,119.97
2345,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.5
6275,1,AFRO Region,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,305
11006,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,340
11152,1,AFRO Region,Population size (in thousands) total,AFR0004,2012,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,906698.21
13784,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,29.9
15594,1,AFRO Region,AIDS-related mortality rate (per 100 000 population),AFR0014,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,71.96
18282,1,AFRO Region,TB mortality rate (per 100 000 population),AFR0013,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,43
18545,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2012,9,Female,2,Per 1000 live births,3,WHO / GHO,214.11
18546,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2012,8,Male,2,Per 1000 live births,3,WHO / GHO,227.91
20250,1,AFRO Region,HIV incidence rate per 1000 uninfected population [SDG 3.3.1],AFR0395,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.48
20816,1,AFRO Region,TB incidence rate [SDG 3.3.2],AFR0334,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,291.77
21092,1,AFRO Region,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,253.35
22152,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,27.7
22158,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2012,9,Female,2,Per 1000 live births,3,WHO / GHO,28
22164,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2012,8,Male,2,Per 1000 live births,3,WHO / GHO,27.3
23289,1,AFRO Region,Anaemia prevalence in children,AFR0300,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,61.4
24815,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2012,9,Female,2,Per 1000 live births,3,WHO / GHO,22.7
25251,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,96.2
25425,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,60
26901,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,86
27662,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,86
28093,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,94
32431,1,AFRO Region,Coverage (%) - All Social Assistance,AFR0153,2012,999,Not Applicable,2,Per 1000 live births,4,WB Database,20.17
32660,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2012,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,28.6
32898,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2012,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,7.61
37262,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2012,11,Rural,2,Per 1000 live births,3,WHO / GHO,25.38
37263,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2012,29,Total,2,Per 1000 live births,3,WHO / GHO,35.27
37264,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2012,12,Urban,2,Per 1000 live births,3,WHO / GHO,44.58
37475,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2012,11,Rural,2,Per 1000 live births,5,UNICEF,36.23
37476,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2012,29,Total,2,Per 1000 live births,5,UNICEF,25.25
37477,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2012,12,Urban,2,Per 1000 live births,5,UNICEF,9.27
38514,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2012,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,10.77
39579,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2012,8,Male,2,Per 1000 live births,20,ITU,10.71
39588,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2012,9,Female,2,Per 1000 live births,20,ITU,2.22
39705,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2012,28,Both sexes (male and female),2,Per 1000 live births,21,ILO,21.6
39715,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2012,8,Male,2,Per 1000 live births,21,ILO,20.79
39725,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2012,9,Female,2,Per 1000 live births,21,ILO,21.83
40626,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2012,999,Not Applicable,2,Per 1000 live births,19,OECD,4381.79
41105,1,AFRO Region,DTP dropout rate (DTP1 -DPT3),AFR0226,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,7.7
43488,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,69
43489,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,27
43490,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
43491,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,46,Measles,2,Per 1000 live births,1,WHO/AFRO,108004
43492,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,2401
43493,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,2049
43494,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,16839
43495,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,51,Polio,2,Per 1000 live births,1,WHO/AFRO,168
43496,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,10850
43497,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,4737
43498,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,246
47461,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2012,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,89.9
95331,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,89.9
79306,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2012,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,69
79307,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2012,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,27
79308,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2012,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
79309,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2012,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,108004
79310,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2012,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,2401
79311,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2012,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,2049
79312,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2012,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,16839
79313,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2012,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,168
79314,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2012,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,10850
79315,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2012,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,4737
79316,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2012,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,246
139716,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2012,29,Total,5,Count (Numeric Integer),35,IHME,2545636
145257,1,AFRO Region,Number of people living with HIV,AFR0019,2012,29,Total,5,Count (Numeric Integer),16,UNAIDS,22400000
102367,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2012,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,10.21
143620,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2012,29,Total,6,Per 1000 population,16,UNAIDS,1.57
62241,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2012,9,Female,7,per 100 000 live births,23,MMEIG,585
74195,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2012,8,Male,8,Per 100 000 population,13,UNStat,10.71
74204,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2012,9,Female,8,Per 100 000 population,13,UNStat,2.22
92941,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2012,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,4381.78
74910,1,AFRO Region,Gender development index score,AFR0347,2012,28,Both sexes (male and female),12,Index,14,UNDP,0.86
10993,1,AFRO Region,Number of people living with HIV,AFR0019,2013,28,Both sexes (male and female),1,Percentage,16,UNAIDS,24188200
11454,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2013,9,Female,1,Percentage,3,WHO / GHO,572
68127,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,73
68754,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,15
69121,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,32
72747,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2013,9,Female,1,Percentage,18,Inter-Parliamentary Union,19.86
72981,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2013,28,Both sexes (male and female),1,Percentage,5,UNICEF,3.9
73460,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,85
73903,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2013,28,Both sexes (male and female),1,Percentage,15,UNESCO,44.54
73913,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2013,9,Female,1,Percentage,15,UNESCO,42.84
73923,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2013,8,Male,1,Percentage,15,UNESCO,46.83
74330,1,AFRO Region,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2013,999,Not Applicable,1,Percentage,3,WHO / GHO,52
75361,1,AFRO Region,GDP growth (annual %),AFR0388,2013,999,Not Applicable,1,Percentage,22,UN DESA,2.22
75549,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2013,9,Female,1,Percentage,1,WHO/AFRO,30.2
76077,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95.8
85796,1,AFRO Region,Availability of basic equipment,AFR0350,2013,999,Not Applicable,1,Percentage,1,WHO/AFRO,87
86011,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,66
91185,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2013,28,Both sexes (male and female),1,Percentage,15,UNESCO,70.58
91189,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2013,9,Female,1,Percentage,15,UNESCO,72.14
91193,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2013,8,Male,1,Percentage,15,UNESCO,68.87
91445,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,84
91485,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,94
91916,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,87
92042,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2013,28,Both sexes (male and female),1,Percentage,5,UNICEF,3.9
95745,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,87
96004,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,73
112374,1,AFRO Region,Pneumococcal vaccination coverage,AFR0186,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,34
113333,1,AFRO Region,TB treatment coverage,AFR0173,2013,29,Total,1,Percentage,3,WHO / GHO,49
124121,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2013,28,Both sexes (male and female),1,Percentage,35,IHME,1.02
125561,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2013,8,Male,1,Percentage,35,IHME,1.06
127001,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2013,9,Female,1,Percentage,35,IHME,0.98
137054,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2013,29,Total,1,Percentage,36,WHO/UNICEF,70
147054,1,AFRO Region,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",AFR0442,2013,29,Total,1,Percentage,13,UNStat,1
147174,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2013,29,Total,1,Percentage,36,WHO/UNICEF,7
147344,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2013,29,Total,1,Percentage,36,WHO/UNICEF,34
148165,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2013,107,Female (10-14 years),1,Percentage,35,IHME,43.54
150907,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2013,66,Female (15-49 years),1,Percentage,35,IHME,24.67
207900,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,70
2330,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2013,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,121.07
2346,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.64
6274,1,AFRO Region,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,297
11007,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,333
11200,1,AFRO Region,Population size (in thousands) total,AFR0004,2013,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,931548.4
13785,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,29.76
15641,1,AFRO Region,AIDS-related mortality rate (per 100 000 population),AFR0014,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,64.73
16884,1,AFRO Region,Death rate due to road traffic injuries (per 100 000 population) [SDG 3.6.1],AFR0017,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,26.76
18281,1,AFRO Region,TB mortality rate (per 100 000 population),AFR0013,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,42
18547,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2013,9,Female,2,Per 1000 live births,3,WHO / GHO,209.78
18548,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2013,8,Male,2,Per 1000 live births,3,WHO / GHO,225.45
20251,1,AFRO Region,HIV incidence rate per 1000 uninfected population [SDG 3.3.1],AFR0395,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.39
20817,1,AFRO Region,TB incidence rate [SDG 3.3.2],AFR0334,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,280.65
21047,1,AFRO Region,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,245.42
22153,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,27.6
22159,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2013,9,Female,2,Per 1000 live births,3,WHO / GHO,27.9
22165,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2013,8,Male,2,Per 1000 live births,3,WHO / GHO,27.1
23288,1,AFRO Region,Anaemia prevalence in children,AFR0300,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,60.8
24814,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2013,9,Female,2,Per 1000 live births,3,WHO / GHO,30.2
25252,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95.8
25426,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,66
26902,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,85
27663,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,87
28094,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,94
32432,1,AFRO Region,Coverage (%) - All Social Assistance,AFR0153,2013,999,Not Applicable,2,Per 1000 live births,4,WB Database,30.91
32661,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2013,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,33.3
32899,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2013,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,9.05
37265,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2013,11,Rural,2,Per 1000 live births,3,WHO / GHO,25.75
37266,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2013,29,Total,2,Per 1000 live births,3,WHO / GHO,35.74
37267,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2013,12,Urban,2,Per 1000 live births,3,WHO / GHO,45.01
37478,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2013,11,Rural,2,Per 1000 live births,5,UNICEF,35.64
37479,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2013,29,Total,2,Per 1000 live births,5,UNICEF,24.64
37480,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2013,12,Urban,2,Per 1000 live births,5,UNICEF,8.93
38515,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2013,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,12.91
39580,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2013,8,Male,2,Per 1000 live births,20,ITU,12.36
39589,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2013,9,Female,2,Per 1000 live births,20,ITU,3.94
39706,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2013,28,Both sexes (male and female),2,Per 1000 live births,21,ILO,21.94
39716,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2013,8,Male,2,Per 1000 live births,21,ILO,20.5
39726,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2013,9,Female,2,Per 1000 live births,21,ILO,23.37
40627,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2013,999,Not Applicable,2,Per 1000 live births,19,OECD,4738.52
41106,1,AFRO Region,DTP dropout rate (DTP1 -DPT3),AFR0226,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,7.6
43155,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,3
43156,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,128
43157,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
43158,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,46,Measles,2,Per 1000 live births,1,WHO/AFRO,171178
43159,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,8147
43160,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,1449
43161,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,9930
43162,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,51,Polio,2,Per 1000 live births,1,WHO/AFRO,93
43163,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,13739
43164,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,5149
43165,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,268
47462,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2013,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,88.5
95332,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,88.5
78973,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2013,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,3
78974,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2013,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,128
78975,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2013,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
78976,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2013,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,171178
78977,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2013,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,8147
78978,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2013,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,1449
78979,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2013,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,9930
78980,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2013,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,93
78981,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2013,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,13739
78982,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2013,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,5149
78983,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2013,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,268
145303,1,AFRO Region,Number of people living with HIV,AFR0019,2013,29,Total,5,Count (Numeric Integer),16,UNAIDS,22900000
147392,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2013,29,Total,5,Count (Numeric Integer),35,IHME,2642630
102368,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2013,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,9.86
143664,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2013,29,Total,6,Per 1000 population,16,UNAIDS,1.46
62242,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2013,9,Female,7,per 100 000 live births,23,MMEIG,572
74196,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2013,8,Male,8,Per 100 000 population,13,UNStat,12.36
74205,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2013,9,Female,8,Per 100 000 population,13,UNStat,3.94
92942,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2013,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,4738.52
74953,1,AFRO Region,Gender development index score,AFR0347,2013,28,Both sexes (male and female),12,Index,14,UNDP,0.87
71531,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013-2018,9,Female,1,Percentage,13,UNStat,59
13838,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013-2018,9,Female,2,Per 1000 live births,3,WHO / GHO,59
10994,1,AFRO Region,Number of people living with HIV,AFR0019,2014,28,Both sexes (male and female),1,Percentage,16,UNAIDS,24577500
11455,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2014,9,Female,1,Percentage,3,WHO / GHO,562
68173,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,74
68781,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,19
69162,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,47
72748,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2014,9,Female,1,Percentage,18,Inter-Parliamentary Union,21.82
72982,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2014,28,Both sexes (male and female),1,Percentage,5,UNICEF,3.5
73461,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,89
73936,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2014,28,Both sexes (male and female),1,Percentage,15,UNESCO,35.09
73949,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2014,9,Female,1,Percentage,15,UNESCO,34.5
73962,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2014,8,Male,1,Percentage,15,UNESCO,35.89
74362,1,AFRO Region,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2014,999,Not Applicable,1,Percentage,3,WHO / GHO,56
75198,1,AFRO Region,"Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting, by age (%)",AFR0103,2014,9,Female,1,Percentage,5,UNICEF,25
75226,1,AFRO Region,Prevalence of female genital mutilation/cutting [SDG 5.3.2],AFR0298,2014,9,Female,1,Percentage,5,UNICEF,25
75362,1,AFRO Region,GDP growth (annual %),AFR0388,2014,999,Not Applicable,1,Percentage,22,UN DESA,2.58
75548,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2014,9,Female,1,Percentage,1,WHO/AFRO,40.6
76078,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,93.4
85798,1,AFRO Region,Availability of basic equipment,AFR0350,2014,999,Not Applicable,1,Percentage,1,WHO/AFRO,75
86012,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,67
91202,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2014,28,Both sexes (male and female),1,Percentage,15,UNESCO,57.08
91211,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2014,9,Female,1,Percentage,15,UNESCO,56.68
91220,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2014,8,Male,1,Percentage,15,UNESCO,57.35
91446,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,86
91486,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
91917,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,89
92043,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2014,28,Both sexes (male and female),1,Percentage,5,UNICEF,3.5
95746,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,89
96005,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,73
103024,1,AFRO Region,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2014,999,Not Applicable,1,Percentage,4,WB Database,35.72
112397,1,AFRO Region,Pneumococcal vaccination coverage,AFR0186,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,48
113380,1,AFRO Region,TB treatment coverage,AFR0173,2014,29,Total,1,Percentage,3,WHO / GHO,48
124169,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2014,28,Both sexes (male and female),1,Percentage,35,IHME,1.03
125609,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2014,8,Male,1,Percentage,35,IHME,1.07
127049,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2014,9,Female,1,Percentage,35,IHME,0.98
137102,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2014,29,Total,1,Percentage,36,WHO/UNICEF,71
147056,1,AFRO Region,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",AFR0442,2014,29,Total,1,Percentage,13,UNStat,3
147186,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2014,29,Total,1,Percentage,36,WHO/UNICEF,10
147346,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2014,29,Total,1,Percentage,36,WHO/UNICEF,48
148166,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2014,107,Female (10-14 years),1,Percentage,35,IHME,43.09
150908,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2014,66,Female (15-49 years),1,Percentage,35,IHME,24.38
207901,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,69
2332,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2014,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,125
2348,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.98
6273,1,AFRO Region,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,291
10999,1,AFRO Region,HIV prevalence among adults aged 15-49 years (%),AFR0377,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,4.5
11008,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,330
11248,1,AFRO Region,Population size (in thousands) total,AFR0004,2014,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,956995.1
13786,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,29.19
15688,1,AFRO Region,AIDS-related mortality rate (per 100 000 population),AFR0014,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,59.07
18280,1,AFRO Region,TB mortality rate (per 100 000 population),AFR0013,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,43
18549,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2014,9,Female,2,Per 1000 live births,3,WHO / GHO,205.99
18550,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2014,8,Male,2,Per 1000 live births,3,WHO / GHO,222.72
20252,1,AFRO Region,HIV incidence rate per 1000 uninfected population [SDG 3.3.1],AFR0395,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.31
20818,1,AFRO Region,TB incidence rate [SDG 3.3.2],AFR0334,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,272.41
21002,1,AFRO Region,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,233.43
22155,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,27.5
22161,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2014,9,Female,2,Per 1000 live births,3,WHO / GHO,27.8
22167,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2014,8,Male,2,Per 1000 live births,3,WHO / GHO,27
23287,1,AFRO Region,Anaemia prevalence in children,AFR0300,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,60.2
24813,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2014,9,Female,2,Per 1000 live births,3,WHO / GHO,40.6
25253,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,93.4
25427,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,67
26903,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,89
27664,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,89
28095,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
32433,1,AFRO Region,Coverage (%) - All Social Assistance,AFR0153,2014,999,Not Applicable,2,Per 1000 live births,4,WB Database,20.87
32662,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2014,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,29.79
32900,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2014,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,5.69
37268,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2014,11,Rural,2,Per 1000 live births,3,WHO / GHO,26.08
37269,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2014,29,Total,2,Per 1000 live births,3,WHO / GHO,36.18
37270,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2014,12,Urban,2,Per 1000 live births,3,WHO / GHO,45.42
37481,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2014,11,Rural,2,Per 1000 live births,5,UNICEF,35.07
37482,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2014,29,Total,2,Per 1000 live births,5,UNICEF,24.04
37483,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2014,12,Urban,2,Per 1000 live births,5,UNICEF,8.61
37631,1,AFRO Region,Annual mean concentrations of fine particulate matter (PM2.5) in urban areas(g/m3),AFR0026,2014,29,Total,2,Per 1000 live births,3,WHO / GHO,36.7
38516,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2014,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,15.68
39581,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2014,8,Male,2,Per 1000 live births,20,ITU,11.31
39590,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2014,9,Female,2,Per 1000 live births,20,ITU,2.89
39707,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2014,28,Both sexes (male and female),2,Per 1000 live births,21,ILO,31.4
39717,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2014,8,Male,2,Per 1000 live births,21,ILO,31.16
39727,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2014,9,Female,2,Per 1000 live births,21,ILO,31.65
40628,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2014,999,Not Applicable,2,Per 1000 live births,19,OECD,4934.27
41107,1,AFRO Region,DTP dropout rate (DTP1 -DPT3),AFR0226,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,7.9
42825,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,14
42826,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,1
42827,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
42828,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,46,Measles,2,Per 1000 live births,1,WHO/AFRO,73914
42829,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,7
42830,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,835
42831,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,10098
42832,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,51,Polio,2,Per 1000 live births,1,WHO/AFRO,51
42833,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,7402
42834,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,2900
42835,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,31
47463,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2014,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,85.6
95333,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,85.6
78643,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2014,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,14
78644,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2014,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,1
78645,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2014,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
78646,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2014,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,73914
78647,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2014,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,7
78648,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2014,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,835
78649,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2014,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,10098
78650,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2014,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,51
78651,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2014,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,7402
78652,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2014,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,2900
78653,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2014,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,31
145349,1,AFRO Region,Number of people living with HIV,AFR0019,2014,29,Total,5,Count (Numeric Integer),16,UNAIDS,23400000
147440,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2014,29,Total,5,Count (Numeric Integer),35,IHME,2750571
102369,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2014,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,9.54
143708,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2014,29,Total,6,Per 1000 population,16,UNAIDS,1.36
62243,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2014,9,Female,7,per 100 000 live births,23,MMEIG,562
74197,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2014,8,Male,8,Per 100 000 population,13,UNStat,11.31
74206,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2014,9,Female,8,Per 100 000 population,13,UNStat,2.89
92943,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2014,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,4934.26
91967,1,AFRO Region,"Annual mean levels of fine particulate matter in cities, urban population (micrograms per cubic meter)",AFR0121,2014,29,Total,11,micrograms per cubic meter,3,WHO / GHO,36.7
74997,1,AFRO Region,Gender development index score,AFR0347,2014,28,Both sexes (male and female),12,Index,14,UNDP,0.87
10995,1,AFRO Region,Number of people living with HIV,AFR0019,2015,28,Both sexes (male and female),1,Percentage,16,UNAIDS,24894500
11456,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2015,9,Female,1,Percentage,3,WHO / GHO,548
68219,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,76
68808,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,26
69203,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,58
72749,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2015,9,Female,1,Percentage,18,Inter-Parliamentary Union,22.13
73462,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,88
73971,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2015,28,Both sexes (male and female),1,Percentage,15,UNESCO,42.8
73980,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2015,9,Female,1,Percentage,15,UNESCO,40.7
73989,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2015,8,Male,1,Percentage,15,UNESCO,45.2
74385,1,AFRO Region,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2015,999,Not Applicable,1,Percentage,3,WHO / GHO,60
75363,1,AFRO Region,GDP growth (annual %),AFR0388,2015,999,Not Applicable,1,Percentage,22,UN DESA,0.53
75547,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2015,9,Female,1,Percentage,1,WHO/AFRO,36.6
76079,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,93.4
85804,1,AFRO Region,Availability of basic equipment,AFR0350,2015,999,Not Applicable,1,Percentage,1,WHO/AFRO,85
86013,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,76
91224,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2015,28,Both sexes (male and female),1,Percentage,15,UNESCO,54.27
91225,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2015,9,Female,1,Percentage,15,UNESCO,61.08
91226,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2015,8,Male,1,Percentage,15,UNESCO,47.6
91447,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91
91487,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,96
91918,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,90
95747,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,90
96006,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,93
103023,1,AFRO Region,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2015,999,Not Applicable,1,Percentage,4,WB Database,35.78
112429,1,AFRO Region,Pneumococcal vaccination coverage,AFR0186,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,60
113427,1,AFRO Region,TB treatment coverage,AFR0173,2015,29,Total,1,Percentage,3,WHO / GHO,49
124217,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2015,28,Both sexes (male and female),1,Percentage,35,IHME,1.04
125657,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2015,8,Male,1,Percentage,35,IHME,1.08
127097,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2015,9,Female,1,Percentage,35,IHME,0.99
137150,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2015,29,Total,1,Percentage,36,WHO/UNICEF,71
147060,1,AFRO Region,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",AFR0442,2015,29,Total,1,Percentage,13,UNStat,3
147204,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2015,29,Total,1,Percentage,36,WHO/UNICEF,18
147348,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2015,29,Total,1,Percentage,36,WHO/UNICEF,60
148167,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2015,107,Female (10-14 years),1,Percentage,35,IHME,43.42
150909,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2015,66,Female (15-49 years),1,Percentage,35,IHME,24.43
207902,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,68
2331,1,AFRO Region,Current health expenditure (CHE) per capita in US$,AFR0263,2015,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,114.57
2347,1,AFRO Region,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,6.22
2502,1,AFRO Region,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,6.91
4382,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,37,Both sexes (15-24 years),2,Per 1000 live births,1,WHO/AFRO,9.7
4394,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,36,Female (15-24 years),2,Per 1000 live births,1,WHO/AFRO,10
4406,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,35,Male (15-24 years),2,Per 1000 live births,1,WHO/AFRO,9.5
4462,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,38,Both sexes (25+ years),2,Per 1000 live births,1,WHO/AFRO,4.6
4474,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,40,Female (25+ years),2,Per 1000 live births,1,WHO/AFRO,5
4486,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,39,Male (25+ years),2,Per 1000 live births,1,WHO/AFRO,4.3
4952,1,AFRO Region,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2015,12,Urban,2,Per 1000 live births,1,WHO/AFRO,48.8
4999,1,AFRO Region,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2015,11,Rural,2,Per 1000 live births,1,WHO/AFRO,43.7
5047,1,AFRO Region,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2015,29,Total,2,Per 1000 live births,1,WHO/AFRO,26
5094,1,AFRO Region,Population using safely managed sanitation services [SDG 6.2.1a/6.2.1b],AFR0291,2015,12,Urban,2,Per 1000 live births,3,WHO / GHO,44.6
5141,1,AFRO Region,Population using safely managed sanitation services [SDG 6.2.1a/6.2.1b],AFR0291,2015,11,Rural,2,Per 1000 live births,3,WHO / GHO,21.4
5189,1,AFRO Region,Population using safely managed sanitation services [SDG 6.2.1a/6.2.1b],AFR0291,2015,29,Total,2,Per 1000 live births,3,WHO / GHO,30.5
6272,1,AFRO Region,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,283
10101,1,AFRO Region,Life expectancy at birth (years),AFR0381,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,60.7
10106,1,AFRO Region,Life expectancy at birth (years),AFR0381,2015,8,Male,2,Per 1000 live births,1,WHO/AFRO,59.1
10111,1,AFRO Region,Life expectancy at birth (years),AFR0381,2015,9,Female,2,Per 1000 live births,1,WHO/AFRO,62.2
10116,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,16.6
10121,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2015,8,Male,2,Per 1000 live births,1,WHO/AFRO,15.8
10126,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2015,9,Female,2,Per 1000 live births,1,WHO/AFRO,17.3
10131,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,53.3
10136,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,52.1
10141,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,54.4
10146,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,12.4
10151,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,11.8
10156,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,13
11000,1,AFRO Region,HIV prevalence among adults aged 15-49 years (%),AFR0377,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,4.4
11296,1,AFRO Region,Population size (in thousands) total,AFR0004,2015,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,983010.98
13787,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,28.66
15735,1,AFRO Region,AIDS-related mortality rate (per 100 000 population),AFR0014,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,54.32
16068,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2015,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,7.4
16308,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,9.9
16548,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,4.9
16788,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,7.4
18175,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,60.7
18180,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,59.1
18185,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,62.2
18279,1,AFRO Region,TB mortality rate (per 100 000 population),AFR0013,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,42
18287,1,AFRO Region,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,20.7
18551,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,200.34
18552,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,216.54
20253,1,AFRO Region,HIV incidence rate per 1000 uninfected population [SDG 3.3.1],AFR0395,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.19
20819,1,AFRO Region,TB incidence rate [SDG 3.3.2],AFR0334,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,261.35
20957,1,AFRO Region,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,224.2
22154,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,27.4
22160,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,27.7
22166,1,AFRO Region,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,26.8
23286,1,AFRO Region,Anaemia prevalence in children,AFR0300,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,59.7
24812,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,36.6
25254,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,93.4
25428,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,76
26904,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,88
27665,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,90
28096,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,96
32434,1,AFRO Region,Coverage (%) - All Social Assistance,AFR0153,2015,999,Not Applicable,2,Per 1000 live births,4,WB Database,19.15
32663,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2015,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,34.35
32901,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2015,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,7.14
37271,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2015,11,Rural,2,Per 1000 live births,3,WHO / GHO,26.39
37272,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2015,29,Total,2,Per 1000 live births,3,WHO / GHO,36.59
37273,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2015,12,Urban,2,Per 1000 live births,3,WHO / GHO,44.54
37484,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2015,11,Rural,2,Per 1000 live births,5,UNICEF,34.49
37485,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2015,29,Total,2,Per 1000 live births,5,UNICEF,23.45
37486,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2015,12,Urban,2,Per 1000 live births,5,UNICEF,8.28
38517,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2015,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,19.69
39582,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2015,8,Male,2,Per 1000 live births,20,ITU,6.77
39591,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2015,9,Female,2,Per 1000 live births,20,ITU,1.66
39708,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2015,28,Both sexes (male and female),2,Per 1000 live births,21,ILO,12.61
39718,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2015,8,Male,2,Per 1000 live births,21,ILO,12.3
39728,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2015,9,Female,2,Per 1000 live births,21,ILO,12.65
40629,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2015,999,Not Applicable,2,Per 1000 live births,19,OECD,5402.99
41108,1,AFRO Region,DTP dropout rate (DTP1 -DPT3),AFR0226,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,7.5
42470,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,78
42471,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,1654
42472,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
42473,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,46,Measles,2,Per 1000 live births,1,WHO/AFRO,52758
42474,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,28492
42475,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,1289
42476,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,7565
42477,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,51,Polio,2,Per 1000 live births,1,WHO/AFRO,18
42478,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,5302
42479,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,3529
42480,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,35
47464,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2015,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,83
85794,1,AFRO Region,Stillbirth rate (per 1000 total births),AFR0011,2015,9,Female,2,Per 1000 live births,7,DHS,23.1
95334,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,83
140075,1,AFRO Region,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2015,12,Urban,2,Per 1000 live births,7,DHS,48.8
140076,1,AFRO Region,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2015,11,Rural,2,Per 1000 live births,7,DHS,43.7
140077,1,AFRO Region,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2015,29,Total,2,Per 1000 live births,7,DHS,26
140953,1,AFRO Region,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2015,999,Not Applicable,2,Per 1000 live births,7,DHS,6.91
78288,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2015,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,78
78289,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2015,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,1654
78290,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2015,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
78291,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2015,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,52758
78292,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2015,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,28492
78293,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2015,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,1289
78294,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2015,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,7565
78295,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2015,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,18
78296,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2015,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,5302
78297,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2015,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,3529
78298,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2015,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,35
99387,1,AFRO Region,"Pre-primary education, duration (years)",AFR0392,2015,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,3
145395,1,AFRO Region,Number of people living with HIV,AFR0019,2015,29,Total,5,Count (Numeric Integer),16,UNAIDS,23900000
147488,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2015,29,Total,5,Count (Numeric Integer),35,IHME,2861400
47472,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2015,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,8.7
103026,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2015,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,9.25
143752,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2015,29,Total,6,Per 1000 population,16,UNAIDS,1.26
62244,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2015,9,Female,7,per 100 000 live births,23,MMEIG,548
74198,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2015,8,Male,8,Per 100 000 population,13,UNStat,6.77
74207,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2015,9,Female,8,Per 100 000 population,13,UNStat,1.66
120890,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,20.7
121130,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2015,8,Male,8,Per 100 000 population,3,WHO / GHO,21.2
121370,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2015,9,Female,8,Per 100 000 population,3,WHO / GHO,20.2
92944,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2015,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,5402.99
75041,1,AFRO Region,Gender development index score,AFR0347,2015,28,Both sexes (male and female),12,Index,14,UNDP,0.87
122366,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2015-2020,28,Both sexes (male and female),1,Percentage,17,UN Population,16.92
122654,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2015-2020,8,Male,1,Percentage,17,UN Population,16.01
122942,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2015-2020,9,Female,1,Percentage,17,UN Population,17.74
25692,1,AFRO Region,Adolescent birth rate [SDG 3.7.2],AFR0293,2015-2020,9,Female,2,Per 1000 live births,1,WHO/AFRO,102.1
70464,1,AFRO Region,Adolescent birth rate [SDG 3.7.2],AFR0293,2015-2020,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,102.1
10996,1,AFRO Region,Number of people living with HIV,AFR0019,2016,28,Both sexes (male and female),1,Percentage,16,UNAIDS,25348100
11457,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2016,9,Female,1,Percentage,3,WHO / GHO,536
68265,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,78
68835,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,31
69244,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,66
72750,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2016,9,Female,1,Percentage,18,Inter-Parliamentary Union,21.91
72983,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2016,28,Both sexes (male and female),1,Percentage,5,UNICEF,2.9
73463,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,89
73998,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2016,28,Both sexes (male and female),1,Percentage,15,UNESCO,38.67
74007,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2016,9,Female,1,Percentage,15,UNESCO,36.16
74016,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2016,8,Male,1,Percentage,15,UNESCO,41.6
74410,1,AFRO Region,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2016,999,Not Applicable,1,Percentage,3,WHO / GHO,59
75199,1,AFRO Region,"Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting, by age (%)",AFR0103,2016,9,Female,1,Percentage,5,UNICEF,28.1
75227,1,AFRO Region,Prevalence of female genital mutilation/cutting [SDG 5.3.2],AFR0298,2016,9,Female,1,Percentage,5,UNICEF,28.1
75364,1,AFRO Region,GDP growth (annual %),AFR0388,2016,999,Not Applicable,1,Percentage,22,UN DESA,0.94
75546,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2016,9,Female,1,Percentage,1,WHO/AFRO,33.5
76080,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,93.2
85809,1,AFRO Region,Availability of basic equipment,AFR0350,2016,999,Not Applicable,1,Percentage,1,WHO/AFRO,65
86014,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,80
91231,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2016,28,Both sexes (male and female),1,Percentage,15,UNESCO,51.57
91236,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2016,9,Female,1,Percentage,15,UNESCO,52.33
91241,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2016,8,Male,1,Percentage,15,UNESCO,50.98
91448,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91
91488,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,97
91919,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,92
92044,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2016,28,Both sexes (male and female),1,Percentage,5,UNICEF,2.9
95748,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,92
96007,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,86
103022,1,AFRO Region,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2016,999,Not Applicable,1,Percentage,4,WB Database,36.36
112465,1,AFRO Region,Pneumococcal vaccination coverage,AFR0186,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,66
113474,1,AFRO Region,TB treatment coverage,AFR0173,2016,29,Total,1,Percentage,3,WHO / GHO,50
124265,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2016,28,Both sexes (male and female),1,Percentage,35,IHME,1.04
125705,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2016,8,Male,1,Percentage,35,IHME,1.09
127145,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2016,9,Female,1,Percentage,35,IHME,1
135464,1,AFRO Region,"Prevalence of anaemia in women aged 15-49, by age and pregnancy status",AFR0299,2016,9,Female,1,Percentage,3,WHO / GHO,39
135800,1,AFRO Region,Annual mean concentrations of fine particulate matter (PM2.5) in urban areas(g/m3),AFR0026,2016,999,Not Applicable,1,Percentage,3,WHO / GHO,35.5
135944,1,AFRO Region,Prevalence of obesity among children and adolescents (5-19 years)(%),AFR0439,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.8
135992,1,AFRO Region,Prevalence of obesity in persons aged 18+years,AFR0021,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,10.6
137198,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2016,29,Total,1,Percentage,36,WHO/UNICEF,72
147065,1,AFRO Region,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",AFR0442,2016,29,Total,1,Percentage,13,UNStat,4
147228,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2016,29,Total,1,Percentage,36,WHO/UNICEF,23
147350,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2016,29,Total,1,Percentage,36,WHO/UNICEF,66
148168,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2016,107,Female (10-14 years),1,Percentage,35,IHME,42.49
148506,1,AFRO Region,Annual expenditure on reproductive health from government domestic health budget,AFR0456,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,15.17
148601,1,AFRO Region,Annual expenditure on family planning from government domestic health budget,AFR0452,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,2.04
150910,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2016,66,Female (15-49 years),1,Percentage,35,IHME,23.58
207903,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,69
4415,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,37,Both sexes (15-24 years),2,Per 1000 live births,1,WHO/AFRO,10.3
4423,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,36,Female (15-24 years),2,Per 1000 live births,1,WHO/AFRO,10.4
4431,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,35,Male (15-24 years),2,Per 1000 live births,1,WHO/AFRO,10.1
4495,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,38,Both sexes (25+ years),2,Per 1000 live births,1,WHO/AFRO,4.7
4503,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,40,Female (25+ years),2,Per 1000 live births,1,WHO/AFRO,5.1
4511,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,39,Male (25+ years),2,Per 1000 live births,1,WHO/AFRO,4.4
6271,1,AFRO Region,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,277
10100,1,AFRO Region,Life expectancy at birth (years),AFR0381,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,61.2
10105,1,AFRO Region,Life expectancy at birth (years),AFR0381,2016,8,Male,2,Per 1000 live births,1,WHO/AFRO,59.6
10110,1,AFRO Region,Life expectancy at birth (years),AFR0381,2016,9,Female,2,Per 1000 live births,1,WHO/AFRO,62.7
10115,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,16.6
10120,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2016,8,Male,2,Per 1000 live births,1,WHO/AFRO,15.9
10125,1,AFRO Region,Life expectancy at age 60 years,AFR0003,2016,9,Female,2,Per 1000 live births,1,WHO/AFRO,17.3
10130,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,53.8
10135,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,52.6
10140,1,AFRO Region,Healthy life expectancy at birth (in years),AFR0002,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,54.9
10145,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,12.5
10150,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,12
10155,1,AFRO Region,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,13.1
10160,1,AFRO Region,Population size (in thousands) total,AFR0004,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,1015368
11001,1,AFRO Region,HIV prevalence among adults aged 15-49 years (%),AFR0377,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,4.2
13788,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,28.15
15782,1,AFRO Region,AIDS-related mortality rate (per 100 000 population),AFR0014,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,50.03
16116,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2016,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,7.4
16356,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,9.9
16596,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,4.8
16836,1,AFRO Region,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,7.4
16929,1,AFRO Region,Death rate due to road traffic injuries (per 100 000 population) [SDG 3.6.1],AFR0017,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,27.37
18174,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,61.2
18179,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,59.6
18184,1,AFRO Region,Average life expectancy at birth (in years),AFR0001,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,62.7
18278,1,AFRO Region,TB mortality rate (per 100 000 population),AFR0013,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,41
18286,1,AFRO Region,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,20.6
18553,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,195.95
18554,1,AFRO Region,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,211.75
20254,1,AFRO Region,HIV incidence rate per 1000 uninfected population [SDG 3.3.1],AFR0395,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.04
20304,1,AFRO Region,"Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (deaths per 100,000 population)",AFR0109,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,38.9
20352,1,AFRO Region,"Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (deaths per 100,000 population)",AFR0109,2016,8,Male,2,Per 1000 live births,1,WHO/AFRO,40.4
20400,1,AFRO Region,"Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (deaths per 100,000 population)",AFR0109,2016,9,Female,2,Per 1000 live births,1,WHO/AFRO,37.5
20820,1,AFRO Region,TB incidence rate [SDG 3.3.2],AFR0334,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,247.16
20912,1,AFRO Region,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,219.92
21320,1,AFRO Region,Hepatitis B surface antigen prevalence (%),AFR0326,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,6.93
22432,1,AFRO Region,Age-standardized prevalence of insufficiently physically active persons aged 18+ years,AFR0308,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,22.1
22433,1,AFRO Region,Age-standardized prevalence of insufficiently physically active persons aged 18+ years,AFR0308,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,25.63
22434,1,AFRO Region,Age-standardized prevalence of insufficiently physically active persons aged 18+ years,AFR0308,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,18.4
23285,1,AFRO Region,Anaemia prevalence in children,AFR0300,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,59.3
24811,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,33.5
25255,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,93.2
25429,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,80
26905,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,89
27666,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,92
28097,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,97
32435,1,AFRO Region,Coverage (%) - All Social Assistance,AFR0153,2016,999,Not Applicable,2,Per 1000 live births,4,WB Database,27.61
32664,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2016,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,33.49
32902,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2016,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,6.98
37274,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2016,11,Rural,2,Per 1000 live births,3,WHO / GHO,27.07
37275,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2016,29,Total,2,Per 1000 live births,3,WHO / GHO,36.84
37276,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2016,12,Urban,2,Per 1000 live births,3,WHO / GHO,45.48
37487,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2016,11,Rural,2,Per 1000 live births,5,UNICEF,33.94
37488,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2016,29,Total,2,Per 1000 live births,5,UNICEF,22.87
37489,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2016,12,Urban,2,Per 1000 live births,5,UNICEF,7.95
37585,1,AFRO Region,Annual mean concentrations of fine particulate matter (PM2.5) in urban areas(g/m3),AFR0026,2016,12,Urban,2,Per 1000 live births,3,WHO / GHO,7.95
38518,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2016,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,20.87
39583,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2016,8,Male,2,Per 1000 live births,20,ITU,18.18
39592,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2016,9,Female,2,Per 1000 live births,20,ITU,4.54
39709,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2016,28,Both sexes (male and female),2,Per 1000 live births,21,ILO,26.31
39719,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2016,8,Male,2,Per 1000 live births,21,ILO,26.89
39729,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2016,9,Female,2,Per 1000 live births,21,ILO,25.7
40630,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2016,999,Not Applicable,2,Per 1000 live births,19,OECD,4819.61
41109,1,AFRO Region,DTP dropout rate (DTP1 -DPT3),AFR0226,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,7.4
42141,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,14
42142,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,2870
42143,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
42144,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,46,Measles,2,Per 1000 live births,1,WHO/AFRO,36269
42145,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,100576
42146,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,1183
42147,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,1435
42148,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,51,Polio,2,Per 1000 live births,1,WHO/AFRO,5
42149,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,4157
42150,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,5787
42151,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,1040
47465,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2016,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,80.5
95335,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,80.5
118682,1,AFRO Region,Top 10 Causes of death,AFR0431,2016,999,Not Applicable,3,String,3,WHO / GHO,\N
64991,1,AFRO Region,Population size (in thousands) total,AFR0004,2016,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,1015368
64993,1,AFRO Region,Population size (in thousands) total,AFR0004,2016,28,Both sexes (male and female),5,Count (Numeric Integer),17,UN Population,1009586
77959,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2016,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,14
77960,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2016,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,2870
77961,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2016,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
77962,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2016,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,36269
77963,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2016,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,100576
77964,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2016,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,1183
77965,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2016,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,1435
77966,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2016,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,5
77967,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2016,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,4157
77968,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2016,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,5787
77969,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2016,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,1040
99386,1,AFRO Region,"Pre-primary education, duration (years)",AFR0392,2016,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,3
145441,1,AFRO Region,Number of people living with HIV,AFR0019,2016,29,Total,5,Count (Numeric Integer),16,UNAIDS,24400000
147536,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2016,29,Total,5,Count (Numeric Integer),35,IHME,2984335
102370,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2016,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,9
143796,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2016,29,Total,6,Per 1000 population,16,UNAIDS,1.17
62245,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2016,9,Female,7,per 100 000 live births,23,MMEIG,536
47566,1,AFRO Region,Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2),AFR0096,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,38.9
47614,1,AFRO Region,Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2),AFR0096,2016,8,Male,8,Per 100 000 population,3,WHO / GHO,40.4
47662,1,AFRO Region,Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2),AFR0096,2016,9,Female,8,Per 100 000 population,3,WHO / GHO,37.5
74199,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2016,8,Male,8,Per 100 000 population,13,UNStat,18.18
74208,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2016,9,Female,8,Per 100 000 population,13,UNStat,4.54
120938,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,20.6
121178,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2016,8,Male,8,Per 100 000 population,3,WHO / GHO,21.1
121418,1,AFRO Region,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2016,9,Female,8,Per 100 000 population,3,WHO / GHO,20.1
130187,1,AFRO Region,Mortality rate attributed to household and ambient air pollution [SDG 3.9.1],AFR0132,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,180.9
130235,1,AFRO Region,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,2.7
92945,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2016,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,4819.6
75085,1,AFRO Region,Gender development index score,AFR0347,2016,28,Both sexes (male and female),12,Index,14,UNDP,0.88
10997,1,AFRO Region,Number of people living with HIV,AFR0019,2017,28,Both sexes (male and female),1,Percentage,16,UNAIDS,25586600
11458,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2017,9,Female,1,Percentage,3,WHO / GHO,525
68311,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,78
68862,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,33
69285,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,68
71350,1,AFRO Region,Coverage of essential health services,AFR0128,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,46
72751,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2017,9,Female,1,Percentage,18,Inter-Parliamentary Union,21.63
72984,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2017,28,Both sexes (male and female),1,Percentage,5,UNICEF,1.5
73464,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91
74020,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2017,28,Both sexes (male and female),1,Percentage,15,UNESCO,32.25
74024,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2017,9,Female,1,Percentage,15,UNESCO,29.95
74458,1,AFRO Region,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2017,999,Not Applicable,1,Percentage,3,WHO / GHO,56
75200,1,AFRO Region,"Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting, by age (%)",AFR0103,2017,9,Female,1,Percentage,5,UNICEF,37.7
75228,1,AFRO Region,Prevalence of female genital mutilation/cutting [SDG 5.3.2],AFR0298,2017,9,Female,1,Percentage,5,UNICEF,37.7
75365,1,AFRO Region,GDP growth (annual %),AFR0388,2017,999,Not Applicable,1,Percentage,22,UN DESA,1.31
75545,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2017,9,Female,1,Percentage,1,WHO/AFRO,28
76081,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91.4
85694,1,AFRO Region,Vitamin A supplementation coverage,AFR0185,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,67.4
85813,1,AFRO Region,Availability of basic equipment,AFR0350,2017,999,Not Applicable,1,Percentage,1,WHO/AFRO,81
86015,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,81
91245,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2017,28,Both sexes (male and female),1,Percentage,15,UNESCO,55.83
91249,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2017,9,Female,1,Percentage,15,UNESCO,58.1
91253,1,AFRO Region,"Primary completion rate, total (% of relevant age group)",AFR0159,2017,8,Male,1,Percentage,15,UNESCO,53.47
91449,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,90
91489,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,96
91920,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,93
92045,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2017,28,Both sexes (male and female),1,Percentage,5,UNICEF,1.5
95749,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,93
96008,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,88
103021,1,AFRO Region,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2017,999,Not Applicable,1,Percentage,4,WB Database,35.53
112504,1,AFRO Region,Pneumococcal vaccination coverage,AFR0186,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,69
113521,1,AFRO Region,TB treatment coverage,AFR0173,2017,29,Total,1,Percentage,3,WHO / GHO,52
124313,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2017,28,Both sexes (male and female),1,Percentage,35,IHME,1.05
125753,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2017,8,Male,1,Percentage,35,IHME,1.1
127193,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2017,9,Female,1,Percentage,35,IHME,1.01
135272,1,AFRO Region,General Government Health Expenditure (GGHE) as % of Total health expenditure (GGE),AFR0272,2017,999,Not Applicable,1,Percentage,3,WHO / GHO,7.2
135560,1,AFRO Region,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29
135608,1,AFRO Region,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,20
135656,1,AFRO Region,Proportion of population using a hand-washing facility with soap and water (%),AFR0437,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28
137246,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2017,29,Total,1,Percentage,36,WHO/UNICEF,73
147071,1,AFRO Region,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",AFR0442,2017,29,Total,1,Percentage,13,UNStat,5
147254,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2017,29,Total,1,Percentage,36,WHO/UNICEF,24
147352,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2017,29,Total,1,Percentage,36,WHO/UNICEF,69
148169,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2017,107,Female (10-14 years),1,Percentage,35,IHME,41.12
148507,1,AFRO Region,Annual expenditure on reproductive health from government domestic health budget,AFR0456,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,15.21
148602,1,AFRO Region,Annual expenditure on family planning from government domestic health budget,AFR0452,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,2.35
150911,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2017,66,Female (15-49 years),1,Percentage,35,IHME,22.89
207904,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,69
4437,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2017,37,Both sexes (15-24 years),2,Per 1000 live births,1,WHO/AFRO,9.9
4443,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2017,36,Female (15-24 years),2,Per 1000 live births,1,WHO/AFRO,10.1
4449,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2017,35,Male (15-24 years),2,Per 1000 live births,1,WHO/AFRO,9.8
4517,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2017,38,Both sexes (25+ years),2,Per 1000 live births,1,WHO/AFRO,4.7
4523,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2017,40,Female (25+ years),2,Per 1000 live births,1,WHO/AFRO,5
4529,1,AFRO Region,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2017,39,Male (25+ years),2,Per 1000 live births,1,WHO/AFRO,4.3
11002,1,AFRO Region,HIV prevalence among adults aged 15-49 years (%),AFR0377,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,4.1
11391,1,AFRO Region,Population size (in thousands) total,AFR0004,2017,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,1036702.48
13789,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,27.67
15829,1,AFRO Region,AIDS-related mortality rate (per 100 000 population),AFR0014,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,46.69
18277,1,AFRO Region,TB mortality rate (per 100 000 population),AFR0013,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,39
18285,1,AFRO Region,Malaria mortality rate (per 100 000 population),AFR0015,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,44.1
20153,1,AFRO Region,Infant mortality rate (per 1 000 live births),AFR0009,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,50.6
20255,1,AFRO Region,HIV incidence rate per 1000 uninfected population [SDG 3.3.1],AFR0395,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.18
20821,1,AFRO Region,TB incidence rate [SDG 3.3.2],AFR0334,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,238.45
20867,1,AFRO Region,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,219.38
23592,1,AFRO Region,Coverage of essential health services,AFR0128,2017,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,46
24810,1,AFRO Region,Contraceptive prevalence rate,AFR0208,2017,9,Female,2,Per 1000 live births,3,WHO / GHO,28
25256,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,91.4
25430,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,81
26476,1,AFRO Region,Vitamin A supplementation coverage,AFR0185,2017,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,67.4
26906,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,91
27667,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,93
28098,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,96
32665,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2017,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,21.65
32903,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2017,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,6.13
37277,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2017,11,Rural,2,Per 1000 live births,3,WHO / GHO,28.41
37278,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2017,29,Total,2,Per 1000 live births,3,WHO / GHO,38.16
37279,1,AFRO Region,Proportion of population using improved sanitation (%),AFR0024,2017,12,Urban,2,Per 1000 live births,3,WHO / GHO,46.39
37490,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2017,11,Rural,2,Per 1000 live births,5,UNICEF,32.09
37491,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2017,29,Total,2,Per 1000 live births,5,UNICEF,21.29
37492,1,AFRO Region,People practicing open defecation (%) of population),AFR0025,2017,12,Urban,2,Per 1000 live births,5,UNICEF,7.09
38519,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2017,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,24.91
39584,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2017,8,Male,2,Per 1000 live births,20,ITU,20.89
39593,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2017,9,Female,2,Per 1000 live births,20,ITU,4.02
39710,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2017,28,Both sexes (male and female),2,Per 1000 live births,21,ILO,20.33
39720,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2017,8,Male,2,Per 1000 live births,21,ILO,20.25
39730,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2017,9,Female,2,Per 1000 live births,21,ILO,20.35
40631,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2017,999,Not Applicable,2,Per 1000 live births,19,OECD,5773.99
41110,1,AFRO Region,DTP dropout rate (DTP1 -DPT3),AFR0226,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,6.5
41787,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,24
41788,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,118
41789,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
41790,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,46,Measles,2,Per 1000 live births,1,WHO/AFRO,72603
41791,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,41490
41792,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,979
41793,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,7082
41794,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,51,Polio,2,Per 1000 live births,1,WHO/AFRO,22
41795,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,6166
41796,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,2791
41797,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,53
47466,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2017,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,78.1
95336,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,78.1
77605,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2017,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,24
77606,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2017,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,118
77607,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2017,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
77608,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2017,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,72603
77609,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2017,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,41490
77610,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2017,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,979
77611,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2017,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,7082
77612,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2017,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,22
77613,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2017,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,6166
77614,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2017,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,2791
77615,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2017,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,53
99385,1,AFRO Region,"Pre-primary education, duration (years)",AFR0392,2017,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,3
130043,1,AFRO Region,Coverage of essential health services,AFR0128,2017,999,Not Applicable,5,Count (Numeric Integer),3,WHO / GHO,46
145487,1,AFRO Region,Number of people living with HIV,AFR0019,2017,29,Total,5,Count (Numeric Integer),16,UNAIDS,24900000
147584,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2017,29,Total,5,Count (Numeric Integer),35,IHME,3120768
102371,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2017,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,8.78
143840,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2017,29,Total,6,Per 1000 population,16,UNAIDS,1.09
62246,1,AFRO Region,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2017,9,Female,7,per 100 000 live births,23,MMEIG,525
74200,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2017,8,Male,8,Per 100 000 population,13,UNStat,20.89
74209,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2017,9,Female,8,Per 100 000 population,13,UNStat,4.02
135848,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2017,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,10.5
92946,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2017,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,5773.98
75129,1,AFRO Region,Gender development index score,AFR0347,2017,28,Both sexes (male and female),12,Index,14,UNDP,0.88
10998,1,AFRO Region,Number of people living with HIV,AFR0019,2018,28,Both sexes (male and female),1,Percentage,16,UNAIDS,25647300
13977,1,AFRO Region,Proportion of women aged 20-24 years who were married or in a union by age 18 (%),AFR0102,2018,9,Female,1,Percentage,1,WHO/AFRO,37
66960,1,AFRO Region,Early marriage,AFR0315,2018,9,Female,1,Percentage,3,WHO / GHO,37
68357,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,78
68889,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,33
69326,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,68
72752,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2018,9,Female,1,Percentage,18,Inter-Parliamentary Union,21.39
72985,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2018,28,Both sexes (male and female),1,Percentage,5,UNICEF,3.4
73465,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,90
74029,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2018,9,Female,1,Percentage,15,UNESCO,13.41
74031,1,AFRO Region,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2018,8,Male,1,Percentage,15,UNESCO,25
74506,1,AFRO Region,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2018,999,Not Applicable,1,Percentage,3,WHO / GHO,42
74643,1,AFRO Region,"IHR Coordination, Communication and Advocacy",AFR0035,2018,999,Not Applicable,1,Percentage,3,WHO / GHO,46
75201,1,AFRO Region,"Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting, by age (%)",AFR0103,2018,9,Female,1,Percentage,5,UNICEF,69.6
75229,1,AFRO Region,Prevalence of female genital mutilation/cutting [SDG 5.3.2],AFR0298,2018,9,Female,1,Percentage,5,UNICEF,69.6
75366,1,AFRO Region,GDP growth (annual %),AFR0388,2018,999,Not Applicable,1,Percentage,22,UN DESA,1.65
76082,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91.2
85818,1,AFRO Region,Availability of basic equipment,AFR0350,2018,999,Not Applicable,1,Percentage,1,WHO/AFRO,58
86016,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,83
91450,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,85
91490,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,96
91921,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,92
92046,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2018,28,Both sexes (male and female),1,Percentage,5,UNICEF,3.4
95750,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,92
96009,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,88
112543,1,AFRO Region,Pneumococcal vaccination coverage,AFR0186,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,69
113567,1,AFRO Region,TB treatment coverage,AFR0173,2018,29,Total,1,Percentage,3,WHO / GHO,55
124361,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2018,28,Both sexes (male and female),1,Percentage,35,IHME,1.07
125801,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2018,8,Male,1,Percentage,35,IHME,1.11
127241,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2018,9,Female,1,Percentage,35,IHME,1.02
130236,1,AFRO Region,Tobacco use among persons aged 15+ years - [SDG 3.a.1] (Also: adolescents),AFR0307,2018,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,12.7
130284,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2018,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,76
130332,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2018,999,Not Applicable,1,Percentage,3,WHO / GHO,26
130380,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2018,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,73
130419,1,AFRO Region,Immunization coverage against HPV,AFR0188,2018,9,Female,1,Percentage,3,WHO / GHO,8
135704,1,AFRO Region,Amount of water and sanitation-related official development assistance that is part of a government coordinated spending plan (constant 2017 US $ millions),AFR0438,2018,999,Not Applicable,1,Percentage,3,WHO / GHO,2774.35
135752,1,AFRO Region,Proportion of population with primary reliance on clean fuels (%) -[SDG 7.1.2],AFR0126,2018,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,18
137294,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2018,29,Total,1,Percentage,36,WHO/UNICEF,73
147078,1,AFRO Region,"Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)",AFR0442,2018,29,Total,1,Percentage,13,UNStat,7
147281,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2018,29,Total,1,Percentage,36,WHO/UNICEF,25
147354,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2018,29,Total,1,Percentage,36,WHO/UNICEF,69
148170,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2018,107,Female (10-14 years),1,Percentage,35,IHME,40.21
148508,1,AFRO Region,Annual expenditure on reproductive health from government domestic health budget,AFR0456,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,15.46
148603,1,AFRO Region,Annual expenditure on family planning from government domestic health budget,AFR0452,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,2.08
150912,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2018,66,Female (15-49 years),1,Percentage,35,IHME,22.2
207905,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,69
10161,1,AFRO Region,Population size (in thousands) total,AFR0004,2018,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,1074844
11003,1,AFRO Region,HIV prevalence among adults aged 15-49 years (%),AFR0377,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,3.9
13790,1,AFRO Region,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,27.16
13932,1,AFRO Region,"Adolescent birth rate (per 1,000 women aged 15-19 years)",AFR0106,2018,9,Female,2,Per 1000 live births,3,WHO / GHO,99.1
15876,1,AFRO Region,AIDS-related mortality rate (per 100 000 population),AFR0014,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,43.91
20256,1,AFRO Region,HIV incidence rate per 1000 uninfected population [SDG 3.3.1],AFR0395,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.03
20822,1,AFRO Region,TB incidence rate [SDG 3.3.2],AFR0334,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,230.59
23336,1,AFRO Region,Early marriage,AFR0315,2018,9,Female,2,Per 1000 live births,1,WHO/AFRO,37
25257,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,91.2
25431,1,AFRO Region,Immunization coverage against Rotavirus vaccine,AFR0187,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,83
25479,1,AFRO Region,Adolescent birth rate [SDG 3.7.2],AFR0293,2018,9,Female,2,Per 1000 live births,20,ITU,99.1
27668,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,92
28099,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,96
32666,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2018,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,33.66
32904,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2018,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,6.56
38520,1,AFRO Region,Individuals using the Internet (% of population),AFR0033,2018,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,34.8
39585,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2018,8,Male,2,Per 1000 live births,20,ITU,20.43
39594,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2018,9,Female,2,Per 1000 live births,20,ITU,4.25
39711,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2018,28,Both sexes (male and female),2,Per 1000 live births,21,ILO,15.4
39721,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2018,8,Male,2,Per 1000 live births,21,ILO,15.8
39731,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2018,9,Female,2,Per 1000 live births,21,ILO,14.95
40632,1,AFRO Region,Net official development assistance received (current US$),AFR0031,2018,999,Not Applicable,2,Per 1000 live births,19,OECD,5865.48
41111,1,AFRO Region,DTP dropout rate (DTP1 -DPT3),AFR0226,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,6.6
41451,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,18
41452,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,1971
41453,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
41454,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,46,Measles,2,Per 1000 live births,1,WHO/AFRO,125426
41455,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,54482
41456,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,1130
41457,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,14001
41458,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,51,Polio,2,Per 1000 live births,1,WHO/AFRO,65
41459,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,11787
41460,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,5235
41461,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,734
47467,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2018,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,76
95337,1,AFRO Region,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,76
64992,1,AFRO Region,Population size (in thousands) total,AFR0004,2018,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,1074844
77269,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2018,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,18
77270,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2018,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,1971
77271,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2018,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
77272,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2018,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,125426
77273,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2018,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,54482
77274,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2018,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,1130
77275,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2018,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,14001
77276,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2018,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,65
77277,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2018,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,11787
77278,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2018,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,5235
77279,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2018,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,734
99384,1,AFRO Region,"Pre-primary education, duration (years)",AFR0392,2018,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,3
129896,1,AFRO Region,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2018,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,592459240
129899,1,AFRO Region,Total alcohol per capita (age 15+ years) consumption [SDG 3.5.2],AFR0310,2018,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,5.9
145533,1,AFRO Region,Number of people living with HIV,AFR0019,2018,29,Total,5,Count (Numeric Integer),16,UNAIDS,25300000
147632,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2018,29,Total,5,Count (Numeric Integer),35,IHME,3271501
102372,1,AFRO Region,Crude death rate (per 1 000 mid-year population),AFR0005,2018,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,8.58
143884,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2018,29,Total,6,Per 1000 population,16,UNAIDS,1
74201,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2018,8,Male,8,Per 100 000 population,13,UNStat,20.43
74210,1,AFRO Region,Number of victims of intentional homicide per 100 000 population,AFR0028,2018,9,Female,8,Per 100 000 population,13,UNStat,4.25
65041,1,AFRO Region,Adolescent birth rate [SDG 3.7.2],AFR0293,2018,9,Female,9,Per 1000 women aged 15-19 years,3,WHO / GHO,99.1
71255,1,AFRO Region,Adolescent birth rate [SDG 3.7.2],AFR0293,2018,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,99.1
92947,1,AFRO Region,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2018,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,5865.47
75173,1,AFRO Region,Gender development index score,AFR0347,2018,28,Both sexes (male and female),12,Index,14,UNDP,0.88
129517,1,AFRO Region,Population size (in thousands) total,AFR0004,2018,8,Male,18,in thousands,50,World Health Statistics,526984
129563,1,AFRO Region,Population size (in thousands) total,AFR0004,2018,9,Female,18,in thousands,50,World Health Statistics,528865
129609,1,AFRO Region,Population size (in thousands) total,AFR0004,2018,28,Both sexes (male and female),18,in thousands,50,World Health Statistics,1048197
129656,1,AFRO Region,Population size (in thousands) total,AFR0004,2018,8,Male,18,in thousands,3,WHO / GHO,526984
129703,1,AFRO Region,Population size (in thousands) total,AFR0004,2018,9,Female,18,in thousands,3,WHO / GHO,528865
130421,1,AFRO Region,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2018,999,Not Applicable,23,Numeric,3,WHO / GHO,4.42
72753,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2019,9,Female,1,Percentage,18,Inter-Parliamentary Union,21.44
72986,1,AFRO Region,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2019,28,Both sexes (male and female),1,Percentage,5,UNICEF,2.9
74554,1,AFRO Region,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2019,999,Not Applicable,1,Percentage,3,WHO / GHO,44
74644,1,AFRO Region,"IHR Coordination, Communication and Advocacy",AFR0035,2019,999,Not Applicable,1,Percentage,3,WHO / GHO,50
92047,1,AFRO Region,Prevalence of overweight in children under 5 u (%),AFR0156,2019,28,Both sexes (male and female),1,Percentage,5,UNICEF,2.9
112146,1,AFRO Region,Percentage of pregnant women that made four or more ANC visits,AFR0135,2019,9,Female,1,Percentage,44,DHS/MICS,54.3
112332,1,AFRO Region,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2019,9,Female,1,Percentage,44,DHS/MICS,82.8
112583,1,AFRO Region,Pneumococcal vaccination coverage,AFR0186,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,70
113568,1,AFRO Region,TB treatment coverage,AFR0173,2019,29,Total,1,Percentage,3,WHO / GHO,57
124409,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2019,28,Both sexes (male and female),1,Percentage,35,IHME,1.09
125849,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2019,8,Male,1,Percentage,35,IHME,1.13
127289,1,AFRO Region,Prevalence chronic obstructive pulmonary diseases,AFR0319,2019,9,Female,1,Percentage,35,IHME,1.04
137342,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2019,29,Total,1,Percentage,36,WHO/UNICEF,74
147308,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2019,29,Total,1,Percentage,36,WHO/UNICEF,33
147356,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2019,29,Total,1,Percentage,36,WHO/UNICEF,70
148171,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2019,107,Female (10-14 years),1,Percentage,35,IHME,40.08
150913,1,AFRO Region,Percentage of maternal deaths due to unsafe abortion,AFR0447,2019,66,Female (15-49 years),1,Percentage,35,IHME,22.25
207649,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,74
207758,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,33
207820,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,70
207906,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,70
32667,1,AFRO Region,Prevalence of stunting in children under 5 u (%),AFR0154,2019,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,32.57
32905,1,AFRO Region,Prevalence of wasting in children under 5 u (%),AFR0155,2019,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,5.74
39712,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2019,28,Both sexes (male and female),2,Per 1000 live births,21,ILO,27.9
39722,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2019,8,Male,2,Per 1000 live births,21,ILO,33.1
39732,1,AFRO Region,"Children in employment, total (% of children ages 7-14)",AFR0030,2019,9,Female,2,Per 1000 live births,21,ILO,22.4
41112,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,9
41113,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,11400
41114,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
41115,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,46,Measles,2,Per 1000 live births,1,WHO/AFRO,618595
41116,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,38795
41117,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,1151
41118,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,4121
41119,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,51,Polio,2,Per 1000 live births,1,WHO/AFRO,318
41120,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,6027
41121,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,49,Non-neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,3606
41122,1,AFRO Region,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,360
76930,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2019,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,9
76931,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2019,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,11400
76932,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2019,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
76933,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2019,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,618595
76934,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2019,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,38795
76935,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2019,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,1151
76936,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2019,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,4121
76937,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2019,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,318
76938,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2019,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,6027
76939,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2019,60,Non-neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,3606
76940,1,AFRO Region,New cases of vaccine-preventable diseases,AFR0324,2019,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,360
99383,1,AFRO Region,"Pre-primary education, duration (years)",AFR0392,2019,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,3
135896,1,AFRO Region,Number of cases of poliomyelitis caused by wild poliovirus (WPV),AFR0425,2019,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,0
145579,1,AFRO Region,Number of people living with HIV,AFR0019,2019,29,Total,5,Count (Numeric Integer),16,UNAIDS,25700000
147680,1,AFRO Region,Number of cancer cases (all cause),AFR0321,2019,29,Total,5,Count (Numeric Integer),35,IHME,3420609
143928,1,AFRO Region,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2019,29,Total,6,Per 1000 population,16,UNAIDS,0.94
72754,1,AFRO Region,Proportion of seats held by women in national parliaments (%),AFR0034,2020,9,Female,1,Percentage,18,Inter-Parliamentary Union,21.84
207650,1,AFRO Region,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2020,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,72
207759,1,AFRO Region,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2020,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,36
207821,1,AFRO Region,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2020,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,68
207907,1,AFRO Region,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2020,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,68
130556,2,ALGERIA,Total fertility rate,AFR0130,1950-1955,9,Female,1,Percentage,17,UN Population,7.28
130557,2,ALGERIA,Total fertility rate,AFR0130,1955-1960,9,Female,1,Percentage,17,UN Population,7.38
130558,2,ALGERIA,Total fertility rate,AFR0130,1960-1965,9,Female,1,Percentage,17,UN Population,7.65
128455,2,ALGERIA,Sex ratio at birth,AFR0428,1962,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
130559,2,ALGERIA,Total fertility rate,AFR0130,1965-1970,9,Female,1,Percentage,17,UN Population,7.65
128454,2,ALGERIA,Sex ratio at birth,AFR0428,1967,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
127847,2,ALGERIA,Life expectancy at birth (years),AFR0381,1970,28,Both sexes (male and female),17,years,4,WB Database,50.37
130560,2,ALGERIA,Total fertility rate,AFR0130,1970-1975,9,Female,1,Percentage,17,UN Population,7.57
131543,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1971,28,Both sexes (male and female),1,Percentage,4,WB Database,74.47
131544,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1972,28,Both sexes (male and female),1,Percentage,4,WB Database,78.6
128453,2,ALGERIA,Sex ratio at birth,AFR0428,1972,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
131545,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1973,28,Both sexes (male and female),1,Percentage,4,WB Database,83.28
134182,2,ALGERIA,School dropout rate,AFR0160,1973,28,Both sexes (male and female),1,Percentage,42,WDI,32.13
131546,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1974,28,Both sexes (male and female),1,Percentage,4,WB Database,87.05
134183,2,ALGERIA,School dropout rate,AFR0160,1974,28,Both sexes (male and female),1,Percentage,42,WDI,28.22
86017,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1975,8,Male,1,Percentage,3,WHO / GHO,30.7
86018,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1975,9,Female,1,Percentage,3,WHO / GHO,32.1
86019,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1975,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.5
131547,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1975,28,Both sexes (male and female),1,Percentage,4,WB Database,89.16
134184,2,ALGERIA,School dropout rate,AFR0160,1975,28,Both sexes (male and female),1,Percentage,42,WDI,25.81
196898,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1975,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.9
198743,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1975,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,26.6
130561,2,ALGERIA,Total fertility rate,AFR0130,1975-1980,9,Female,1,Percentage,17,UN Population,7.18
86155,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1976,8,Male,1,Percentage,3,WHO / GHO,30.6
86156,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1976,9,Female,1,Percentage,3,WHO / GHO,32.1
86157,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1976,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.5
131548,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1976,28,Both sexes (male and female),1,Percentage,4,WB Database,92.15
134185,2,ALGERIA,School dropout rate,AFR0160,1976,28,Both sexes (male and female),1,Percentage,42,WDI,23.84
196899,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1976,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.2
198744,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1976,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27
86293,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1977,8,Male,1,Percentage,3,WHO / GHO,30.5
86294,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1977,9,Female,1,Percentage,3,WHO / GHO,32.1
86295,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1977,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.5
131549,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1977,28,Both sexes (male and female),1,Percentage,4,WB Database,94.1
134186,2,ALGERIA,School dropout rate,AFR0160,1977,28,Both sexes (male and female),1,Percentage,42,WDI,22.27
196900,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1977,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.4
198745,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1977,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.5
128452,2,ALGERIA,Sex ratio at birth,AFR0428,1977,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
86431,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1978,8,Male,1,Percentage,3,WHO / GHO,30.5
86432,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1978,9,Female,1,Percentage,3,WHO / GHO,32.2
86433,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1978,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.5
131550,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1978,28,Both sexes (male and female),1,Percentage,4,WB Database,95.15
134187,2,ALGERIA,School dropout rate,AFR0160,1978,28,Both sexes (male and female),1,Percentage,42,WDI,21.22
196901,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1978,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.7
198746,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1978,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28
86569,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1979,8,Male,1,Percentage,3,WHO / GHO,30.4
86570,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1979,9,Female,1,Percentage,3,WHO / GHO,32.2
86571,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1979,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.5
131551,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1979,28,Both sexes (male and female),1,Percentage,4,WB Database,94.87
134188,2,ALGERIA,School dropout rate,AFR0160,1979,28,Both sexes (male and female),1,Percentage,42,WDI,21.13
196902,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1979,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8
198747,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1979,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.5
47663,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1980,8,Male,1,Percentage,3,WHO / GHO,4.7
47664,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1980,9,Female,1,Percentage,3,WHO / GHO,5.6
47665,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1980,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.2
86707,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1980,8,Male,1,Percentage,3,WHO / GHO,30.4
86708,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1980,9,Female,1,Percentage,3,WHO / GHO,32.3
86709,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1980,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.5
131552,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1980,28,Both sexes (male and female),1,Percentage,4,WB Database,94.77
134189,2,ALGERIA,School dropout rate,AFR0160,1980,28,Both sexes (male and female),1,Percentage,42,WDI,20.01
196903,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1980,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8.3
198748,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1980,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29
141510,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1980,124,Geophysical,5,Count (Numeric Integer),35,IHME,2633
130562,2,ALGERIA,Total fertility rate,AFR0130,1980-1985,9,Female,1,Percentage,17,UN Population,6.32
47801,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1981,8,Male,1,Percentage,3,WHO / GHO,4.8
47802,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1981,9,Female,1,Percentage,3,WHO / GHO,5.7
47803,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1981,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.3
86845,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1981,8,Male,1,Percentage,3,WHO / GHO,30.4
86846,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1981,9,Female,1,Percentage,3,WHO / GHO,32.3
86847,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1981,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.5
131553,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1981,28,Both sexes (male and female),1,Percentage,4,WB Database,93.68
134190,2,ALGERIA,School dropout rate,AFR0160,1981,28,Both sexes (male and female),1,Percentage,42,WDI,19.75
196904,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1981,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8.6
198749,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1981,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29.6
142024,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1981,126,Hydrological,5,Count (Numeric Integer),35,IHME,43
47939,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1982,8,Male,1,Percentage,3,WHO / GHO,4.9
47940,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1982,9,Female,1,Percentage,3,WHO / GHO,5.8
47941,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1982,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.4
86983,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1982,8,Male,1,Percentage,3,WHO / GHO,30.4
86984,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1982,9,Female,1,Percentage,3,WHO / GHO,32.4
86985,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1982,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.6
131554,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1982,28,Both sexes (male and female),1,Percentage,4,WB Database,92.56
134191,2,ALGERIA,School dropout rate,AFR0160,1982,28,Both sexes (male and female),1,Percentage,42,WDI,20.07
196905,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1982,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9
198750,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1982,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.3
128451,2,ALGERIA,Sex ratio at birth,AFR0428,1982,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
142026,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1982,126,Hydrological,5,Count (Numeric Integer),35,IHME,37
48077,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1983,8,Male,1,Percentage,3,WHO / GHO,5.1
48078,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1983,9,Female,1,Percentage,3,WHO / GHO,6
48079,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1983,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.5
87121,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,8,Male,1,Percentage,3,WHO / GHO,30.5
87122,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,9,Female,1,Percentage,3,WHO / GHO,32.5
87123,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.6
131555,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1983,28,Both sexes (male and female),1,Percentage,4,WB Database,91.36
134192,2,ALGERIA,School dropout rate,AFR0160,1983,28,Both sexes (male and female),1,Percentage,42,WDI,20.74
196906,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1983,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9.4
198751,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1983,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31
7179,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.5
7180,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.5
7181,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.6
48215,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1984,8,Male,1,Percentage,3,WHO / GHO,5.2
48216,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1984,9,Female,1,Percentage,3,WHO / GHO,6.1
48217,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1984,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.7
87259,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,8,Male,1,Percentage,3,WHO / GHO,30.5
87260,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,9,Female,1,Percentage,3,WHO / GHO,32.5
87261,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.7
131556,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1984,28,Both sexes (male and female),1,Percentage,4,WB Database,90.95
134193,2,ALGERIA,School dropout rate,AFR0160,1984,28,Both sexes (male and female),1,Percentage,42,WDI,19.71
196907,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1984,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9.7
198752,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1984,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.7
7182,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.5
7183,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.5
7184,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.7
142028,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1984,126,Hydrological,5,Count (Numeric Integer),35,IHME,54
48353,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1985,8,Male,1,Percentage,3,WHO / GHO,5.4
48354,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1985,9,Female,1,Percentage,3,WHO / GHO,6.3
48355,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1985,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.8
87397,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,8,Male,1,Percentage,3,WHO / GHO,30.5
87398,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,9,Female,1,Percentage,3,WHO / GHO,32.6
87399,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.7
131557,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1985,28,Both sexes (male and female),1,Percentage,4,WB Database,90.08
134194,2,ALGERIA,School dropout rate,AFR0160,1985,28,Both sexes (male and female),1,Percentage,42,WDI,19.35
196908,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1985,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,10.2
198753,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1985,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,32.5
7185,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.5
7186,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.6
7187,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.7
141514,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1985,124,Geophysical,5,Count (Numeric Integer),35,IHME,30
142029,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1985,126,Hydrological,5,Count (Numeric Integer),35,IHME,26
130563,2,ALGERIA,Total fertility rate,AFR0130,1985-1990,9,Female,1,Percentage,17,UN Population,5.3
48491,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1986,8,Male,1,Percentage,3,WHO / GHO,5.6
48492,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1986,9,Female,1,Percentage,3,WHO / GHO,6.4
48493,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1986,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6
87535,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,8,Male,1,Percentage,3,WHO / GHO,30.5
87536,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,9,Female,1,Percentage,3,WHO / GHO,32.6
87537,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.7
131558,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1986,28,Both sexes (male and female),1,Percentage,4,WB Database,89.05
134195,2,ALGERIA,School dropout rate,AFR0160,1986,28,Both sexes (male and female),1,Percentage,42,WDI,18.18
196909,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1986,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,10.6
198754,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1986,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,33.2
7188,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.5
7189,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.6
7190,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.7
48629,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1987,8,Male,1,Percentage,3,WHO / GHO,5.7
48630,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1987,9,Female,1,Percentage,3,WHO / GHO,6.6
48631,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1987,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.2
87673,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,8,Male,1,Percentage,3,WHO / GHO,30.5
87674,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,9,Female,1,Percentage,3,WHO / GHO,32.6
87675,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.7
131559,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1987,28,Both sexes (male and female),1,Percentage,4,WB Database,90.25
134196,2,ALGERIA,School dropout rate,AFR0160,1987,28,Both sexes (male and female),1,Percentage,42,WDI,16.86
196910,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1987,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11
198755,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1987,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,34
7191,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.5
7192,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.6
7193,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.7
128450,2,ALGERIA,Sex ratio at birth,AFR0428,1987,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
141516,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1987,124,Geophysical,5,Count (Numeric Integer),35,IHME,1
207397,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,1987-1992,28,Both sexes (male and female),1,Percentage,5,UNICEF,76.5
48767,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1988,8,Male,1,Percentage,3,WHO / GHO,5.9
48768,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1988,9,Female,1,Percentage,3,WHO / GHO,6.7
48769,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1988,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.4
87811,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,8,Male,1,Percentage,3,WHO / GHO,30.5
87812,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,9,Female,1,Percentage,3,WHO / GHO,32.6
87813,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.7
131560,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1988,28,Both sexes (male and female),1,Percentage,4,WB Database,91.76
134197,2,ALGERIA,School dropout rate,AFR0160,1988,28,Both sexes (male and female),1,Percentage,42,WDI,15.74
196911,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1988,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.5
198756,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1988,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,34.7
7194,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.5
7195,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.6
7196,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.7
202185,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,1988-1992,29,Total,1,Percentage,36,WHO/UNICEF,58
48905,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1989,8,Male,1,Percentage,3,WHO / GHO,6.1
48906,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1989,9,Female,1,Percentage,3,WHO / GHO,6.9
48907,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1989,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.5
87949,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,8,Male,1,Percentage,3,WHO / GHO,30.5
87950,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,9,Female,1,Percentage,3,WHO / GHO,32.6
87951,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.7
131561,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1989,28,Both sexes (male and female),1,Percentage,4,WB Database,92
134198,2,ALGERIA,School dropout rate,AFR0160,1989,28,Both sexes (male and female),1,Percentage,42,WDI,14.66
196912,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1989,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.9
198757,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1989,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,35.5
7197,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.5
7198,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.6
7199,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.7
141517,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1989,124,Geophysical,5,Count (Numeric Integer),35,IHME,22
11459,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,1990,9,Female,1,Percentage,3,WHO / GHO,216
49043,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1990,8,Male,1,Percentage,3,WHO / GHO,6.3
49044,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1990,9,Female,1,Percentage,3,WHO / GHO,7.1
49045,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1990,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.7
88087,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1990,8,Male,1,Percentage,3,WHO / GHO,30.4
88088,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1990,9,Female,1,Percentage,3,WHO / GHO,32.5
88089,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1990,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.6
98487,2,ALGERIA,Immunization coverage against Tetanus,AFR0189,1990,28,Both sexes (male and female),1,Percentage,4,WB Database,89
109992,2,ALGERIA,TB case detection rate,AFR0176,1990,29,Total,1,Percentage,3,WHO / GHO,67
123018,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1990,28,Both sexes (male and female),1,Percentage,35,IHME,0.89
124458,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1990,8,Male,1,Percentage,35,IHME,0.95
125898,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1990,9,Female,1,Percentage,35,IHME,0.83
131562,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1990,28,Both sexes (male and female),1,Percentage,4,WB Database,92.59
134199,2,ALGERIA,School dropout rate,AFR0160,1990,28,Both sexes (male and female),1,Percentage,42,WDI,14.13
135994,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1990,29,Total,1,Percentage,36,WHO/UNICEF,89
195610,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,1990,28,Both sexes (male and female),1,Percentage,35,IHME,9.18
196913,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1990,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,12.4
198758,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1990,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,36.3
7200,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1990,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.4
12399,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1990,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,23.39
47376,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1990,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,49.51
128449,2,ALGERIA,Sex ratio at birth,AFR0428,1990,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
119092,2,ALGERIA,Number of road traffic injuries,AFR0140,1990,29,Total,5,Count (Numeric Integer),35,IHME,30751
137391,2,ALGERIA,Number of cancer cases (all cause),AFR0321,1990,29,Total,5,Count (Numeric Integer),35,IHME,62017
142653,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1990,29,Total,6,Per 1000 population,16,UNAIDS,\N
143973,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1990,8,Male,6,Per 1000 population,16,UNAIDS,\N
127848,2,ALGERIA,Life expectancy at birth (years),AFR0381,1990,28,Both sexes (male and female),17,years,4,WB Database,66.94
122127,2,ALGERIA,Life expectancy at age 60 years,AFR0003,1990-1995,28,Both sexes (male and female),1,Percentage,17,UN Population,17.26
122415,2,ALGERIA,Life expectancy at age 60 years,AFR0003,1990-1995,8,Male,1,Percentage,17,UN Population,16.37
122703,2,ALGERIA,Life expectancy at age 60 years,AFR0003,1990-1995,9,Female,1,Percentage,17,UN Population,18.14
130564,2,ALGERIA,Total fertility rate,AFR0130,1990-1995,9,Female,1,Percentage,17,UN Population,4.12
49181,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1991,8,Male,1,Percentage,3,WHO / GHO,6.5
49182,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1991,9,Female,1,Percentage,3,WHO / GHO,7.3
49183,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1991,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.9
88225,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1991,8,Male,1,Percentage,3,WHO / GHO,30.4
88226,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1991,9,Female,1,Percentage,3,WHO / GHO,32.5
88227,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1991,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.6
96023,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1991,999,Not Applicable,1,Percentage,4,WB Database,20.6
110032,2,ALGERIA,TB case detection rate,AFR0176,1991,29,Total,1,Percentage,3,WHO / GHO,67
123066,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1991,28,Both sexes (male and female),1,Percentage,35,IHME,0.9
124506,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1991,8,Male,1,Percentage,35,IHME,0.97
125946,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1991,9,Female,1,Percentage,35,IHME,0.83
131563,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1991,28,Both sexes (male and female),1,Percentage,4,WB Database,94.45
134200,2,ALGERIA,School dropout rate,AFR0160,1991,28,Both sexes (male and female),1,Percentage,42,WDI,12.39
136037,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1991,29,Total,1,Percentage,36,WHO/UNICEF,89
195611,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,1991,28,Both sexes (male and female),1,Percentage,35,IHME,9.53
196914,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1991,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,12.8
198759,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1991,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,37.1
12400,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1991,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,23
47377,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1991,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,48.18
119139,2,ALGERIA,Number of road traffic injuries,AFR0140,1991,29,Total,5,Count (Numeric Integer),35,IHME,31476
137439,2,ALGERIA,Number of cancer cases (all cause),AFR0321,1991,29,Total,5,Count (Numeric Integer),35,IHME,64295
142697,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1991,29,Total,6,Per 1000 population,16,UNAIDS,\N
144017,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1991,8,Male,6,Per 1000 population,16,UNAIDS,\N
49319,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1992,8,Male,1,Percentage,3,WHO / GHO,6.7
49320,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1992,9,Female,1,Percentage,3,WHO / GHO,7.5
49321,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1992,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.1
88363,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1992,8,Male,1,Percentage,3,WHO / GHO,30.3
88364,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1992,9,Female,1,Percentage,3,WHO / GHO,32.3
88365,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1992,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.5
96069,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1992,999,Not Applicable,1,Percentage,4,WB Database,24.3
110068,2,ALGERIA,TB case detection rate,AFR0176,1992,29,Total,1,Percentage,3,WHO / GHO,68
123114,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1992,28,Both sexes (male and female),1,Percentage,35,IHME,0.91
124554,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1992,8,Male,1,Percentage,35,IHME,0.98
125994,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1992,9,Female,1,Percentage,35,IHME,0.85
131564,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1992,28,Both sexes (male and female),1,Percentage,4,WB Database,96.48
134201,2,ALGERIA,School dropout rate,AFR0160,1992,28,Both sexes (male and female),1,Percentage,42,WDI,11.29
136081,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1992,29,Total,1,Percentage,36,WHO/UNICEF,88
195612,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,1992,28,Both sexes (male and female),1,Percentage,35,IHME,9.82
196915,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1992,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,13.3
198760,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1992,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,37.9
12401,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1992,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,22.65
47378,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1992,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,47.05
128448,2,ALGERIA,Sex ratio at birth,AFR0428,1992,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
119186,2,ALGERIA,Number of road traffic injuries,AFR0140,1992,29,Total,5,Count (Numeric Integer),35,IHME,32162
137487,2,ALGERIA,Number of cancer cases (all cause),AFR0321,1992,29,Total,5,Count (Numeric Integer),35,IHME,66415
142060,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1992,126,Hydrological,5,Count (Numeric Integer),35,IHME,21
142741,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1992,29,Total,6,Per 1000 population,16,UNAIDS,\N
144061,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1992,8,Male,6,Per 1000 population,16,UNAIDS,\N
49457,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1993,8,Male,1,Percentage,3,WHO / GHO,6.9
49458,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1993,9,Female,1,Percentage,3,WHO / GHO,7.7
49459,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1993,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.3
88501,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1993,8,Male,1,Percentage,3,WHO / GHO,30.2
88502,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1993,9,Female,1,Percentage,3,WHO / GHO,32.2
88503,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1993,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.3
96115,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1993,999,Not Applicable,1,Percentage,4,WB Database,26.2
110102,2,ALGERIA,TB case detection rate,AFR0176,1993,29,Total,1,Percentage,3,WHO / GHO,68
123162,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1993,28,Both sexes (male and female),1,Percentage,35,IHME,0.93
124602,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1993,8,Male,1,Percentage,35,IHME,1
126042,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1993,9,Female,1,Percentage,35,IHME,0.86
131565,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1993,28,Both sexes (male and female),1,Percentage,4,WB Database,96.79
134202,2,ALGERIA,School dropout rate,AFR0160,1993,28,Both sexes (male and female),1,Percentage,42,WDI,11.78
136125,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1993,29,Total,1,Percentage,36,WHO/UNICEF,88
195613,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,1993,28,Both sexes (male and female),1,Percentage,35,IHME,10.11
196916,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1993,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,13.8
198761,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1993,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,38.7
12402,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1993,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,22.34
47379,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1993,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,45.96
119233,2,ALGERIA,Number of road traffic injuries,AFR0140,1993,29,Total,5,Count (Numeric Integer),35,IHME,32816
137535,2,ALGERIA,Number of cancer cases (all cause),AFR0321,1993,29,Total,5,Count (Numeric Integer),35,IHME,68550
142061,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1993,126,Hydrological,5,Count (Numeric Integer),35,IHME,22
142785,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1993,29,Total,6,Per 1000 population,16,UNAIDS,\N
144105,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1993,8,Male,6,Per 1000 population,16,UNAIDS,\N
49595,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1994,8,Male,1,Percentage,3,WHO / GHO,7.2
49596,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1994,9,Female,1,Percentage,3,WHO / GHO,7.9
49597,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1994,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.5
88639,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1994,8,Male,1,Percentage,3,WHO / GHO,30.1
88640,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1994,9,Female,1,Percentage,3,WHO / GHO,32.1
88641,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1994,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31.2
96161,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1994,999,Not Applicable,1,Percentage,4,WB Database,27.7
110139,2,ALGERIA,TB case detection rate,AFR0176,1994,29,Total,1,Percentage,3,WHO / GHO,68
123210,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1994,28,Both sexes (male and female),1,Percentage,35,IHME,0.94
124650,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1994,8,Male,1,Percentage,35,IHME,1.02
126090,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1994,9,Female,1,Percentage,35,IHME,0.87
131566,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1994,28,Both sexes (male and female),1,Percentage,4,WB Database,97.42
134203,2,ALGERIA,School dropout rate,AFR0160,1994,28,Both sexes (male and female),1,Percentage,42,WDI,11.83
136170,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1994,29,Total,1,Percentage,36,WHO/UNICEF,87
195614,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,1994,28,Both sexes (male and female),1,Percentage,35,IHME,10.19
196917,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1994,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,14.3
198762,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1994,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,39.5
12403,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1994,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,22.02
47380,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1994,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,44.77
119280,2,ALGERIA,Number of road traffic injuries,AFR0140,1994,29,Total,5,Count (Numeric Integer),35,IHME,33447
137583,2,ALGERIA,Number of cancer cases (all cause),AFR0321,1994,29,Total,5,Count (Numeric Integer),35,IHME,70969
141522,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1994,124,Geophysical,5,Count (Numeric Integer),35,IHME,171
142065,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1994,126,Hydrological,5,Count (Numeric Integer),35,IHME,32
142622,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1994,128,Climatological,5,Count (Numeric Integer),35,IHME,22
142829,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1994,29,Total,6,Per 1000 population,16,UNAIDS,\N
144149,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1994,8,Male,6,Per 1000 population,16,UNAIDS,\N
11460,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,1995,9,Female,1,Percentage,3,WHO / GHO,192
49733,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1995,8,Male,1,Percentage,3,WHO / GHO,7.4
49734,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1995,9,Female,1,Percentage,3,WHO / GHO,8.1
49735,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1995,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.7
88777,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1995,8,Male,1,Percentage,3,WHO / GHO,29.9
88778,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1995,9,Female,1,Percentage,3,WHO / GHO,31.9
88779,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1995,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,31
96207,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1995,999,Not Applicable,1,Percentage,4,WB Database,31.8
103512,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1995,999,Not Applicable,1,Percentage,3,WHO / GHO,0.05
104956,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1995,999,Not Applicable,1,Percentage,3,WHO / GHO,26.95
110174,2,ALGERIA,TB case detection rate,AFR0176,1995,29,Total,1,Percentage,3,WHO / GHO,68
123258,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1995,28,Both sexes (male and female),1,Percentage,35,IHME,0.96
124698,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1995,8,Male,1,Percentage,35,IHME,1.04
126138,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1995,9,Female,1,Percentage,35,IHME,0.88
131567,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1995,28,Both sexes (male and female),1,Percentage,4,WB Database,97.44
134204,2,ALGERIA,School dropout rate,AFR0160,1995,28,Both sexes (male and female),1,Percentage,42,WDI,11.61
136215,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1995,29,Total,1,Percentage,36,WHO/UNICEF,88
156263,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1995,999,Not Applicable,1,Percentage,3,WHO / GHO,26.95
195615,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,1995,28,Both sexes (male and female),1,Percentage,35,IHME,10.42
196918,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1995,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,14.8
198763,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1995,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,40.3
12404,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1995,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,21.73
47381,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1995,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,43.56
119327,2,ALGERIA,Number of road traffic injuries,AFR0140,1995,29,Total,5,Count (Numeric Integer),35,IHME,34060
137631,2,ALGERIA,Number of cancer cases (all cause),AFR0321,1995,29,Total,5,Count (Numeric Integer),35,IHME,73785
142873,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1995,29,Total,6,Per 1000 population,16,UNAIDS,\N
144193,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1995,8,Male,6,Per 1000 population,16,UNAIDS,\N
122175,2,ALGERIA,Life expectancy at age 60 years,AFR0003,1995-2000,28,Both sexes (male and female),1,Percentage,17,UN Population,18.25
122463,2,ALGERIA,Life expectancy at age 60 years,AFR0003,1995-2000,8,Male,1,Percentage,17,UN Population,17.46
122751,2,ALGERIA,Life expectancy at age 60 years,AFR0003,1995-2000,9,Female,1,Percentage,17,UN Population,19.05
130565,2,ALGERIA,Total fertility rate,AFR0130,1995-2000,9,Female,1,Percentage,17,UN Population,2.89
207398,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,1995-2000,28,Both sexes (male and female),1,Percentage,5,UNICEF,92
49871,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1996,8,Male,1,Percentage,3,WHO / GHO,7.6
49872,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1996,9,Female,1,Percentage,3,WHO / GHO,8.3
49873,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1996,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8
88915,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1996,8,Male,1,Percentage,3,WHO / GHO,29.8
88916,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1996,9,Female,1,Percentage,3,WHO / GHO,31.7
88917,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1996,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.9
96253,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1996,999,Not Applicable,1,Percentage,4,WB Database,28.5
103511,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1996,999,Not Applicable,1,Percentage,3,WHO / GHO,0.05
104955,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1996,999,Not Applicable,1,Percentage,3,WHO / GHO,24.4
110215,2,ALGERIA,TB case detection rate,AFR0176,1996,29,Total,1,Percentage,3,WHO / GHO,68
123306,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1996,28,Both sexes (male and female),1,Percentage,35,IHME,0.98
124746,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1996,8,Male,1,Percentage,35,IHME,1.06
126186,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1996,9,Female,1,Percentage,35,IHME,0.89
131568,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1996,28,Both sexes (male and female),1,Percentage,4,WB Database,98.59
134205,2,ALGERIA,School dropout rate,AFR0160,1996,28,Both sexes (male and female),1,Percentage,42,WDI,12.08
136260,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1996,29,Total,1,Percentage,36,WHO/UNICEF,88
156262,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1996,999,Not Applicable,1,Percentage,3,WHO / GHO,24.4
195616,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,1996,28,Both sexes (male and female),1,Percentage,35,IHME,10.85
196919,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1996,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,15.3
198764,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1996,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,41.1
12405,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1996,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,21.53
47382,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1996,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,42.48
119374,2,ALGERIA,Number of road traffic injuries,AFR0140,1996,29,Total,5,Count (Numeric Integer),35,IHME,34602
137679,2,ALGERIA,Number of cancer cases (all cause),AFR0321,1996,29,Total,5,Count (Numeric Integer),35,IHME,76626
142082,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1996,126,Hydrological,5,Count (Numeric Integer),35,IHME,4
142917,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1996,29,Total,6,Per 1000 population,16,UNAIDS,\N
144237,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1996,8,Male,6,Per 1000 population,16,UNAIDS,\N
50009,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1997,8,Male,1,Percentage,3,WHO / GHO,7.8
50010,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1997,9,Female,1,Percentage,3,WHO / GHO,8.5
50011,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1997,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8.2
89053,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1997,8,Male,1,Percentage,3,WHO / GHO,29.6
89054,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1997,9,Female,1,Percentage,3,WHO / GHO,31.5
89055,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1997,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.7
96299,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1997,999,Not Applicable,1,Percentage,4,WB Database,25.4
103510,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1997,999,Not Applicable,1,Percentage,3,WHO / GHO,0.03
104954,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1997,999,Not Applicable,1,Percentage,3,WHO / GHO,28.02
110255,2,ALGERIA,TB case detection rate,AFR0176,1997,29,Total,1,Percentage,3,WHO / GHO,67
123354,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1997,28,Both sexes (male and female),1,Percentage,35,IHME,0.99
124794,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1997,8,Male,1,Percentage,35,IHME,1.08
126234,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1997,9,Female,1,Percentage,35,IHME,0.91
131569,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1997,28,Both sexes (male and female),1,Percentage,4,WB Database,99.75
134206,2,ALGERIA,School dropout rate,AFR0160,1997,28,Both sexes (male and female),1,Percentage,42,WDI,12.64
136305,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1997,29,Total,1,Percentage,36,WHO/UNICEF,89
156261,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1997,999,Not Applicable,1,Percentage,3,WHO / GHO,28.02
195617,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,1997,28,Both sexes (male and female),1,Percentage,35,IHME,10.78
196920,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1997,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,15.8
198765,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1997,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,41.9
12406,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1997,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,21.41
47383,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1997,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,41.56
128447,2,ALGERIA,Sex ratio at birth,AFR0428,1997,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
119421,2,ALGERIA,Number of road traffic injuries,AFR0140,1997,29,Total,5,Count (Numeric Integer),35,IHME,35032
137727,2,ALGERIA,Number of cancer cases (all cause),AFR0321,1997,29,Total,5,Count (Numeric Integer),35,IHME,79230
141654,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1997,125,Biological,5,Count (Numeric Integer),35,IHME,1
142089,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1997,126,Hydrological,5,Count (Numeric Integer),35,IHME,4
142961,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1997,29,Total,6,Per 1000 population,16,UNAIDS,\N
144281,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1997,8,Male,6,Per 1000 population,16,UNAIDS,\N
50149,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1998,8,Male,1,Percentage,3,WHO / GHO,8.1
50150,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1998,9,Female,1,Percentage,3,WHO / GHO,8.7
50151,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1998,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8.4
89191,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1998,8,Male,1,Percentage,3,WHO / GHO,29.4
89192,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1998,9,Female,1,Percentage,3,WHO / GHO,31.2
89193,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1998,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.5
96345,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1998,999,Not Applicable,1,Percentage,4,WB Database,26.8
103509,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1998,999,Not Applicable,1,Percentage,3,WHO / GHO,0.03
104953,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1998,999,Not Applicable,1,Percentage,3,WHO / GHO,28.81
110293,2,ALGERIA,TB case detection rate,AFR0176,1998,29,Total,1,Percentage,3,WHO / GHO,67
123402,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1998,28,Both sexes (male and female),1,Percentage,35,IHME,1.01
124842,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1998,8,Male,1,Percentage,35,IHME,1.11
126282,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1998,9,Female,1,Percentage,35,IHME,0.92
131570,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1998,28,Both sexes (male and female),1,Percentage,4,WB Database,100.91
136350,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1998,29,Total,1,Percentage,36,WHO/UNICEF,85
156260,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1998,999,Not Applicable,1,Percentage,3,WHO / GHO,28.81
195618,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,1998,28,Both sexes (male and female),1,Percentage,35,IHME,11.05
196921,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1998,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,16.3
198766,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1998,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,42.7
12407,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1998,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,21.37
47384,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1998,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,40.83
119468,2,ALGERIA,Number of road traffic injuries,AFR0140,1998,29,Total,5,Count (Numeric Integer),35,IHME,35395
137775,2,ALGERIA,Number of cancer cases (all cause),AFR0321,1998,29,Total,5,Count (Numeric Integer),35,IHME,81331
143005,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1998,29,Total,6,Per 1000 population,16,UNAIDS,\N
144325,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1998,8,Male,6,Per 1000 population,16,UNAIDS,\N
50288,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1999,8,Male,1,Percentage,3,WHO / GHO,8.3
50289,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1999,9,Female,1,Percentage,3,WHO / GHO,9
50290,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1999,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8.6
89329,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1999,8,Male,1,Percentage,3,WHO / GHO,29.2
89330,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1999,9,Female,1,Percentage,3,WHO / GHO,31
89331,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1999,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.2
96391,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1999,999,Not Applicable,1,Percentage,4,WB Database,28.3
103508,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1999,999,Not Applicable,1,Percentage,3,WHO / GHO,0.08
104952,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1999,999,Not Applicable,1,Percentage,3,WHO / GHO,29.68
110334,2,ALGERIA,TB case detection rate,AFR0176,1999,29,Total,1,Percentage,3,WHO / GHO,67
123450,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1999,28,Both sexes (male and female),1,Percentage,35,IHME,1.04
124890,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1999,8,Male,1,Percentage,35,IHME,1.13
126330,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1999,9,Female,1,Percentage,35,IHME,0.94
131571,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,1999,28,Both sexes (male and female),1,Percentage,4,WB Database,102.75
134207,2,ALGERIA,School dropout rate,AFR0160,1999,28,Both sexes (male and female),1,Percentage,42,WDI,9.95
136395,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1999,29,Total,1,Percentage,36,WHO/UNICEF,83
152576,2,ALGERIA,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,1999,999,Not Applicable,1,Percentage,40,National Health Account Report,2.9
156259,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1999,999,Not Applicable,1,Percentage,3,WHO / GHO,29.68
195619,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,1999,28,Both sexes (male and female),1,Percentage,35,IHME,11.61
196922,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,1999,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,16.8
198767,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,1999,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,43.6
12408,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1999,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,21.33
47385,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1999,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,40.24
119515,2,ALGERIA,Number of road traffic injuries,AFR0140,1999,29,Total,5,Count (Numeric Integer),35,IHME,35747
137823,2,ALGERIA,Number of cancer cases (all cause),AFR0321,1999,29,Total,5,Count (Numeric Integer),35,IHME,84319
141525,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1999,124,Geophysical,5,Count (Numeric Integer),35,IHME,22
142104,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1999,126,Hydrological,5,Count (Numeric Integer),35,IHME,12
143049,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1999,29,Total,6,Per 1000 population,16,UNAIDS,\N
144369,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1999,8,Male,6,Per 1000 population,16,UNAIDS,0.01
11461,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2000,9,Female,1,Percentage,3,WHO / GHO,161
50428,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2000,8,Male,1,Percentage,3,WHO / GHO,8.6
50429,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2000,9,Female,1,Percentage,3,WHO / GHO,9.2
50430,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8.9
67530,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2000,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,86
68404,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2000,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,78
72757,2,ALGERIA,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2000,28,Both sexes (male and female),1,Percentage,5,UNICEF,14.7
84221,2,ALGERIA,TB case detection rate,AFR0176,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
89467,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2000,8,Male,1,Percentage,3,WHO / GHO,29
89468,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2000,9,Female,1,Percentage,3,WHO / GHO,30.7
89469,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30
92948,2,ALGERIA,GDP growth (annual %),AFR0388,2000,999,Not Applicable,1,Percentage,22,UN DESA,2.4
93622,2,ALGERIA,Social security funds as % of General government health expenditure (GGHE),AFR0294,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,35.52
93623,2,ALGERIA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,96.72
96437,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2000,999,Not Applicable,1,Percentage,4,WB Database,29.7
98488,2,ALGERIA,Immunization coverage against Tetanus,AFR0189,2000,28,Both sexes (male and female),1,Percentage,4,WB Database,86
102373,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2000,999,Not Applicable,1,Percentage,4,WB Database,25.79
103507,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,0.1
109780,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,25.79
110371,2,ALGERIA,TB case detection rate,AFR0176,2000,29,Total,1,Percentage,3,WHO / GHO,67
111223,2,ALGERIA,TB treatment success rate,AFR0216,2000,29,Total,1,Percentage,3,WHO / GHO,87
112151,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2000,9,Female,1,Percentage,44,DHS/MICS,79
112762,2,ALGERIA,TB treatment coverage,AFR0173,2000,29,Total,1,Percentage,3,WHO / GHO,87
115953,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,26.05
116985,2,ALGERIA,TB treatment success rate,AFR0216,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,69.6
123498,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2000,28,Both sexes (male and female),1,Percentage,35,IHME,1.06
124938,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2000,8,Male,1,Percentage,35,IHME,1.16
126378,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2000,9,Female,1,Percentage,35,IHME,0.96
131572,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2000,28,Both sexes (male and female),1,Percentage,4,WB Database,105.16
134208,2,ALGERIA,School dropout rate,AFR0160,2000,28,Both sexes (male and female),1,Percentage,42,WDI,9.25
136442,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2000,29,Total,1,Percentage,36,WHO/UNICEF,86
138358,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2000,29,Total,1,Percentage,3,WHO / GHO,87
138359,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,69.6
147088,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2000,29,Total,1,Percentage,36,WHO/UNICEF,78
151365,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,2.18
152577,2,ALGERIA,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,2000,999,Not Applicable,1,Percentage,40,National Health Account Report,3.1
156258,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,25.79
182003,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,27.98
182869,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,3.48
184601,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
185467,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,0.05
188138,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,8.78
189004,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,8.78
191041,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,25.7
195620,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2000,28,Both sexes (male and female),1,Percentage,35,IHME,11.81
196923,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,17.4
198768,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,44.4
202186,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2000,29,Total,1,Percentage,36,WHO/UNICEF,79
202187,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2000,12,Urban,1,Percentage,36,WHO/UNICEF,81
202188,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2000,11,Rural,1,Percentage,36,WHO/UNICEF,76
202225,2,ALGERIA,Institutional deliveries,AFR0200,2000,29,Total,1,Percentage,36,WHO/UNICEF,92
202226,2,ALGERIA,Institutional deliveries,AFR0200,2000,12,Urban,1,Percentage,36,WHO/UNICEF,94
202227,2,ALGERIA,Institutional deliveries,AFR0200,2000,11,Rural,1,Percentage,36,WHO/UNICEF,88
1,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.49
2,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,61.3
3,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,282.38
2349,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.95
2350,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,71.96
2351,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,27.98
2352,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,8.79
2353,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,2.51
2354,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,44.12
2355,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,203.21
2356,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,17.16
2357,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,79.02
2503,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,25.79
2504,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1.37
2505,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.05
2506,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.03
2507,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.15
2508,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,15.81
2509,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,72.84
7236,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2000,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.2
7237,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2000,11,Rural,2,Per 1000 live births,3,WHO / GHO,83.32
7238,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2000,29,Total,2,Per 1000 live births,3,WHO / GHO,89.84
12409,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,21.34
15877,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,4.1
16117,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,8,Male,2,Per 1000 live births,3,WHO / GHO,5.6
16357,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,9,Female,2,Per 1000 live births,3,WHO / GHO,2.5
16597,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,4.1
18295,2,ALGERIA,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,21.1
18555,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2000,9,Female,2,Per 1000 live births,3,WHO / GHO,63.98
18556,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2000,8,Male,2,Per 1000 live births,3,WHO / GHO,86.71
21228,2,ALGERIA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.3
22679,2,ALGERIA,HIV prevalence rate (per 1000 population),AFR0020,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.1
24065,2,ALGERIA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2000,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,3.1
24277,2,ALGERIA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2000,9,Female,2,Per 1000 live births,5,UNICEF,2.9
24470,2,ALGERIA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2000,8,Male,2,Per 1000 live births,5,UNICEF,3.3
25486,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2000,9,Female,2,Per 1000 live births,1,WHO/AFRO,6
25697,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,1.3
25698,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,9,Female,2,Per 1000 live births,20,ITU,1.1
25699,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,8,Male,2,Per 1000 live births,20,ITU,1.4
28111,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2000,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.6
29827,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2000,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,60
30897,2,ALGERIA,TB case detection rate,AFR0176,2000,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
32438,2,ALGERIA,Prevalence of stunting in children under 5 u (%),AFR0154,2000,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,23.6
32668,2,ALGERIA,Prevalence of wasting in children under 5 u (%),AFR0155,2000,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,3.1
32908,2,ALGERIA,Prevalence of overweight in children under 5 u (%),AFR0156,2000,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,14.7
37280,2,ALGERIA,People practicing open defecation (%) of population),AFR0025,2000,29,Total,2,Per 1000 live births,5,UNICEF,6.38
37281,2,ALGERIA,People practicing open defecation (%) of population),AFR0025,2000,11,Rural,2,Per 1000 live births,5,UNICEF,3.11
37282,2,ALGERIA,People practicing open defecation (%) of population),AFR0025,2000,12,Urban,2,Per 1000 live births,5,UNICEF,0.63
37680,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2000,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.49
38538,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2000,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,3.16
39733,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2000,999,Not Applicable,2,Per 1000 live births,19,OECD,364.78
47121,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
47153,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
47386,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2000,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,39.67
140078,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2000,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.2
140079,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2000,11,Rural,2,Per 1000 live births,3,WHO / GHO,83.32
140080,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2000,29,Total,2,Per 1000 live births,3,WHO / GHO,89.84
140954,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2000,999,Not Applicable,2,Per 1000 live births,7,DHS,8.79
140971,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2000,999,Not Applicable,2,Per 1000 live births,7,DHS,15.81
82939,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2000,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
82971,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2000,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
119562,2,ALGERIA,Number of road traffic injuries,AFR0140,2000,29,Total,5,Count (Numeric Integer),35,IHME,36138
137871,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2000,29,Total,5,Count (Numeric Integer),35,IHME,87735
142117,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2000,126,Hydrological,5,Count (Numeric Integer),35,IHME,28
142527,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2000,127,Meteorological,5,Count (Numeric Integer),35,IHME,4
144706,2,ALGERIA,Number of people living with HIV,AFR0019,2000,29,Total,5,Count (Numeric Integer),16,UNAIDS,2000
152807,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,70,0-4 years,5,Count (Numeric Integer),17,UN Population,3084850
153041,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,71,5-9 years,5,Count (Numeric Integer),17,UN Population,3687881
153274,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,72,10-14 years,5,Count (Numeric Integer),17,UN Population,3894224
153504,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,73,15-19 years,5,Count (Numeric Integer),17,UN Population,3754079
153736,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,74,20-24 years,5,Count (Numeric Integer),17,UN Population,3297744
153967,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,75,25-29 years,5,Count (Numeric Integer),17,UN Population,2726931
154198,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,76,30-34 years,5,Count (Numeric Integer),17,UN Population,2278529
154431,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,77,35-39 years,5,Count (Numeric Integer),17,UN Population,1932114
154664,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,78,40-44 years,5,Count (Numeric Integer),17,UN Population,1563988
154896,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,79,45-49 years,5,Count (Numeric Integer),17,UN Population,1301865
155128,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,80,50-54 years,5,Count (Numeric Integer),17,UN Population,848762
155363,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,81,55-59 years,5,Count (Numeric Integer),17,UN Population,693715
155592,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,82,60-64 years,5,Count (Numeric Integer),17,UN Population,640435
155823,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,83,65-69 years,5,Count (Numeric Integer),17,UN Population,548032
156055,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,84,70-74 years,5,Count (Numeric Integer),17,UN Population,381796
177396,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,85,75-79 years,5,Count (Numeric Integer),17,UN Population,222217
177626,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,86,80-84 years,5,Count (Numeric Integer),17,UN Population,127472
177858,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,1010,85-89 years,5,Count (Numeric Integer),17,UN Population,45651
178172,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,1011,90-94 years,5,Count (Numeric Integer),17,UN Population,10760
178407,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,1012,95-99 years,5,Count (Numeric Integer),17,UN Population,1126
143093,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2000,29,Total,6,Per 1000 population,16,UNAIDS,0.01
144413,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2000,8,Male,6,Per 1000 population,16,UNAIDS,0.01
62247,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2000,9,Female,7,per 100 000 live births,23,MMEIG,161
70468,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,1.3
70469,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,9,Female,8,Per 100 000 population,13,UNStat,1.1
70470,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,8,Male,8,Per 100 000 population,13,UNStat,1.4
83151,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2000,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,60
104402,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2000,8,Male,8,Per 100 000 population,3,WHO / GHO,10.79
104403,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2000,9,Female,8,Per 100 000 population,3,WHO / GHO,3.58
109162,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2000,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,7.23
120747,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2000,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,21.1
120987,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2000,8,Male,8,Per 100 000 population,3,WHO / GHO,23.1
121227,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2000,9,Female,8,Per 100 000 population,3,WHO / GHO,19.1
70258,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2000,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,6
69378,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2000,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.59
92048,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2000,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,364.77
97454,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2000,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,72.82
113748,2,ALGERIA,Total Health Expenditure (constant US$),AFR0349,2000,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,3254.43
114208,2,ALGERIA,Total Health Expenditure (International US$),AFR0348,2000,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,1911.64
74706,2,ALGERIA,Gender development index score,AFR0347,2000,28,Both sexes (male and female),12,Index,14,UNDP,0.78
106146,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2000,999,Not Applicable,14,Per Capita,3,WHO / GHO,61.3
106965,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2000,999,Not Applicable,14,Per Capita,42,WDI,0.14
107783,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2000,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.03
114685,2,ALGERIA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2000,999,Not Applicable,14,Per Capita,4,WB Database,282.31
115151,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2000,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,72.82
127849,2,ALGERIA,Life expectancy at birth (years),AFR0381,2000,28,Both sexes (male and female),17,years,4,WB Database,70.64
213218,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2000,28,Both sexes (male and female),23,Numeric,75,WHO/GHO_2021,62.7
213406,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2000,8,Male,23,Numeric,75,WHO/GHO_2021,62.6
213594,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2000,9,Female,23,Numeric,75,WHO/GHO_2021,62.8
183735,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2000,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,61.5
187199,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2000,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.03
190175,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2000,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,15.8
194468,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2000,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,17.2
186333,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2000,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.14
191907,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2000,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,73.4
193602,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2000,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,79.7
122223,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2000-2005,28,Both sexes (male and female),1,Percentage,17,UN Population,19.63
122511,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2000-2005,8,Male,1,Percentage,17,UN Population,18.93
122799,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2000-2005,9,Female,1,Percentage,17,UN Population,20.32
131336,2,ALGERIA,Total fertility rate,AFR0130,2000-2005,9,Female,1,Percentage,17,UN Population,2.38
11462,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2001,9,Female,1,Percentage,3,WHO / GHO,155
50567,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2001,8,Male,1,Percentage,3,WHO / GHO,8.8
50568,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2001,9,Female,1,Percentage,3,WHO / GHO,9.4
50569,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9.1
67576,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2001,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,89
68431,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2001,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,73
84222,2,ALGERIA,TB case detection rate,AFR0176,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
89605,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2001,8,Male,1,Percentage,3,WHO / GHO,28.8
89606,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2001,9,Female,1,Percentage,3,WHO / GHO,30.4
89607,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29.7
92949,2,ALGERIA,GDP growth (annual %),AFR0388,2001,999,Not Applicable,1,Percentage,22,UN DESA,1.66
93714,2,ALGERIA,Social security funds as % of General government health expenditure (GGHE),AFR0294,2001,999,Not Applicable,1,Percentage,3,WHO / GHO,33.26
93715,2,ALGERIA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2001,999,Not Applicable,1,Percentage,3,WHO / GHO,96.01
96483,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2001,999,Not Applicable,1,Percentage,4,WB Database,27.2
103506,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2001,999,Not Applicable,1,Percentage,3,WHO / GHO,0.13
104951,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2001,999,Not Applicable,1,Percentage,3,WHO / GHO,21.67
110411,2,ALGERIA,TB case detection rate,AFR0176,2001,29,Total,1,Percentage,3,WHO / GHO,67
111259,2,ALGERIA,TB treatment success rate,AFR0216,2001,29,Total,1,Percentage,3,WHO / GHO,84
112799,2,ALGERIA,TB treatment coverage,AFR0173,2001,29,Total,1,Percentage,3,WHO / GHO,84
115954,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,25.76
116984,2,ALGERIA,TB treatment success rate,AFR0216,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,67.2
123546,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2001,28,Both sexes (male and female),1,Percentage,35,IHME,1.09
124986,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2001,8,Male,1,Percentage,35,IHME,1.19
126426,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2001,9,Female,1,Percentage,35,IHME,0.98
131573,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2001,28,Both sexes (male and female),1,Percentage,4,WB Database,104.02
134209,2,ALGERIA,School dropout rate,AFR0160,2001,28,Both sexes (male and female),1,Percentage,42,WDI,7.25
136489,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2001,29,Total,1,Percentage,36,WHO/UNICEF,89
138360,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2001,29,Total,1,Percentage,3,WHO / GHO,84
138361,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,67.2
147091,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2001,29,Total,1,Percentage,36,WHO/UNICEF,73
152578,2,ALGERIA,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,2001,999,Not Applicable,1,Percentage,40,National Health Account Report,3.8
156257,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2001,999,Not Applicable,1,Percentage,3,WHO / GHO,21.67
182048,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,23.72
182914,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,3.83
184646,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
185512,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,0.04
188183,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,9.36
189049,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,9.36
191086,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,21.6
192800,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,2.05
195621,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2001,28,Both sexes (male and female),1,Percentage,35,IHME,12.17
196924,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,17.9
198769,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,45.3
136,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.84
137,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2001,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,66.5
138,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2001,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,323.02
2358,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.95
2359,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,76.23
2360,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,23.73
2361,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,9.36
2362,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2001,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,2.93
2363,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,50.69
2364,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,246.23
2365,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,15.78
2366,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,76.64
2510,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2001,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,21.67
2511,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2001,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1.21
2512,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.05
2513,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.03
2514,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.15
2515,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,14.41
2516,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,69.99
7239,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2001,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.28
7240,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2001,11,Rural,2,Per 1000 live births,3,WHO / GHO,83.68
7241,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2001,29,Total,2,Per 1000 live births,3,WHO / GHO,90.12
12410,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2001,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,21.23
18557,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2001,9,Female,2,Per 1000 live births,3,WHO / GHO,61.74
18558,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2001,8,Male,2,Per 1000 live births,3,WHO / GHO,83.55
28154,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2001,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,1.34
29828,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2001,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,58
30898,2,ALGERIA,TB case detection rate,AFR0176,2001,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
37681,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2001,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.65
38539,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2001,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,3.42
39734,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2001,999,Not Applicable,2,Per 1000 live births,19,OECD,291.15
46944,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,51,Polio,2,Per 1000 live births,1,WHO/AFRO,1
46991,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,137
47027,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,15
47079,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,3
47387,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2001,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,38.9
140081,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2001,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.28
140082,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2001,11,Rural,2,Per 1000 live births,3,WHO / GHO,83.68
140083,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2001,29,Total,2,Per 1000 live births,3,WHO / GHO,90.12
140955,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2001,999,Not Applicable,2,Per 1000 live births,7,DHS,9.36
140972,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2001,999,Not Applicable,2,Per 1000 live births,7,DHS,14.41
82762,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2001,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,1
82809,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2001,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,137
82845,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2001,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,15
82897,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2001,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,3
119609,2,ALGERIA,Number of road traffic injuries,AFR0140,2001,29,Total,5,Count (Numeric Integer),35,IHME,36555
137919,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2001,29,Total,5,Count (Numeric Integer),35,IHME,91764
142129,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2001,126,Hydrological,5,Count (Numeric Integer),35,IHME,921
144752,2,ALGERIA,Number of people living with HIV,AFR0019,2001,29,Total,5,Count (Numeric Integer),16,UNAIDS,2300
143137,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2001,29,Total,6,Per 1000 population,16,UNAIDS,0.01
144457,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2001,8,Male,6,Per 1000 population,16,UNAIDS,0.01
62248,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2001,9,Female,7,per 100 000 live births,23,MMEIG,155
83152,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2001,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,58
69424,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2001,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,1.34
92049,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2001,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,291.15
97453,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2001,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,69.98
106145,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2001,999,Not Applicable,14,Per Capita,3,WHO / GHO,66.5
106964,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2001,999,Not Applicable,14,Per Capita,42,WDI,0.14
107782,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2001,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.03
115150,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2001,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,69.98
183780,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2001,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,66.8
187244,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2001,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.03
190220,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2001,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,14.4
194513,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2001,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,15.8
186378,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2001,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.15
191952,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2001,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,70.5
193647,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2001,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,77.22
11463,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2002,9,Female,1,Percentage,3,WHO / GHO,148
50707,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2002,8,Male,1,Percentage,3,WHO / GHO,9.1
50708,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2002,9,Female,1,Percentage,3,WHO / GHO,9.7
50709,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9.4
67622,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2002,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,86
68458,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2002,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,93
72758,2,ALGERIA,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2002,28,Both sexes (male and female),1,Percentage,5,UNICEF,15.1
84223,2,ALGERIA,TB case detection rate,AFR0176,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
89743,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2002,8,Male,1,Percentage,3,WHO / GHO,28.6
89744,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2002,9,Female,1,Percentage,3,WHO / GHO,30.1
89745,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29.5
92950,2,ALGERIA,GDP growth (annual %),AFR0388,2002,999,Not Applicable,1,Percentage,22,UN DESA,4.26
93802,2,ALGERIA,Social security funds as % of General government health expenditure (GGHE),AFR0294,2002,999,Not Applicable,1,Percentage,3,WHO / GHO,33.91
93803,2,ALGERIA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2002,999,Not Applicable,1,Percentage,3,WHO / GHO,95.71
96529,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2002,999,Not Applicable,1,Percentage,4,WB Database,25.8
103505,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2002,999,Not Applicable,1,Percentage,3,WHO / GHO,0.04
104950,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2002,999,Not Applicable,1,Percentage,3,WHO / GHO,22.52
110452,2,ALGERIA,TB case detection rate,AFR0176,2002,29,Total,1,Percentage,3,WHO / GHO,68
111300,2,ALGERIA,TB treatment success rate,AFR0216,2002,29,Total,1,Percentage,3,WHO / GHO,89
112181,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2002,9,Female,1,Percentage,44,DHS/MICS,80.7
112841,2,ALGERIA,TB treatment coverage,AFR0173,2002,29,Total,1,Percentage,3,WHO / GHO,89
115955,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,25.93
116983,2,ALGERIA,TB treatment success rate,AFR0216,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,71.2
123594,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2002,28,Both sexes (male and female),1,Percentage,35,IHME,1.11
125034,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2002,8,Male,1,Percentage,35,IHME,1.22
126474,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2002,9,Female,1,Percentage,35,IHME,1
131574,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2002,28,Both sexes (male and female),1,Percentage,4,WB Database,105.14
134210,2,ALGERIA,School dropout rate,AFR0160,2002,28,Both sexes (male and female),1,Percentage,42,WDI,6.1
136536,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2002,29,Total,1,Percentage,36,WHO/UNICEF,86
138362,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2002,29,Total,1,Percentage,3,WHO / GHO,89
138363,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,71.2
147096,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2002,29,Total,1,Percentage,36,WHO/UNICEF,93
152579,2,ALGERIA,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,2002,999,Not Applicable,1,Percentage,40,National Health Account Report,4.1
156256,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2002,999,Not Applicable,1,Percentage,3,WHO / GHO,22.52
182093,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,24.67
182959,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,3.73
184691,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
185557,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,0.04
188228,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,8.18
189094,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,8.18
191131,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,22.5
192844,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,2.15
195622,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2002,28,Both sexes (male and female),1,Percentage,35,IHME,12.55
196925,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,18.5
198770,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,46.1
200633,2,ALGERIA,Contraceptive prevalence rate,AFR0208,2002,9,Female,1,Percentage,22,UN DESA,57
202189,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2002,29,Total,1,Percentage,36,WHO/UNICEF,80.7
202190,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2002,12,Urban,1,Percentage,36,WHO/UNICEF,87.6
202191,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2002,11,Rural,1,Percentage,36,WHO/UNICEF,72.4
202228,2,ALGERIA,Institutional deliveries,AFR0200,2002,29,Total,1,Percentage,36,WHO/UNICEF,90.2
202229,2,ALGERIA,Institutional deliveries,AFR0200,2002,12,Urban,1,Percentage,36,WHO/UNICEF,95.2
202230,2,ALGERIA,Institutional deliveries,AFR0200,2002,11,Rural,1,Percentage,36,WHO/UNICEF,84
207399,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,28,Both sexes (male and female),1,Percentage,5,UNICEF,90.2
271,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.73
272,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2002,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,66.17
273,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2002,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,332.41
2367,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.96
2368,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,75.28
2369,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,24.68
2370,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,8.19
2371,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2002,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,2.81
2372,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,49.81
2373,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,250.23
2374,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,16.33
2375,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,82.03
2517,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2002,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,22.52
2518,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2002,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1.2
2519,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.04
2520,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.03
2521,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.15
2522,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,14.91
2523,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,74.88
3759,2,ALGERIA,Physicians density (per 1000 population),AFR0287,2002,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1.11
4012,2,ALGERIA,Other health workers density (per 1000 population),AFR0066,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.18
4177,2,ALGERIA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2002,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,2.18
7242,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2002,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.36
7243,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2002,11,Rural,2,Per 1000 live births,3,WHO / GHO,84.04
7244,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2002,29,Total,2,Per 1000 live births,3,WHO / GHO,90.39
12411,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2002,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,21.02
18559,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2002,9,Female,2,Per 1000 live births,3,WHO / GHO,58.68
18560,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2002,8,Male,2,Per 1000 live births,3,WHO / GHO,80.75
24088,2,ALGERIA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2002,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,9.6
24301,2,ALGERIA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2002,9,Female,2,Per 1000 live births,5,UNICEF,9.3
24494,2,ALGERIA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2002,8,Male,2,Per 1000 live births,5,UNICEF,10
28198,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2002,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.73
29829,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2002,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,59
30899,2,ALGERIA,TB case detection rate,AFR0176,2002,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
32439,2,ALGERIA,Prevalence of stunting in children under 5 u (%),AFR0154,2002,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,24.04
32669,2,ALGERIA,Prevalence of wasting in children under 5 u (%),AFR0155,2002,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,9.62
32909,2,ALGERIA,Prevalence of overweight in children under 5 u (%),AFR0156,2002,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,15.1
37682,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2002,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,1.59
38540,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2002,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,3.42
39735,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2002,999,Not Applicable,2,Per 1000 live births,19,OECD,38.57
46668,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
46714,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,57
46751,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,4
46809,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,46,Measles,2,Per 1000 live births,1,WHO/AFRO,5862
46852,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
47388,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2002,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,37.82
140084,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2002,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.36
140085,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2002,11,Rural,2,Per 1000 live births,3,WHO / GHO,84.04
140086,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2002,29,Total,2,Per 1000 live births,3,WHO / GHO,90.39
140956,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2002,999,Not Applicable,2,Per 1000 live births,7,DHS,8.19
140973,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2002,999,Not Applicable,2,Per 1000 live births,7,DHS,14.91
128446,2,ALGERIA,Sex ratio at birth,AFR0428,2002,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
82486,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2002,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
82532,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2002,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,57
82569,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2002,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,4
82627,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2002,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,5862
82670,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2002,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
119656,2,ALGERIA,Number of road traffic injuries,AFR0140,2002,29,Total,5,Count (Numeric Integer),35,IHME,36944
137967,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2002,29,Total,5,Count (Numeric Integer),35,IHME,96020
142149,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2002,126,Hydrological,5,Count (Numeric Integer),35,IHME,29
144798,2,ALGERIA,Number of people living with HIV,AFR0019,2002,29,Total,5,Count (Numeric Integer),16,UNAIDS,2700
179100,2,ALGERIA,Number of medical doctors,AFR0469,2002,29,Total,5,Count (Numeric Integer),3,WHO / GHO,35368
76465,2,ALGERIA,Dentistry personnel density (per 1000 population),AFR0285,2002,28,Both sexes (male and female),6,Per 1000 population,38,Global Health Workforce Statistics,27.82
76634,2,ALGERIA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2002,999,Not Applicable,6,Per 1000 population,38,Global Health Workforce Statistics,218.96
95116,2,ALGERIA,Laboratory health workers density (per 1000 population),AFR0283,2002,999,Not Applicable,6,Per 1000 population,3,WHO / GHO,0.28
95230,2,ALGERIA,Environmental and public health workers density (per 1000 population),AFR0282,2002,999,Not Applicable,6,Per 1000 population,3,WHO / GHO,0.08
109563,2,ALGERIA,Pharmaceutical personnel density (per 1000 population),AFR0284,2002,28,Both sexes (male and female),6,Per 1000 population,38,Global Health Workforce Statistics,0.2
121489,2,ALGERIA,Other health workers density (per 1000 population),AFR0066,2002,29,Total,6,Per 1000 population,3,WHO / GHO,0.18
143181,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2002,29,Total,6,Per 1000 population,16,UNAIDS,0.01
144501,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2002,8,Male,6,Per 1000 population,16,UNAIDS,0.02
62249,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2002,9,Female,7,per 100 000 live births,23,MMEIG,148
83153,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2002,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,59
69470,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2002,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.73
92050,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2002,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,38.57
97452,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2002,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,74.86
95302,2,ALGERIA,"Pharmacists (per 10,000 population)",AFR0253,2002,28,Both sexes (male and female),13,Per 10 000 population,3,WHO / GHO,1.7
109429,2,ALGERIA,"Pharmacists (per 10,000 population)",AFR0253,2002,28,Both sexes (male and female),13,Per 10 000 population,38,Global Health Workforce Statistics,1.69
151402,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2002,1000,Dentists,13,Per 10 000 population,3,WHO / GHO,2.78
151403,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2002,1002,Nursing and midwifery personnel,13,Per 10 000 population,3,WHO / GHO,21.8
151404,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2002,1003,Pharmacists,13,Per 10 000 population,3,WHO / GHO,1.69
151405,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2002,1001,Medical doctors,13,Per 10 000 population,3,WHO / GHO,11.1
106144,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2002,999,Not Applicable,14,Per Capita,3,WHO / GHO,66.17
106963,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2002,999,Not Applicable,14,Per Capita,42,WDI,0.14
107781,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2002,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.02
115149,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2002,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,74.86
183825,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2002,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,66.4
187289,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2002,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.02
190265,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2002,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,14.9
194558,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2002,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,16.4
186423,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2002,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.14
191997,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2002,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,75.4
193692,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2002,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,82.67
11464,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2003,9,Female,1,Percentage,3,WHO / GHO,145
50846,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2003,8,Male,1,Percentage,3,WHO / GHO,9.3
50847,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2003,9,Female,1,Percentage,3,WHO / GHO,9.9
50848,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9.6
67668,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2003,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,87
68485,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2003,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,96
84224,2,ALGERIA,TB case detection rate,AFR0176,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
89881,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2003,8,Male,1,Percentage,3,WHO / GHO,28.4
89882,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2003,9,Female,1,Percentage,3,WHO / GHO,29.8
89883,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29.2
92951,2,ALGERIA,GDP growth (annual %),AFR0388,2003,999,Not Applicable,1,Percentage,22,UN DESA,5.84
93891,2,ALGERIA,Social security funds as % of General government health expenditure (GGHE),AFR0294,2003,999,Not Applicable,1,Percentage,3,WHO / GHO,33.39
93892,2,ALGERIA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2003,999,Not Applicable,1,Percentage,3,WHO / GHO,95.34
96575,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2003,999,Not Applicable,1,Percentage,4,WB Database,23.7
103504,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2003,999,Not Applicable,1,Percentage,3,WHO / GHO,0.08
104949,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2003,999,Not Applicable,1,Percentage,3,WHO / GHO,21.15
110496,2,ALGERIA,TB case detection rate,AFR0176,2003,29,Total,1,Percentage,3,WHO / GHO,68
111343,2,ALGERIA,TB treatment success rate,AFR0216,2003,29,Total,1,Percentage,3,WHO / GHO,90
112885,2,ALGERIA,TB treatment coverage,AFR0173,2003,29,Total,1,Percentage,3,WHO / GHO,90
115956,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,25.98
116982,2,ALGERIA,TB treatment success rate,AFR0216,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72
123642,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2003,28,Both sexes (male and female),1,Percentage,35,IHME,1.14
125082,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2003,8,Male,1,Percentage,35,IHME,1.26
126522,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2003,9,Female,1,Percentage,35,IHME,1.03
131575,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2003,28,Both sexes (male and female),1,Percentage,4,WB Database,105.93
134211,2,ALGERIA,School dropout rate,AFR0160,2003,28,Both sexes (male and female),1,Percentage,42,WDI,5.64
136583,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2003,29,Total,1,Percentage,36,WHO/UNICEF,87
138364,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2003,29,Total,1,Percentage,3,WHO / GHO,90
138365,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72
147102,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2003,29,Total,1,Percentage,36,WHO/UNICEF,96
152580,2,ALGERIA,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,2003,999,Not Applicable,1,Percentage,40,National Health Account Report,4.4
156255,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2003,999,Not Applicable,1,Percentage,3,WHO / GHO,21.15
182138,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,23.25
183004,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,3.6
184736,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
185602,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,0.05
188273,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,8.57
189139,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,8.57
191176,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,21.1
192888,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,2.1
195623,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2003,28,Both sexes (male and female),1,Percentage,35,IHME,12.8
196926,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,19.1
198771,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,47
406,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.6
407,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2003,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,75.42
408,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2003,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,346.46
2376,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.95
2377,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,76.69
2378,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,23.26
2379,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,8.58
2380,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2003,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,2.76
2381,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,57.84
2382,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,265.72
2383,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,17.54
2384,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,80.57
2524,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2003,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,21.15
2525,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2003,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1.13
2526,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.05
2527,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.04
2528,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.17
2529,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,15.95
2530,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,73.27
7245,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2003,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.45
7246,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2003,11,Rural,2,Per 1000 live births,3,WHO / GHO,84.4
7247,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2003,29,Total,2,Per 1000 live births,3,WHO / GHO,90.66
12412,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2003,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,20.69
18561,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2003,9,Female,2,Per 1000 live births,3,WHO / GHO,60.63
18562,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2003,8,Male,2,Per 1000 live births,3,WHO / GHO,83.25
28242,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2003,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.55
29830,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2003,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,61
30900,2,ALGERIA,TB case detection rate,AFR0176,2003,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
37683,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2003,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,2.2
38541,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2003,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,6.17
39736,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2003,999,Not Applicable,2,Per 1000 live births,19,OECD,31.59
46400,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
46446,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,22
46478,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,3
46533,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,46,Measles,2,Per 1000 live births,1,WHO/AFRO,15374
46576,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,7
47389,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2003,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,36.5
140087,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2003,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.45
140088,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2003,11,Rural,2,Per 1000 live births,3,WHO / GHO,84.4
140089,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2003,29,Total,2,Per 1000 live births,3,WHO / GHO,90.66
140957,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2003,999,Not Applicable,2,Per 1000 live births,7,DHS,8.58
140974,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2003,999,Not Applicable,2,Per 1000 live births,7,DHS,15.95
82218,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2003,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
82264,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2003,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,22
82296,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2003,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,3
82351,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2003,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,15374
82394,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2003,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,7
119703,2,ALGERIA,Number of road traffic injuries,AFR0140,2003,29,Total,5,Count (Numeric Integer),35,IHME,37317
138015,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2003,29,Total,5,Count (Numeric Integer),35,IHME,100109
141530,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2003,124,Geophysical,5,Count (Numeric Integer),35,IHME,2266
142163,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2003,126,Hydrological,5,Count (Numeric Integer),35,IHME,13
142541,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2003,127,Meteorological,5,Count (Numeric Integer),35,IHME,13
144844,2,ALGERIA,Number of people living with HIV,AFR0019,2003,29,Total,5,Count (Numeric Integer),16,UNAIDS,3100
143225,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2003,29,Total,6,Per 1000 population,16,UNAIDS,0.02
144545,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2003,8,Male,6,Per 1000 population,16,UNAIDS,0.02
62250,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2003,9,Female,7,per 100 000 live births,23,MMEIG,145
83154,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2003,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,61
69516,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2003,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.55
92051,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2003,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,31.59
97451,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2003,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,73.25
106143,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2003,999,Not Applicable,14,Per Capita,3,WHO / GHO,75.42
106962,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2003,999,Not Applicable,14,Per Capita,42,WDI,0.17
107780,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2003,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.03
115148,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2003,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,73.25
183870,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2003,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,75.7
187334,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2003,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.03
190310,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2003,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,16
194603,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2003,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,17.6
186468,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2003,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.17
192042,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2003,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,73.7
193737,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2003,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,81.08
11465,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2004,9,Female,1,Percentage,3,WHO / GHO,134
50986,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2004,8,Male,1,Percentage,3,WHO / GHO,9.6
50987,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2004,9,Female,1,Percentage,3,WHO / GHO,10.2
50988,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9.9
67714,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2004,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,86
68512,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2004,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,94
84225,2,ALGERIA,TB case detection rate,AFR0176,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
90019,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2004,8,Male,1,Percentage,3,WHO / GHO,28.2
90020,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2004,9,Female,1,Percentage,3,WHO / GHO,29.4
90021,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.9
92952,2,ALGERIA,GDP growth (annual %),AFR0388,2004,999,Not Applicable,1,Percentage,22,UN DESA,2.93
93982,2,ALGERIA,Social security funds as % of General government health expenditure (GGHE),AFR0294,2004,999,Not Applicable,1,Percentage,3,WHO / GHO,33.46
93983,2,ALGERIA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2004,999,Not Applicable,1,Percentage,3,WHO / GHO,94.57
96621,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2004,999,Not Applicable,1,Percentage,4,WB Database,17.6
103503,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2004,999,Not Applicable,1,Percentage,3,WHO / GHO,0.04
104948,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2004,999,Not Applicable,1,Percentage,3,WHO / GHO,26.09
110540,2,ALGERIA,TB case detection rate,AFR0176,2004,29,Total,1,Percentage,3,WHO / GHO,68
111387,2,ALGERIA,TB treatment success rate,AFR0216,2004,29,Total,1,Percentage,3,WHO / GHO,91
112930,2,ALGERIA,TB treatment coverage,AFR0173,2004,29,Total,1,Percentage,3,WHO / GHO,91
115957,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,24.23
116981,2,ALGERIA,TB treatment success rate,AFR0216,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72.8
123690,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2004,28,Both sexes (male and female),1,Percentage,35,IHME,1.17
125130,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2004,8,Male,1,Percentage,35,IHME,1.29
126570,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2004,9,Female,1,Percentage,35,IHME,1.05
131576,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2004,28,Both sexes (male and female),1,Percentage,4,WB Database,106.89
134212,2,ALGERIA,School dropout rate,AFR0160,2004,28,Both sexes (male and female),1,Percentage,42,WDI,4.92
136630,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2004,29,Total,1,Percentage,36,WHO/UNICEF,86
138366,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2004,29,Total,1,Percentage,3,WHO / GHO,91
138367,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72.8
147108,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2004,29,Total,1,Percentage,36,WHO/UNICEF,94
156254,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2004,999,Not Applicable,1,Percentage,3,WHO / GHO,26.09
182183,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,28.59
183049,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,3.54
184781,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
185647,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,0.04
188318,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,8.21
189184,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,8.21
191221,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,26
192932,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,2.5
195624,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2004,28,Both sexes (male and female),1,Percentage,35,IHME,13.36
196927,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,19.6
198772,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,47.9
541,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.54
542,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2004,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,92.12
543,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2004,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,360.67
2385,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.95
2386,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,71.35
2387,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,28.6
2388,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,8.22
2389,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2004,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,2.53
2390,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,65.73
2391,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,257.35
2392,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,26.34
2393,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,103.15
2531,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2004,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,26.09
2532,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2004,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1.06
2533,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.05
2534,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.04
2535,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.17
2536,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,24.04
2537,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,94.11
3184,2,ALGERIA,Hospital bed density (per 10 000 population),AFR0231,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,17
7201,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2004,11,Rural,2,Per 1000 live births,3,WHO / GHO,74.96
7202,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2004,29,Total,2,Per 1000 live births,3,WHO / GHO,85.02
7248,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2004,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.53
7249,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2004,11,Rural,2,Per 1000 live births,3,WHO / GHO,84.75
7250,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2004,29,Total,2,Per 1000 live births,3,WHO / GHO,90.92
12413,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2004,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,20.13
18563,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2004,9,Female,2,Per 1000 live births,3,WHO / GHO,52.12
18564,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2004,8,Male,2,Per 1000 live births,3,WHO / GHO,73.78
28286,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2004,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.5
29831,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2004,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,61
30901,2,ALGERIA,TB case detection rate,AFR0176,2004,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
37684,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2004,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,4.63
38542,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2004,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,6.17
39737,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2004,999,Not Applicable,2,Per 1000 live births,19,OECD,37.2
46121,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
46167,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,7
46198,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,3
46253,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,46,Measles,2,Per 1000 live births,1,WHO/AFRO,3289
46297,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,8
47390,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2004,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,35.04
140090,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2004,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.53
140091,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2004,11,Rural,2,Per 1000 live births,3,WHO / GHO,84.75
140092,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2004,29,Total,2,Per 1000 live births,3,WHO / GHO,90.92
140958,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2004,999,Not Applicable,2,Per 1000 live births,7,DHS,8.22
140975,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2004,999,Not Applicable,2,Per 1000 live births,7,DHS,24.04
81939,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2004,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
81985,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2004,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,7
82016,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2004,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,3
82071,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2004,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,3289
82115,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2004,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,8
119750,2,ALGERIA,Number of road traffic injuries,AFR0140,2004,29,Total,5,Count (Numeric Integer),35,IHME,37688
138063,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2004,29,Total,5,Count (Numeric Integer),35,IHME,105463
142181,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2004,126,Hydrological,5,Count (Numeric Integer),35,IHME,3
144890,2,ALGERIA,Number of people living with HIV,AFR0019,2004,29,Total,5,Count (Numeric Integer),16,UNAIDS,3500
143269,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2004,29,Total,6,Per 1000 population,16,UNAIDS,0.02
144589,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2004,8,Male,6,Per 1000 population,16,UNAIDS,0.02
62251,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2004,9,Female,7,per 100 000 live births,23,MMEIG,134
83155,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2004,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,61
69562,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2004,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.49
92052,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2004,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,37.19
97450,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2004,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,94.09
106142,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2004,999,Not Applicable,14,Per Capita,3,WHO / GHO,92.12
106961,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2004,999,Not Applicable,14,Per Capita,42,WDI,0.16
107779,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2004,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.04
115147,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2004,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,94.09
183915,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2004,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,92.5
187379,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2004,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.04
190355,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2004,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,24.1
194648,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2004,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,26.4
186513,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2004,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.16
192087,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2004,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,94.6
193782,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2004,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,103.7
207400,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004-2006,28,Both sexes (male and female),1,Percentage,5,UNICEF,95.2
11466,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2005,9,Female,1,Percentage,3,WHO / GHO,127
51125,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2005,8,Male,1,Percentage,3,WHO / GHO,9.9
51126,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2005,9,Female,1,Percentage,3,WHO / GHO,10.4
51127,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,10.2
67760,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2005,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,88
68539,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2005,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,94
84226,2,ALGERIA,TB case detection rate,AFR0176,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
90157,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2005,8,Male,1,Percentage,3,WHO / GHO,28
90158,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2005,9,Female,1,Percentage,3,WHO / GHO,29
90159,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.6
92953,2,ALGERIA,GDP growth (annual %),AFR0388,2005,999,Not Applicable,1,Percentage,22,UN DESA,4.44
94072,2,ALGERIA,Social security funds as % of General government health expenditure (GGHE),AFR0294,2005,999,Not Applicable,1,Percentage,3,WHO / GHO,34.66
94073,2,ALGERIA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2005,999,Not Applicable,1,Percentage,3,WHO / GHO,94.61
96667,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2005,999,Not Applicable,1,Percentage,4,WB Database,15.2
98489,2,ALGERIA,Immunization coverage against Tetanus,AFR0189,2005,28,Both sexes (male and female),1,Percentage,4,WB Database,88
102374,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2005,999,Not Applicable,1,Percentage,4,WB Database,28.09
103502,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2005,999,Not Applicable,1,Percentage,3,WHO / GHO,0.08
109779,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2005,999,Not Applicable,1,Percentage,3,WHO / GHO,28.09
110586,2,ALGERIA,TB case detection rate,AFR0176,2005,29,Total,1,Percentage,3,WHO / GHO,68
111432,2,ALGERIA,TB treatment success rate,AFR0216,2005,29,Total,1,Percentage,3,WHO / GHO,87
112976,2,ALGERIA,TB treatment coverage,AFR0173,2005,29,Total,1,Percentage,3,WHO / GHO,87
115958,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,24.43
116980,2,ALGERIA,TB treatment success rate,AFR0216,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,69.6
123738,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2005,28,Both sexes (male and female),1,Percentage,35,IHME,1.19
125178,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2005,8,Male,1,Percentage,35,IHME,1.32
126618,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2005,9,Female,1,Percentage,35,IHME,1.07
131577,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2005,28,Both sexes (male and female),1,Percentage,4,WB Database,107.59
134213,2,ALGERIA,School dropout rate,AFR0160,2005,28,Both sexes (male and female),1,Percentage,42,WDI,4.6
136677,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2005,29,Total,1,Percentage,36,WHO/UNICEF,88
138368,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2005,29,Total,1,Percentage,3,WHO / GHO,87
138369,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,69.6
147115,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2005,29,Total,1,Percentage,36,WHO/UNICEF,94
156253,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2005,999,Not Applicable,1,Percentage,3,WHO / GHO,28.09
182228,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,30.62
183094,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,3.23
184826,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
185692,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,0.07
188363,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,8.26
189229,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,8.26
191266,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,28
192976,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,2.53
195625,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2005,28,Both sexes (male and female),1,Percentage,35,IHME,13.67
196928,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,20.2
198773,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,48.9
676,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.24
677,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2005,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,100.29
678,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2005,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,354.96
2394,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.92
2395,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,69.29
2396,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,30.63
2397,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,8.27
2398,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2005,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,2.24
2399,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,69.49
2400,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,245.95
2401,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,30.72
2402,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,108.72
2538,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2005,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,28.09
2539,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2005,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1.16
2540,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.08
2541,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.08
2542,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.28
2543,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,28.18
2544,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.72
3810,2,ALGERIA,Physicians density (per 1000 population),AFR0287,2005,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1.02
4059,2,ALGERIA,Other health workers density (per 1000 population),AFR0066,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,2.98
7203,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2005,12,Urban,2,Per 1000 live births,3,WHO / GHO,90.8
7204,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2005,11,Rural,2,Per 1000 live births,3,WHO / GHO,75.62
7205,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2005,29,Total,2,Per 1000 live births,3,WHO / GHO,85.31
7251,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2005,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.61
7252,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2005,11,Rural,2,Per 1000 live births,3,WHO / GHO,85.11
7253,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2005,29,Total,2,Per 1000 live births,3,WHO / GHO,91.18
12414,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,19.54
15925,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2005,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,3.8
16165,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2005,8,Male,2,Per 1000 live births,3,WHO / GHO,5.3
16405,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2005,9,Female,2,Per 1000 live births,3,WHO / GHO,2.2
16645,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,3.8
18294,2,ALGERIA,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,17.6
18565,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2005,9,Female,2,Per 1000 live births,3,WHO / GHO,48.02
18566,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2005,8,Male,2,Per 1000 live births,3,WHO / GHO,69.81
21183,2,ALGERIA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.15
22636,2,ALGERIA,HIV prevalence rate (per 1000 population),AFR0020,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.1
25485,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2005,9,Female,2,Per 1000 live births,1,WHO/AFRO,4.4
25835,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2005,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,1
25836,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2005,9,Female,2,Per 1000 live births,20,ITU,0.8
25837,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2005,8,Male,2,Per 1000 live births,20,ITU,1.2
28331,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2005,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.67
29832,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2005,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,64
30902,2,ALGERIA,TB case detection rate,AFR0176,2005,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
37685,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2005,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,5.84
38543,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2005,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,6.17
39738,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2005,999,Not Applicable,2,Per 1000 live births,19,OECD,51.73
45842,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
45888,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,18
45917,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,8
45970,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,46,Measles,2,Per 1000 live births,1,WHO/AFRO,2302
46011,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,7
47391,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2005,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,33.52
140093,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2005,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.61
140094,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2005,11,Rural,2,Per 1000 live births,3,WHO / GHO,85.11
140095,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2005,29,Total,2,Per 1000 live births,3,WHO / GHO,91.18
140959,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2005,999,Not Applicable,2,Per 1000 live births,7,DHS,8.27
140976,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2005,999,Not Applicable,2,Per 1000 live births,7,DHS,28.18
81660,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2005,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
81706,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2005,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,18
81735,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2005,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,8
81788,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2005,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,2302
81829,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2005,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,7
119797,2,ALGERIA,Number of road traffic injuries,AFR0140,2005,29,Total,5,Count (Numeric Integer),35,IHME,38069
138111,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2005,29,Total,5,Count (Numeric Integer),35,IHME,110803
142189,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2005,126,Hydrological,5,Count (Numeric Integer),35,IHME,11
142548,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2005,127,Meteorological,5,Count (Numeric Integer),35,IHME,10
144936,2,ALGERIA,Number of people living with HIV,AFR0019,2005,29,Total,5,Count (Numeric Integer),16,UNAIDS,4000
152808,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,70,0-4 years,5,Count (Numeric Integer),17,UN Population,2960281
153042,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,71,5-9 years,5,Count (Numeric Integer),17,UN Population,3049865
153275,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,72,10-14 years,5,Count (Numeric Integer),17,UN Population,3667166
153505,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,73,15-19 years,5,Count (Numeric Integer),17,UN Population,3875132
153737,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,74,20-24 years,5,Count (Numeric Integer),17,UN Population,3728506
153968,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,75,25-29 years,5,Count (Numeric Integer),17,UN Population,3221854
154199,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,76,30-34 years,5,Count (Numeric Integer),17,UN Population,2616645
154432,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,77,35-39 years,5,Count (Numeric Integer),17,UN Population,2200558
154665,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,78,40-44 years,5,Count (Numeric Integer),17,UN Population,1877991
154897,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,79,45-49 years,5,Count (Numeric Integer),17,UN Population,1520474
155129,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,80,50-54 years,5,Count (Numeric Integer),17,UN Population,1265162
155364,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,81,55-59 years,5,Count (Numeric Integer),17,UN Population,838293
155593,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,82,60-64 years,5,Count (Numeric Integer),17,UN Population,697008
155824,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,83,65-69 years,5,Count (Numeric Integer),17,UN Population,613598
156056,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,84,70-74 years,5,Count (Numeric Integer),17,UN Population,482015
177397,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,85,75-79 years,5,Count (Numeric Integer),17,UN Population,300689
177627,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,86,80-84 years,5,Count (Numeric Integer),17,UN Population,148842
177859,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,1010,85-89 years,5,Count (Numeric Integer),17,UN Population,66216
178173,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,1011,90-94 years,5,Count (Numeric Integer),17,UN Population,16696
178408,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,1012,95-99 years,5,Count (Numeric Integer),17,UN Population,2571
179099,2,ALGERIA,Number of medical doctors,AFR0469,2005,29,Total,5,Count (Numeric Integer),3,WHO / GHO,33952
76281,2,ALGERIA,Pharmaceutical personnel density (per 1000 population),AFR0284,2005,28,Both sexes (male and female),6,Per 1000 population,38,Global Health Workforce Statistics,18.41
76464,2,ALGERIA,Dentistry personnel density (per 1000 population),AFR0285,2005,28,Both sexes (male and female),6,Per 1000 population,38,Global Health Workforce Statistics,27.22
121534,2,ALGERIA,Other health workers density (per 1000 population),AFR0066,2005,29,Total,6,Per 1000 population,3,WHO / GHO,3.02
143313,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2005,29,Total,6,Per 1000 population,16,UNAIDS,0.02
144633,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2005,8,Male,6,Per 1000 population,16,UNAIDS,0.02
62252,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2005,9,Female,7,per 100 000 live births,23,MMEIG,127
70606,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2005,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,1
70607,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2005,9,Female,8,Per 100 000 population,13,UNStat,0.8
70608,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2005,8,Male,8,Per 100 000 population,13,UNStat,1.2
83156,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2005,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,64
104400,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2005,8,Male,8,Per 100 000 population,3,WHO / GHO,9.77
104401,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2005,9,Female,8,Per 100 000 population,3,WHO / GHO,2.99
109161,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2005,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,6.42
120795,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2005,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,17.6
121035,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2005,8,Male,8,Per 100 000 population,3,WHO / GHO,18.9
121275,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2005,9,Female,8,Per 100 000 population,3,WHO / GHO,16.2
70257,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2005,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,4.4
69608,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2005,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.66
92053,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2005,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,51.73
97449,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2005,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,99.7
113749,2,ALGERIA,Total Health Expenditure (constant US$),AFR0349,2005,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,3886.34
114209,2,ALGERIA,Total Health Expenditure (International US$),AFR0348,2005,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,3338.63
74743,2,ALGERIA,Gender development index score,AFR0347,2005,28,Both sexes (male and female),12,Index,14,UNDP,0.8
95301,2,ALGERIA,"Pharmacists (per 10,000 population)",AFR0253,2005,28,Both sexes (male and female),13,Per 10 000 population,3,WHO / GHO,1.84
109428,2,ALGERIA,"Pharmacists (per 10,000 population)",AFR0253,2005,28,Both sexes (male and female),13,Per 10 000 population,38,Global Health Workforce Statistics,1.84
151584,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2005,1000,Dentists,13,Per 10 000 population,3,WHO / GHO,2.72
151585,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2005,1003,Pharmacists,13,Per 10 000 population,3,WHO / GHO,1.84
151586,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2005,1001,Medical doctors,13,Per 10 000 population,3,WHO / GHO,10.2
106141,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2005,999,Not Applicable,14,Per Capita,3,WHO / GHO,100.3
106960,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2005,999,Not Applicable,14,Per Capita,42,WDI,0.28
107778,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2005,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.08
114684,2,ALGERIA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2005,999,Not Applicable,14,Per Capita,4,WB Database,354.87
115146,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2005,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,99.7
127850,2,ALGERIA,Life expectancy at birth (years),AFR0381,2005,28,Both sexes (male and female),17,years,4,WB Database,73.07
183960,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2005,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,100
187424,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2005,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.07
190400,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2005,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,28.2
194693,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2005,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,30.8
186558,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2005,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.28
192132,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2005,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,100
193827,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2005,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,109.2
122271,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2005-2010,28,Both sexes (male and female),1,Percentage,17,UN Population,20.91
122559,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2005-2010,8,Male,1,Percentage,17,UN Population,20.38
122847,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2005-2010,9,Female,1,Percentage,17,UN Population,21.43
130566,2,ALGERIA,Total fertility rate,AFR0130,2005-2010,9,Female,1,Percentage,17,UN Population,2.72
11467,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2006,9,Female,1,Percentage,3,WHO / GHO,122
51265,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2006,8,Male,1,Percentage,3,WHO / GHO,10.1
51266,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2006,9,Female,1,Percentage,3,WHO / GHO,10.7
51267,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,10.4
67806,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2006,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
68566,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2006,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,98
72756,2,ALGERIA,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2006,28,Both sexes (male and female),1,Percentage,5,UNICEF,12.9
84227,2,ALGERIA,TB case detection rate,AFR0176,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
90295,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2006,8,Male,1,Percentage,3,WHO / GHO,27.8
90296,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2006,9,Female,1,Percentage,3,WHO / GHO,28.6
90297,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.2
92954,2,ALGERIA,GDP growth (annual %),AFR0388,2006,999,Not Applicable,1,Percentage,22,UN DESA,0.21
94164,2,ALGERIA,Social security funds as % of General government health expenditure (GGHE),AFR0294,2006,999,Not Applicable,1,Percentage,3,WHO / GHO,36.38
94165,2,ALGERIA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2006,999,Not Applicable,1,Percentage,3,WHO / GHO,94.62
96713,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2006,999,Not Applicable,1,Percentage,4,WB Database,12.2
103501,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2006,999,Not Applicable,1,Percentage,3,WHO / GHO,0.15
104947,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2006,999,Not Applicable,1,Percentage,3,WHO / GHO,29.12
110631,2,ALGERIA,TB case detection rate,AFR0176,2006,29,Total,1,Percentage,3,WHO / GHO,68
111475,2,ALGERIA,TB treatment success rate,AFR0216,2006,29,Total,1,Percentage,3,WHO / GHO,91
112208,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2006,9,Female,1,Percentage,44,DHS/MICS,89.4
113020,2,ALGERIA,TB treatment coverage,AFR0173,2006,29,Total,1,Percentage,3,WHO / GHO,91
115959,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,25.32
116979,2,ALGERIA,TB treatment success rate,AFR0216,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72.8
123786,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2006,28,Both sexes (male and female),1,Percentage,35,IHME,1.21
125226,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2006,8,Male,1,Percentage,35,IHME,1.34
126666,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2006,9,Female,1,Percentage,35,IHME,1.09
131578,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2006,28,Both sexes (male and female),1,Percentage,4,WB Database,108.16
134214,2,ALGERIA,School dropout rate,AFR0160,2006,28,Both sexes (male and female),1,Percentage,42,WDI,4.36
136724,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2006,29,Total,1,Percentage,36,WHO/UNICEF,95
138370,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2006,29,Total,1,Percentage,3,WHO / GHO,91
138371,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72.8
147122,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2006,29,Total,1,Percentage,36,WHO/UNICEF,98
149545,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,9,Female,1,Percentage,12,UNICEF / MICS,95.2
156252,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2006,999,Not Applicable,1,Percentage,3,WHO / GHO,29.12
182273,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,31.48
183139,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,3.35
184871,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
185737,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,0.05
188408,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,7.96
189274,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,7.96
191311,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,29.1
193020,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,2.36
195626,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2006,28,Both sexes (male and female),1,Percentage,35,IHME,13.95
196929,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,20.8
198774,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,49.8
200634,2,ALGERIA,Contraceptive prevalence rate,AFR0208,2006,9,Female,1,Percentage,22,UN DESA,61.4
202192,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2006,29,Total,1,Percentage,36,WHO/UNICEF,89.4
202193,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2006,12,Urban,1,Percentage,36,WHO/UNICEF,93.7
202194,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2006,11,Rural,1,Percentage,36,WHO/UNICEF,84.6
202195,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2006,19,First Quintile,1,Percentage,36,WHO/UNICEF,75.9
202196,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2006,20,Second Quintile,1,Percentage,36,WHO/UNICEF,89.4
202197,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2006,1023,Middle,1,Percentage,36,WHO/UNICEF,92.9
202198,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2006,22,Fourth Quintile,1,Percentage,36,WHO/UNICEF,94.7
202199,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2006,23,Fifth Quintile,1,Percentage,36,WHO/UNICEF,97.8
202231,2,ALGERIA,Institutional deliveries,AFR0200,2006,29,Total,1,Percentage,36,WHO/UNICEF,95.3
202232,2,ALGERIA,Institutional deliveries,AFR0200,2006,12,Urban,1,Percentage,36,WHO/UNICEF,98.3
202233,2,ALGERIA,Institutional deliveries,AFR0200,2006,11,Rural,1,Percentage,36,WHO/UNICEF,91.8
202234,2,ALGERIA,Institutional deliveries,AFR0200,2006,19,First Quintile,1,Percentage,36,WHO/UNICEF,87.9
202235,2,ALGERIA,Institutional deliveries,AFR0200,2006,20,Second Quintile,1,Percentage,36,WHO/UNICEF,96.6
202236,2,ALGERIA,Institutional deliveries,AFR0200,2006,1023,Middle,1,Percentage,36,WHO/UNICEF,96.8
202237,2,ALGERIA,Institutional deliveries,AFR0200,2006,22,Fourth Quintile,1,Percentage,36,WHO/UNICEF,98.1
202238,2,ALGERIA,Institutional deliveries,AFR0200,2006,23,Fifth Quintile,1,Percentage,36,WHO/UNICEF,98.8
811,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.36
812,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2006,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,116.24
813,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2006,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,380.23
2403,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.95
2404,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,68.46
2405,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,31.48
2406,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,7.96
2407,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2006,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,2.3
2408,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,79.58
2409,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,260.31
2410,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,36.6
2411,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,119.71
2545,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2006,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,29.12
2546,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2006,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1.12
2547,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.05
2548,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.06
2549,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.2
2550,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,33.85
2551,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,110.73
3629,2,ALGERIA,Civil registration coverage of births (%),AFR0062,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.3
7206,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2006,12,Urban,2,Per 1000 live births,3,WHO / GHO,90.69
7207,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2006,11,Rural,2,Per 1000 live births,3,WHO / GHO,76.28
7208,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2006,29,Total,2,Per 1000 live births,3,WHO / GHO,85.58
7254,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2006,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.69
7255,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2006,11,Rural,2,Per 1000 live births,3,WHO / GHO,85.47
7256,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2006,29,Total,2,Per 1000 live births,3,WHO / GHO,91.43
12415,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2006,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,18.99
18567,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2006,9,Female,2,Per 1000 live births,3,WHO / GHO,45.17
18568,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2006,8,Male,2,Per 1000 live births,3,WHO / GHO,67.82
24116,2,ALGERIA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2006,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,4.1
24328,2,ALGERIA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2006,9,Female,2,Per 1000 live births,5,UNICEF,4.3
24522,2,ALGERIA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2006,8,Male,2,Per 1000 live births,5,UNICEF,4
28376,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2006,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.43
29833,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2006,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,63
30903,2,ALGERIA,TB case detection rate,AFR0176,2006,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
32437,2,ALGERIA,Prevalence of stunting in children under 5 u (%),AFR0154,2006,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,15.45
32671,2,ALGERIA,Prevalence of wasting in children under 5 u (%),AFR0155,2006,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,4.13
32907,2,ALGERIA,Prevalence of overweight in children under 5 u (%),AFR0156,2006,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,12.9
37686,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2006,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,7.38
38544,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2006,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,6.17
39739,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2006,999,Not Applicable,2,Per 1000 live births,19,OECD,38.53
45540,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
45586,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,23
45614,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,5
45673,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,46,Measles,2,Per 1000 live births,1,WHO/AFRO,944
45731,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,3
47392,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2006,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,32.05
140096,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2006,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.69
140097,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2006,11,Rural,2,Per 1000 live births,3,WHO / GHO,85.47
140098,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2006,29,Total,2,Per 1000 live births,3,WHO / GHO,91.43
140960,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2006,999,Not Applicable,2,Per 1000 live births,7,DHS,7.96
140977,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2006,999,Not Applicable,2,Per 1000 live births,7,DHS,33.85
81358,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2006,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
81404,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2006,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,23
81432,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2006,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,5
81491,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2006,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,944
81549,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2006,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,3
119844,2,ALGERIA,Number of road traffic injuries,AFR0140,2006,29,Total,5,Count (Numeric Integer),35,IHME,38417
138159,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2006,29,Total,5,Count (Numeric Integer),35,IHME,116276
141539,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2006,124,Geophysical,5,Count (Numeric Integer),35,IHME,4
142201,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2006,126,Hydrological,5,Count (Numeric Integer),35,IHME,1
144982,2,ALGERIA,Number of people living with HIV,AFR0019,2006,29,Total,5,Count (Numeric Integer),16,UNAIDS,4600
143357,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2006,29,Total,6,Per 1000 population,16,UNAIDS,0.02
144677,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2006,8,Male,6,Per 1000 population,16,UNAIDS,0.02
62253,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2006,9,Female,7,per 100 000 live births,23,MMEIG,122
83157,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2006,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,63
69654,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2006,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.42
92054,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2006,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,38.52
97448,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2006,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,110.7
106140,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2006,999,Not Applicable,14,Per Capita,3,WHO / GHO,116.2
106959,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2006,999,Not Applicable,14,Per Capita,42,WDI,0.19
107777,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2006,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.06
115145,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2006,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,110.7
184005,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2006,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,116
187469,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2006,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.06
190445,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2006,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,33.9
194738,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2006,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,36.7
186603,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2006,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.19
192177,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2006,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,111
193872,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2006,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,120.2
11468,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2007,9,Female,1,Percentage,3,WHO / GHO,119
51404,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2007,8,Male,1,Percentage,3,WHO / GHO,10.4
51405,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2007,9,Female,1,Percentage,3,WHO / GHO,10.9
51406,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,10.7
67852,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2007,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
68593,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2007,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
84228,2,ALGERIA,TB case detection rate,AFR0176,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
90433,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2007,8,Male,1,Percentage,3,WHO / GHO,27.5
90434,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2007,9,Female,1,Percentage,3,WHO / GHO,28.2
90435,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.9
92955,2,ALGERIA,GDP growth (annual %),AFR0388,2007,999,Not Applicable,1,Percentage,22,UN DESA,1.81
94255,2,ALGERIA,Social security funds as % of General government health expenditure (GGHE),AFR0294,2007,999,Not Applicable,1,Percentage,3,WHO / GHO,34.88
94256,2,ALGERIA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2007,999,Not Applicable,1,Percentage,3,WHO / GHO,94.7
96759,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2007,999,Not Applicable,1,Percentage,4,WB Database,13.7
103500,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2007,999,Not Applicable,1,Percentage,3,WHO / GHO,0.12
104946,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2007,999,Not Applicable,1,Percentage,3,WHO / GHO,28.09
110674,2,ALGERIA,TB case detection rate,AFR0176,2007,29,Total,1,Percentage,3,WHO / GHO,68
111515,2,ALGERIA,TB treatment success rate,AFR0216,2007,29,Total,1,Percentage,3,WHO / GHO,90
113061,2,ALGERIA,TB treatment coverage,AFR0173,2007,29,Total,1,Percentage,3,WHO / GHO,90
115960,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,24.69
116978,2,ALGERIA,TB treatment success rate,AFR0216,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72
123834,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2007,28,Both sexes (male and female),1,Percentage,35,IHME,1.23
125274,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2007,8,Male,1,Percentage,35,IHME,1.36
126714,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2007,9,Female,1,Percentage,35,IHME,1.1
131579,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2007,28,Both sexes (male and female),1,Percentage,4,WB Database,109.53
134215,2,ALGERIA,School dropout rate,AFR0160,2007,28,Both sexes (male and female),1,Percentage,42,WDI,4.11
136771,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2007,29,Total,1,Percentage,36,WHO/UNICEF,95
138372,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2007,29,Total,1,Percentage,3,WHO / GHO,90
138373,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72
147129,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2007,29,Total,1,Percentage,36,WHO/UNICEF,95
156251,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2007,999,Not Applicable,1,Percentage,3,WHO / GHO,28.09
182318,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,30.14
183184,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,3.82
184916,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
185782,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,0.06
188453,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,8.02
189319,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,8.02
191356,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,28
193065,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,2.05
195627,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2007,28,Both sexes (male and female),1,Percentage,35,IHME,14.22
196930,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,21.4
198775,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,50.8
946,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.82
947,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2007,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,150.38
948,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2007,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,452.6
2412,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.93
2413,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,69.79
2414,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,30.15
2415,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,8.02
2416,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2007,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,2.67
2417,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,104.95
2418,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,315.86
2419,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,45.33
2420,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,136.44
2552,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2007,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,28.09
2553,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2007,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.99
2554,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.07
2555,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.1
2556,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.3
2557,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,42.24
2558,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,127.13
3832,2,ALGERIA,Physicians density (per 1000 population),AFR0287,2007,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1.19
4077,2,ALGERIA,Other health workers density (per 1000 population),AFR0066,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.28
4250,2,ALGERIA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2007,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1.92
7209,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2007,12,Urban,2,Per 1000 live births,3,WHO / GHO,90.57
7210,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2007,11,Rural,2,Per 1000 live births,3,WHO / GHO,76.94
7211,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2007,29,Total,2,Per 1000 live births,3,WHO / GHO,85.85
7257,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2007,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.78
7258,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2007,11,Rural,2,Per 1000 live births,3,WHO / GHO,85.83
7259,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2007,29,Total,2,Per 1000 live births,3,WHO / GHO,91.68
12416,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2007,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,18.47
18569,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2007,9,Female,2,Per 1000 live births,3,WHO / GHO,43.8
18570,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2007,8,Male,2,Per 1000 live births,3,WHO / GHO,67.27
25484,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2007,9,Female,2,Per 1000 live births,1,WHO/AFRO,9
28420,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2007,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,1.94
29834,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2007,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,63
30904,2,ALGERIA,TB case detection rate,AFR0176,2007,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
37687,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2007,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,9.45
38545,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2007,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,6.17
39740,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2007,999,Not Applicable,2,Per 1000 live births,19,OECD,37.16
45211,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
45257,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,0
45289,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,4
45350,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,46,Measles,2,Per 1000 live births,1,WHO/AFRO,0
45412,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
47393,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2007,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,30.67
140099,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2007,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.78
140100,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2007,11,Rural,2,Per 1000 live births,3,WHO / GHO,85.83
140101,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2007,29,Total,2,Per 1000 live births,3,WHO / GHO,91.68
140961,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2007,999,Not Applicable,2,Per 1000 live births,7,DHS,8.02
140978,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2007,999,Not Applicable,2,Per 1000 live births,7,DHS,42.24
128445,2,ALGERIA,Sex ratio at birth,AFR0428,2007,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
81029,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2007,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
81075,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2007,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,0
81107,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2007,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,4
81168,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2007,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,0
81230,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2007,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
119891,2,ALGERIA,Number of road traffic injuries,AFR0140,2007,29,Total,5,Count (Numeric Integer),35,IHME,38707
138207,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2007,29,Total,5,Count (Numeric Integer),35,IHME,121472
142217,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2007,126,Hydrological,5,Count (Numeric Integer),35,IHME,15
142641,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2007,128,Climatological,5,Count (Numeric Integer),35,IHME,8
145028,2,ALGERIA,Number of people living with HIV,AFR0019,2007,29,Total,5,Count (Numeric Integer),16,UNAIDS,5300
179098,2,ALGERIA,Number of medical doctors,AFR0469,2007,29,Total,5,Count (Numeric Integer),3,WHO / GHO,40857
76463,2,ALGERIA,Dentistry personnel density (per 1000 population),AFR0285,2007,28,Both sexes (male and female),6,Per 1000 population,38,Global Health Workforce Statistics,31.09
76633,2,ALGERIA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2007,999,Not Applicable,6,Per 1000 population,38,Global Health Workforce Statistics,192.93
95115,2,ALGERIA,Laboratory health workers density (per 1000 population),AFR0283,2007,999,Not Applicable,6,Per 1000 population,3,WHO / GHO,0.29
95229,2,ALGERIA,Environmental and public health workers density (per 1000 population),AFR0282,2007,999,Not Applicable,6,Per 1000 population,3,WHO / GHO,0.07
109562,2,ALGERIA,Pharmaceutical personnel density (per 1000 population),AFR0284,2007,28,Both sexes (male and female),6,Per 1000 population,38,Global Health Workforce Statistics,0.24
121551,2,ALGERIA,Other health workers density (per 1000 population),AFR0066,2007,29,Total,6,Per 1000 population,3,WHO / GHO,3.32
143401,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2007,29,Total,6,Per 1000 population,16,UNAIDS,0.02
62254,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2007,9,Female,7,per 100 000 live births,23,MMEIG,119
83158,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2007,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,63
70256,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2007,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,9
69700,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2007,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,1.93
92055,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2007,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,37.15
97447,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2007,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,127.1
95300,2,ALGERIA,"Pharmacists (per 10,000 population)",AFR0253,2007,28,Both sexes (male and female),13,Per 10 000 population,3,WHO / GHO,2.17
109427,2,ALGERIA,"Pharmacists (per 10,000 population)",AFR0253,2007,28,Both sexes (male and female),13,Per 10 000 population,38,Global Health Workforce Statistics,2.17
151667,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2007,1000,Dentists,13,Per 10 000 population,3,WHO / GHO,3.1
151668,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2007,1002,Nursing and midwifery personnel,13,Per 10 000 population,3,WHO / GHO,19.2
151669,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2007,1003,Pharmacists,13,Per 10 000 population,3,WHO / GHO,2.17
151670,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2007,1001,Medical doctors,13,Per 10 000 population,3,WHO / GHO,11.9
106139,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2007,999,Not Applicable,14,Per Capita,3,WHO / GHO,150.4
106958,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2007,999,Not Applicable,14,Per Capita,42,WDI,0.3
107776,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2007,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.1
115144,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2007,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,127.1
184050,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2007,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,150
187514,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2007,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.1
190490,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2007,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,42.4
194783,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2007,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,45.5
186648,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2007,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.3
192222,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2007,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,127
193917,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2007,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,137
11469,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2008,9,Female,1,Percentage,3,WHO / GHO,117
51544,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2008,8,Male,1,Percentage,3,WHO / GHO,10.7
51545,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2008,9,Female,1,Percentage,3,WHO / GHO,11.2
51546,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,10.9
67898,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2008,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,93
68620,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2008,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,96
68917,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2008,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
84229,2,ALGERIA,TB case detection rate,AFR0176,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
90571,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2008,8,Male,1,Percentage,3,WHO / GHO,27.3
90572,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2008,9,Female,1,Percentage,3,WHO / GHO,27.8
90573,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.6
92956,2,ALGERIA,GDP growth (annual %),AFR0388,2008,999,Not Applicable,1,Percentage,22,UN DESA,0.74
94347,2,ALGERIA,Social security funds as % of General government health expenditure (GGHE),AFR0294,2008,999,Not Applicable,1,Percentage,3,WHO / GHO,35.18
94348,2,ALGERIA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2008,999,Not Applicable,1,Percentage,3,WHO / GHO,94.7
96805,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2008,999,Not Applicable,1,Percentage,4,WB Database,11.3
103499,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2008,999,Not Applicable,1,Percentage,3,WHO / GHO,0.19
104945,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2008,999,Not Applicable,1,Percentage,3,WHO / GHO,26.15
110714,2,ALGERIA,TB case detection rate,AFR0176,2008,29,Total,1,Percentage,3,WHO / GHO,67
111558,2,ALGERIA,TB treatment success rate,AFR0216,2008,29,Total,1,Percentage,3,WHO / GHO,90
113105,2,ALGERIA,TB treatment coverage,AFR0173,2008,29,Total,1,Percentage,3,WHO / GHO,90
115961,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,25.64
116977,2,ALGERIA,TB treatment success rate,AFR0216,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72
123882,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2008,28,Both sexes (male and female),1,Percentage,35,IHME,1.25
125322,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2008,8,Male,1,Percentage,35,IHME,1.38
126762,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2008,9,Female,1,Percentage,35,IHME,1.12
131580,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2008,28,Both sexes (male and female),1,Percentage,4,WB Database,109.23
133663,2,ALGERIA,"Proportion of total government spending on essential services (education, health and social protection[SDG1.a.2]",AFR0419,2008,999,Not Applicable,1,Percentage,51,UNESCO/IMF,11.43
134216,2,ALGERIA,School dropout rate,AFR0160,2008,28,Both sexes (male and female),1,Percentage,42,WDI,2.73
136818,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2008,29,Total,1,Percentage,36,WHO/UNICEF,93
138374,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2008,29,Total,1,Percentage,3,WHO / GHO,90
138375,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72
147136,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2008,29,Total,1,Percentage,36,WHO/UNICEF,96
148242,2,ALGERIA,Antenatal care attendees who were positive for syphilis (%),AFR0457,2008,9,Female,1,Percentage,3,WHO / GHO,0.84
156250,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2008,999,Not Applicable,1,Percentage,3,WHO / GHO,26.15
182363,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,27.96
183229,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,4.2
184961,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
185827,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,0.03
188498,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,7.97
189364,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,7.97
191401,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,26.1
193109,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,1.82
195628,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2008,28,Both sexes (male and female),1,Percentage,35,IHME,14.55
196931,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,22
198776,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,51.8
1081,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,4.2
1082,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2008,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,206.11
1083,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2008,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,511.04
2421,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.96
2422,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,72
2423,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,27.97
2424,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,7.97
2425,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2008,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,3.03
2426,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,148.39
2427,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,367.93
2428,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,57.65
2429,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,142.93
2559,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2008,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,26.15
2560,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2008,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.89
2561,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.04
2562,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.08
2563,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.19
2564,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,53.89
2565,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,133.62
7212,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2008,12,Urban,2,Per 1000 live births,3,WHO / GHO,90.46
7213,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2008,11,Rural,2,Per 1000 live births,3,WHO / GHO,77.6
7214,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2008,29,Total,2,Per 1000 live births,3,WHO / GHO,86.1
7260,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2008,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.86
7261,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2008,11,Rural,2,Per 1000 live births,3,WHO / GHO,86.19
7262,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2008,29,Total,2,Per 1000 live births,3,WHO / GHO,91.92
12417,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2008,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,17.96
18571,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2008,9,Female,2,Per 1000 live births,3,WHO / GHO,43.17
18572,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2008,8,Male,2,Per 1000 live births,3,WHO / GHO,66.28
25483,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2008,9,Female,2,Per 1000 live births,1,WHO/AFRO,8.8
28464,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2008,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.31
29835,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2008,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,59
30905,2,ALGERIA,TB case detection rate,AFR0176,2008,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
37688,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2008,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,10.18
38546,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2008,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,7.71
39741,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2008,999,Not Applicable,2,Per 1000 live births,19,OECD,32.19
44813,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
44850,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,1339
44890,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
44936,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,28
44967,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,3
45012,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,0
45030,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,46,Measles,2,Per 1000 live births,1,WHO/AFRO,217
45074,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
45091,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
45115,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,0
47394,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2008,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,29.43
140102,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2008,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.86
140103,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2008,11,Rural,2,Per 1000 live births,3,WHO / GHO,86.19
140104,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2008,29,Total,2,Per 1000 live births,3,WHO / GHO,91.92
140962,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2008,999,Not Applicable,2,Per 1000 live births,7,DHS,7.97
140979,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2008,999,Not Applicable,2,Per 1000 live births,7,DHS,53.89
128444,2,ALGERIA,Sex ratio at birth,AFR0428,2008,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
80631,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2008,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
80668,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2008,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,1339
80708,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2008,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
80754,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2008,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,28
80785,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2008,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,3
80830,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2008,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,0
80848,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2008,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,217
80892,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2008,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
80909,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2008,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
80933,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2008,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,0
119938,2,ALGERIA,Number of road traffic injuries,AFR0140,2008,29,Total,5,Count (Numeric Integer),35,IHME,38988
138255,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2008,29,Total,5,Count (Numeric Integer),35,IHME,126549
142244,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2008,126,Hydrological,5,Count (Numeric Integer),35,IHME,93
145074,2,ALGERIA,Number of people living with HIV,AFR0019,2008,29,Total,5,Count (Numeric Integer),16,UNAIDS,6000
102089,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2008,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,4.63
143445,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2008,29,Total,6,Per 1000 population,16,UNAIDS,0.03
62255,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2008,9,Female,7,per 100 000 live births,23,MMEIG,117
83159,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2008,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,59
70255,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2008,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,8.8
69746,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2008,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.3
92056,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2008,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,32.19
97446,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2008,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,133.6
106138,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2008,999,Not Applicable,14,Per Capita,3,WHO / GHO,206.1
106957,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2008,999,Not Applicable,14,Per Capita,42,WDI,0.18
107775,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2008,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.07
115143,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2008,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,133.6
184095,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2008,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,206
187559,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2008,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.07
190535,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2008,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,54
194828,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2008,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,57.8
186693,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2008,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.18
192267,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2008,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,134
193962,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2008,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,143.5
11470,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2009,9,Female,1,Percentage,3,WHO / GHO,117
51683,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2009,8,Male,1,Percentage,3,WHO / GHO,11
51684,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2009,9,Female,1,Percentage,3,WHO / GHO,11.4
51685,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.2
67944,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2009,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
68647,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2009,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,98
68958,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2009,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
84230,2,ALGERIA,TB case detection rate,AFR0176,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
90709,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2009,8,Male,1,Percentage,3,WHO / GHO,27.1
90710,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2009,9,Female,1,Percentage,3,WHO / GHO,27.3
90711,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.2
92957,2,ALGERIA,GDP growth (annual %),AFR0388,2009,999,Not Applicable,1,Percentage,22,UN DESA,-0.13
94441,2,ALGERIA,Social security funds as % of General government health expenditure (GGHE),AFR0294,2009,999,Not Applicable,1,Percentage,3,WHO / GHO,33.09
94442,2,ALGERIA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2009,999,Not Applicable,1,Percentage,3,WHO / GHO,94.7
96851,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2009,999,Not Applicable,1,Percentage,4,WB Database,10.1
103498,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2009,999,Not Applicable,1,Percentage,3,WHO / GHO,0.04
104944,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2009,999,Not Applicable,1,Percentage,3,WHO / GHO,27.45
110760,2,ALGERIA,TB case detection rate,AFR0176,2009,29,Total,1,Percentage,3,WHO / GHO,67
111603,2,ALGERIA,TB treatment success rate,AFR0216,2009,29,Total,1,Percentage,3,WHO / GHO,91
113151,2,ALGERIA,TB treatment coverage,AFR0173,2009,29,Total,1,Percentage,3,WHO / GHO,91
115962,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,25.98
116976,2,ALGERIA,TB treatment success rate,AFR0216,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72.8
123930,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2009,28,Both sexes (male and female),1,Percentage,35,IHME,1.27
125370,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2009,8,Male,1,Percentage,35,IHME,1.41
126810,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2009,9,Female,1,Percentage,35,IHME,1.13
131581,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2009,28,Both sexes (male and female),1,Percentage,4,WB Database,112.36
134217,2,ALGERIA,School dropout rate,AFR0160,2009,28,Both sexes (male and female),1,Percentage,42,WDI,1
136865,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2009,29,Total,1,Percentage,36,WHO/UNICEF,95
138376,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2009,29,Total,1,Percentage,3,WHO / GHO,91
138377,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72.8
147143,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2009,29,Total,1,Percentage,36,WHO/UNICEF,98
156249,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2009,999,Not Applicable,1,Percentage,3,WHO / GHO,27.45
179344,2,ALGERIA,Access to electricity (% of population),AFR0380,2009,999,Not Applicable,1,Percentage,4,WB Database,98.7
182408,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,29.06
183274,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,5.35
185006,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
185872,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,0.03
188543,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,8.92
189409,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,8.92
191446,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,27.4
193153,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,1.61
195629,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2009,28,Both sexes (male and female),1,Percentage,35,IHME,14.86
196932,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,22.7
198777,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,52.8
1216,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.36
1217,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2009,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,207.35
1218,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2009,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,656.11
2430,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.97
2431,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,70.9
2432,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,29.06
2433,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,8.92
2434,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2009,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,3.8
2435,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,147.02
2436,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,465.21
2437,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,60.26
2438,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,190.69
2566,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2009,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,27.45
2567,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2009,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.71
2568,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.03
2569,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.07
2570,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.21
2571,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,56.92
2572,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,180.1
7215,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2009,12,Urban,2,Per 1000 live births,3,WHO / GHO,90.35
7216,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2009,11,Rural,2,Per 1000 live births,3,WHO / GHO,78.25
7217,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2009,29,Total,2,Per 1000 live births,3,WHO / GHO,86.34
7263,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2009,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.94
7264,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2009,11,Rural,2,Per 1000 live births,3,WHO / GHO,86.54
7265,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2009,29,Total,2,Per 1000 live births,3,WHO / GHO,92.16
12418,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2009,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,17.46
18573,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2009,9,Female,2,Per 1000 live births,3,WHO / GHO,42.77
18574,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2009,8,Male,2,Per 1000 live births,3,WHO / GHO,65.9
25482,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2009,9,Female,2,Per 1000 live births,1,WHO/AFRO,9.6
28507,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2009,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.34
29836,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2009,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,61
30906,2,ALGERIA,TB case detection rate,AFR0176,2009,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
37689,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2009,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,11.23
38547,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2009,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,7.71
39742,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2009,999,Not Applicable,2,Per 1000 live births,19,OECD,33.72
44487,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
44523,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,23
44561,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
44607,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,1
44638,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,0
44700,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,46,Measles,2,Per 1000 live births,1,WHO/AFRO,107
44744,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
44761,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
47395,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2009,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,28.33
140105,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2009,12,Urban,2,Per 1000 live births,3,WHO / GHO,94.94
140106,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2009,11,Rural,2,Per 1000 live births,3,WHO / GHO,86.54
140107,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2009,29,Total,2,Per 1000 live births,3,WHO / GHO,92.16
140963,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2009,999,Not Applicable,2,Per 1000 live births,7,DHS,8.92
140980,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2009,999,Not Applicable,2,Per 1000 live births,7,DHS,56.92
128443,2,ALGERIA,Sex ratio at birth,AFR0428,2009,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
80305,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2009,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
80341,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2009,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,23
80379,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2009,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
80425,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2009,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,1
80456,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2009,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,0
80518,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2009,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,107
80562,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2009,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
80579,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2009,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
119985,2,ALGERIA,Number of road traffic injuries,AFR0140,2009,29,Total,5,Count (Numeric Integer),35,IHME,39315
138303,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2009,29,Total,5,Count (Numeric Integer),35,IHME,131673
142264,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2009,126,Hydrological,5,Count (Numeric Integer),35,IHME,33
145120,2,ALGERIA,Number of people living with HIV,AFR0019,2009,29,Total,5,Count (Numeric Integer),16,UNAIDS,6900
102090,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2009,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,4.64
143489,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2009,29,Total,6,Per 1000 population,16,UNAIDS,0.03
62256,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2009,9,Female,7,per 100 000 live births,23,MMEIG,117
83160,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2009,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,61
70254,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2009,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,9.6
69792,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2009,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.33
92057,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2009,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,33.72
97445,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2009,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,180.1
106137,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2009,999,Not Applicable,14,Per Capita,3,WHO / GHO,207.3
106956,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2009,999,Not Applicable,14,Per Capita,42,WDI,0.2
107774,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2009,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.06
115142,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2009,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,180.1
184140,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2009,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,208
187604,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2009,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.06
190580,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2009,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,57.1
194873,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2009,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,60.4
186738,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2009,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.2
192312,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2009,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,180
194007,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2009,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,191.5
10576,2,ALGERIA,Number of people living with HIV,AFR0019,2010,28,Both sexes (male and female),1,Percentage,16,UNAIDS,7100
11471,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2010,9,Female,1,Percentage,3,WHO / GHO,115
51823,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2010,8,Male,1,Percentage,3,WHO / GHO,11.2
51824,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2010,9,Female,1,Percentage,3,WHO / GHO,11.6
51825,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.4
67990,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2010,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
68674,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2010,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
68999,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2010,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
71955,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2010,28,Both sexes (male and female),1,Percentage,16,UNAIDS,28
72423,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2010,9,Female,1,Percentage,16,UNAIDS,54
73411,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
73496,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2010,28,Both sexes (male and female),1,Percentage,20,ITU,12.5
74211,2,ALGERIA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2010,999,Not Applicable,1,Percentage,3,WHO / GHO,51
75764,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,99
75780,2,ALGERIA,Social security funds as % of General government health expenditure (GGHE),AFR0294,2010,999,Not Applicable,1,Percentage,3,WHO / GHO,32.05
75781,2,ALGERIA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2010,999,Not Applicable,1,Percentage,3,WHO / GHO,94.7
84231,2,ALGERIA,TB case detection rate,AFR0176,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
91867,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
95698,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
96897,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2010,999,Not Applicable,1,Percentage,4,WB Database,9.96
98490,2,ALGERIA,Immunization coverage against Tetanus,AFR0189,2010,28,Both sexes (male and female),1,Percentage,4,WB Database,95
102375,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2010,999,Not Applicable,1,Percentage,4,WB Database,28.88
103497,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2010,999,Not Applicable,1,Percentage,3,WHO / GHO,0.02
109778,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2010,999,Not Applicable,1,Percentage,3,WHO / GHO,28.88
110806,2,ALGERIA,TB case detection rate,AFR0176,2010,29,Total,1,Percentage,3,WHO / GHO,67
111647,2,ALGERIA,TB treatment success rate,AFR0216,2010,29,Total,1,Percentage,3,WHO / GHO,89
113196,2,ALGERIA,TB treatment coverage,AFR0173,2010,29,Total,1,Percentage,3,WHO / GHO,89
115963,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,26.39
116975,2,ALGERIA,TB treatment success rate,AFR0216,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,71.2
123978,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2010,28,Both sexes (male and female),1,Percentage,35,IHME,1.29
125418,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2010,8,Male,1,Percentage,35,IHME,1.43
126858,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2010,9,Female,1,Percentage,35,IHME,1.15
131582,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2010,28,Both sexes (male and female),1,Percentage,4,WB Database,115.34
134218,2,ALGERIA,School dropout rate,AFR0160,2010,28,Both sexes (male and female),1,Percentage,42,WDI,1.08
136912,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2010,29,Total,1,Percentage,36,WHO/UNICEF,95
138378,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2010,29,Total,1,Percentage,3,WHO / GHO,89
138379,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,71.2
141097,2,ALGERIA,Effective PMTCT coverage,AFR0213,2010,9,Female,1,Percentage,16,UNAIDS,54
147150,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2010,29,Total,1,Percentage,36,WHO/UNICEF,95
148172,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2010,107,Female (10-14 years),1,Percentage,35,IHME,7.19
149902,2,ALGERIA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2010,9,Female,1,Percentage,16,UNAIDS,22.09
150914,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2010,66,Female (15-49 years),1,Percentage,35,IHME,2.36
156248,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2010,999,Not Applicable,1,Percentage,3,WHO / GHO,28.88
179345,2,ALGERIA,Access to electricity (% of population),AFR0380,2010,999,Not Applicable,1,Percentage,4,WB Database,98.8
182453,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,30.48
183319,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,5.11
185051,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
185917,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,0.02
188588,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,9.54
189454,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,9.54
191491,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,28.8
193197,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,1.6
195630,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2010,28,Both sexes (male and female),1,Percentage,35,IHME,15.23
196933,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,23.3
198778,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,53.9
207908,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2010,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
1351,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.12
1352,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2010,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,228.4
1353,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2010,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,645.29
2439,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.97
2440,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,69.48
2441,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,30.49
2442,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,9.54
2443,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2010,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,3.56
2444,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,158.7
2445,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,448.36
2446,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,69.64
2447,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,196.75
2573,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2010,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,28.88
2574,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2010,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.74
2575,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.03
2576,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.06
2577,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.18
2578,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,65.97
2579,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,186.37
2897,2,ALGERIA,Total density per million population: Linear Accelerator (numeric),AFR0080,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.2
2969,2,ALGERIA,Total density per million population: Telecobalt Unit,AFR0084,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.28
3042,2,ALGERIA,Total density per million population: Radiotherapy units,AFR0083,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.48
4530,2,ALGERIA,GDP growth (annual %),AFR0388,2010,999,Not Applicable,2,Per 1000 live births,22,UN DESA,1.73
5196,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,104
5525,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,92
5854,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,116
6284,2,ALGERIA,TB mortality rate (per 100 000 population),AFR0013,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,8.5
6653,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.05
6741,2,ALGERIA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,0.1
7158,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2010,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.6
7159,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2010,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.1
7160,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2010,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.5
7218,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2010,12,Urban,2,Per 1000 live births,3,WHO / GHO,90.24
7219,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2010,11,Rural,2,Per 1000 live births,3,WHO / GHO,78.91
7220,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2010,29,Total,2,Per 1000 live births,3,WHO / GHO,86.56
7266,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2010,12,Urban,2,Per 1000 live births,3,WHO / GHO,95.03
7267,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2010,11,Rural,2,Per 1000 live births,3,WHO / GHO,86.9
7268,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2010,29,Total,2,Per 1000 live births,3,WHO / GHO,92.39
7287,2,ALGERIA,Access to electricity (% of population),AFR0380,2010,29,Total,2,Per 1000 live births,1,WHO/AFRO,98.89
7294,2,ALGERIA,Access to electricity (% of population),AFR0380,2010,11,Rural,2,Per 1000 live births,1,WHO/AFRO,97.59
7615,2,ALGERIA,Life expectancy at birth (years),AFR0381,2010,8,Male,2,Per 1000 live births,1,WHO/AFRO,74.4
7944,2,ALGERIA,Life expectancy at birth (years),AFR0381,2010,9,Female,2,Per 1000 live births,1,WHO/AFRO,76.4
8273,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,21.3
8602,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2010,8,Male,2,Per 1000 live births,1,WHO/AFRO,20.7
8931,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2010,9,Female,2,Per 1000 live births,1,WHO/AFRO,21.8
9256,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,64.5
9397,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,64.4
9538,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,64.6
9679,2,ALGERIA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,15.1
9820,2,ALGERIA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,15.1
9961,2,ALGERIA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,15.1
10162,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.04
11055,2,ALGERIA,Population size (in thousands) total,AFR0004,2010,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,35977.46
12419,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,16.97
15973,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2010,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,3.3
16213,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,4.9
16453,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,1.8
16693,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,3.3
17193,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,75.4
17522,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,74.4
17851,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,76.4
18189,2,ALGERIA,Malaria mortality rate (per 100 000 population),AFR0015,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.05
18293,2,ALGERIA,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,15.4
18575,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,41.9
18576,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,64.16
20401,2,ALGERIA,TB incidence rate [SDG 3.3.2],AFR0334,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,78
21138,2,ALGERIA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0
21321,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,26.8
21322,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,26.9
21323,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,26.9
22593,2,ALGERIA,HIV prevalence rate (per 1000 population),AFR0020,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.1
23238,2,ALGERIA,Anaemia prevalence in children,AFR0300,2010,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,30.7
23640,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2010,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,10260
25203,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
25973,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2010,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.9
25974,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2010,9,Female,2,Per 1000 live births,20,ITU,0.7
25975,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2010,8,Male,2,Per 1000 live births,20,ITU,1.1
26853,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27283,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27614,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
28045,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
28550,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2010,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,1.56
29194,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2010,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,54
29404,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,28
29837,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,62
30663,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,133
30907,2,ALGERIA,TB case detection rate,AFR0176,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
38548,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2010,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,7.71
39743,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2010,999,Not Applicable,2,Per 1000 live births,19,OECD,33.02
41056,2,ALGERIA,DTP dropout rate (DTP1 -DPT3),AFR0226,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,4
44166,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
44201,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,212
44237,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
44281,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,0
44312,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,0
44356,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,0
44374,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,46,Measles,2,Per 1000 live births,1,WHO/AFRO,103
44418,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
44433,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
44461,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,0
47396,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2010,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,27.4
140108,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2010,12,Urban,2,Per 1000 live births,3,WHO / GHO,95.03
140109,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2010,11,Rural,2,Per 1000 live births,3,WHO / GHO,86.9
140110,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2010,29,Total,2,Per 1000 live births,3,WHO / GHO,92.39
140964,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2010,999,Not Applicable,2,Per 1000 live births,7,DHS,9.54
140981,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2010,999,Not Applicable,2,Per 1000 live births,7,DHS,65.97
141098,2,ALGERIA,Effective PMTCT coverage,AFR0213,2010,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,54
128442,2,ALGERIA,Sex ratio at birth,AFR0428,2010,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
71532,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2010,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,10260
79984,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2010,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
80019,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2010,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,212
80055,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2010,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
80099,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2010,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,0
80130,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2010,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,0
80174,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2010,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,0
80192,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2010,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,103
80236,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2010,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
80251,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2010,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
80279,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2010,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,0
120032,2,ALGERIA,Number of road traffic injuries,AFR0140,2010,29,Total,5,Count (Numeric Integer),35,IHME,39743
138351,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2010,29,Total,5,Count (Numeric Integer),35,IHME,137385
145166,2,ALGERIA,Number of people living with HIV,AFR0019,2010,29,Total,5,Count (Numeric Integer),16,UNAIDS,7900
152809,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,70,0-4 years,5,Count (Numeric Integer),17,UN Population,3852284
153043,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,71,5-9 years,5,Count (Numeric Integer),17,UN Population,2930876
153276,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,72,10-14 years,5,Count (Numeric Integer),17,UN Population,3032492
153506,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,73,15-19 years,5,Count (Numeric Integer),17,UN Population,3640920
153738,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,74,20-24 years,5,Count (Numeric Integer),17,UN Population,3827645
153969,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,75,25-29 years,5,Count (Numeric Integer),17,UN Population,3639855
154200,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,76,30-34 years,5,Count (Numeric Integer),17,UN Population,3085084
154433,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,77,35-39 years,5,Count (Numeric Integer),17,UN Population,2500646
154666,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,78,40-44 years,5,Count (Numeric Integer),17,UN Population,2132263
154898,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,79,45-49 years,5,Count (Numeric Integer),17,UN Population,1821545
155130,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,80,50-54 years,5,Count (Numeric Integer),17,UN Population,1468732
155365,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,81,55-59 years,5,Count (Numeric Integer),17,UN Population,1240578
155594,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,82,60-64 years,5,Count (Numeric Integer),17,UN Population,841530
155825,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,83,65-69 years,5,Count (Numeric Integer),17,UN Population,676184
156057,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,84,70-74 years,5,Count (Numeric Integer),17,UN Population,558599
177398,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,85,75-79 years,5,Count (Numeric Integer),17,UN Population,401814
177628,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,86,80-84 years,5,Count (Numeric Integer),17,UN Population,214653
177860,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,1010,85-89 years,5,Count (Numeric Integer),17,UN Population,81875
178174,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,1011,90-94 years,5,Count (Numeric Integer),17,UN Population,25390
178409,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,1012,95-99 years,5,Count (Numeric Integer),17,UN Population,4126
47259,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2010,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,4.75
102091,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2010,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,4.65
143533,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2010,29,Total,6,Per 1000 population,16,UNAIDS,0.03
62257,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2010,9,Female,7,per 100 000 live births,23,MMEIG,115
47473,2,ALGERIA,AIDS-related mortality rate (per 100 000 population),AFR0014,2010,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,0.55
70744,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2010,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,0.9
70745,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2010,9,Female,8,Per 100 000 population,13,UNStat,0.7
70746,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2010,8,Male,8,Per 100 000 population,13,UNStat,1.1
83161,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2010,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,62
83987,2,ALGERIA,"TB prevalence rate per 100,000 population per year",AFR0332,2010,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,133
104398,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2010,8,Male,8,Per 100 000 population,3,WHO / GHO,8.58
104399,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2010,9,Female,8,Per 100 000 population,3,WHO / GHO,2.47
108595,2,ALGERIA,Malaria mortality rate (per 100 000 population),AFR0015,2010,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,0.04
109160,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2010,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,5.55
120843,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2010,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,15.4
121083,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2010,8,Male,8,Per 100 000 population,3,WHO / GHO,16.4
121323,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2010,9,Female,8,Per 100 000 population,3,WHO / GHO,14.4
69838,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2010,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,1.56
92058,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2010,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,33.01
97444,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2010,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,186.3
113750,2,ALGERIA,Total Health Expenditure (constant US$),AFR0349,2010,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,6965.11
114210,2,ALGERIA,Total Health Expenditure (International US$),AFR0348,2010,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,8249.25
74784,2,ALGERIA,Gender development index score,AFR0347,2010,28,Both sexes (male and female),12,Index,14,UNDP,0.83
106136,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2010,999,Not Applicable,14,Per Capita,3,WHO / GHO,228.4
106955,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2010,999,Not Applicable,14,Per Capita,42,WDI,0.18
107773,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2010,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.06
114683,2,ALGERIA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2010,999,Not Applicable,14,Per Capita,4,WB Database,645.13
115141,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2010,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,186.3
127851,2,ALGERIA,Life expectancy at birth (years),AFR0381,2010,28,Both sexes (male and female),17,years,4,WB Database,74.94
213171,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2010,28,Both sexes (male and female),23,Numeric,75,WHO/GHO_2021,65.5
213359,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2010,8,Male,23,Numeric,75,WHO/GHO_2021,65.9
213547,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2010,9,Female,23,Numeric,75,WHO/GHO_2021,65.2
184185,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2010,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,229
187649,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2010,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.06
190625,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2010,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,66.2
194918,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2010,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,69.9
186783,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2010,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.18
192357,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2010,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,187
194052,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2010,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,197.4
149502,2,ALGERIA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2010-2013,9,Female,1,Percentage,12,UNICEF / MICS,16
207401,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010-2013,28,Both sexes (male and female),1,Percentage,5,UNICEF,96.6
122319,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2010-2015,28,Both sexes (male and female),1,Percentage,17,UN Population,21.54
122607,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2010-2015,8,Male,1,Percentage,17,UN Population,21.03
122895,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2010-2015,9,Female,1,Percentage,17,UN Population,22.06
130567,2,ALGERIA,Total fertility rate,AFR0130,2010-2015,9,Female,1,Percentage,17,UN Population,2.96
131194,2,ALGERIA,Proportion of women aged 20-24 years who were married or in a union by age 18 (%),AFR0102,2010-2017,9,Female,1,Percentage,3,WHO / GHO,3
131238,2,ALGERIA,Proportion of women aged 20-24 years who were married or in a union before age 15 (%),AFR0382,2010-2017,9,Female,1,Percentage,3,WHO / GHO,0
135465,2,ALGERIA,"Proportion of ever-partnered women and girls subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months, by age (%)",AFR0101,2010-2017,9,Female,1,Percentage,3,WHO / GHO,\N
130044,2,ALGERIA,Proportion of population with large household expenditures on health (greater than 10%) as a share of total household expenditure or income (%),AFR0107,2010-2018,999,Not Applicable,1,Percentage,3,WHO / GHO,\N
130092,2,ALGERIA,Proportion of the population with large household expenditure on health as a share of total household consumption or income [SDG 3.8.2],AFR0052,2010-2018,999,Not Applicable,1,Percentage,3,WHO / GHO,\N
22722,2,ALGERIA,Prevalence of exclusive breastfeeding in infants aged six months or less (Exclusive BF),AFR0306,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,25.4
22769,2,ALGERIA,Early initiation of breastfeeding (%),AFR0305,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,35.7
22815,2,ALGERIA,Children under 5 years who are stunted [SDG 2.2.1],AFR0303,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,11.7
22863,2,ALGERIA,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,12.4
22910,2,ALGERIA,Incidence of low birth weight among newborns,AFR0304,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,6.7
130508,2,ALGERIA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2010-2018,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,1.55
129948,2,ALGERIA,"Adolescent birth rate (per 1,000 women aged 15-19 years)",AFR0106,2010-2018,28,Both sexes (male and female),9,Per 1000 women aged 15-19 years,3,WHO / GHO,9.7
130460,2,ALGERIA,Density of medical doctors (per 10 000 population),AFR0434,2010-2018,28,Both sexes (male and female),13,Per 10 000 population,3,WHO / GHO,17.2
129795,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010-2019,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,97
129900,2,ALGERIA,Proportion of women married or in a union of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (% of women aged 15-49 years),AFR0105,2010-2019,9,Female,1,Percentage,3,WHO / GHO,74.7
130422,2,ALGERIA,Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis [SDG 3.b.3],AFR0399,2010-2019,999,Not Applicable,1,Percentage,3,WHO / GHO,\N
135273,2,ALGERIA,Prevalence of wasting in children under 5 u (%),AFR0155,2010-2019,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.1
135321,2,ALGERIA,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2010-2019,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,12.4
135369,2,ALGERIA,Prevalence of stunting in children under 5 u (%),AFR0154,2010-2019,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.7
135210,2,ALGERIA,Density of dentists (per 10 000 population ),AFR0435,2010-2019,28,Both sexes (male and female),13,Per 10 000 population,3,WHO / GHO,3.7
10622,2,ALGERIA,Number of people living with HIV,AFR0019,2011,28,Both sexes (male and female),1,Percentage,16,UNAIDS,8000
11472,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2011,9,Female,1,Percentage,3,WHO / GHO,116
51962,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2011,8,Male,1,Percentage,3,WHO / GHO,11.5
51964,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2011,9,Female,1,Percentage,3,WHO / GHO,11.9
51965,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.7
68036,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2011,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
68701,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2011,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,96
69040,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2011,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
72000,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2011,28,Both sexes (male and female),1,Percentage,16,UNAIDS,30
72464,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2011,9,Female,1,Percentage,16,UNAIDS,49
73364,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
73497,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2011,28,Both sexes (male and female),1,Percentage,20,ITU,14.9
74235,2,ALGERIA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2011,999,Not Applicable,1,Percentage,3,WHO / GHO,11
75750,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,99
75868,2,ALGERIA,Social security funds as % of General government health expenditure (GGHE),AFR0294,2011,999,Not Applicable,1,Percentage,3,WHO / GHO,31.63
75869,2,ALGERIA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2011,999,Not Applicable,1,Percentage,3,WHO / GHO,94.7
84232,2,ALGERIA,TB case detection rate,AFR0176,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
91820,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
95653,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
96943,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2011,999,Not Applicable,1,Percentage,4,WB Database,9.96
98491,2,ALGERIA,Immunization coverage against Tetanus,AFR0189,2011,28,Both sexes (male and female),1,Percentage,4,WB Database,95
102376,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2011,999,Not Applicable,1,Percentage,4,WB Database,27.87
103496,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2011,999,Not Applicable,1,Percentage,3,WHO / GHO,0.01
109777,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2011,999,Not Applicable,1,Percentage,3,WHO / GHO,27.87
110851,2,ALGERIA,TB case detection rate,AFR0176,2011,29,Total,1,Percentage,3,WHO / GHO,63
111692,2,ALGERIA,TB treatment success rate,AFR0216,2011,29,Total,1,Percentage,3,WHO / GHO,92
113241,2,ALGERIA,TB treatment coverage,AFR0173,2011,29,Total,1,Percentage,3,WHO / GHO,92
115964,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,24.58
116974,2,ALGERIA,TB treatment success rate,AFR0216,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,73.6
124026,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2011,28,Both sexes (male and female),1,Percentage,35,IHME,1.31
125466,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2011,8,Male,1,Percentage,35,IHME,1.46
126906,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2011,9,Female,1,Percentage,35,IHME,1.17
131583,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2011,28,Both sexes (male and female),1,Percentage,4,WB Database,116.57
134219,2,ALGERIA,School dropout rate,AFR0160,2011,28,Both sexes (male and female),1,Percentage,42,WDI,0.91
136959,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2011,29,Total,1,Percentage,36,WHO/UNICEF,95
138380,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2011,29,Total,1,Percentage,3,WHO / GHO,92
138381,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,73.6
141099,2,ALGERIA,Effective PMTCT coverage,AFR0213,2011,9,Female,1,Percentage,16,UNAIDS,49
147157,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2011,29,Total,1,Percentage,36,WHO/UNICEF,96
148173,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2011,107,Female (10-14 years),1,Percentage,35,IHME,6.43
148243,2,ALGERIA,Antenatal care attendees who were positive for syphilis (%),AFR0457,2011,9,Female,1,Percentage,3,WHO / GHO,1.85
149903,2,ALGERIA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2011,9,Female,1,Percentage,16,UNAIDS,22.5
150915,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2011,66,Female (15-49 years),1,Percentage,35,IHME,2.17
152581,2,ALGERIA,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,2011,999,Not Applicable,1,Percentage,40,National Health Account Report,5.1
156247,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2011,999,Not Applicable,1,Percentage,3,WHO / GHO,27.87
179346,2,ALGERIA,Access to electricity (% of population),AFR0380,2011,999,Not Applicable,1,Percentage,4,WB Database,99
182499,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,29.36
183365,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,5.26
185097,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
185963,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,0.01
188634,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,9.27
189500,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,9.27
191537,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,27.8
193242,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,1.48
195631,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2011,28,Both sexes (male and female),1,Percentage,35,IHME,15.57
196934,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,24
198779,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,55
207909,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2011,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
1489,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.27
1490,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2011,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,286.15
1491,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2011,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,684.27
2448,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.99
2449,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,70.62
2450,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,29.36
2451,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,9.27
2452,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2011,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,3.72
2453,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,202.09
2454,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,483.26
2455,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,84.02
2456,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,200.92
2580,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2011,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,27.87
2581,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2011,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.72
2582,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.01
2583,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.04
2584,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.08
2585,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,79.76
2586,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,190.73
4577,2,ALGERIA,GDP growth (annual %),AFR0388,2011,999,Not Applicable,2,Per 1000 live births,22,UN DESA,0.94
5195,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,103
5524,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2011,9,Female,2,Per 1000 live births,3,WHO / GHO,91
5853,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2011,8,Male,2,Per 1000 live births,3,WHO / GHO,115
6283,2,ALGERIA,TB mortality rate (per 100 000 population),AFR0013,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,8
6787,2,ALGERIA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,0.1
7161,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2011,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.5
7162,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2011,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.1
7163,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2011,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.5
7221,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2011,12,Urban,2,Per 1000 live births,3,WHO / GHO,90.12
7222,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2011,11,Rural,2,Per 1000 live births,3,WHO / GHO,79.57
7223,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2011,29,Total,2,Per 1000 live births,3,WHO / GHO,86.77
7269,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2011,12,Urban,2,Per 1000 live births,3,WHO / GHO,95.11
7270,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2011,11,Rural,2,Per 1000 live births,3,WHO / GHO,87.26
7271,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2011,29,Total,2,Per 1000 live births,3,WHO / GHO,92.61
7286,2,ALGERIA,Access to electricity (% of population),AFR0380,2011,29,Total,2,Per 1000 live births,1,WHO/AFRO,98.96
7293,2,ALGERIA,Access to electricity (% of population),AFR0380,2011,11,Rural,2,Per 1000 live births,1,WHO/AFRO,97.77
7300,2,ALGERIA,Access to electricity (% of population),AFR0380,2011,12,Urban,2,Per 1000 live births,1,WHO/AFRO,99.51
7614,2,ALGERIA,Life expectancy at birth (years),AFR0381,2011,8,Male,2,Per 1000 live births,1,WHO/AFRO,74.6
7943,2,ALGERIA,Life expectancy at birth (years),AFR0381,2011,9,Female,2,Per 1000 live births,1,WHO/AFRO,76.6
8272,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,21.4
8601,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2011,8,Male,2,Per 1000 live births,1,WHO/AFRO,20.9
8930,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2011,9,Female,2,Per 1000 live births,1,WHO/AFRO,21.9
10208,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.05
11103,2,ALGERIA,Population size (in thousands) total,AFR0004,2011,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,36661.45
12420,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,16.55
15309,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2011,28,Both sexes (male and female),2,Per 1000 live births,4,WB Database,4.77
15501,2,ALGERIA,AIDS-related mortality rate (per 100 000 population),AFR0014,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.55
17192,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,75.6
17521,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2011,8,Male,2,Per 1000 live births,3,WHO / GHO,74.6
17850,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2011,9,Female,2,Per 1000 live births,3,WHO / GHO,76.6
18577,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2011,9,Female,2,Per 1000 live births,3,WHO / GHO,41.15
18578,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2011,8,Male,2,Per 1000 live births,3,WHO / GHO,63.03
20402,2,ALGERIA,TB incidence rate [SDG 3.3.2],AFR0334,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,73
21093,2,ALGERIA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0
21459,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2011,8,Male,2,Per 1000 live births,3,WHO / GHO,26.5
21460,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2011,9,Female,2,Per 1000 live births,3,WHO / GHO,26.4
21461,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,26.5
23191,2,ALGERIA,Anaemia prevalence in children,AFR0300,2011,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,30.3
23641,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2011,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,11831
25156,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
25481,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2011,9,Female,2,Per 1000 live births,1,WHO/AFRO,10.7
26806,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27236,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27567,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27998,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
28593,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2011,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,2.83
29235,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2011,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,49
29449,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,30
29838,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,58
30709,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,129
30908,2,ALGERIA,TB case detection rate,AFR0176,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
38549,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2011,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,7.71
39744,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2011,999,Not Applicable,2,Per 1000 live births,19,OECD,34.4
41009,2,ALGERIA,DTP dropout rate (DTP1 -DPT3),AFR0226,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,4
43833,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
43871,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,170
43910,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
43957,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,1
43988,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,0
44033,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,0
44049,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,46,Measles,2,Per 1000 live births,1,WHO/AFRO,112
44094,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
44111,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,1
44139,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,0
47397,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2011,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,26.67
140111,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2011,12,Urban,2,Per 1000 live births,3,WHO / GHO,95.11
140112,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2011,11,Rural,2,Per 1000 live births,3,WHO / GHO,87.26
140113,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2011,29,Total,2,Per 1000 live births,3,WHO / GHO,92.61
140965,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2011,999,Not Applicable,2,Per 1000 live births,7,DHS,9.27
140982,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2011,999,Not Applicable,2,Per 1000 live births,7,DHS,79.76
141100,2,ALGERIA,Effective PMTCT coverage,AFR0213,2011,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,49
128441,2,ALGERIA,Sex ratio at birth,AFR0428,2011,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
71533,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2011,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,11831
79651,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2011,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
79689,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2011,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,170
79728,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2011,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
79775,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2011,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,1
79806,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2011,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,0
79851,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2011,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,0
79867,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2011,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,112
79912,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2011,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
79929,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2011,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,1
79957,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2011,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,0
120079,2,ALGERIA,Number of road traffic injuries,AFR0140,2011,29,Total,5,Count (Numeric Integer),35,IHME,40253
139669,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2011,29,Total,5,Count (Numeric Integer),35,IHME,143844
142311,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2011,126,Hydrological,5,Count (Numeric Integer),35,IHME,10
145212,2,ALGERIA,Number of people living with HIV,AFR0019,2011,29,Total,5,Count (Numeric Integer),16,UNAIDS,8900
62037,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2011,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,4.76
143577,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2011,29,Total,6,Per 1000 population,16,UNAIDS,0.04
62258,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2011,9,Female,7,per 100 000 live births,23,MMEIG,116
83162,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2011,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,58
84033,2,ALGERIA,"TB prevalence rate per 100,000 population per year",AFR0332,2011,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,129
108596,2,ALGERIA,Malaria mortality rate (per 100 000 population),AFR0015,2011,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,0
70253,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2011,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,10.7
69884,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2011,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,2.83
92059,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2011,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,34.4
97443,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2011,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,190.7
113751,2,ALGERIA,Total Health Expenditure (constant US$),AFR0349,2011,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,7372.1
114211,2,ALGERIA,Total Health Expenditure (International US$),AFR0348,2011,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,10535.98
74826,2,ALGERIA,Gender development index score,AFR0347,2011,28,Both sexes (male and female),12,Index,14,UNDP,0.83
106135,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2011,999,Not Applicable,14,Per Capita,3,WHO / GHO,286.2
106954,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2011,999,Not Applicable,14,Per Capita,42,WDI,0.08
107772,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2011,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.03
114682,2,ALGERIA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2011,999,Not Applicable,14,Per Capita,4,WB Database,684.26
115140,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2011,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,190.7
127852,2,ALGERIA,Life expectancy at birth (years),AFR0381,2011,28,Both sexes (male and female),17,years,4,WB Database,75.2
184231,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2011,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,287
187695,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2011,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.03
190671,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2011,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,80.1
194964,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2011,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,84.3
186829,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2011,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.08
192403,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2011,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,191
194098,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2011,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,201.7
37632,2,ALGERIA,Average death rate due to natural disasters y (per 100 000 population),AFR0027,2011-2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,0.05
72987,2,ALGERIA,Average death rate due to natural disasters y (per 100 000 population),AFR0027,2011-2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,0.05
73466,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2011-2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,1
13839,2,ALGERIA,Demand for family planning satisfied with modern methods [SDG 3.7.1],AFR0207,2011-2017,9,Female,1,Percentage,3,WHO / GHO,77
76083,2,ALGERIA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2011-2017,9,Female,1,Percentage,1,WHO/AFRO,67
140989,2,ALGERIA,Proportion of women married or in a union of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (% of women aged 15-49 years),AFR0105,2011-2017,9,Female,1,Percentage,3,WHO / GHO,77
24016,2,ALGERIA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2011-2017,9,Female,2,Per 1000 live births,3,WHO / GHO,67
10668,2,ALGERIA,Number of people living with HIV,AFR0019,2012,28,Both sexes (male and female),1,Percentage,16,UNAIDS,9000
11473,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2012,9,Female,1,Percentage,3,WHO / GHO,116
52102,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2012,8,Male,1,Percentage,3,WHO / GHO,11.7
52103,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2012,9,Female,1,Percentage,3,WHO / GHO,12.1
52104,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.9
68082,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2012,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
68728,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2012,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
69081,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2012,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
72045,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2012,28,Both sexes (male and female),1,Percentage,16,UNAIDS,33
72505,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2012,9,Female,1,Percentage,16,UNAIDS,40
72755,2,ALGERIA,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2012,28,Both sexes (male and female),1,Percentage,5,UNICEF,12.4
73317,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
73498,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2012,28,Both sexes (male and female),1,Percentage,20,ITU,18.2
74273,2,ALGERIA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2012,999,Not Applicable,1,Percentage,3,WHO / GHO,19
75397,2,ALGERIA,Contraceptive prevalence rate,AFR0208,2012,9,Female,1,Percentage,1,WHO/AFRO,57.4
75736,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,99
75955,2,ALGERIA,Social security funds as % of General government health expenditure (GGHE),AFR0294,2012,999,Not Applicable,1,Percentage,3,WHO / GHO,29.11
75956,2,ALGERIA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2012,999,Not Applicable,1,Percentage,3,WHO / GHO,94.7
84233,2,ALGERIA,TB case detection rate,AFR0176,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
91773,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
95608,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
96989,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2012,999,Not Applicable,1,Percentage,4,WB Database,10.9
98492,2,ALGERIA,Immunization coverage against Tetanus,AFR0189,2012,28,Both sexes (male and female),1,Percentage,4,WB Database,95
102377,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2012,999,Not Applicable,1,Percentage,4,WB Database,25.71
103495,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2012,999,Not Applicable,1,Percentage,3,WHO / GHO,0.04
105497,2,ALGERIA,Immunization coverage,AFR0405,2012,999,Not Applicable,1,Percentage,3,WHO / GHO,79.36
105498,2,ALGERIA,Immunization coverage,AFR0405,2012,15,Primary Education,1,Percentage,3,WHO / GHO,86.34
105499,2,ALGERIA,Immunization coverage,AFR0405,2012,68,Secondary or Higher Education,1,Percentage,3,WHO / GHO,88.3
109596,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2012,999,Not Applicable,1,Percentage,3,WHO / GHO,25.7
110898,2,ALGERIA,TB case detection rate,AFR0176,2012,29,Total,1,Percentage,3,WHO / GHO,64
111737,2,ALGERIA,TB treatment success rate,AFR0216,2012,29,Total,1,Percentage,3,WHO / GHO,90
112086,2,ALGERIA,Percentage of pregnant women that made four or more ANC visits,AFR0135,2012,9,Female,1,Percentage,44,DHS/MICS,67.3
112268,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2012,9,Female,1,Percentage,44,DHS/MICS,92.7
113287,2,ALGERIA,TB treatment coverage,AFR0173,2012,29,Total,1,Percentage,3,WHO / GHO,90
115965,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,22.66
116973,2,ALGERIA,TB treatment success rate,AFR0216,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72
124074,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2012,28,Both sexes (male and female),1,Percentage,35,IHME,1.34
125514,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2012,8,Male,1,Percentage,35,IHME,1.49
126954,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2012,9,Female,1,Percentage,35,IHME,1.19
131584,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2012,28,Both sexes (male and female),1,Percentage,4,WB Database,118.08
134220,2,ALGERIA,School dropout rate,AFR0160,2012,28,Both sexes (male and female),1,Percentage,42,WDI,0.85
137007,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2012,29,Total,1,Percentage,36,WHO/UNICEF,95
138382,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2012,29,Total,1,Percentage,3,WHO / GHO,90
138383,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72
141101,2,ALGERIA,Effective PMTCT coverage,AFR0213,2012,9,Female,1,Percentage,16,UNAIDS,40
147165,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2012,29,Total,1,Percentage,36,WHO/UNICEF,95
148174,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2012,107,Female (10-14 years),1,Percentage,35,IHME,6.2
149904,2,ALGERIA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2012,9,Female,1,Percentage,16,UNAIDS,24.16
150916,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2012,66,Female (15-49 years),1,Percentage,35,IHME,2.05
156246,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2012,999,Not Applicable,1,Percentage,3,WHO / GHO,25.7
179347,2,ALGERIA,Access to electricity (% of population),AFR0380,2012,999,Not Applicable,1,Percentage,4,WB Database,98.7
182545,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,27.03
183411,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,6
185143,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
186009,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,0.03
188680,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,10
189546,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,10
191583,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,25.7
193285,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,1.32
195632,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2012,28,Both sexes (male and female),1,Percentage,35,IHME,15.92
196935,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,24.7
198780,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,56.1
202200,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2012,29,Total,1,Percentage,36,WHO/UNICEF,92.7
202201,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2012,12,Urban,1,Percentage,36,WHO/UNICEF,93.6
202202,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2012,11,Rural,1,Percentage,36,WHO/UNICEF,91.3
202203,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2012,19,First Quintile,1,Percentage,36,WHO/UNICEF,87.6
202204,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2012,20,Second Quintile,1,Percentage,36,WHO/UNICEF,93.3
202205,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2012,1023,Middle,1,Percentage,36,WHO/UNICEF,92.8
202206,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2012,22,Fourth Quintile,1,Percentage,36,WHO/UNICEF,95
202207,2,ALGERIA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2012,23,Fifth Quintile,1,Percentage,36,WHO/UNICEF,96.1
202208,2,ALGERIA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2012,29,Total,1,Percentage,36,WHO/UNICEF,67.3
202209,2,ALGERIA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2012,12,Urban,1,Percentage,36,WHO/UNICEF,72.3
202210,2,ALGERIA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2012,11,Rural,1,Percentage,36,WHO/UNICEF,59.5
202211,2,ALGERIA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2012,19,First Quintile,1,Percentage,36,WHO/UNICEF,53.9
202212,2,ALGERIA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2012,20,Second Quintile,1,Percentage,36,WHO/UNICEF,65.7
202213,2,ALGERIA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2012,1023,Middle,1,Percentage,36,WHO/UNICEF,64.6
202214,2,ALGERIA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2012,22,Fourth Quintile,1,Percentage,36,WHO/UNICEF,74.4
202215,2,ALGERIA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2012,23,Fifth Quintile,1,Percentage,36,WHO/UNICEF,82.3
202216,2,ALGERIA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2012,29,Total,1,Percentage,36,WHO/UNICEF,16
202217,2,ALGERIA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2012,12,Urban,1,Percentage,36,WHO/UNICEF,17.8
202218,2,ALGERIA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2012,11,Rural,1,Percentage,36,WHO/UNICEF,13.2
202219,2,ALGERIA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2012,19,First Quintile,1,Percentage,36,WHO/UNICEF,13.2
202220,2,ALGERIA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2012,20,Second Quintile,1,Percentage,36,WHO/UNICEF,15.9
202221,2,ALGERIA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2012,1023,Middle,1,Percentage,36,WHO/UNICEF,15.6
202222,2,ALGERIA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2012,22,Fourth Quintile,1,Percentage,36,WHO/UNICEF,15.1
202223,2,ALGERIA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2012,23,Fifth Quintile,1,Percentage,36,WHO/UNICEF,21.1
202224,2,ALGERIA,Demand for family planning satisfied with modern methods [SDG 3.7.1],AFR0207,2012,29,Total,1,Percentage,36,WHO/UNICEF,77.2
202239,2,ALGERIA,Institutional deliveries,AFR0200,2012,29,Total,1,Percentage,36,WHO/UNICEF,96.8
202240,2,ALGERIA,Institutional deliveries,AFR0200,2012,12,Urban,1,Percentage,36,WHO/UNICEF,97.8
202241,2,ALGERIA,Institutional deliveries,AFR0200,2012,11,Rural,1,Percentage,36,WHO/UNICEF,95.4
202242,2,ALGERIA,Institutional deliveries,AFR0200,2012,19,First Quintile,1,Percentage,36,WHO/UNICEF,95.4
202243,2,ALGERIA,Institutional deliveries,AFR0200,2012,20,Second Quintile,1,Percentage,36,WHO/UNICEF,96.7
202244,2,ALGERIA,Institutional deliveries,AFR0200,2012,1023,Middle,1,Percentage,36,WHO/UNICEF,96.3
202245,2,ALGERIA,Institutional deliveries,AFR0200,2012,22,Fourth Quintile,1,Percentage,36,WHO/UNICEF,97.6
202246,2,ALGERIA,Institutional deliveries,AFR0200,2012,23,Fifth Quintile,1,Percentage,36,WHO/UNICEF,98.7
207910,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2012,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
1627,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,6
1628,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2012,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,333.94
1629,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2012,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,804.33
2457,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.97
2458,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,72.93
2459,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,27.04
2460,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,10.05
2461,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2012,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,4.38
2462,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,243.54
2463,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,586.6
2464,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,90.29
2465,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,217.48
2587,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2012,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,25.72
2588,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2012,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.63
2589,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.03
2590,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.11
2591,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.26
2592,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,85.87
2593,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,206.84
4624,2,ALGERIA,GDP growth (annual %),AFR0388,2012,999,Not Applicable,2,Per 1000 live births,22,UN DESA,1.35
5194,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,101
5523,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2012,9,Female,2,Per 1000 live births,3,WHO / GHO,89
5852,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2012,8,Male,2,Per 1000 live births,3,WHO / GHO,113
6282,2,ALGERIA,TB mortality rate (per 100 000 population),AFR0013,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,8
6833,2,ALGERIA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,0.1
7164,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2012,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.5
7165,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2012,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.2
7166,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2012,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.5
7224,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2012,12,Urban,2,Per 1000 live births,3,WHO / GHO,90.01
7225,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2012,11,Rural,2,Per 1000 live births,3,WHO / GHO,80.23
7226,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2012,29,Total,2,Per 1000 live births,3,WHO / GHO,86.97
7272,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2012,12,Urban,2,Per 1000 live births,3,WHO / GHO,95.19
7273,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2012,11,Rural,2,Per 1000 live births,3,WHO / GHO,87.62
7274,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2012,29,Total,2,Per 1000 live births,3,WHO / GHO,92.84
7285,2,ALGERIA,Access to electricity (% of population),AFR0380,2012,29,Total,2,Per 1000 live births,1,WHO/AFRO,98.77
7292,2,ALGERIA,Access to electricity (% of population),AFR0380,2012,11,Rural,2,Per 1000 live births,1,WHO/AFRO,97.86
7299,2,ALGERIA,Access to electricity (% of population),AFR0380,2012,12,Urban,2,Per 1000 live births,1,WHO/AFRO,99.26
7613,2,ALGERIA,Life expectancy at birth (years),AFR0381,2012,8,Male,2,Per 1000 live births,1,WHO/AFRO,74.8
7942,2,ALGERIA,Life expectancy at birth (years),AFR0381,2012,9,Female,2,Per 1000 live births,1,WHO/AFRO,76.8
8271,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,21.5
8600,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2012,8,Male,2,Per 1000 live births,1,WHO/AFRO,21
8929,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2012,9,Female,2,Per 1000 live births,1,WHO/AFRO,22
10254,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.05
11151,2,ALGERIA,Population size (in thousands) total,AFR0004,2012,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,37383.9
12421,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,16.22
15356,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2012,28,Both sexes (male and female),2,Per 1000 live births,4,WB Database,4.77
15548,2,ALGERIA,AIDS-related mortality rate (per 100 000 population),AFR0014,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.53
17191,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,75.8
17520,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2012,8,Male,2,Per 1000 live births,3,WHO / GHO,74.8
17849,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2012,9,Female,2,Per 1000 live births,3,WHO / GHO,76.8
18579,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2012,9,Female,2,Per 1000 live births,3,WHO / GHO,41.04
18580,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2012,8,Male,2,Per 1000 live births,3,WHO / GHO,62.69
20403,2,ALGERIA,TB incidence rate [SDG 3.3.2],AFR0334,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,73
21048,2,ALGERIA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.02
21597,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2012,8,Male,2,Per 1000 live births,3,WHO / GHO,26.3
21598,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2012,9,Female,2,Per 1000 live births,3,WHO / GHO,26
21599,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,26.2
23144,2,ALGERIA,Anaemia prevalence in children,AFR0300,2012,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,29.9
23642,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2012,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,7471
24186,2,ALGERIA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2012,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,4.1
24389,2,ALGERIA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2012,9,Female,2,Per 1000 live births,5,UNICEF,3.8
24585,2,ALGERIA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2012,8,Male,2,Per 1000 live births,5,UNICEF,4.4
24662,2,ALGERIA,Contraceptive prevalence rate,AFR0208,2012,9,Female,2,Per 1000 live births,3,WHO / GHO,57.4
25109,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
26759,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27189,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27520,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27951,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
28639,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2012,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.48
29276,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2012,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,40
29494,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,33
29839,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,59
30756,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,125
30909,2,ALGERIA,TB case detection rate,AFR0176,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
32436,2,ALGERIA,Prevalence of stunting in children under 5 u (%),AFR0154,2012,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,11.69
32670,2,ALGERIA,Prevalence of wasting in children under 5 u (%),AFR0155,2012,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,4.11
32906,2,ALGERIA,Prevalence of overweight in children under 5 u (%),AFR0156,2012,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,12.4
38550,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2012,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,7.97
39417,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2012,8,Male,2,Per 1000 live births,20,ITU,1.03
39418,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2012,9,Female,2,Per 1000 live births,20,ITU,0.28
39595,2,ALGERIA,"Children in employment, total (% of children ages 7-14)",AFR0030,2012,28,Both sexes (male and female),2,Per 1000 live births,21,ILO,4.26
39596,2,ALGERIA,"Children in employment, total (% of children ages 7-14)",AFR0030,2012,9,Female,2,Per 1000 live births,21,ILO,3.72
39597,2,ALGERIA,"Children in employment, total (% of children ages 7-14)",AFR0030,2012,8,Male,2,Per 1000 live births,21,ILO,4.78
39745,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2012,999,Not Applicable,2,Per 1000 live births,19,OECD,27.38
40962,2,ALGERIA,DTP dropout rate (DTP1 -DPT3),AFR0226,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,4
43499,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
43538,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,420
43578,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
43624,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,104
43654,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,0
43699,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,0
43714,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,46,Measles,2,Per 1000 live births,1,WHO/AFRO,18
43758,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
43773,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
43802,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,0
47398,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2012,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,26.14
140114,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2012,12,Urban,2,Per 1000 live births,3,WHO / GHO,95.19
140115,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2012,11,Rural,2,Per 1000 live births,3,WHO / GHO,87.62
140116,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2012,29,Total,2,Per 1000 live births,3,WHO / GHO,92.84
140966,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2012,999,Not Applicable,2,Per 1000 live births,7,DHS,10.05
140983,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2012,999,Not Applicable,2,Per 1000 live births,7,DHS,85.87
141102,2,ALGERIA,Effective PMTCT coverage,AFR0213,2012,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,40
128440,2,ALGERIA,Sex ratio at birth,AFR0428,2012,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
71534,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2012,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,7471
79317,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2012,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
79356,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2012,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,420
79396,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2012,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
79442,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2012,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,104
79472,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2012,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,0
79517,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2012,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,0
79532,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2012,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,18
79576,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2012,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
79591,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2012,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
79620,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2012,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,0
120126,2,ALGERIA,Number of road traffic injuries,AFR0140,2012,29,Total,5,Count (Numeric Integer),35,IHME,40779
139717,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2012,29,Total,5,Count (Numeric Integer),35,IHME,150574
142327,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2012,126,Hydrological,5,Count (Numeric Integer),35,IHME,49
145258,2,ALGERIA,Number of people living with HIV,AFR0019,2012,29,Total,5,Count (Numeric Integer),16,UNAIDS,10000
62084,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2012,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,4.77
143621,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2012,29,Total,6,Per 1000 population,16,UNAIDS,0.04
62259,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2012,9,Female,7,per 100 000 live births,23,MMEIG,116
74033,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2012,8,Male,8,Per 100 000 population,13,UNStat,1.03
74034,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2012,9,Female,8,Per 100 000 population,13,UNStat,0.28
83163,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2012,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,59
84080,2,ALGERIA,"TB prevalence rate per 100,000 population per year",AFR0332,2012,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,125
108597,2,ALGERIA,Malaria mortality rate (per 100 000 population),AFR0015,2012,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,0
69930,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2012,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.47
92060,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2012,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,27.38
97442,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2012,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,207
113752,2,ALGERIA,Total Health Expenditure (constant US$),AFR0349,2012,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,8682.78
114212,2,ALGERIA,Total Health Expenditure (International US$),AFR0348,2012,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,12544.61
74868,2,ALGERIA,Gender development index score,AFR0347,2012,28,Both sexes (male and female),12,Index,14,UNDP,0.84
106134,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2012,999,Not Applicable,14,Per Capita,3,WHO / GHO,333.9
106953,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2012,999,Not Applicable,14,Per Capita,42,WDI,0.25
107771,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2012,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.11
114681,2,ALGERIA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2012,999,Not Applicable,14,Per Capita,4,WB Database,804.93
115139,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2012,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,207
127853,2,ALGERIA,Life expectancy at birth (years),AFR0381,2012,28,Both sexes (male and female),17,years,4,WB Database,75.44
184277,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2012,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,335
187741,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2012,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.1
190717,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2012,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,86.2
195010,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2012,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,90.7
186875,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2012,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.25
192449,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2012,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,208
194144,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2012,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,218.7
75562,2,ALGERIA,Completeness of birth registration (%),AFR0245,2012-2013,28,Both sexes (male and female),1,Percentage,13,UNStat,99.6
75607,2,ALGERIA,Civil registration coverage of births (%),AFR0062,2012-2013,28,Both sexes (male and female),1,Percentage,13,UNStat,99.6
200635,2,ALGERIA,Contraceptive prevalence rate,AFR0208,2012-2013,9,Female,1,Percentage,22,UN DESA,57.12
3631,2,ALGERIA,Civil registration coverage of births (%),AFR0062,2012-2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.6
10714,2,ALGERIA,Number of people living with HIV,AFR0019,2013,28,Both sexes (male and female),1,Percentage,16,UNAIDS,10000
11474,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2013,9,Female,1,Percentage,3,WHO / GHO,115
52242,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2013,8,Male,1,Percentage,3,WHO / GHO,12
52243,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2013,9,Female,1,Percentage,3,WHO / GHO,12.3
52244,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,12.2
68128,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
68755,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,93
69122,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
72090,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2013,28,Both sexes (male and female),1,Percentage,16,UNAIDS,40
72546,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2013,9,Female,1,Percentage,16,UNAIDS,57
73270,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
73499,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2013,28,Both sexes (male and female),1,Percentage,20,ITU,22.5
73894,2,ALGERIA,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2013,28,Both sexes (male and female),1,Percentage,15,UNESCO,56.5
73904,2,ALGERIA,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2013,9,Female,1,Percentage,15,UNESCO,64.65
73914,2,ALGERIA,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2013,8,Male,1,Percentage,15,UNESCO,48.61
74295,2,ALGERIA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2013,999,Not Applicable,1,Percentage,3,WHO / GHO,40
75722,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,99
84234,2,ALGERIA,TB case detection rate,AFR0176,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
91726,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
95563,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
97035,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2013,999,Not Applicable,1,Percentage,4,WB Database,9.81
98493,2,ALGERIA,Immunization coverage against Tetanus,AFR0189,2013,28,Both sexes (male and female),1,Percentage,4,WB Database,95
102378,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2013,999,Not Applicable,1,Percentage,4,WB Database,27.56
103494,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2013,999,Not Applicable,1,Percentage,3,WHO / GHO,0.01
109776,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2013,999,Not Applicable,1,Percentage,3,WHO / GHO,26.44
110944,2,ALGERIA,TB case detection rate,AFR0176,2013,29,Total,1,Percentage,3,WHO / GHO,80
111783,2,ALGERIA,TB treatment success rate,AFR0216,2013,29,Total,1,Percentage,3,WHO / GHO,91
113334,2,ALGERIA,TB treatment coverage,AFR0173,2013,29,Total,1,Percentage,3,WHO / GHO,91
113574,2,ALGERIA,Percentage of children (aged 1-14 years) who experienced any physical punishment and/or psychological aggression by caregivers,AFR0432,2013,8,Male,1,Percentage,44,DHS/MICS,87.7
113602,2,ALGERIA,Percentage of children (aged 1-14 years) who experienced any physical punishment and/or psychological aggression by caregivers,AFR0432,2013,9,Female,1,Percentage,44,DHS/MICS,84.9
113630,2,ALGERIA,Percentage of children (aged 1-14 years) who experienced any physical punishment and/or psychological aggression by caregivers,AFR0432,2013,28,Both sexes (male and female),1,Percentage,44,DHS/MICS,86.3
113655,2,ALGERIA,"Percentage of children (aged 36-59 months) developmentally on track in at least 3 of the 4 following domains: literacy-numeracy, physical, social-emotional and learning",AFR0433,2013,8,Male,1,Percentage,44,DHS/MICS,67
113682,2,ALGERIA,"Percentage of children (aged 36-59 months) developmentally on track in at least 3 of the 4 following domains: literacy-numeracy, physical, social-emotional and learning",AFR0433,2013,9,Female,1,Percentage,44,DHS/MICS,73.6
113709,2,ALGERIA,"Percentage of children (aged 36-59 months) developmentally on track in at least 3 of the 4 following domains: literacy-numeracy, physical, social-emotional and learning",AFR0433,2013,28,Both sexes (male and female),1,Percentage,44,DHS/MICS,70.2
115966,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,25.59
116972,2,ALGERIA,TB treatment success rate,AFR0216,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72.8
121683,2,ALGERIA,Percentage of children (aged 1-14 years) who experienced any physical punishment and/or psychological aggression by caregivers,AFR0432,2013,8,Male,1,Percentage,46,"DHS,MICS",87.7
121711,2,ALGERIA,Percentage of children (aged 1-14 years) who experienced any physical punishment and/or psychological aggression by caregivers,AFR0432,2013,9,Female,1,Percentage,46,"DHS,MICS",84.9
121739,2,ALGERIA,Percentage of children (aged 1-14 years) who experienced any physical punishment and/or psychological aggression by caregivers,AFR0432,2013,29,Total,1,Percentage,46,"DHS,MICS",86.3
121764,2,ALGERIA,"Percentage of children (aged 36-59 months) developmentally on track in at least 3 of the 4 following domains: literacy-numeracy, physical, social-emotional and learning",AFR0433,2013,8,Male,1,Percentage,46,"DHS,MICS",67
121791,2,ALGERIA,"Percentage of children (aged 36-59 months) developmentally on track in at least 3 of the 4 following domains: literacy-numeracy, physical, social-emotional and learning",AFR0433,2013,9,Female,1,Percentage,46,"DHS,MICS",73.6
121818,2,ALGERIA,"Percentage of children (aged 36-59 months) developmentally on track in at least 3 of the 4 following domains: literacy-numeracy, physical, social-emotional and learning",AFR0433,2013,29,Total,1,Percentage,46,"DHS,MICS",70.2
124122,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2013,28,Both sexes (male and female),1,Percentage,35,IHME,1.38
125562,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2013,8,Male,1,Percentage,35,IHME,1.53
127002,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2013,9,Female,1,Percentage,35,IHME,1.22
127342,2,ALGERIA,Percentage of children (aged 1-14 years) who experienced any physical punishment and/or psychological aggression by caregivers,AFR0432,2013,29,Total,1,Percentage,12,UNICEF / MICS,86.3
127370,2,ALGERIA,Percentage of children (aged 1-14 years) who experienced any physical punishment and/or psychological aggression by caregivers,AFR0432,2013,8,Male,1,Percentage,12,UNICEF / MICS,87.7
127398,2,ALGERIA,Percentage of children (aged 1-14 years) who experienced any physical punishment and/or psychological aggression by caregivers,AFR0432,2013,9,Female,1,Percentage,12,UNICEF / MICS,84.9
131585,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2013,28,Both sexes (male and female),1,Percentage,4,WB Database,119.54
137055,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2013,29,Total,1,Percentage,36,WHO/UNICEF,95
138384,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2013,29,Total,1,Percentage,3,WHO / GHO,91
138385,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72.8
141103,2,ALGERIA,Effective PMTCT coverage,AFR0213,2013,9,Female,1,Percentage,16,UNAIDS,57
147175,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2013,29,Total,1,Percentage,36,WHO/UNICEF,93
148175,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2013,107,Female (10-14 years),1,Percentage,35,IHME,5.73
149546,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,9,Female,1,Percentage,12,UNICEF / MICS,96.6
149905,2,ALGERIA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2013,9,Female,1,Percentage,16,UNAIDS,20.04
150917,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2013,66,Female (15-49 years),1,Percentage,35,IHME,1.92
156245,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2013,999,Not Applicable,1,Percentage,3,WHO / GHO,26.44
179597,2,ALGERIA,Access to electricity (% of population),AFR0380,2013,999,Not Applicable,1,Percentage,4,WB Database,99.5
182591,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,28.93
183457,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,6.03
185189,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
186055,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,0.01
188726,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,11.8
189592,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,11.8
191629,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,27.5
193330,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,1.36
195633,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2013,28,Both sexes (male and female),1,Percentage,35,IHME,16.18
196936,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,25.3
198781,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,57.2
207911,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
1765,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,6.04
1766,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2013,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,330.22
1767,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2013,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,827.85
2466,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.99
2467,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,71.05
2468,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,28.94
2469,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,11.85
2470,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2013,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,4.29
2471,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,234.62
2472,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,588.17
2473,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,95.56
2474,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,239.57
2594,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2013,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,27.56
2595,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2013,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.63
2596,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.01
2597,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.04
2598,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.1
2599,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,91.02
2600,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,228.17
3630,2,ALGERIA,Civil registration coverage of births (%),AFR0062,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,90
4671,2,ALGERIA,GDP growth (annual %),AFR0388,2013,999,Not Applicable,2,Per 1000 live births,22,UN DESA,0.73
5193,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,100
5522,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2013,9,Female,2,Per 1000 live births,3,WHO / GHO,88
5851,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2013,8,Male,2,Per 1000 live births,3,WHO / GHO,111
6281,2,ALGERIA,TB mortality rate (per 100 000 population),AFR0013,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,7.4
6879,2,ALGERIA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,0.1
7167,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2013,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.4
7168,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2013,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.2
7169,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2013,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.5
7227,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2013,12,Urban,2,Per 1000 live births,3,WHO / GHO,89.9
7228,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2013,11,Rural,2,Per 1000 live births,3,WHO / GHO,80.89
7229,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2013,29,Total,2,Per 1000 live births,3,WHO / GHO,87.15
7275,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2013,12,Urban,2,Per 1000 live births,3,WHO / GHO,95.28
7276,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2013,11,Rural,2,Per 1000 live births,3,WHO / GHO,87.98
7277,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2013,29,Total,2,Per 1000 live births,3,WHO / GHO,93.05
7284,2,ALGERIA,Access to electricity (% of population),AFR0380,2013,29,Total,2,Per 1000 live births,1,WHO/AFRO,99.14
7291,2,ALGERIA,Access to electricity (% of population),AFR0380,2013,11,Rural,2,Per 1000 live births,1,WHO/AFRO,98.19
7298,2,ALGERIA,Access to electricity (% of population),AFR0380,2013,12,Urban,2,Per 1000 live births,1,WHO/AFRO,99.55
7612,2,ALGERIA,Life expectancy at birth (years),AFR0381,2013,8,Male,2,Per 1000 live births,1,WHO/AFRO,75
7941,2,ALGERIA,Life expectancy at birth (years),AFR0381,2013,9,Female,2,Per 1000 live births,1,WHO/AFRO,76.9
8270,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,21.6
8599,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2013,8,Male,2,Per 1000 live births,1,WHO/AFRO,21.1
8928,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2013,9,Female,2,Per 1000 live births,1,WHO/AFRO,22.1
10300,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.05
11199,2,ALGERIA,Population size (in thousands) total,AFR0004,2013,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,38140.13
12422,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,15.94
15403,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2013,28,Both sexes (male and female),2,Per 1000 live births,4,WB Database,4.78
15595,2,ALGERIA,AIDS-related mortality rate (per 100 000 population),AFR0014,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.52
16837,2,ALGERIA,Death rate due to road traffic injuries (per 100 000 population) [SDG 3.6.1],AFR0017,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,23.8
17190,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,75.9
17519,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2013,8,Male,2,Per 1000 live births,3,WHO / GHO,75
17848,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2013,9,Female,2,Per 1000 live births,3,WHO / GHO,76.9
18581,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2013,9,Female,2,Per 1000 live births,3,WHO / GHO,40.43
18582,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2013,8,Male,2,Per 1000 live births,3,WHO / GHO,61.48
20404,2,ALGERIA,TB incidence rate [SDG 3.3.2],AFR0334,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,68
21003,2,ALGERIA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0
21735,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2013,8,Male,2,Per 1000 live births,3,WHO / GHO,26
21736,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2013,9,Female,2,Per 1000 live births,3,WHO / GHO,25.5
21737,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,25.8
23097,2,ALGERIA,Anaemia prevalence in children,AFR0300,2013,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,29.7
23643,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2013,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,22713
25062,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
25480,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2013,9,Female,2,Per 1000 live births,1,WHO/AFRO,12.4
26712,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27142,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27473,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27904,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
28685,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2013,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.29
29317,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2013,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,57
29539,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,40
29840,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,54
30803,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,121
30910,2,ALGERIA,TB case detection rate,AFR0176,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
38551,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2013,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,31.6
39419,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2013,8,Male,2,Per 1000 live births,20,ITU,0.88
39420,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2013,9,Female,2,Per 1000 live births,20,ITU,0.21
39746,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2013,999,Not Applicable,2,Per 1000 live births,19,OECD,79.4
40915,2,ALGERIA,DTP dropout rate (DTP1 -DPT3),AFR0226,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,4
43202,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,414
43244,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
43291,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,69
43322,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,0
43367,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,27
43383,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,46,Measles,2,Per 1000 live births,1,WHO/AFRO,25
43443,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
47399,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2013,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,25.72
140117,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2013,12,Urban,2,Per 1000 live births,3,WHO / GHO,95.28
140118,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2013,11,Rural,2,Per 1000 live births,3,WHO / GHO,87.98
140119,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2013,29,Total,2,Per 1000 live births,3,WHO / GHO,93.05
140967,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2013,999,Not Applicable,2,Per 1000 live births,7,DHS,11.85
140984,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2013,999,Not Applicable,2,Per 1000 live births,7,DHS,91.02
141104,2,ALGERIA,Effective PMTCT coverage,AFR0213,2013,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,57
128439,2,ALGERIA,Sex ratio at birth,AFR0428,2013,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
71535,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2013,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,22713
79020,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2013,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,414
79062,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2013,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
79109,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2013,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,69
79140,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2013,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,0
79185,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2013,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,27
79201,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2013,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,25
79261,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2013,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
120173,2,ALGERIA,Number of road traffic injuries,AFR0140,2013,29,Total,5,Count (Numeric Integer),35,IHME,41318
145304,2,ALGERIA,Number of people living with HIV,AFR0019,2013,29,Total,5,Count (Numeric Integer),16,UNAIDS,12000
147393,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2013,29,Total,5,Count (Numeric Integer),35,IHME,157967
62131,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2013,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,4.77
143665,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2013,29,Total,6,Per 1000 population,16,UNAIDS,0.04
62260,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2013,9,Female,7,per 100 000 live births,23,MMEIG,115
74035,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2013,8,Male,8,Per 100 000 population,13,UNStat,0.88
74036,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2013,9,Female,8,Per 100 000 population,13,UNStat,0.2
83164,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2013,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,54
84127,2,ALGERIA,"TB prevalence rate per 100,000 population per year",AFR0332,2013,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,121
108598,2,ALGERIA,Malaria mortality rate (per 100 000 population),AFR0015,2013,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,0
70252,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2013,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,12.4
69976,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2013,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.28
92061,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2013,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,79.39
97441,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2013,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,228.7
113753,2,ALGERIA,Total Health Expenditure (constant US$),AFR0349,2013,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,8978.34
114213,2,ALGERIA,Total Health Expenditure (International US$),AFR0348,2013,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,12660.29
74911,2,ALGERIA,Gender development index score,AFR0347,2013,28,Both sexes (male and female),12,Index,14,UNDP,0.84
106133,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2013,999,Not Applicable,14,Per Capita,3,WHO / GHO,330.2
106952,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2013,999,Not Applicable,14,Per Capita,42,WDI,0.16
107770,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2013,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.06
114680,2,ALGERIA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2013,999,Not Applicable,14,Per Capita,4,WB Database,829.6
115138,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2013,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,228.7
127854,2,ALGERIA,Life expectancy at birth (years),AFR0381,2013,28,Both sexes (male and female),17,years,4,WB Database,75.66
184323,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2013,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,331
187787,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2013,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.06
190763,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2013,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,91.4
195056,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2013,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,96
186921,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2013,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.16
192495,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2013,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,229
194190,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2013,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,241.4
71484,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013-2018,9,Female,1,Percentage,13,UNStat,96.6
13791,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013-2018,9,Female,2,Per 1000 live births,3,WHO / GHO,96.6
10760,2,ALGERIA,Number of people living with HIV,AFR0019,2014,28,Both sexes (male and female),1,Percentage,16,UNAIDS,11000
11475,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2014,9,Female,1,Percentage,3,WHO / GHO,114
52381,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2014,8,Male,1,Percentage,3,WHO / GHO,12.3
52382,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2014,9,Female,1,Percentage,3,WHO / GHO,12.6
52383,2,ALGERIA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,12.4
68174,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
68782,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,99
69163,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
72135,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2014,28,Both sexes (male and female),1,Percentage,16,UNAIDS,46
72587,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2014,9,Female,1,Percentage,16,UNAIDS,28
73223,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
73500,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2014,28,Both sexes (male and female),1,Percentage,20,ITU,29.5
74331,2,ALGERIA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2014,999,Not Applicable,1,Percentage,3,WHO / GHO,71
75708,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,99
84235,2,ALGERIA,TB case detection rate,AFR0176,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
91679,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
95518,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
97081,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2014,999,Not Applicable,1,Percentage,4,WB Database,10.2
98494,2,ALGERIA,Immunization coverage against Tetanus,AFR0189,2014,28,Both sexes (male and female),1,Percentage,4,WB Database,95
99078,2,ALGERIA,Smoking (%),AFR0056,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.4
102379,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2014,999,Not Applicable,1,Percentage,4,WB Database,26.65
102839,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2014,999,Not Applicable,1,Percentage,4,WB Database,26.65
103493,2,ALGERIA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2014,999,Not Applicable,1,Percentage,3,WHO / GHO,0.03
109775,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2014,999,Not Applicable,1,Percentage,3,WHO / GHO,26.5
110990,2,ALGERIA,TB case detection rate,AFR0176,2014,29,Total,1,Percentage,3,WHO / GHO,80
111829,2,ALGERIA,TB treatment success rate,AFR0216,2014,29,Total,1,Percentage,3,WHO / GHO,88
113381,2,ALGERIA,TB treatment coverage,AFR0173,2014,29,Total,1,Percentage,3,WHO / GHO,88
115967,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,26.59
116971,2,ALGERIA,TB treatment success rate,AFR0216,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,70.4
124170,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2014,28,Both sexes (male and female),1,Percentage,35,IHME,1.41
125610,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2014,8,Male,1,Percentage,35,IHME,1.58
127050,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2014,9,Female,1,Percentage,35,IHME,1.25
131586,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2014,28,Both sexes (male and female),1,Percentage,4,WB Database,118.5
137103,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2014,29,Total,1,Percentage,36,WHO/UNICEF,95
138386,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2014,29,Total,1,Percentage,3,WHO / GHO,88
138387,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,70.4
141105,2,ALGERIA,Effective PMTCT coverage,AFR0213,2014,9,Female,1,Percentage,16,UNAIDS,28
147187,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2014,29,Total,1,Percentage,36,WHO/UNICEF,99
148176,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2014,107,Female (10-14 years),1,Percentage,35,IHME,5.3
148244,2,ALGERIA,Antenatal care attendees who were positive for syphilis (%),AFR0457,2014,9,Female,1,Percentage,3,WHO / GHO,0.2
148387,2,ALGERIA,Antenatal client syphilis screening,AFR0454,2014,9,Female,1,Percentage,3,WHO / GHO,64.1
149802,2,ALGERIA,Percentage of women accessing antenatal care services who tested positive for syphilis and were treated,AFR0448,2014,9,Female,1,Percentage,3,WHO / GHO,100
149906,2,ALGERIA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2014,9,Female,1,Percentage,16,UNAIDS,24.9
150918,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2014,66,Female (15-49 years),1,Percentage,35,IHME,1.83
156244,2,ALGERIA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2014,999,Not Applicable,1,Percentage,3,WHO / GHO,26.5
179598,2,ALGERIA,Access to electricity (% of population),AFR0380,2014,999,Not Applicable,1,Percentage,4,WB Database,99.8
182637,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,27.95
183503,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,6.54
185235,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
186101,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,0.03
188772,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,11.6
189638,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,11.6
191675,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,26.6
193375,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,1.29
195634,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2014,28,Both sexes (male and female),1,Percentage,35,IHME,16.41
196937,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,26
198782,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,58.4
207912,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
1903,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,6.55
1904,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2014,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,357.9
1905,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2014,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,929.96
2475,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.97
2476,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,72.01
2477,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,27.96
2478,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,11.61
2479,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2014,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,4.71
2480,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,257.72
2481,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,669.65
2482,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,100.07
2483,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,260.01
2601,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2014,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,26.66
2602,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2014,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.58
2603,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.03
2604,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.11
2605,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.3
2606,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,95.41
2607,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,247.91
2968,2,ALGERIA,Total density per million population: Linear Accelerator (numeric),AFR0080,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.18
3041,2,ALGERIA,Total density per million population: Telecobalt Unit,AFR0084,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.26
3115,2,ALGERIA,Total density per million population: Radiotherapy units,AFR0083,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.43
4718,2,ALGERIA,GDP growth (annual %),AFR0388,2014,999,Not Applicable,2,Per 1000 live births,22,UN DESA,1.74
5192,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,98
5521,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2014,9,Female,2,Per 1000 live births,3,WHO / GHO,86
5850,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2014,8,Male,2,Per 1000 live births,3,WHO / GHO,109
6280,2,ALGERIA,TB mortality rate (per 100 000 population),AFR0013,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,7.9
6925,2,ALGERIA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,0.1
7170,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2014,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.4
7171,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2014,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.3
7172,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2014,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.5
7233,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2014,12,Urban,2,Per 1000 live births,3,WHO / GHO,89.79
7234,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2014,11,Rural,2,Per 1000 live births,3,WHO / GHO,81.55
7235,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2014,29,Total,2,Per 1000 live births,3,WHO / GHO,87.33
7278,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2014,12,Urban,2,Per 1000 live births,3,WHO / GHO,95.36
7279,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2014,11,Rural,2,Per 1000 live births,3,WHO / GHO,88.33
7280,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2014,29,Total,2,Per 1000 live births,3,WHO / GHO,93.26
7283,2,ALGERIA,Access to electricity (% of population),AFR0380,2014,29,Total,2,Per 1000 live births,1,WHO/AFRO,99.23
7290,2,ALGERIA,Access to electricity (% of population),AFR0380,2014,11,Rural,2,Per 1000 live births,1,WHO/AFRO,98.43
7297,2,ALGERIA,Access to electricity (% of population),AFR0380,2014,12,Urban,2,Per 1000 live births,1,WHO/AFRO,99.58
7611,2,ALGERIA,Life expectancy at birth (years),AFR0381,2014,8,Male,2,Per 1000 live births,1,WHO/AFRO,75.1
7940,2,ALGERIA,Life expectancy at birth (years),AFR0381,2014,9,Female,2,Per 1000 live births,1,WHO/AFRO,77.1
8269,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,21.7
8598,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2014,8,Male,2,Per 1000 live births,1,WHO/AFRO,21.2
8927,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2014,9,Female,2,Per 1000 live births,1,WHO/AFRO,22.2
10346,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.05
11247,2,ALGERIA,Population size (in thousands) total,AFR0004,2014,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,38923.69
12423,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,15.7
15450,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2014,28,Both sexes (male and female),2,Per 1000 live births,4,WB Database,4.78
15642,2,ALGERIA,AIDS-related mortality rate (per 100 000 population),AFR0014,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.51
17189,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,76.1
17518,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2014,8,Male,2,Per 1000 live births,3,WHO / GHO,75.1
17847,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2014,9,Female,2,Per 1000 live births,3,WHO / GHO,77.1
18583,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2014,9,Female,2,Per 1000 live births,3,WHO / GHO,39.79
18584,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2014,8,Male,2,Per 1000 live births,3,WHO / GHO,60.34
20405,2,ALGERIA,TB incidence rate [SDG 3.3.2],AFR0334,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,72
20958,2,ALGERIA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0
22012,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2014,8,Male,2,Per 1000 live births,3,WHO / GHO,25.7
22013,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2014,9,Female,2,Per 1000 live births,3,WHO / GHO,25.1
22014,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,25.4
23050,2,ALGERIA,Anaemia prevalence in children,AFR0300,2014,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,29.6
23644,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2014,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,5460
25015,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
26665,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27095,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27426,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27857,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
28731,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2014,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.17
29358,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2014,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,28
29584,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,46
29841,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,58
30850,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,118
30911,2,ALGERIA,TB case detection rate,AFR0176,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
37586,2,ALGERIA,Annual mean concentrations of fine particulate matter (PM2.5) in urban areas(g/m3),AFR0026,2014,29,Total,2,Per 1000 live births,3,WHO / GHO,26
38552,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2014,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,31.6
39421,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2014,8,Male,2,Per 1000 live births,20,ITU,2.5
39422,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2014,9,Female,2,Per 1000 live births,20,ITU,0.44
39747,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2014,999,Not Applicable,2,Per 1000 live births,19,OECD,52.57
40868,2,ALGERIA,DTP dropout rate (DTP1 -DPT3),AFR0226,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,4
42871,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,3
42914,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
42961,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,0
42991,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,0
43051,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,46,Measles,2,Per 1000 live births,1,WHO/AFRO,0
43111,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
47400,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2014,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,25.33
140120,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2014,12,Urban,2,Per 1000 live births,3,WHO / GHO,95.36
140121,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2014,11,Rural,2,Per 1000 live births,3,WHO / GHO,88.33
140122,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2014,29,Total,2,Per 1000 live births,3,WHO / GHO,93.26
140968,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2014,999,Not Applicable,2,Per 1000 live births,7,DHS,11.61
140985,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2014,999,Not Applicable,2,Per 1000 live births,7,DHS,95.41
141106,2,ALGERIA,Effective PMTCT coverage,AFR0213,2014,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,28
94763,2,ALGERIA,Availability of national list of approved medical devices for procurement or reimbursement,AFR0059,2014,999,Not Applicable,3,String,3,WHO / GHO,\N
94924,2,ALGERIA,Availability of technical specifications of medical devices to support procurement or donations,AFR0061,2014,999,Not Applicable,3,String,3,WHO / GHO,\N
128438,2,ALGERIA,Sex ratio at birth,AFR0428,2014,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
71536,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2014,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,5460
78689,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2014,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,3
78732,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2014,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
78779,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2014,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,0
78809,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2014,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,0
78869,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2014,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,0
78929,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2014,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
120220,2,ALGERIA,Number of road traffic injuries,AFR0140,2014,29,Total,5,Count (Numeric Integer),35,IHME,41862
141545,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2014,124,Geophysical,5,Count (Numeric Integer),35,IHME,6
145350,2,ALGERIA,Number of people living with HIV,AFR0019,2014,29,Total,5,Count (Numeric Integer),16,UNAIDS,13000
147441,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2014,29,Total,5,Count (Numeric Integer),35,IHME,166143
62178,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2014,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,4.77
76632,2,ALGERIA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2014,999,Not Applicable,6,Per 1000 population,38,Global Health Workforce Statistics,28.62
143709,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2014,29,Total,6,Per 1000 population,16,UNAIDS,0.04
62261,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2014,9,Female,7,per 100 000 live births,23,MMEIG,114
74037,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2014,8,Male,8,Per 100 000 population,13,UNStat,2.5
74038,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2014,9,Female,8,Per 100 000 population,13,UNStat,0.44
83165,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2014,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,58
84174,2,ALGERIA,"TB prevalence rate per 100,000 population per year",AFR0332,2014,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,118
108599,2,ALGERIA,Malaria mortality rate (per 100 000 population),AFR0015,2014,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,0
70022,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2014,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.17
92062,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2014,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,52.56
97440,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2014,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,248.7
113754,2,ALGERIA,Total Health Expenditure (constant US$),AFR0349,2014,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,10109.22
114214,2,ALGERIA,Total Health Expenditure (International US$),AFR0348,2014,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,13998.59
91922,2,ALGERIA,"Annual mean levels of fine particulate matter in cities, urban population (micrograms per cubic meter)",AFR0121,2014,29,Total,11,micrograms per cubic meter,3,WHO / GHO,26
74954,2,ALGERIA,Gender development index score,AFR0347,2014,28,Both sexes (male and female),12,Index,14,UNDP,0.84
152203,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2014,1002,Nursing and midwifery personnel,13,Per 10 000 population,3,WHO / GHO,2.86
106132,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2014,999,Not Applicable,14,Per Capita,3,WHO / GHO,357.9
106951,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2014,999,Not Applicable,14,Per Capita,42,WDI,0.32
107769,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2014,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.13
114679,2,ALGERIA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2014,999,Not Applicable,14,Per Capita,4,WB Database,932.82
115137,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2014,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,248.7
127855,2,ALGERIA,Life expectancy at birth (years),AFR0381,2014,28,Both sexes (male and female),17,years,4,WB Database,75.88
184369,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2014,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,359
187833,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2014,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.12
190809,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2014,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,95.8
195102,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2014,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,100
186967,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2014,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.32
192541,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2014,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,250
194236,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2014,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,262.2
10806,2,ALGERIA,Number of people living with HIV,AFR0019,2015,28,Both sexes (male and female),1,Percentage,16,UNAIDS,12000
11476,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2015,9,Female,1,Percentage,3,WHO / GHO,114
68220,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
68809,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,99
69204,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
71303,2,ALGERIA,Coverage of essential health services,AFR0128,2015,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,76
72180,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2015,28,Both sexes (male and female),1,Percentage,16,UNAIDS,53
72405,2,ALGERIA,People living with HIV who know their status,AFR0181,2015,28,Both sexes (male and female),1,Percentage,16,UNAIDS,74
72628,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2015,9,Female,1,Percentage,16,UNAIDS,25
72633,2,ALGERIA,Viral load suppression,AFR0178,2015,28,Both sexes (male and female),1,Percentage,16,UNAIDS,36
73176,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
73501,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2015,28,Both sexes (male and female),1,Percentage,20,ITU,38.2
74363,2,ALGERIA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2015,999,Not Applicable,1,Percentage,3,WHO / GHO,72
75694,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,99
84236,2,ALGERIA,TB case detection rate,AFR0176,2015,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
91395,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
91632,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
95473,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,95
97127,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,999,Not Applicable,1,Percentage,4,WB Database,11.2
98495,2,ALGERIA,Immunization coverage against Tetanus,AFR0189,2015,28,Both sexes (male and female),1,Percentage,4,WB Database,95
99409,2,ALGERIA,Viral load suppression,AFR0178,2015,29,Total,1,Percentage,16,UNAIDS,36
99482,2,ALGERIA,Viral load suppression,AFR0178,2015,45,Male (15+ years),1,Percentage,16,UNAIDS,31
99555,2,ALGERIA,Viral load suppression,AFR0178,2015,42,Female (15+ years),1,Percentage,16,UNAIDS,39
102380,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2015,999,Not Applicable,1,Percentage,4,WB Database,28.2
102838,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2015,999,Not Applicable,1,Percentage,4,WB Database,28.2
103053,2,ALGERIA,Service availability index (%) (high-level indicator),AFR0229,2015,999,Not Applicable,1,Percentage,4,WB Database,76
103194,2,ALGERIA,Service availability index (%),AFR0049,2015,999,Not Applicable,1,Percentage,4,WB Database,76
111037,2,ALGERIA,TB case detection rate,AFR0176,2015,29,Total,1,Percentage,3,WHO / GHO,80
111875,2,ALGERIA,TB treatment success rate,AFR0216,2015,29,Total,1,Percentage,3,WHO / GHO,90
113428,2,ALGERIA,TB treatment coverage,AFR0173,2015,29,Total,1,Percentage,3,WHO / GHO,90
115968,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2015,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.15
116970,2,ALGERIA,TB treatment success rate,AFR0216,2015,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72
124218,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2015,28,Both sexes (male and female),1,Percentage,35,IHME,1.45
125658,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2015,8,Male,1,Percentage,35,IHME,1.61
127098,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2015,9,Female,1,Percentage,35,IHME,1.28
131587,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2015,28,Both sexes (male and female),1,Percentage,4,WB Database,115.88
137151,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2015,29,Total,1,Percentage,36,WHO/UNICEF,95
138388,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2015,29,Total,1,Percentage,3,WHO / GHO,90
138389,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2015,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72
141107,2,ALGERIA,Effective PMTCT coverage,AFR0213,2015,9,Female,1,Percentage,16,UNAIDS,25
147205,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2015,29,Total,1,Percentage,36,WHO/UNICEF,99
148177,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2015,107,Female (10-14 years),1,Percentage,35,IHME,4.88
149907,2,ALGERIA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2015,9,Female,1,Percentage,16,UNAIDS,25.04
150919,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2015,66,Female (15-49 years),1,Percentage,35,IHME,1.75
179599,2,ALGERIA,Access to electricity (% of population),AFR0380,2015,999,Not Applicable,1,Percentage,4,WB Database,99.9
182683,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,29.51
183549,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,6.97
185281,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
186147,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,0.02
188818,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,10.7
189684,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,10.7
190085,2,ALGERIA,Health Capital Expenditure (HK) % Gross Domestic Product (GDP),AFR0065,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,0.01
191721,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,28.2
193420,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,1.3
195635,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2015,28,Both sexes (male and female),1,Percentage,35,IHME,16.72
196938,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2015,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,26.7
198783,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2015,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,59.5
207913,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,95
2041,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,6.98
2042,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2015,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,290.5
2043,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2015,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1020.55
2484,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.97
2485,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,70.46
2486,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,29.51
2487,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,10.73
2488,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2015,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,4.92
2489,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,204.69
2490,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,719.07
2491,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,85.74
2492,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,301.21
2608,2,ALGERIA,Health Capital Expenditure (HK) % Gross Domestic Product (GDP),AFR0065,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.01
2609,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2015,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,28.21
2610,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2015,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.55
2611,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.03
2612,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.08
2613,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.27
2614,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,81.95
2615,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,287.88
3262,2,ALGERIA,Hospital bed density (per 10 000 population),AFR0231,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,19
4370,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,37,Both sexes (15-24 years),2,Per 1000 live births,1,WHO/AFRO,29.8
4383,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,36,Female (15-24 years),2,Per 1000 live births,1,WHO/AFRO,45.3
4395,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,35,Male (15-24 years),2,Per 1000 live births,1,WHO/AFRO,26.7
4450,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,38,Both sexes (25+ years),2,Per 1000 live births,1,WHO/AFRO,8
4463,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,40,Female (25+ years),2,Per 1000 live births,1,WHO/AFRO,12.3
4475,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,39,Male (25+ years),2,Per 1000 live births,1,WHO/AFRO,7
4765,2,ALGERIA,GDP growth (annual %),AFR0388,2015,999,Not Applicable,2,Per 1000 live births,22,UN DESA,1.73
4906,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2015,12,Urban,2,Per 1000 live births,1,WHO/AFRO,95.4
4953,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2015,11,Rural,2,Per 1000 live births,1,WHO/AFRO,88.7
5000,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2015,29,Total,2,Per 1000 live births,1,WHO/AFRO,93.5
5048,2,ALGERIA,Population using safely managed sanitation services [SDG 6.2.1a/6.2.1b],AFR0291,2015,12,Urban,2,Per 1000 live births,3,WHO / GHO,89.7
5095,2,ALGERIA,Population using safely managed sanitation services [SDG 6.2.1a/6.2.1b],AFR0291,2015,11,Rural,2,Per 1000 live births,3,WHO / GHO,82.2
5142,2,ALGERIA,Population using safely managed sanitation services [SDG 6.2.1a/6.2.1b],AFR0291,2015,29,Total,2,Per 1000 live births,3,WHO / GHO,87.5
5191,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,96
5520,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,85
5849,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,108
6279,2,ALGERIA,TB mortality rate (per 100 000 population),AFR0013,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,8.1
6971,2,ALGERIA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,0.1
7173,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2015,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.4
7174,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2015,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.3
7175,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2015,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.5
7230,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2015,12,Urban,2,Per 1000 live births,3,WHO / GHO,89.67
7231,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2015,11,Rural,2,Per 1000 live births,3,WHO / GHO,82.21
7232,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2015,29,Total,2,Per 1000 live births,3,WHO / GHO,87.49
7282,2,ALGERIA,Access to electricity (% of population),AFR0380,2015,29,Total,2,Per 1000 live births,1,WHO/AFRO,99.34
7289,2,ALGERIA,Access to electricity (% of population),AFR0380,2015,11,Rural,2,Per 1000 live births,1,WHO/AFRO,98.69
7296,2,ALGERIA,Access to electricity (% of population),AFR0380,2015,12,Urban,2,Per 1000 live births,1,WHO/AFRO,99.61
7610,2,ALGERIA,Life expectancy at birth (years),AFR0381,2015,8,Male,2,Per 1000 live births,1,WHO/AFRO,75.3
7939,2,ALGERIA,Life expectancy at birth (years),AFR0381,2015,9,Female,2,Per 1000 live births,1,WHO/AFRO,77.2
8268,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,21.8
8597,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2015,8,Male,2,Per 1000 live births,1,WHO/AFRO,21.3
8926,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2015,9,Female,2,Per 1000 live births,1,WHO/AFRO,22.3
9255,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,65.3
9396,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,65.2
9537,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,65.4
9678,2,ALGERIA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,15.6
9819,2,ALGERIA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,15.6
9960,2,ALGERIA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,15.7
10392,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.05
11295,2,ALGERIA,Population size (in thousands) total,AFR0004,2015,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,39728.03
12424,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,15.45
15497,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2015,28,Both sexes (male and female),2,Per 1000 live births,4,WB Database,4.77
15689,2,ALGERIA,AIDS-related mortality rate (per 100 000 population),AFR0014,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.5
16021,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2015,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,3.2
16261,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,4.8
16501,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,1.7
16741,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,3.2
17188,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,76.2
17517,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,75.3
17846,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,77.2
18292,2,ALGERIA,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,14.4
18585,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,39.06
18586,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,59.24
20406,2,ALGERIA,TB incidence rate [SDG 3.3.2],AFR0334,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,75
20913,2,ALGERIA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0
21873,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,25.4
21874,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,24.6
21875,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,25.1
23003,2,ALGERIA,Anaemia prevalence in children,AFR0300,2015,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,29.7
23545,2,ALGERIA,Coverage of essential health services,AFR0128,2015,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,76
23639,2,ALGERIA,Stillbirth rate (per 1000 total births),AFR0011,2015,28,Both sexes (male and female),2,Per 1000 live births,7,DHS,19.3
23645,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2015,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,7561
24968,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
26111,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2015,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.8
26112,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2015,9,Female,2,Per 1000 live births,20,ITU,0.6
26113,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2015,8,Male,2,Per 1000 live births,20,ITU,1
26618,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27048,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27379,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
27810,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
28777,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2015,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.32
29399,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2015,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,25
29629,2,ALGERIA,Viral load suppression,AFR0178,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,36
29702,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,53
29842,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,60
30912,2,ALGERIA,TB case detection rate,AFR0176,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
38553,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2015,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,31.6
39423,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2015,8,Male,2,Per 1000 live births,20,ITU,2.34
39424,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2015,9,Female,2,Per 1000 live births,20,ITU,0.37
39748,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2015,999,Not Applicable,2,Per 1000 live births,19,OECD,35.14
40671,2,ALGERIA,Hepatitis B surface antigen prevalence (%),AFR0326,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,0.2
40821,2,ALGERIA,DTP dropout rate (DTP1 -DPT3),AFR0226,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,4
42481,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
42519,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,3
42562,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
42609,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,0
42642,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,0
42684,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,67
42706,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,46,Measles,2,Per 1000 live births,1,WHO/AFRO,63
42750,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
42771,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
42802,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,0
47401,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2015,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,24.94
85793,2,ALGERIA,Stillbirth rate (per 1000 total births),AFR0011,2015,9,Female,2,Per 1000 live births,7,DHS,19.3
140123,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2015,12,Urban,2,Per 1000 live births,7,DHS,95.4
140124,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2015,11,Rural,2,Per 1000 live births,7,DHS,88.7
140125,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2015,29,Total,2,Per 1000 live births,7,DHS,93.5
140969,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2015,999,Not Applicable,2,Per 1000 live births,7,DHS,10.73
140986,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2015,999,Not Applicable,2,Per 1000 live births,7,DHS,81.95
141108,2,ALGERIA,Effective PMTCT coverage,AFR0213,2015,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,25
67055,2,ALGERIA,Existence of national screening program for cervical cancer,AFR0418,2015,999,Not Applicable,3,String,3,WHO / GHO,\N
67196,2,ALGERIA,Most widely used screening method in national cervical cancer screening program,AFR0415,2015,999,Not Applicable,3,String,3,WHO / GHO,\N
67337,2,ALGERIA,Type of national cervical cancer screening program,AFR0416,2015,999,Not Applicable,3,String,3,WHO / GHO,\N
67428,2,ALGERIA,Coverage of national cervical cancer screening program (%),AFR0417,2015,999,Not Applicable,3,String,3,WHO / GHO,\N
118959,2,ALGERIA,Functional system of health accounts based on international standards,AFR0237,2015,999,Not Applicable,3,String,10,WHO / GHED,\N
129457,2,ALGERIA,Existence of national screening program for cervical cancer,AFR0418,2015,9,Female,3,String,3,WHO / GHO,\N
128437,2,ALGERIA,Sex ratio at birth,AFR0428,2015,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
71537,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2015,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,7561
78299,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2015,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
78337,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2015,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,3
78380,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2015,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
78427,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2015,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,0
78460,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2015,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,0
78502,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2015,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,67
78524,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2015,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,63
78568,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2015,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
78589,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2015,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
78620,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2015,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,0
99155,2,ALGERIA,"Pre-primary education, duration (years)",AFR0392,2015,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,1
120267,2,ALGERIA,Number of road traffic injuries,AFR0140,2015,29,Total,5,Count (Numeric Integer),35,IHME,42403
142371,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2015,126,Hydrological,5,Count (Numeric Integer),35,IHME,12
145396,2,ALGERIA,Number of people living with HIV,AFR0019,2015,29,Total,5,Count (Numeric Integer),16,UNAIDS,15000
147489,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2015,29,Total,5,Count (Numeric Integer),35,IHME,174512
152810,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,70,0-4 years,5,Count (Numeric Integer),17,UN Population,4653816
153044,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,71,5-9 years,5,Count (Numeric Integer),17,UN Population,3830665
153277,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,72,10-14 years,5,Count (Numeric Integer),17,UN Population,2920447
153507,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,73,15-19 years,5,Count (Numeric Integer),17,UN Population,3017324
153739,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,74,20-24 years,5,Count (Numeric Integer),17,UN Population,3597822
153970,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,75,25-29 years,5,Count (Numeric Integer),17,UN Population,3753383
154201,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,76,30-34 years,5,Count (Numeric Integer),17,UN Population,3574503
154434,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,77,35-39 years,5,Count (Numeric Integer),17,UN Population,3042320
154667,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,78,40-44 years,5,Count (Numeric Integer),17,UN Population,2465081
154899,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,79,45-49 years,5,Count (Numeric Integer),17,UN Population,2098573
155131,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,80,50-54 years,5,Count (Numeric Integer),17,UN Population,1783746
155366,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,81,55-59 years,5,Count (Numeric Integer),17,UN Population,1444151
155595,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,82,60-64 years,5,Count (Numeric Integer),17,UN Population,1216683
155826,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,83,65-69 years,5,Count (Numeric Integer),17,UN Population,799681
156058,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,84,70-74 years,5,Count (Numeric Integer),17,UN Population,609823
177399,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,85,75-79 years,5,Count (Numeric Integer),17,UN Population,466261
177629,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,86,80-84 years,5,Count (Numeric Integer),17,UN Population,291145
177861,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,1010,85-89 years,5,Count (Numeric Integer),17,UN Population,122654
178175,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,1011,90-94 years,5,Count (Numeric Integer),17,UN Population,32905
178410,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,1012,95-99 years,5,Count (Numeric Integer),17,UN Population,6454
62225,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2015,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,4.77
100696,2,ALGERIA,HIV prevalence rate (per 1000 population),AFR0020,2015,42,Female (15+ years),6,Per 1000 population,16,UNAIDS,0.1
143753,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2015,29,Total,6,Per 1000 population,16,UNAIDS,0.05
62262,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2015,9,Female,7,per 100 000 live births,23,MMEIG,114
70882,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2015,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,0.8
70883,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2015,9,Female,8,Per 100 000 population,13,UNStat,0.6
70884,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2015,8,Male,8,Per 100 000 population,13,UNStat,1
71946,2,ALGERIA,Hepatitis B surface antigen prevalence (%),AFR0326,2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,200
74039,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2015,8,Male,8,Per 100 000 population,13,UNStat,2.33
74040,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2015,9,Female,8,Per 100 000 population,13,UNStat,0.37
83166,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,60
104396,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2015,8,Male,8,Per 100 000 population,3,WHO / GHO,6.6
104397,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2015,9,Female,8,Per 100 000 population,3,WHO / GHO,1.95
108600,2,ALGERIA,Malaria mortality rate (per 100 000 population),AFR0015,2015,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,0
109159,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,4.3
120565,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 1,AFR0196,2015,29,Total,8,Per 100 000 population,36,WHO/UNICEF,8
120891,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,14.4
121131,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2015,8,Male,8,Per 100 000 population,3,WHO / GHO,15.4
121371,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2015,9,Female,8,Per 100 000 population,3,WHO / GHO,13.3
70068,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2015,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.32
92063,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2015,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,35.14
97439,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2015,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,288.5
113755,2,ALGERIA,Total Health Expenditure (constant US$),AFR0349,2015,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,11173.78
114215,2,ALGERIA,Total Health Expenditure (International US$),AFR0348,2015,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,11582.82
74998,2,ALGERIA,Gender development index score,AFR0347,2015,28,Both sexes (male and female),12,Index,14,UNDP,0.85
97391,2,ALGERIA,Hospital bed density (per 10 000 population),AFR0231,2015,999,Not Applicable,13,Per 10 000 population,3,WHO / GHO,19
106131,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2015,999,Not Applicable,14,Per Capita,3,WHO / GHO,290.5
106950,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2015,999,Not Applicable,14,Per Capita,42,WDI,0.27
107768,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2015,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.07
114678,2,ALGERIA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2015,999,Not Applicable,14,Per Capita,4,WB Database,1022.89
115136,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2015,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,288.5
127856,2,ALGERIA,Life expectancy at birth (years),AFR0381,2015,28,Both sexes (male and female),17,years,4,WB Database,76.09
213124,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2015,28,Both sexes (male and female),23,Numeric,75,WHO/GHO_2021,66
213312,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2015,8,Male,23,Numeric,75,WHO/GHO_2021,66.3
213500,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2015,9,Female,23,Numeric,75,WHO/GHO_2021,65.7
213687,2,ALGERIA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2015,28,Both sexes (male and female),23,Numeric,75,WHO/GHO_2021,15.9
184415,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2015,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,291
187879,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2015,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.07
190855,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2015,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,82.2
195148,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2015,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,86
187013,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2015,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.27
192587,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2015,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,289
194282,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2015,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,302.9
118582,2,ALGERIA,Existence of national health sector policy/strategy/plan,AFR0250,2015-2019,999,Not Applicable,3,String,1,WHO/AFRO,\N
122367,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2015-2020,28,Both sexes (male and female),1,Percentage,17,UN Population,22.08
122655,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2015-2020,8,Male,1,Percentage,17,UN Population,21.53
122943,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2015-2020,9,Female,1,Percentage,17,UN Population,22.65
130568,2,ALGERIA,Total fertility rate,AFR0130,2015-2020,9,Female,1,Percentage,17,UN Population,3.05
10852,2,ALGERIA,Number of people living with HIV,AFR0019,2016,28,Both sexes (male and female),1,Percentage,16,UNAIDS,14000
11477,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2016,9,Female,1,Percentage,3,WHO / GHO,113
68266,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,91
68836,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,96
69245,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,61
72225,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2016,28,Both sexes (male and female),1,Percentage,16,UNAIDS,59
72638,2,ALGERIA,Viral load suppression,AFR0178,2016,28,Both sexes (male and female),1,Percentage,16,UNAIDS,40
73129,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,94
73502,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2016,28,Both sexes (male and female),1,Percentage,20,ITU,42.94
74386,2,ALGERIA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2016,999,Not Applicable,1,Percentage,3,WHO / GHO,73
75680,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,99
84237,2,ALGERIA,TB case detection rate,AFR0176,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
91348,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91
91585,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91
95428,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91
95830,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,61
97173,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,999,Not Applicable,1,Percentage,4,WB Database,10.2
98496,2,ALGERIA,Immunization coverage against Tetanus,AFR0189,2016,28,Both sexes (male and female),1,Percentage,4,WB Database,91
99077,2,ALGERIA,Smoking (%),AFR0056,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.2
99414,2,ALGERIA,Viral load suppression,AFR0178,2016,29,Total,1,Percentage,16,UNAIDS,40
99487,2,ALGERIA,Viral load suppression,AFR0178,2016,45,Male (15+ years),1,Percentage,16,UNAIDS,35
99560,2,ALGERIA,Viral load suppression,AFR0178,2016,42,Female (15+ years),1,Percentage,16,UNAIDS,43
102381,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2016,999,Not Applicable,1,Percentage,4,WB Database,30.88
102837,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2016,999,Not Applicable,1,Percentage,4,WB Database,30.88
111083,2,ALGERIA,TB case detection rate,AFR0176,2016,29,Total,1,Percentage,3,WHO / GHO,80
112466,2,ALGERIA,Pneumococcal vaccination coverage,AFR0186,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,61
115969,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.03
116969,2,ALGERIA,TB treatment success rate,AFR0216,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72
121972,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2016,29,Total,1,Percentage,36,WHO/UNICEF,61
124266,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2016,28,Both sexes (male and female),1,Percentage,35,IHME,1.48
125706,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2016,8,Male,1,Percentage,35,IHME,1.64
127146,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2016,9,Female,1,Percentage,35,IHME,1.31
131588,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2016,28,Both sexes (male and female),1,Percentage,4,WB Database,113.83
135417,2,ALGERIA,"Prevalence of anaemia in women aged 15-49, by age and pregnancy status",AFR0299,2016,9,Female,1,Percentage,3,WHO / GHO,35.7
135753,2,ALGERIA,Annual mean concentrations of fine particulate matter (PM2.5) in urban areas(g/m3),AFR0026,2016,999,Not Applicable,1,Percentage,3,WHO / GHO,34.5
135897,2,ALGERIA,Prevalence of obesity among children and adolescents (5-19 years)(%),AFR0439,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,13.5
135945,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.4
137199,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2016,29,Total,1,Percentage,36,WHO/UNICEF,91
138390,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72
147229,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2016,29,Total,1,Percentage,36,WHO/UNICEF,96
148178,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2016,107,Female (10-14 years),1,Percentage,35,IHME,4.63
149908,2,ALGERIA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2016,9,Female,1,Percentage,16,UNAIDS,21.54
150920,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2016,66,Female (15-49 years),1,Percentage,35,IHME,1.71
179600,2,ALGERIA,Access to electricity (% of population),AFR0380,2016,999,Not Applicable,1,Percentage,4,WB Database,99.9
180099,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2016,9,Female,1,Percentage,16,UNAIDS,40
182729,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,32.29
183595,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,6.6
185327,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
186193,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,0.02
188864,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,10.7
189730,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,10.7
191767,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,30.8
193465,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,1.4
195636,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2016,28,Both sexes (male and female),1,Percentage,35,IHME,17.06
198784,2,ALGERIA,Prevalence of overweight in persons aged 18+years,AFR0383,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,60.7
207914,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,94
2179,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,6.65
2180,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2016,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,260.41
2181,2,ALGERIA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2016,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,998.15
2493,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,99.98
2494,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE),AFR0274,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,67.69
2495,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,32.29
2496,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,10.73
2497,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP),AFR0088,2016,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,4.5
2498,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in US$,AFR0090,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,176.27
2499,2,ALGERIA,Domestic General Government Health Expenditure (GGHE-D) per Capita in PPP Int$,AFR0089,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,675.62
2500,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,84.09
2501,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,322.3
2616,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2016,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,30.88
2617,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2016,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.57
2618,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.02
2619,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.06
2620,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.23
2621,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in US$,AFR0070,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,80.42
2622,2,ALGERIA,Out-of-Pocket Expenditure (OOPS) per Capita in PPP Int$,AFR0069,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,308.26
4407,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,37,Both sexes (15-24 years),2,Per 1000 live births,1,WHO/AFRO,25.7
4416,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,36,Female (15-24 years),2,Per 1000 live births,1,WHO/AFRO,44.9
4424,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,35,Male (15-24 years),2,Per 1000 live births,1,WHO/AFRO,22.1
4487,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,38,Both sexes (25+ years),2,Per 1000 live births,1,WHO/AFRO,7.7
4496,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,40,Female (25+ years),2,Per 1000 live births,1,WHO/AFRO,15
4504,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,39,Male (25+ years),2,Per 1000 live births,1,WHO/AFRO,5.8
4812,2,ALGERIA,GDP growth (annual %),AFR0388,2016,999,Not Applicable,2,Per 1000 live births,22,UN DESA,1.33
5190,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
5519,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,84
5848,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,106
6278,2,ALGERIA,TB mortality rate (per 100 000 population),AFR0013,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,7.7
7017,2,ALGERIA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,0.1
7176,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2016,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.4
7177,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2016,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.4
7178,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2016,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.6
7281,2,ALGERIA,Access to electricity (% of population),AFR0380,2016,29,Total,2,Per 1000 live births,1,WHO/AFRO,99.44
7288,2,ALGERIA,Access to electricity (% of population),AFR0380,2016,11,Rural,2,Per 1000 live births,1,WHO/AFRO,98.96
7295,2,ALGERIA,Access to electricity (% of population),AFR0380,2016,12,Urban,2,Per 1000 live births,1,WHO/AFRO,99.63
7609,2,ALGERIA,Life expectancy at birth (years),AFR0381,2016,8,Male,2,Per 1000 live births,1,WHO/AFRO,75.4
7938,2,ALGERIA,Life expectancy at birth (years),AFR0381,2016,9,Female,2,Per 1000 live births,1,WHO/AFRO,77.4
8267,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,21.9
8596,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2016,8,Male,2,Per 1000 live births,1,WHO/AFRO,21.4
8925,2,ALGERIA,Life expectancy at age 60 years,AFR0003,2016,9,Female,2,Per 1000 live births,1,WHO/AFRO,22.5
9254,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,65.5
9395,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,65.4
9536,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,65.6
9677,2,ALGERIA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,15.8
9818,2,ALGERIA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,15.7
9959,2,ALGERIA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,15.8
10438,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.05
11343,2,ALGERIA,Population size (in thousands) total,AFR0004,2016,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,40551.39
12425,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,15.18
15736,2,ALGERIA,AIDS-related mortality rate (per 100 000 population),AFR0014,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.49
16069,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2016,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,3.2
16309,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,4.7
16549,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,1.7
16789,2,ALGERIA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,3.2
17187,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,76.4
17516,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,75.4
17845,2,ALGERIA,Average life expectancy at birth (in years),AFR0001,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,77.4
18291,2,ALGERIA,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,14.2
18587,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,38.23
18588,2,ALGERIA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,58.05
20257,2,ALGERIA,"Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (deaths per 100,000 population)",AFR0109,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.9
20305,2,ALGERIA,"Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (deaths per 100,000 population)",AFR0109,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,1.7
20353,2,ALGERIA,"Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (deaths per 100,000 population)",AFR0109,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,2
20407,2,ALGERIA,TB incidence rate [SDG 3.3.2],AFR0334,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,70
20868,2,ALGERIA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0
21273,2,ALGERIA,Hepatitis B surface antigen prevalence (%),AFR0326,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.8
22168,2,ALGERIA,Total alcohol per capita (age 15+ years) consumption [SDG 3.5.2],AFR0310,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,32.3
22169,2,ALGERIA,Total alcohol per capita (age 15+ years) consumption [SDG 3.5.2],AFR0310,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,11.6
22170,2,ALGERIA,Total alcohol per capita (age 15+ years) consumption [SDG 3.5.2],AFR0310,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,27.2
22306,2,ALGERIA,Age-standardized prevalence of insufficiently physically active persons aged 18+ years,AFR0308,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,26.92
22307,2,ALGERIA,Age-standardized prevalence of insufficiently physically active persons aged 18+ years,AFR0308,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,40.25
22308,2,ALGERIA,Age-standardized prevalence of insufficiently physically active persons aged 18+ years,AFR0308,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,33.58
22956,2,ALGERIA,Anaemia prevalence in children,AFR0300,2016,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,30
23646,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2016,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,10752
24921,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
26249,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.8
26250,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,9,Female,2,Per 1000 live births,20,ITU,0.6
26251,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,8,Male,2,Per 1000 live births,20,ITU,0.9
26387,2,ALGERIA,Mortality rate attributed to household and ambient air pollution [SDG 3.9.1],AFR0132,2016,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,50
26571,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,94
27001,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,91
27332,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,91
27763,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,96
28823,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2016,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.79
29024,2,ALGERIA,People living with HIV who know their status,AFR0181,2016,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,73
29634,2,ALGERIA,Viral load suppression,AFR0178,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,40
29747,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,59
29843,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,56
30913,2,ALGERIA,TB case detection rate,AFR0176,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
36954,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2016,29,Total,2,Per 1000 live births,3,WHO / GHO,87.54
36957,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2016,11,Rural,2,Per 1000 live births,3,WHO / GHO,82.21
36958,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2016,12,Urban,2,Per 1000 live births,3,WHO / GHO,89.67
37497,2,ALGERIA,Annual mean concentrations of fine particulate matter (PM2.5) in urban areas(g/m3),AFR0026,2016,12,Urban,2,Per 1000 live births,3,WHO / GHO,34.5
37513,2,ALGERIA,Annual mean concentrations of fine particulate matter (PM2.5) in urban areas(g/m3),AFR0026,2016,29,Total,2,Per 1000 live births,3,WHO / GHO,35.17
38554,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2016,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,31.6
39749,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2016,999,Not Applicable,2,Per 1000 live births,19,OECD,36.01
40774,2,ALGERIA,DTP dropout rate (DTP1 -DPT3),AFR0226,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,5
42152,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
42189,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,13
42232,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
42279,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,2
42307,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,0
42347,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,0
42368,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,46,Measles,2,Per 1000 live births,1,WHO/AFRO,41
42411,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
42424,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
42449,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,0
47402,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2016,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,24.5
140970,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2016,999,Not Applicable,2,Per 1000 live births,7,DHS,10.73
140987,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2016,999,Not Applicable,2,Per 1000 live births,7,DHS,80.42
128436,2,ALGERIA,Sex ratio at birth,AFR0428,2016,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
71538,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2016,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,10752
77970,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2016,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
78007,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2016,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,13
78050,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2016,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
78097,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2016,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,2
78125,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2016,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,0
78165,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2016,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,0
78186,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2016,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,41
78229,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2016,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
78242,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2016,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
78267,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2016,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,0
99154,2,ALGERIA,"Pre-primary education, duration (years)",AFR0392,2016,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,1
120314,2,ALGERIA,Number of road traffic injuries,AFR0140,2016,29,Total,5,Count (Numeric Integer),35,IHME,42873
145442,2,ALGERIA,Number of people living with HIV,AFR0019,2016,29,Total,5,Count (Numeric Integer),16,UNAIDS,16000
147537,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2016,29,Total,5,Count (Numeric Integer),35,IHME,183359
179097,2,ALGERIA,Number of medical doctors,AFR0469,2016,29,Total,5,Count (Numeric Integer),3,WHO / GHO,74309
47341,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2016,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,4.76
76631,2,ALGERIA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2016,999,Not Applicable,6,Per 1000 population,38,Global Health Workforce Statistics,224.3
102092,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2016,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,4.71
143797,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2016,29,Total,6,Per 1000 population,16,UNAIDS,0.05
62263,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2016,9,Female,7,per 100 000 live births,23,MMEIG,113
47519,2,ALGERIA,Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2),AFR0096,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,1.9
47567,2,ALGERIA,Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2),AFR0096,2016,8,Male,8,Per 100 000 population,3,WHO / GHO,1.7
47615,2,ALGERIA,Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2),AFR0096,2016,9,Female,8,Per 100 000 population,3,WHO / GHO,2
65079,2,ALGERIA,Death rate due to road traffic injuries (per 100 000 population) [SDG 3.6.1],AFR0017,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,\N
71020,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,0.8
71021,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,9,Female,8,Per 100 000 population,13,UNStat,0.6
71022,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,8,Male,8,Per 100 000 population,13,UNStat,0.9
71159,2,ALGERIA,Mortality rate attributed to household and ambient air pollution [SDG 3.9.1],AFR0132,2016,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,50
83167,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,56
103351,2,ALGERIA,Mortality attributable to joint effects of household and ambient air pollution,AFR0129,2016,29,Total,8,Per 100 000 population,3,WHO / GHO,49.7
103398,2,ALGERIA,Mortality attributable to joint effects of household and ambient air pollution,AFR0129,2016,9,Female,8,Per 100 000 population,3,WHO / GHO,44
103445,2,ALGERIA,Mortality attributable to joint effects of household and ambient air pollution,AFR0129,2016,8,Male,8,Per 100 000 population,3,WHO / GHO,55
104394,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2016,8,Male,8,Per 100 000 population,3,WHO / GHO,6.41
104395,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2016,9,Female,8,Per 100 000 population,3,WHO / GHO,1.9
108601,2,ALGERIA,Malaria mortality rate (per 100 000 population),AFR0015,2016,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,0
109158,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,4.18
120502,2,ALGERIA,"Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (deaths per 100,000 population)",AFR0109,2016,29,Total,8,Per 100 000 population,3,WHO / GHO,1.9
120585,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 1,AFR0196,2016,29,Total,8,Per 100 000 population,36,WHO/UNICEF,94
120939,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,14.2
121179,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2016,8,Male,8,Per 100 000 population,3,WHO / GHO,15.2
121419,2,ALGERIA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2016,9,Female,8,Per 100 000 population,3,WHO / GHO,13.2
130140,2,ALGERIA,Mortality rate attributed to household and ambient air pollution [SDG 3.9.1],AFR0132,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,49.7
130188,2,ALGERIA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,0.8
141034,2,ALGERIA,"Mortality rate attributed to household air pollution (deaths per 100,000 population)",AFR0108,2016,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,50
70114,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2016,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.78
92064,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2016,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,36.01
97438,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2016,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,306.5
105993,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2016,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,0.02
113756,2,ALGERIA,Total Health Expenditure (constant US$),AFR0349,2016,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,10912.32
114216,2,ALGERIA,Total Health Expenditure (International US$),AFR0348,2016,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,10574.72
116830,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2016,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,0.02
75042,2,ALGERIA,Gender development index score,AFR0347,2016,28,Both sexes (male and female),12,Index,14,UNDP,0.85
152328,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2016,1002,Nursing and midwifery personnel,13,Per 10 000 population,3,WHO / GHO,22.4
152329,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2016,1001,Medical doctors,13,Per 10 000 population,3,WHO / GHO,18.3
106130,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2016,999,Not Applicable,14,Per Capita,3,WHO / GHO,260.4
106949,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2016,999,Not Applicable,14,Per Capita,42,WDI,0.24
107767,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2016,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.06
114677,2,ALGERIA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2016,999,Not Applicable,14,Per Capita,4,WB Database,992.56
115135,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2016,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,306.5
127857,2,ALGERIA,Life expectancy at birth (years),AFR0381,2016,28,Both sexes (male and female),17,years,4,WB Database,76.3
184461,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2016,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,260
187925,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2016,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.06
190901,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2016,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,80.5
195194,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2016,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,84.2
187059,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2016,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.24
192633,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2016,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,306
194328,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2016,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,320.8
10898,2,ALGERIA,Number of people living with HIV,AFR0019,2017,28,Both sexes (male and female),1,Percentage,16,UNAIDS,15000
11478,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2017,9,Female,1,Percentage,3,WHO / GHO,112
52521,2,ALGERIA,Tobacco use among persons aged 15+ years - [SDG 3.a.1] (Also: adolescents),AFR0307,2017,8,Male,1,Percentage,3,WHO / GHO,36.4
52522,2,ALGERIA,Tobacco use among persons aged 15+ years - [SDG 3.a.1] (Also: adolescents),AFR0307,2017,9,Female,1,Percentage,3,WHO / GHO,1.4
52523,2,ALGERIA,Tobacco use among persons aged 15+ years - [SDG 3.a.1] (Also: adolescents),AFR0307,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,18.9
68312,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,91
68863,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,92
69286,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,89
71256,2,ALGERIA,Coverage of essential health services,AFR0128,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,78
72270,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2017,28,Both sexes (male and female),1,Percentage,16,UNAIDS,62
72649,2,ALGERIA,Viral load suppression,AFR0178,2017,28,Both sexes (male and female),1,Percentage,16,UNAIDS,42
73082,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,88
73503,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2017,28,Both sexes (male and female),1,Percentage,20,ITU,47.69
74411,2,ALGERIA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2017,999,Not Applicable,1,Percentage,3,WHO / GHO,75
75666,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,99
84238,2,ALGERIA,TB case detection rate,AFR0176,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
91301,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91
91538,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91
95383,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91
95791,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,89
97219,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2017,999,Not Applicable,1,Percentage,4,WB Database,11.9
98497,2,ALGERIA,Immunization coverage against Tetanus,AFR0189,2017,28,Both sexes (male and female),1,Percentage,4,WB Database,91
99425,2,ALGERIA,Viral load suppression,AFR0178,2017,29,Total,1,Percentage,16,UNAIDS,42
99498,2,ALGERIA,Viral load suppression,AFR0178,2017,45,Male (15+ years),1,Percentage,16,UNAIDS,38
99571,2,ALGERIA,Viral load suppression,AFR0178,2017,42,Female (15+ years),1,Percentage,16,UNAIDS,45
102382,2,ALGERIA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2017,999,Not Applicable,1,Percentage,4,WB Database,32.54
102836,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2017,999,Not Applicable,1,Percentage,4,WB Database,32.54
103052,2,ALGERIA,Service availability index (%) (high-level indicator),AFR0229,2017,999,Not Applicable,1,Percentage,4,WB Database,78
103193,2,ALGERIA,Service availability index (%),AFR0049,2017,999,Not Applicable,1,Percentage,4,WB Database,78
111130,2,ALGERIA,TB case detection rate,AFR0176,2017,29,Total,1,Percentage,3,WHO / GHO,80
111967,2,ALGERIA,TB treatment success rate,AFR0216,2017,29,Total,1,Percentage,3,WHO / GHO,91
112505,2,ALGERIA,Pneumococcal vaccination coverage,AFR0186,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,89
113522,2,ALGERIA,TB treatment coverage,AFR0173,2017,29,Total,1,Percentage,3,WHO / GHO,91
115970,2,ALGERIA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,26.34
116968,2,ALGERIA,TB treatment success rate,AFR0216,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72.8
122010,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2017,29,Total,1,Percentage,36,WHO/UNICEF,89
124314,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2017,28,Both sexes (male and female),1,Percentage,35,IHME,1.51
125754,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2017,8,Male,1,Percentage,35,IHME,1.67
127194,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2017,9,Female,1,Percentage,35,IHME,1.35
131589,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2017,28,Both sexes (male and female),1,Percentage,4,WB Database,111.76
135268,2,ALGERIA,General Government Health Expenditure (GGHE) as % of Total health expenditure (GGE),AFR0272,2017,999,Not Applicable,1,Percentage,3,WHO / GHO,10.7
135513,2,ALGERIA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,\N
135561,2,ALGERIA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,18
135609,2,ALGERIA,Proportion of population using a hand-washing facility with soap and water (%),AFR0437,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,84
137247,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2017,29,Total,1,Percentage,36,WHO/UNICEF,91
138391,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2017,29,Total,1,Percentage,3,WHO / GHO,91
138392,2,ALGERIA,Tuberculosis treatment success rate,AFR0335,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,72.8
147255,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2017,29,Total,1,Percentage,36,WHO/UNICEF,92
148179,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2017,107,Female (10-14 years),1,Percentage,35,IHME,4.32
149909,2,ALGERIA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2017,9,Female,1,Percentage,16,UNAIDS,20.04
150921,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2017,66,Female (15-49 years),1,Percentage,35,IHME,1.7
179601,2,ALGERIA,Access to electricity (% of population),AFR0380,2017,999,Not Applicable,1,Percentage,4,WB Database,100
180140,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2017,9,Female,1,Percentage,16,UNAIDS,47
182775,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,34.01
183641,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,6.38
185373,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
186239,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,0.02
188910,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,10.7
189776,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,10.7
191813,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,32.5
193510,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,1.47
195637,2,ALGERIA,Share of premature deaths attributed to high body mass index,AFR0475,2017,28,Both sexes (male and female),1,Percentage,35,IHME,17.47
207915,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,88
4859,2,ALGERIA,GDP growth (annual %),AFR0388,2017,999,Not Applicable,2,Per 1000 live births,22,UN DESA,-0.35
6189,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2017,8,Male,2,Per 1000 live births,3,WHO / GHO,104
6236,2,ALGERIA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2017,9,Female,2,Per 1000 live births,3,WHO / GHO,81.79
6606,2,ALGERIA,TB mortality rate (per 100 000 population),AFR0013,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,7.6
6654,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0
7063,2,ALGERIA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,0.1
10484,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.05
11390,2,ALGERIA,Population size (in thousands) total,AFR0004,2017,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,41389.19
12426,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,14.88
15783,2,ALGERIA,AIDS-related mortality rate (per 100 000 population),AFR0014,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.48
18190,2,ALGERIA,Malaria mortality rate (per 100 000 population),AFR0015,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0
20154,2,ALGERIA,Infant mortality rate (per 1 000 live births),AFR0009,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,20.6
20408,2,ALGERIA,TB incidence rate [SDG 3.3.2],AFR0334,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,70
20823,2,ALGERIA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0
23498,2,ALGERIA,Coverage of essential health services,AFR0128,2017,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,78
23647,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,13140
24874,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
26524,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,88
26954,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,91
27716,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,95
28869,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2017,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.44
29066,2,ALGERIA,People living with HIV who know their status,AFR0181,2017,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,72
29645,2,ALGERIA,Viral load suppression,AFR0178,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,42
29792,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,62
29844,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,56
30914,2,ALGERIA,TB case detection rate,AFR0176,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
36955,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2017,29,Total,2,Per 1000 live births,3,WHO / GHO,87.59
36956,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2017,11,Rural,2,Per 1000 live births,3,WHO / GHO,82.21
36959,2,ALGERIA,Proportion of population using improved sanitation (%),AFR0024,2017,12,Urban,2,Per 1000 live births,3,WHO / GHO,89.67
38555,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2017,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,31.6
39750,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2017,999,Not Applicable,2,Per 1000 live births,19,OECD,59.5
40727,2,ALGERIA,DTP dropout rate (DTP1 -DPT3),AFR0226,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,4
41798,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
41841,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,110
41884,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
41931,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,6
41961,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,0
42004,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,0
42027,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,46,Measles,2,Per 1000 live births,1,WHO/AFRO,112
42072,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
42090,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
47403,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2017,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,24.02
67008,2,ALGERIA,Existence of national screening program for cervical cancer,AFR0418,2017,999,Not Applicable,3,String,3,WHO / GHO,\N
67149,2,ALGERIA,Most widely used screening method in national cervical cancer screening program,AFR0415,2017,999,Not Applicable,3,String,3,WHO / GHO,\N
67290,2,ALGERIA,Type of national cervical cancer screening program,AFR0416,2017,999,Not Applicable,3,String,3,WHO / GHO,\N
67406,2,ALGERIA,Coverage of national cervical cancer screening program (%),AFR0417,2017,999,Not Applicable,3,String,3,WHO / GHO,\N
129462,2,ALGERIA,Existence of national screening program for cervical cancer,AFR0418,2017,9,Female,3,String,3,WHO / GHO,\N
128435,2,ALGERIA,Sex ratio at birth,AFR0428,2017,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
71539,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2017,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,13140
77616,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2017,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
77659,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2017,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,110
77702,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2017,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
77749,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2017,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,6
77779,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2017,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,0
77822,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2017,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,0
77845,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2017,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,112
77890,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2017,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
77908,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2017,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
98305,2,ALGERIA,"Secondary education, duration (years)",AFR0393,2017,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,7
99153,2,ALGERIA,"Pre-primary education, duration (years)",AFR0392,2017,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,1
120361,2,ALGERIA,Number of road traffic injuries,AFR0140,2017,29,Total,5,Count (Numeric Integer),35,IHME,43476
129996,2,ALGERIA,Coverage of essential health services,AFR0128,2017,999,Not Applicable,5,Count (Numeric Integer),3,WHO / GHO,78
145488,2,ALGERIA,Number of people living with HIV,AFR0019,2017,29,Total,5,Count (Numeric Integer),16,UNAIDS,18000
147585,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2017,29,Total,5,Count (Numeric Integer),35,IHME,193720
102093,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2017,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,4.71
143841,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2017,29,Total,6,Per 1000 population,16,UNAIDS,0.05
62264,2,ALGERIA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2017,9,Female,7,per 100 000 live births,23,MMEIG,112
83168,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2017,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,56
104392,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2017,8,Male,8,Per 100 000 population,3,WHO / GHO,2.35
104393,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2017,9,Female,8,Per 100 000 population,3,WHO / GHO,0.73
108602,2,ALGERIA,Malaria mortality rate (per 100 000 population),AFR0015,2017,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,0
109157,2,ALGERIA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2017,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,1.55
120618,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 1,AFR0196,2017,29,Total,8,Per 100 000 population,36,WHO/UNICEF,92
135801,2,ALGERIA,Number of victims of intentional homicide per 100 000 population,AFR0028,2017,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,1.5
70160,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2017,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.44
92065,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2017,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,59.49
97437,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2017,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,317.3
105994,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2017,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,0.01
113757,2,ALGERIA,Total Health Expenditure (constant US$),AFR0349,2017,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,10680.5
114217,2,ALGERIA,Total Health Expenditure (International US$),AFR0348,2017,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,10680.5
116829,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2017,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,0.01
75086,2,ALGERIA,Gender development index score,AFR0347,2017,28,Both sexes (male and female),12,Index,14,UNDP,0.86
152426,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2017,1002,Nursing and midwifery personnel,13,Per 10 000 population,3,WHO / GHO,22.2
152427,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2017,1001,Medical doctors,13,Per 10 000 population,3,WHO / GHO,17.8
106129,2,ALGERIA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2017,999,Not Applicable,14,Per Capita,3,WHO / GHO,258.5
106948,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2017,999,Not Applicable,14,Per Capita,42,WDI,0.2
107766,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2017,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.05
114676,2,ALGERIA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2017,999,Not Applicable,14,Per Capita,4,WB Database,974.8
115134,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2017,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,317.3
127858,2,ALGERIA,Life expectancy at birth (years),AFR0381,2017,28,Both sexes (male and female),17,years,4,WB Database,76.5
184507,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2017,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,258
187971,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2017,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.07
190947,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2017,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,83.9
195240,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2017,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,87.7
187105,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2017,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.28
192679,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2017,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,315
194374,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2017,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,330
10944,2,ALGERIA,Number of people living with HIV,AFR0019,2018,28,Both sexes (male and female),1,Percentage,16,UNAIDS,16000
13933,2,ALGERIA,Proportion of women aged 20-24 years who were married or in a union by age 18 (%),AFR0102,2018,9,Female,1,Percentage,1,WHO/AFRO,3
68358,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,91
68890,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,77
69327,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,91
72315,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2018,28,Both sexes (male and female),1,Percentage,16,UNAIDS,65
72659,2,ALGERIA,Viral load suppression,AFR0178,2018,28,Both sexes (male and female),1,Percentage,16,UNAIDS,44
73035,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,80
74459,2,ALGERIA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2018,999,Not Applicable,1,Percentage,3,WHO / GHO,80
74556,2,ALGERIA,"IHR Coordination, Communication and Advocacy",AFR0035,2018,999,Not Applicable,1,Percentage,3,WHO / GHO,90
75652,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,99
84239,2,ALGERIA,TB case detection rate,AFR0176,2018,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,80
91254,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91
91491,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91
92958,2,ALGERIA,GDP growth (annual %),AFR0388,2018,999,Not Applicable,1,Percentage,22,UN DESA,-0.62
95338,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91
95751,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,91
97265,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2018,999,Not Applicable,1,Percentage,4,WB Database,11.8
98498,2,ALGERIA,Immunization coverage against Tetanus,AFR0189,2018,28,Both sexes (male and female),1,Percentage,4,WB Database,91
99435,2,ALGERIA,Viral load suppression,AFR0178,2018,29,Total,1,Percentage,16,UNAIDS,44
99508,2,ALGERIA,Viral load suppression,AFR0178,2018,45,Male (15+ years),1,Percentage,16,UNAIDS,40
99581,2,ALGERIA,Viral load suppression,AFR0178,2018,42,Female (15+ years),1,Percentage,16,UNAIDS,47
109114,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2018,28,Both sexes (male and female),1,Percentage,4,WB Database,49
111177,2,ALGERIA,TB case detection rate,AFR0176,2018,29,Total,1,Percentage,3,WHO / GHO,80
112544,2,ALGERIA,Pneumococcal vaccination coverage,AFR0186,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,91
122048,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2018,29,Total,1,Percentage,36,WHO/UNICEF,91
124362,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2018,28,Both sexes (male and female),1,Percentage,35,IHME,1.55
125802,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2018,8,Male,1,Percentage,35,IHME,1.72
127242,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2018,9,Female,1,Percentage,35,IHME,1.38
130237,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2018,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,91
130285,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2018,999,Not Applicable,1,Percentage,3,WHO / GHO,77
130333,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2018,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,91
130381,2,ALGERIA,Immunization coverage against HPV,AFR0188,2018,9,Female,1,Percentage,3,WHO / GHO,\N
131590,2,ALGERIA,"School enrolment, primary (% gross)",AFR0391,2018,28,Both sexes (male and female),1,Percentage,4,WB Database,109.88
135657,2,ALGERIA,Amount of water and sanitation-related official development assistance that is part of a government coordinated spending plan (constant 2017 US $ millions),AFR0438,2018,999,Not Applicable,1,Percentage,3,WHO / GHO,4.07
135705,2,ALGERIA,Proportion of population with primary reliance on clean fuels (%) -[SDG 7.1.2],AFR0126,2018,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,95
137295,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2018,29,Total,1,Percentage,36,WHO/UNICEF,91
147282,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2018,29,Total,1,Percentage,36,WHO/UNICEF,77
148180,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2018,107,Female (10-14 years),1,Percentage,35,IHME,4.34
149161,2,ALGERIA,Percentage of lower secondary schools providing life skills-based HIV and sexuality education,AFR0460,2018,999,Not Applicable,1,Percentage,15,UNESCO,78.57
149910,2,ALGERIA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2018,9,Female,1,Percentage,16,UNAIDS,18.83
150922,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2018,66,Female (15-49 years),1,Percentage,35,IHME,1.7
179602,2,ALGERIA,Access to electricity (% of population),AFR0380,2018,999,Not Applicable,1,Percentage,4,WB Database,100
180181,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2018,9,Female,1,Percentage,16,UNAIDS,53
182822,2,ALGERIA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,34.13
183688,2,ALGERIA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,6.21
185420,2,ALGERIA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,99.9
186286,2,ALGERIA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,0.02
188957,2,ALGERIA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,10.7
189823,2,ALGERIA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,10.7
191860,2,ALGERIA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,32.6
193556,2,ALGERIA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,1.49
207916,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,80
7109,2,ALGERIA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,0.1
10530,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.05
11392,2,ALGERIA,Population size (in thousands) total,AFR0004,2018,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,42008.05
12427,2,ALGERIA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,14.56
13885,2,ALGERIA,"Adolescent birth rate (per 1,000 women aged 15-19 years)",AFR0106,2018,9,Female,2,Per 1000 live births,3,WHO / GHO,12.4
13978,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,96
15830,2,ALGERIA,AIDS-related mortality rate (per 100 000 population),AFR0014,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.47
20201,2,ALGERIA,HIV incidence rate per 1000 uninfected population [SDG 3.3.1],AFR0395,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.05
20409,2,ALGERIA,TB incidence rate [SDG 3.3.2],AFR0334,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,69
22550,2,ALGERIA,HIV prevalence rate (per 1000 population),AFR0020,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0.1
23292,2,ALGERIA,Early marriage,AFR0315,2018,9,Female,2,Per 1000 live births,3,WHO / GHO,2.5
24827,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,99
25432,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2018,9,Female,2,Per 1000 live births,20,ITU,12.4
26477,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,80
26907,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,91
27669,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,96
28915,2,ALGERIA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2018,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.29
29108,2,ALGERIA,People living with HIV who know their status,AFR0181,2018,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,70
29655,2,ALGERIA,Viral load suppression,AFR0178,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,44
29845,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,56
30915,2,ALGERIA,TB case detection rate,AFR0176,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,80
37690,2,ALGERIA,Individuals using the Internet (% of population),AFR0033,2018,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,49.04
38556,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2018,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,25.76
39751,2,ALGERIA,Net official development assistance received (current US$),AFR0031,2018,999,Not Applicable,2,Per 1000 live births,19,OECD,35.84
40680,2,ALGERIA,DTP dropout rate (DTP1 -DPT3),AFR0226,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,5
41462,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
41503,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,624
41547,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
41592,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,17
41623,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,0
41684,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,46,Measles,2,Per 1000 live births,1,WHO/AFRO,3356
41741,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
47404,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2018,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,23.48
129843,2,ALGERIA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,23
128434,2,ALGERIA,Sex ratio at birth,AFR0428,2018,28,Both sexes (male and female),4,Ratio,4,WB Database,1.05
77280,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2018,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
77321,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2018,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,624
77365,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2018,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
77410,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2018,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,17
77441,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2018,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,0
77502,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2018,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,3356
77559,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2018,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
98304,2,ALGERIA,"Secondary education, duration (years)",AFR0393,2018,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,7
99152,2,ALGERIA,"Pre-primary education, duration (years)",AFR0392,2018,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,1
120408,2,ALGERIA,Number of road traffic injuries,AFR0140,2018,29,Total,5,Count (Numeric Integer),35,IHME,44272
129849,2,ALGERIA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2018,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,10909
142420,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2018,126,Hydrological,5,Count (Numeric Integer),35,IHME,6
145534,2,ALGERIA,Number of people living with HIV,AFR0019,2018,29,Total,5,Count (Numeric Integer),16,UNAIDS,20000
147633,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2018,29,Total,5,Count (Numeric Integer),35,IHME,206900
179096,2,ALGERIA,Number of medical doctors,AFR0469,2018,29,Total,5,Count (Numeric Integer),3,WHO / GHO,72604
76280,2,ALGERIA,Pharmaceutical personnel density (per 1000 population),AFR0284,2018,28,Both sexes (male and female),6,Per 1000 population,38,Global Health Workforce Statistics,44.54
76462,2,ALGERIA,Dentistry personnel density (per 1000 population),AFR0285,2018,28,Both sexes (male and female),6,Per 1000 population,38,Global Health Workforce Statistics,36.56
76630,2,ALGERIA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2018,999,Not Applicable,6,Per 1000 population,38,Global Health Workforce Statistics,154.77
102094,2,ALGERIA,Crude death rate (per 1 000 mid-year population),AFR0005,2018,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,4.71
143885,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2018,29,Total,6,Per 1000 population,16,UNAIDS,0.05
83169,2,ALGERIA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2018,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,56
108603,2,ALGERIA,Malaria mortality rate (per 100 000 population),AFR0015,2018,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,0
120654,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 1,AFR0196,2018,29,Total,8,Per 100 000 population,36,WHO/UNICEF,94
64994,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2018,9,Female,9,Per 1000 women aged 15-19 years,3,WHO / GHO,12.4
71208,2,ALGERIA,Adolescent birth rate [SDG 3.7.2],AFR0293,2018,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,12.4
70206,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2018,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,0.28
92066,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2018,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,35.84
116828,2,ALGERIA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2018,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,0
75130,2,ALGERIA,Gender development index score,AFR0347,2018,28,Both sexes (male and female),12,Index,14,UNDP,0.86
131008,2,ALGERIA,Radiation Emergencies,AFR0414,2018,999,Not Applicable,12,Index,3,WHO / GHO,100
131101,2,ALGERIA,Risk Communication,AFR0039,2018,999,Not Applicable,12,Index,3,WHO / GHO,60
109020,2,ALGERIA,"Pharmacists (per 10,000 population)",AFR0253,2018,28,Both sexes (male and female),13,Per 10 000 population,38,Global Health Workforce Statistics,4.45
152490,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2018,1000,Dentists,13,Per 10 000 population,3,WHO / GHO,3.65
152491,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2018,1002,Nursing and midwifery personnel,13,Per 10 000 population,3,WHO / GHO,15.4
152492,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2018,1003,Pharmacists,13,Per 10 000 population,3,WHO / GHO,4.45
152493,2,ALGERIA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2018,1001,Medical doctors,13,Per 10 000 population,3,WHO / GHO,17.1
127859,2,ALGERIA,Life expectancy at birth (years),AFR0381,2018,28,Both sexes (male and female),17,years,4,WB Database,76.69
129472,2,ALGERIA,Population size (in thousands) total,AFR0004,2018,8,Male,18,in thousands,50,World Health Statistics,21332
129518,2,ALGERIA,Population size (in thousands) total,AFR0004,2018,9,Female,18,in thousands,50,World Health Statistics,20896
129564,2,ALGERIA,Population size (in thousands) total,AFR0004,2018,28,Both sexes (male and female),18,in thousands,50,World Health Statistics,42228
129610,2,ALGERIA,Population size (in thousands) total,AFR0004,2018,8,Male,18,in thousands,3,WHO / GHO,21332
129657,2,ALGERIA,Population size (in thousands) total,AFR0004,2018,9,Female,18,in thousands,3,WHO / GHO,20896
129704,2,ALGERIA,Population size (in thousands) total,AFR0004,2018,28,Both sexes (male and female),18,in thousands,3,WHO / GHO,42228
184554,2,ALGERIA,Current health expenditure (CHE) per capita in US$,AFR0263,2018,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,255
188018,2,ALGERIA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2018,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.06
190994,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2018,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,83.5
195287,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2018,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,87.3
187152,2,ALGERIA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2018,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.25
192726,2,ALGERIA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2018,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,314
194421,2,ALGERIA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2018,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,328.6
72360,2,ALGERIA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2019,28,Both sexes (male and female),1,Percentage,16,UNAIDS,67
72681,2,ALGERIA,Viral load suppression,AFR0178,2019,28,Both sexes (male and female),1,Percentage,16,UNAIDS,50
74507,2,ALGERIA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2019,999,Not Applicable,1,Percentage,3,WHO / GHO,80
74555,2,ALGERIA,"IHR Coordination, Communication and Advocacy",AFR0035,2019,999,Not Applicable,1,Percentage,3,WHO / GHO,90
97311,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2019,999,Not Applicable,1,Percentage,4,WB Database,11.7
98499,2,ALGERIA,Immunization coverage against Tetanus,AFR0189,2019,28,Both sexes (male and female),1,Percentage,4,WB Database,91
99457,2,ALGERIA,Viral load suppression,AFR0178,2019,29,Total,1,Percentage,16,UNAIDS,50
99530,2,ALGERIA,Viral load suppression,AFR0178,2019,45,Male (15+ years),1,Percentage,16,UNAIDS,46
99603,2,ALGERIA,Viral load suppression,AFR0178,2019,42,Female (15+ years),1,Percentage,16,UNAIDS,51
103146,2,ALGERIA,Service availability index (%) (high-level indicator),AFR0229,2019,999,Not Applicable,1,Percentage,4,WB Database,78
103287,2,ALGERIA,Service availability index (%),AFR0049,2019,999,Not Applicable,1,Percentage,4,WB Database,78
112584,2,ALGERIA,Pneumococcal vaccination coverage,AFR0186,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,91
122087,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2019,29,Total,1,Percentage,36,WHO/UNICEF,91
124410,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2019,28,Both sexes (male and female),1,Percentage,35,IHME,1.59
125850,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2019,8,Male,1,Percentage,35,IHME,1.77
127290,2,ALGERIA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2019,9,Female,1,Percentage,35,IHME,1.41
137343,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2019,29,Total,1,Percentage,36,WHO/UNICEF,91
147309,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2019,29,Total,1,Percentage,36,WHO/UNICEF,77
148181,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2019,107,Female (10-14 years),1,Percentage,35,IHME,4.31
149547,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,9,Female,1,Percentage,12,UNICEF / MICS,98.8
149911,2,ALGERIA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2019,9,Female,1,Percentage,16,UNAIDS,17.8
150923,2,ALGERIA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2019,66,Female (15-49 years),1,Percentage,35,IHME,1.63
180222,2,ALGERIA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2019,9,Female,1,Percentage,16,UNAIDS,55
207651,2,ALGERIA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,91
207760,2,ALGERIA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,77
207822,2,ALGERIA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,91
207917,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,80
29150,2,ALGERIA,People living with HIV who know their status,AFR0181,2019,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,76
29677,2,ALGERIA,Viral load suppression,AFR0178,2019,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,50
38557,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2019,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,25.76
41161,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,31
41205,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
41343,2,ALGERIA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,46,Measles,2,Per 1000 live births,1,WHO/AFRO,2585
66961,2,ALGERIA,Existence of national screening program for cervical cancer,AFR0418,2019,999,Not Applicable,3,String,3,WHO / GHO,\N
67102,2,ALGERIA,Most widely used screening method in national cervical cancer screening program,AFR0415,2019,999,Not Applicable,3,String,3,WHO / GHO,\N
67243,2,ALGERIA,Type of national cervical cancer screening program,AFR0416,2019,999,Not Applicable,3,String,3,WHO / GHO,\N
67384,2,ALGERIA,Coverage of national cervical cancer screening program (%),AFR0417,2019,999,Not Applicable,3,String,3,WHO / GHO,\N
129467,2,ALGERIA,Existence of national screening program for cervical cancer,AFR0418,2019,9,Female,3,String,3,WHO / GHO,\N
76979,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2019,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,31
77023,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2019,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
77161,2,ALGERIA,New cases of vaccine-preventable diseases,AFR0324,2019,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,2585
98303,2,ALGERIA,"Secondary education, duration (years)",AFR0393,2019,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,7
99151,2,ALGERIA,"Pre-primary education, duration (years)",AFR0392,2019,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,1
120455,2,ALGERIA,Number of road traffic injuries,AFR0140,2019,29,Total,5,Count (Numeric Integer),35,IHME,45103
135849,2,ALGERIA,Number of cases of poliomyelitis caused by wild poliovirus (WPV),AFR0425,2019,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,0
142601,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2019,127,Meteorological,5,Count (Numeric Integer),35,IHME,8
145580,2,ALGERIA,Number of people living with HIV,AFR0019,2019,29,Total,5,Count (Numeric Integer),16,UNAIDS,22000
147681,2,ALGERIA,Number of cancer cases (all cause),AFR0321,2019,29,Total,5,Count (Numeric Integer),35,IHME,220102
102044,2,ALGERIA,HIV prevalence rate (per 1000 population),AFR0020,2019,36,Female (15-24 years),6,Per 1000 population,16,UNAIDS,0.1
143929,2,ALGERIA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2019,29,Total,6,Per 1000 population,16,UNAIDS,0.05
120699,2,ALGERIA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 1,AFR0196,2019,29,Total,8,Per 100 000 population,36,WHO/UNICEF,94
131007,2,ALGERIA,Radiation Emergencies,AFR0414,2019,999,Not Applicable,12,Index,3,WHO / GHO,100
131100,2,ALGERIA,Risk Communication,AFR0039,2019,999,Not Applicable,12,Index,3,WHO / GHO,60
213077,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2019,28,Both sexes (male and female),23,Numeric,75,WHO/GHO_2021,66.4
213265,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2019,8,Male,23,Numeric,75,WHO/GHO_2021,66.7
213453,2,ALGERIA,Healthy life expectancy at birth (in years),AFR0002,2019,9,Female,23,Numeric,75,WHO/GHO_2021,66.1
213641,2,ALGERIA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2019,28,Both sexes (male and female),23,Numeric,75,WHO/GHO_2021,16
97357,2,ALGERIA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2020,999,Not Applicable,1,Percentage,4,WB Database,11.5
195563,2,ALGERIA,Prevalence of obesity in persons aged 18+years,AFR0021,2020,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.4
7155,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2020,44,Male (18+ years),2,Per 1000 live births,3,WHO / GHO,30.7
7156,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2020,43,Female (18+ years),2,Per 1000 live births,3,WHO / GHO,32.1
7157,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2020,41,Both sexes (18+ years),2,Per 1000 live births,3,WHO / GHO,31.5
28960,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2020,8,Male,2,Per 1000 live births,3,WHO / GHO,30.7
28961,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2020,9,Female,2,Per 1000 live births,3,WHO / GHO,32.1
28962,2,ALGERIA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2020,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,31.5
38558,2,ALGERIA,Proportion of seats held by women in national parliaments (%),AFR0034,2020,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,25.76
98302,2,ALGERIA,"Secondary education, duration (years)",AFR0393,2020,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,7
142607,2,ALGERIA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2020,127,Meteorological,5,Count (Numeric Integer),35,IHME,8
152811,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,70,0-4 years,5,Count (Numeric Integer),17,UN Population,5041518
153045,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,71,5-9 years,5,Count (Numeric Integer),17,UN Population,4635972
153278,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,72,10-14 years,5,Count (Numeric Integer),17,UN Population,3821402
153508,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,73,15-19 years,5,Count (Numeric Integer),17,UN Population,2910345
153740,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,74,20-24 years,5,Count (Numeric Integer),17,UN Population,2999837
153971,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,75,25-29 years,5,Count (Numeric Integer),17,UN Population,3573878
154202,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,76,30-34 years,5,Count (Numeric Integer),17,UN Population,3727719
154435,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,77,35-39 years,5,Count (Numeric Integer),17,UN Population,3547516
154668,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,78,40-44 years,5,Count (Numeric Integer),17,UN Population,3014029
154900,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,79,45-49 years,5,Count (Numeric Integer),17,UN Population,2434590
155132,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,80,50-54 years,5,Count (Numeric Integer),17,UN Population,2061884
155367,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,81,55-59 years,5,Count (Numeric Integer),17,UN Population,1738172
155596,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,82,60-64 years,5,Count (Numeric Integer),17,UN Population,1387342
155827,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,83,65-69 years,5,Count (Numeric Integer),17,UN Population,1143200
156059,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,84,70-74 years,5,Count (Numeric Integer),17,UN Population,723938
177630,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,86,80-84 years,5,Count (Numeric Integer),17,UN Population,343627
177862,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,1010,85-89 years,5,Count (Numeric Integer),17,UN Population,171049
178176,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,1011,90-94 years,5,Count (Numeric Integer),17,UN Population,51370
178411,2,ALGERIA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,1012,95-99 years,5,Count (Numeric Integer),17,UN Population,8796
151364,2,ALGERIA,Percentage of deaths occurring with cause of death according to international standards,AFR0242,2020-2021,65,Both sexes (15-49 yeras),23,Numeric,1,WHO/AFRO,34
130569,3,ANGOLA,Total fertility rate,AFR0130,1950-1955,9,Female,1,Percentage,17,UN Population,6
130570,3,ANGOLA,Total fertility rate,AFR0130,1955-1960,9,Female,1,Percentage,17,UN Population,6.5
130571,3,ANGOLA,Total fertility rate,AFR0130,1960-1965,9,Female,1,Percentage,17,UN Population,6.9
128477,3,ANGOLA,Sex ratio at birth,AFR0428,1962,28,Both sexes (male and female),4,Ratio,4,WB Database,1.02
130572,3,ANGOLA,Total fertility rate,AFR0130,1965-1970,9,Female,1,Percentage,17,UN Population,7.3
128476,3,ANGOLA,Sex ratio at birth,AFR0428,1967,28,Both sexes (male and female),4,Ratio,4,WB Database,1.02
131591,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1970,28,Both sexes (male and female),1,Percentage,4,WB Database,58.57
127860,3,ANGOLA,Life expectancy at birth (years),AFR0381,1970,28,Both sexes (male and female),17,years,4,WB Database,40.91
130573,3,ANGOLA,Total fertility rate,AFR0130,1970-1975,9,Female,1,Percentage,17,UN Population,7.5
131592,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1971,28,Both sexes (male and female),1,Percentage,4,WB Database,64.3
131593,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1972,28,Both sexes (male and female),1,Percentage,4,WB Database,67.91
128475,3,ANGOLA,Sex ratio at birth,AFR0428,1972,28,Both sexes (male and female),4,Ratio,4,WB Database,1.02
131594,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1973,28,Both sexes (male and female),1,Percentage,4,WB Database,75.89
86020,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1975,8,Male,1,Percentage,3,WHO / GHO,28.3
86021,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1975,9,Female,1,Percentage,3,WHO / GHO,25.6
86022,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1975,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27
196939,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1975,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0.8
198785,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1975,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.3
130574,3,ANGOLA,Total fertility rate,AFR0130,1975-1980,9,Female,1,Percentage,17,UN Population,7.46
86158,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1976,8,Male,1,Percentage,3,WHO / GHO,28.5
86159,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1976,9,Female,1,Percentage,3,WHO / GHO,25.9
86160,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1976,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.2
196940,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1976,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0.9
198786,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1976,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.6
86296,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1977,8,Male,1,Percentage,3,WHO / GHO,28.6
86297,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1977,9,Female,1,Percentage,3,WHO / GHO,26.2
86298,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1977,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.5
196941,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1977,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0.9
198787,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1977,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.8
128474,3,ANGOLA,Sex ratio at birth,AFR0428,1977,28,Both sexes (male and female),4,Ratio,4,WB Database,1.02
86434,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1978,8,Male,1,Percentage,3,WHO / GHO,28.8
86435,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1978,9,Female,1,Percentage,3,WHO / GHO,26.5
86436,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1978,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.7
196942,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1978,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1
198788,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1978,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8
86572,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1979,8,Male,1,Percentage,3,WHO / GHO,28.9
86573,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1979,9,Female,1,Percentage,3,WHO / GHO,26.7
86574,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1979,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.9
131595,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1979,28,Both sexes (male and female),1,Percentage,4,WB Database,142.74
196943,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1979,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.1
198789,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1979,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8.2
47666,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1980,8,Male,1,Percentage,3,WHO / GHO,2.6
47667,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1980,9,Female,1,Percentage,3,WHO / GHO,2.9
47668,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1980,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.7
86710,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1980,8,Male,1,Percentage,3,WHO / GHO,29
86711,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1980,9,Female,1,Percentage,3,WHO / GHO,27
86712,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1980,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.1
131596,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1980,28,Both sexes (male and female),1,Percentage,4,WB Database,123.54
196944,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1980,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.1
198790,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1980,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8.5
130575,3,ANGOLA,Total fertility rate,AFR0130,1980-1985,9,Female,1,Percentage,17,UN Population,7.46
47804,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1981,8,Male,1,Percentage,3,WHO / GHO,2.7
47805,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1981,9,Female,1,Percentage,3,WHO / GHO,2.9
47806,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1981,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.8
86848,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1981,8,Male,1,Percentage,3,WHO / GHO,29.1
86849,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1981,9,Female,1,Percentage,3,WHO / GHO,27.3
86850,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1981,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.3
131597,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1981,28,Both sexes (male and female),1,Percentage,4,WB Database,114.48
196945,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1981,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.2
198791,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1981,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8.7
47942,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1982,8,Male,1,Percentage,3,WHO / GHO,2.7
47943,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1982,9,Female,1,Percentage,3,WHO / GHO,3
47944,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1982,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.9
86986,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1982,8,Male,1,Percentage,3,WHO / GHO,29.3
86987,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1982,9,Female,1,Percentage,3,WHO / GHO,27.5
86988,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1982,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.5
131598,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1982,28,Both sexes (male and female),1,Percentage,4,WB Database,103.94
134221,3,ANGOLA,School dropout rate,AFR0160,1982,28,Both sexes (male and female),1,Percentage,42,WDI,54.8
196946,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1982,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.3
198792,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1982,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9
128473,3,ANGOLA,Sex ratio at birth,AFR0428,1982,28,Both sexes (male and female),4,Ratio,4,WB Database,1.02
48080,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1983,8,Male,1,Percentage,3,WHO / GHO,2.8
48081,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1983,9,Female,1,Percentage,3,WHO / GHO,3.1
48082,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1983,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3
87124,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,8,Male,1,Percentage,3,WHO / GHO,29.4
87125,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,9,Female,1,Percentage,3,WHO / GHO,27.8
87126,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.7
131599,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1983,28,Both sexes (male and female),1,Percentage,4,WB Database,91.82
134222,3,ANGOLA,School dropout rate,AFR0160,1983,28,Both sexes (male and female),1,Percentage,42,WDI,57.46
196947,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1983,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.3
198793,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1983,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9.2
48218,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1984,8,Male,1,Percentage,3,WHO / GHO,3
48219,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1984,9,Female,1,Percentage,3,WHO / GHO,3.2
48220,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1984,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.1
87262,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,8,Male,1,Percentage,3,WHO / GHO,29.6
87263,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,9,Female,1,Percentage,3,WHO / GHO,28
87264,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.9
131600,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1984,28,Both sexes (male and female),1,Percentage,4,WB Database,73.38
196948,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1984,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.4
198794,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1984,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9.5
48356,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1985,8,Male,1,Percentage,3,WHO / GHO,3.1
48357,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1985,9,Female,1,Percentage,3,WHO / GHO,3.3
48358,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1985,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.2
87400,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,8,Male,1,Percentage,3,WHO / GHO,29.8
87401,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,9,Female,1,Percentage,3,WHO / GHO,28.2
87402,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29.1
131601,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1985,28,Both sexes (male and female),1,Percentage,4,WB Database,79.39
196949,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1985,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.5
198795,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1985,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9.8
130576,3,ANGOLA,Total fertility rate,AFR0130,1985-1990,9,Female,1,Percentage,17,UN Population,7.4
48494,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1986,8,Male,1,Percentage,3,WHO / GHO,3.2
48495,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1986,9,Female,1,Percentage,3,WHO / GHO,3.4
48496,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1986,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.3
87538,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,8,Male,1,Percentage,3,WHO / GHO,29.9
87539,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,9,Female,1,Percentage,3,WHO / GHO,28.4
87540,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29.3
131602,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1986,28,Both sexes (male and female),1,Percentage,4,WB Database,79.46
196950,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1986,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.6
198796,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1986,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,10.1
48632,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1987,8,Male,1,Percentage,3,WHO / GHO,3.4
48633,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1987,9,Female,1,Percentage,3,WHO / GHO,3.5
48634,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1987,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.4
87676,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,8,Male,1,Percentage,3,WHO / GHO,30.1
87677,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,9,Female,1,Percentage,3,WHO / GHO,28.6
87678,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29.4
131603,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1987,28,Both sexes (male and female),1,Percentage,4,WB Database,77.87
196951,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1987,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.7
198797,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1987,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,10.4
128472,3,ANGOLA,Sex ratio at birth,AFR0428,1987,28,Both sexes (male and female),4,Ratio,4,WB Database,1.02
141572,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1987,125,Biological,5,Count (Numeric Integer),35,IHME,59
48770,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1988,8,Male,1,Percentage,3,WHO / GHO,3.5
48771,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1988,9,Female,1,Percentage,3,WHO / GHO,3.6
48772,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1988,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.6
87814,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,8,Male,1,Percentage,3,WHO / GHO,30.3
87815,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,9,Female,1,Percentage,3,WHO / GHO,28.8
87816,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29.6
131604,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1988,28,Both sexes (male and female),1,Percentage,4,WB Database,77.6
196952,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1988,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.8
198798,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1988,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,10.7
48908,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1989,8,Male,1,Percentage,3,WHO / GHO,3.7
48909,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1989,9,Female,1,Percentage,3,WHO / GHO,3.8
48910,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1989,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.7
87952,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,8,Male,1,Percentage,3,WHO / GHO,30.4
87953,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,9,Female,1,Percentage,3,WHO / GHO,29
87954,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29.8
131605,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1989,28,Both sexes (male and female),1,Percentage,4,WB Database,73.04
196953,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1989,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.9
198799,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1989,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.1
141590,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1989,125,Biological,5,Count (Numeric Integer),35,IHME,766
11479,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,1990,9,Female,1,Percentage,3,WHO / GHO,1160
49046,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1990,8,Male,1,Percentage,3,WHO / GHO,3.9
49047,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1990,9,Female,1,Percentage,3,WHO / GHO,3.9
49048,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1990,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.9
88090,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1990,8,Male,1,Percentage,3,WHO / GHO,30.6
88091,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1990,9,Female,1,Percentage,3,WHO / GHO,29.2
88092,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1990,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30
98500,3,ANGOLA,Immunization coverage against Tetanus,AFR0189,1990,28,Both sexes (male and female),1,Percentage,4,WB Database,24
109993,3,ANGOLA,TB case detection rate,AFR0176,1990,29,Total,1,Percentage,3,WHO / GHO,48
123019,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1990,28,Both sexes (male and female),1,Percentage,35,IHME,0.86
124459,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1990,8,Male,1,Percentage,35,IHME,0.81
125899,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1990,9,Female,1,Percentage,35,IHME,0.91
131606,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1990,28,Both sexes (male and female),1,Percentage,4,WB Database,66.8
135995,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1990,29,Total,1,Percentage,36,WHO/UNICEF,24
195638,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,1990,28,Both sexes (male and female),1,Percentage,35,IHME,0.69
196954,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1990,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2
198800,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1990,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.4
12428,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1990,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,53.78
47405,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1990,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,223.4
128471,3,ANGOLA,Sex ratio at birth,AFR0428,1990,28,Both sexes (male and female),4,Ratio,4,WB Database,1.02
119093,3,ANGOLA,Number of road traffic injuries,AFR0140,1990,29,Total,5,Count (Numeric Integer),35,IHME,9460
137392,3,ANGOLA,Number of cancer cases (all cause),AFR0321,1990,29,Total,5,Count (Numeric Integer),35,IHME,17935
142654,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1990,29,Total,6,Per 1000 population,16,UNAIDS,0.26
143974,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1990,8,Male,6,Per 1000 population,16,UNAIDS,0.19
127861,3,ANGOLA,Life expectancy at birth (years),AFR0381,1990,28,Both sexes (male and female),17,years,4,WB Database,45.31
122128,3,ANGOLA,Life expectancy at age 60 years,AFR0003,1990-1995,28,Both sexes (male and female),1,Percentage,17,UN Population,14.03
122416,3,ANGOLA,Life expectancy at age 60 years,AFR0003,1990-1995,8,Male,1,Percentage,17,UN Population,13.32
122704,3,ANGOLA,Life expectancy at age 60 years,AFR0003,1990-1995,9,Female,1,Percentage,17,UN Population,14.57
130577,3,ANGOLA,Total fertility rate,AFR0130,1990-1995,9,Female,1,Percentage,17,UN Population,7.1
49184,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1991,8,Male,1,Percentage,3,WHO / GHO,4
49185,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1991,9,Female,1,Percentage,3,WHO / GHO,4
49186,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1991,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4
88228,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1991,8,Male,1,Percentage,3,WHO / GHO,30.7
88229,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1991,9,Female,1,Percentage,3,WHO / GHO,29.4
88230,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1991,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.1
96011,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1991,999,Not Applicable,1,Percentage,4,WB Database,3.7
110033,3,ANGOLA,TB case detection rate,AFR0176,1991,29,Total,1,Percentage,3,WHO / GHO,50
123067,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1991,28,Both sexes (male and female),1,Percentage,35,IHME,0.86
124507,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1991,8,Male,1,Percentage,35,IHME,0.81
125947,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1991,9,Female,1,Percentage,35,IHME,0.91
131607,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1991,28,Both sexes (male and female),1,Percentage,4,WB Database,64.25
136038,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1991,29,Total,1,Percentage,36,WHO/UNICEF,26
195639,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,1991,28,Both sexes (male and female),1,Percentage,35,IHME,0.71
196955,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1991,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.2
198801,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1991,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.8
12429,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1991,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,53.8
47406,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1991,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,223.5
119140,3,ANGOLA,Number of road traffic injuries,AFR0140,1991,29,Total,5,Count (Numeric Integer),35,IHME,9683
137440,3,ANGOLA,Number of cancer cases (all cause),AFR0321,1991,29,Total,5,Count (Numeric Integer),35,IHME,18473
142698,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1991,29,Total,6,Per 1000 population,16,UNAIDS,0.31
144018,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1991,8,Male,6,Per 1000 population,16,UNAIDS,0.22
49322,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1992,8,Male,1,Percentage,3,WHO / GHO,4.2
49323,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1992,9,Female,1,Percentage,3,WHO / GHO,4.1
49324,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1992,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.2
88366,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1992,8,Male,1,Percentage,3,WHO / GHO,30.8
88367,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1992,9,Female,1,Percentage,3,WHO / GHO,29.5
88368,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1992,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.2
96057,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1992,999,Not Applicable,1,Percentage,4,WB Database,3.74
110069,3,ANGOLA,TB case detection rate,AFR0176,1992,29,Total,1,Percentage,3,WHO / GHO,48
123115,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1992,28,Both sexes (male and female),1,Percentage,35,IHME,0.85
124555,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1992,8,Male,1,Percentage,35,IHME,0.8
125995,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1992,9,Female,1,Percentage,35,IHME,0.9
136082,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1992,29,Total,1,Percentage,36,WHO/UNICEF,21
195640,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,1992,28,Both sexes (male and female),1,Percentage,35,IHME,0.73
196956,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1992,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.3
198802,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1992,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,12.1
12430,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1992,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,53.8
47407,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1992,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,223.5
128470,3,ANGOLA,Sex ratio at birth,AFR0428,1992,28,Both sexes (male and female),4,Ratio,4,WB Database,1.02
119187,3,ANGOLA,Number of road traffic injuries,AFR0140,1992,29,Total,5,Count (Numeric Integer),35,IHME,9930
137488,3,ANGOLA,Number of cancer cases (all cause),AFR0321,1992,29,Total,5,Count (Numeric Integer),35,IHME,19152
142742,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1992,29,Total,6,Per 1000 population,16,UNAIDS,0.36
144062,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1992,8,Male,6,Per 1000 population,16,UNAIDS,0.26
49460,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1993,8,Male,1,Percentage,3,WHO / GHO,4.3
49461,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1993,9,Female,1,Percentage,3,WHO / GHO,4.2
49462,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1993,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.3
88504,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1993,8,Male,1,Percentage,3,WHO / GHO,30.9
88505,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1993,9,Female,1,Percentage,3,WHO / GHO,29.7
88506,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1993,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.4
96103,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1993,999,Not Applicable,1,Percentage,4,WB Database,3.8
110103,3,ANGOLA,TB case detection rate,AFR0176,1993,29,Total,1,Percentage,3,WHO / GHO,33
123163,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1993,28,Both sexes (male and female),1,Percentage,35,IHME,0.85
124603,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1993,8,Male,1,Percentage,35,IHME,0.8
126043,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1993,9,Female,1,Percentage,35,IHME,0.9
136126,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1993,29,Total,1,Percentage,36,WHO/UNICEF,30
195641,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,1993,28,Both sexes (male and female),1,Percentage,35,IHME,0.73
196957,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1993,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.4
198803,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1993,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,12.5
12431,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1993,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,53.8
47408,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1993,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,223.6
119234,3,ANGOLA,Number of road traffic injuries,AFR0140,1993,29,Total,5,Count (Numeric Integer),35,IHME,10198
137536,3,ANGOLA,Number of cancer cases (all cause),AFR0321,1993,29,Total,5,Count (Numeric Integer),35,IHME,19960
142786,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1993,29,Total,6,Per 1000 population,16,UNAIDS,0.43
144106,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1993,8,Male,6,Per 1000 population,16,UNAIDS,0.3
49598,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1994,8,Male,1,Percentage,3,WHO / GHO,4.4
49599,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1994,9,Female,1,Percentage,3,WHO / GHO,4.4
49600,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1994,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.4
88642,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1994,8,Male,1,Percentage,3,WHO / GHO,30.9
88643,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1994,9,Female,1,Percentage,3,WHO / GHO,29.8
88644,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1994,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.5
96149,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1994,999,Not Applicable,1,Percentage,4,WB Database,3.81
110140,3,ANGOLA,TB case detection rate,AFR0176,1994,29,Total,1,Percentage,3,WHO / GHO,27
123211,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1994,28,Both sexes (male and female),1,Percentage,35,IHME,0.84
124651,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1994,8,Male,1,Percentage,35,IHME,0.79
126091,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1994,9,Female,1,Percentage,35,IHME,0.89
136171,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1994,29,Total,1,Percentage,36,WHO/UNICEF,27
195642,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,1994,28,Both sexes (male and female),1,Percentage,35,IHME,0.8
196958,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1994,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.6
198804,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1994,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,12.9
12432,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1994,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,53.73
47409,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1994,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,223.5
119281,3,ANGOLA,Number of road traffic injuries,AFR0140,1994,29,Total,5,Count (Numeric Integer),35,IHME,10492
137584,3,ANGOLA,Number of cancer cases (all cause),AFR0321,1994,29,Total,5,Count (Numeric Integer),35,IHME,20745
142830,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1994,29,Total,6,Per 1000 population,16,UNAIDS,0.49
144150,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1994,8,Male,6,Per 1000 population,16,UNAIDS,0.34
11480,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,1995,9,Female,1,Percentage,3,WHO / GHO,1150
49736,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1995,8,Male,1,Percentage,3,WHO / GHO,4.6
49737,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1995,9,Female,1,Percentage,3,WHO / GHO,4.5
49738,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1995,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.5
88780,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1995,8,Male,1,Percentage,3,WHO / GHO,30.9
88781,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1995,9,Female,1,Percentage,3,WHO / GHO,30
88782,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1995,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.5
96195,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1995,999,Not Applicable,1,Percentage,4,WB Database,3.81
103532,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1995,999,Not Applicable,1,Percentage,3,WHO / GHO,4.6
104969,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1995,999,Not Applicable,1,Percentage,3,WHO / GHO,20.26
110175,3,ANGOLA,TB case detection rate,AFR0176,1995,29,Total,1,Percentage,3,WHO / GHO,19
123259,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1995,28,Both sexes (male and female),1,Percentage,35,IHME,0.84
124699,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1995,8,Male,1,Percentage,35,IHME,0.79
126139,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1995,9,Female,1,Percentage,35,IHME,0.89
136216,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1995,29,Total,1,Percentage,36,WHO/UNICEF,24
156283,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1995,999,Not Applicable,1,Percentage,3,WHO / GHO,20.26
195643,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,1995,28,Both sexes (male and female),1,Percentage,35,IHME,0.85
196959,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1995,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.7
198805,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1995,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,13.3
12433,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1995,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,53.66
47410,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1995,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,222.8
119328,3,ANGOLA,Number of road traffic injuries,AFR0140,1995,29,Total,5,Count (Numeric Integer),35,IHME,10829
137632,3,ANGOLA,Number of cancer cases (all cause),AFR0321,1995,29,Total,5,Count (Numeric Integer),35,IHME,21156
142874,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1995,29,Total,6,Per 1000 population,16,UNAIDS,0.55
144194,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1995,8,Male,6,Per 1000 population,16,UNAIDS,0.39
207295,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,1995-1996,28,Both sexes (male and female),1,Percentage,5,UNICEF,22.5
122176,3,ANGOLA,Life expectancy at age 60 years,AFR0003,1995-2000,28,Both sexes (male and female),1,Percentage,17,UN Population,14.04
122464,3,ANGOLA,Life expectancy at age 60 years,AFR0003,1995-2000,8,Male,1,Percentage,17,UN Population,13.27
122752,3,ANGOLA,Life expectancy at age 60 years,AFR0003,1995-2000,9,Female,1,Percentage,17,UN Population,14.63
130578,3,ANGOLA,Total fertility rate,AFR0130,1995-2000,9,Female,1,Percentage,17,UN Population,6.75
49874,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1996,8,Male,1,Percentage,3,WHO / GHO,4.7
49875,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1996,9,Female,1,Percentage,3,WHO / GHO,4.6
49876,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1996,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.7
88918,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1996,8,Male,1,Percentage,3,WHO / GHO,30.9
88919,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1996,9,Female,1,Percentage,3,WHO / GHO,30.1
88920,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1996,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.6
96241,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1996,999,Not Applicable,1,Percentage,4,WB Database,3.82
103531,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1996,999,Not Applicable,1,Percentage,3,WHO / GHO,4.55
104968,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1996,999,Not Applicable,1,Percentage,3,WHO / GHO,21.07
110216,3,ANGOLA,TB case detection rate,AFR0176,1996,29,Total,1,Percentage,3,WHO / GHO,54
123307,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1996,28,Both sexes (male and female),1,Percentage,35,IHME,0.84
124747,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1996,8,Male,1,Percentage,35,IHME,0.78
126187,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1996,9,Female,1,Percentage,35,IHME,0.89
136261,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1996,29,Total,1,Percentage,36,WHO/UNICEF,28
156282,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1996,999,Not Applicable,1,Percentage,3,WHO / GHO,21.07
195644,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,1996,28,Both sexes (male and female),1,Percentage,35,IHME,0.87
196960,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1996,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.9
198806,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1996,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,13.7
200884,3,ANGOLA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,1996,29,Total,1,Percentage,36,WHO/UNICEF,31.5
200902,3,ANGOLA,Institutional deliveries,AFR0200,1996,29,Total,1,Percentage,36,WHO/UNICEF,15.7
12434,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1996,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,53.38
47411,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1996,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,221.2
119375,3,ANGOLA,Number of road traffic injuries,AFR0140,1996,29,Total,5,Count (Numeric Integer),35,IHME,11217
137680,3,ANGOLA,Number of cancer cases (all cause),AFR0321,1996,29,Total,5,Count (Numeric Integer),35,IHME,21163
142918,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1996,29,Total,6,Per 1000 population,16,UNAIDS,0.63
144238,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1996,8,Male,6,Per 1000 population,16,UNAIDS,0.44
50012,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1997,8,Male,1,Percentage,3,WHO / GHO,4.8
50013,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1997,9,Female,1,Percentage,3,WHO / GHO,4.7
50014,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1997,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.8
89056,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1997,8,Male,1,Percentage,3,WHO / GHO,30.9
89057,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1997,9,Female,1,Percentage,3,WHO / GHO,30.2
89058,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1997,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.6
96287,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1997,999,Not Applicable,1,Percentage,4,WB Database,3.82
103530,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1997,999,Not Applicable,1,Percentage,3,WHO / GHO,13.04
104967,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1997,999,Not Applicable,1,Percentage,3,WHO / GHO,28.04
110256,3,ANGOLA,TB case detection rate,AFR0176,1997,29,Total,1,Percentage,3,WHO / GHO,50
123355,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1997,28,Both sexes (male and female),1,Percentage,35,IHME,0.83
124795,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1997,8,Male,1,Percentage,35,IHME,0.78
126235,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1997,9,Female,1,Percentage,35,IHME,0.88
131608,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,1997,28,Both sexes (male and female),1,Percentage,4,WB Database,71.53
136306,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1997,29,Total,1,Percentage,36,WHO/UNICEF,41
156281,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1997,999,Not Applicable,1,Percentage,3,WHO / GHO,28.04
195645,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,1997,28,Both sexes (male and female),1,Percentage,35,IHME,0.9
196961,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1997,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.1
198807,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1997,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,14.1
3747,3,ANGOLA,Physicians density (per 1000 population),AFR0287,1997,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.06
4162,3,ANGOLA,Nursing and midwifery personnel density (per 1000 population),AFR0286,1997,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.99
12435,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1997,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,52.97
14001,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1997,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,218.83
63093,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1997,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,218.8
128469,3,ANGOLA,Sex ratio at birth,AFR0428,1997,28,Both sexes (male and female),4,Ratio,4,WB Database,1.02
119422,3,ANGOLA,Number of road traffic injuries,AFR0140,1997,29,Total,5,Count (Numeric Integer),35,IHME,11652
137728,3,ANGOLA,Number of cancer cases (all cause),AFR0321,1997,29,Total,5,Count (Numeric Integer),35,IHME,21746
142962,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1997,29,Total,6,Per 1000 population,16,UNAIDS,0.7
144282,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1997,8,Male,6,Per 1000 population,16,UNAIDS,0.49
50152,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1998,8,Male,1,Percentage,3,WHO / GHO,5
50153,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1998,9,Female,1,Percentage,3,WHO / GHO,4.9
50154,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1998,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.9
89194,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1998,8,Male,1,Percentage,3,WHO / GHO,30.8
89195,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1998,9,Female,1,Percentage,3,WHO / GHO,30.3
89196,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1998,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.7
96333,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1998,999,Not Applicable,1,Percentage,4,WB Database,3.81
103529,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1998,999,Not Applicable,1,Percentage,3,WHO / GHO,7.33
104966,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1998,999,Not Applicable,1,Percentage,3,WHO / GHO,42.81
110294,3,ANGOLA,TB case detection rate,AFR0176,1998,29,Total,1,Percentage,3,WHO / GHO,45
123403,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1998,28,Both sexes (male and female),1,Percentage,35,IHME,0.83
124843,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1998,8,Male,1,Percentage,35,IHME,0.77
126283,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1998,9,Female,1,Percentage,35,IHME,0.88
134223,3,ANGOLA,School dropout rate,AFR0160,1998,28,Both sexes (male and female),1,Percentage,42,WDI,54.65
136351,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1998,29,Total,1,Percentage,36,WHO/UNICEF,47
156280,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1998,999,Not Applicable,1,Percentage,3,WHO / GHO,42.81
195646,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,1998,28,Both sexes (male and female),1,Percentage,35,IHME,0.96
196962,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1998,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.2
198808,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1998,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,14.5
12436,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1998,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,52.37
14002,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1998,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,215.3
63094,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1998,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,215.2
119469,3,ANGOLA,Number of road traffic injuries,AFR0140,1998,29,Total,5,Count (Numeric Integer),35,IHME,12119
137776,3,ANGOLA,Number of cancer cases (all cause),AFR0321,1998,29,Total,5,Count (Numeric Integer),35,IHME,23065
141671,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1998,125,Biological,5,Count (Numeric Integer),35,IHME,115
143006,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1998,29,Total,6,Per 1000 population,16,UNAIDS,0.78
144326,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1998,8,Male,6,Per 1000 population,16,UNAIDS,0.54
50291,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1999,8,Male,1,Percentage,3,WHO / GHO,5.2
50292,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1999,9,Female,1,Percentage,3,WHO / GHO,5
50293,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1999,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.1
89332,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1999,8,Male,1,Percentage,3,WHO / GHO,30.8
89333,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1999,9,Female,1,Percentage,3,WHO / GHO,30.4
89334,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1999,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.7
96379,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1999,999,Not Applicable,1,Percentage,4,WB Database,3.84
103528,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1999,999,Not Applicable,1,Percentage,3,WHO / GHO,2.16
104965,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1999,999,Not Applicable,1,Percentage,3,WHO / GHO,22.56
110335,3,ANGOLA,TB case detection rate,AFR0176,1999,29,Total,1,Percentage,3,WHO / GHO,43
123451,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1999,28,Both sexes (male and female),1,Percentage,35,IHME,0.82
124891,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1999,8,Male,1,Percentage,35,IHME,0.77
126331,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,1999,9,Female,1,Percentage,35,IHME,0.88
136396,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1999,29,Total,1,Percentage,36,WHO/UNICEF,21
156279,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1999,999,Not Applicable,1,Percentage,3,WHO / GHO,22.56
177089,3,ANGOLA,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,1999,999,Not Applicable,1,Percentage,40,National Health Account Report,0
195647,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,1999,28,Both sexes (male and female),1,Percentage,35,IHME,1.04
196963,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,1999,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.4
198809,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,1999,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,14.9
12437,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1999,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,51.54
14003,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1999,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,210.87
63095,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1999,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,210.8
119516,3,ANGOLA,Number of road traffic injuries,AFR0140,1999,29,Total,5,Count (Numeric Integer),35,IHME,12607
137824,3,ANGOLA,Number of cancer cases (all cause),AFR0321,1999,29,Total,5,Count (Numeric Integer),35,IHME,24330
141690,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1999,125,Biological,5,Count (Numeric Integer),35,IHME,147
143050,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1999,29,Total,6,Per 1000 population,16,UNAIDS,0.86
144370,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1999,8,Male,6,Per 1000 population,16,UNAIDS,0.6
11481,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2000,9,Female,1,Percentage,3,WHO / GHO,827
50431,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2000,8,Male,1,Percentage,3,WHO / GHO,5.3
50432,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2000,9,Female,1,Percentage,3,WHO / GHO,5.2
50433,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.2
67531,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2000,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,19
68405,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2000,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
84240,3,ANGOLA,TB case detection rate,AFR0176,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,33
89470,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2000,8,Male,1,Percentage,3,WHO / GHO,30.7
89471,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2000,9,Female,1,Percentage,3,WHO / GHO,30.5
89472,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.7
92959,3,ANGOLA,GDP growth (annual %),AFR0388,2000,999,Not Applicable,1,Percentage,22,UN DESA,-0.27
93624,3,ANGOLA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,71.38
96425,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2000,999,Not Applicable,1,Percentage,4,WB Database,3.83
98501,3,ANGOLA,Immunization coverage against Tetanus,AFR0189,2000,28,Both sexes (male and female),1,Percentage,4,WB Database,31
102383,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2000,999,Not Applicable,1,Percentage,4,WB Database,27.3
103527,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,3.08
109785,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,22.52
110372,3,ANGOLA,TB case detection rate,AFR0176,2000,29,Total,1,Percentage,3,WHO / GHO,46
111224,3,ANGOLA,TB treatment success rate,AFR0216,2000,29,Total,1,Percentage,3,WHO / GHO,68
112763,3,ANGOLA,TB treatment coverage,AFR0173,2000,29,Total,1,Percentage,3,WHO / GHO,68
115971,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
117002,3,ANGOLA,TB treatment success rate,AFR0216,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.6
123499,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2000,28,Both sexes (male and female),1,Percentage,35,IHME,0.82
124939,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2000,8,Male,1,Percentage,35,IHME,0.77
126379,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2000,9,Female,1,Percentage,35,IHME,0.88
131282,3,ANGOLA,Proportion of urban population living in slums (%),AFR0118,2000,28,Both sexes (male and female),1,Percentage,4,WB Database,86.5
133664,3,ANGOLA,"Proportion of total government spending on essential services (education, health and social protection[SDG1.a.2]",AFR0419,2000,999,Not Applicable,1,Percentage,51,UNESCO/IMF,5.26
136443,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2000,29,Total,1,Percentage,36,WHO/UNICEF,31
138393,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2000,29,Total,1,Percentage,3,WHO / GHO,68
138394,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.6
151366,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,13.9
156278,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,22.52
177123,3,ANGOLA,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,2000,999,Not Applicable,1,Percentage,40,National Health Account Report,0
182004,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,41.27
182870,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,1.9
184602,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,99.4
185468,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,0.51
188139,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,2.73
189005,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,2.73
191042,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,27.3
195648,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2000,28,Both sexes (male and female),1,Percentage,35,IHME,1.11
196964,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.6
198810,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,15.4
4,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,2.33
5,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,12.96
6,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,64.93
12438,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,50.51
14004,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,205.69
15878,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,7.9
16118,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,8,Male,2,Per 1000 live births,3,WHO / GHO,11.9
16358,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,9,Female,2,Per 1000 live births,3,WHO / GHO,4
16598,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,7.9
18300,3,ANGOLA,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,24
18589,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2000,9,Female,2,Per 1000 live births,3,WHO / GHO,327.42
18590,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2000,8,Male,2,Per 1000 live births,3,WHO / GHO,371.67
21229,3,ANGOLA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,222.39
22680,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1
25700,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,4.9
25701,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,9,Female,2,Per 1000 live births,20,ITU,3.4
25702,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,8,Male,2,Per 1000 live births,20,ITU,6.5
28112,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2000,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,21.5
29846,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2000,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,98
30916,3,ANGOLA,TB case detection rate,AFR0176,2000,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,33
37283,3,ANGOLA,People practicing open defecation (%) of population),AFR0025,2000,29,Total,2,Per 1000 live births,5,UNICEF,42.87
37284,3,ANGOLA,People practicing open defecation (%) of population),AFR0025,2000,11,Rural,2,Per 1000 live births,5,UNICEF,54.86
37285,3,ANGOLA,People practicing open defecation (%) of population),AFR0025,2000,12,Urban,2,Per 1000 live births,5,UNICEF,18.04
37691,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2000,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.11
38559,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2000,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,15.45
39752,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2000,999,Not Applicable,2,Per 1000 live births,19,OECD,53.02
47122,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
47154,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,51,Polio,2,Per 1000 live births,1,WHO/AFRO,115
47200,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,560
63096,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2000,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,205.6
82940,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2000,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
82972,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2000,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,115
83018,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2000,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,560
83049,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2000,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,131
83088,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2000,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
119563,3,ANGOLA,Number of road traffic injuries,AFR0140,2000,29,Total,5,Count (Numeric Integer),35,IHME,13117
137872,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2000,29,Total,5,Count (Numeric Integer),35,IHME,25143
141714,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2000,125,Biological,5,Count (Numeric Integer),35,IHME,18
142118,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2000,126,Hydrological,5,Count (Numeric Integer),35,IHME,31
144707,3,ANGOLA,Number of people living with HIV,AFR0019,2000,29,Total,5,Count (Numeric Integer),16,UNAIDS,75000
152659,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,70,0-4 years,5,Count (Numeric Integer),17,UN Population,3082554
152892,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,71,5-9 years,5,Count (Numeric Integer),17,UN Population,2514939
153125,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,72,10-14 years,5,Count (Numeric Integer),17,UN Population,2141142
153356,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,73,15-19 years,5,Count (Numeric Integer),17,UN Population,1776192
153587,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,74,20-24 years,5,Count (Numeric Integer),17,UN Population,1450569
153820,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,75,25-29 years,5,Count (Numeric Integer),17,UN Population,1205787
154051,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,76,30-34 years,5,Count (Numeric Integer),17,UN Population,904725
154283,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,77,35-39 years,5,Count (Numeric Integer),17,UN Population,825947
154516,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,78,40-44 years,5,Count (Numeric Integer),17,UN Population,636573
154747,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,79,45-49 years,5,Count (Numeric Integer),17,UN Population,458223
154979,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,80,50-54 years,5,Count (Numeric Integer),17,UN Population,397134
155213,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,81,55-59 years,5,Count (Numeric Integer),17,UN Population,313560
155445,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,82,60-64 years,5,Count (Numeric Integer),17,UN Population,267276
155675,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,83,65-69 years,5,Count (Numeric Integer),17,UN Population,196310
155906,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,84,70-74 years,5,Count (Numeric Integer),17,UN Population,125981
156138,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,85,75-79 years,5,Count (Numeric Integer),17,UN Population,60633
177479,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,86,80-84 years,5,Count (Numeric Integer),17,UN Population,27846
177710,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,1010,85-89 years,5,Count (Numeric Integer),17,UN Population,8013
178022,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,1011,90-94 years,5,Count (Numeric Integer),17,UN Population,1837
178257,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,1012,95-99 years,5,Count (Numeric Integer),17,UN Population,217
178492,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2000,1009,100+ years,5,Count (Numeric Integer),17,UN Population,19
143094,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2000,29,Total,6,Per 1000 population,16,UNAIDS,0.93
144414,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2000,8,Male,6,Per 1000 population,16,UNAIDS,0.65
62265,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2000,9,Female,7,per 100 000 live births,23,MMEIG,827
70471,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,4.9
70472,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,9,Female,8,Per 100 000 population,13,UNStat,3.4
70473,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,8,Male,8,Per 100 000 population,13,UNStat,6.5
83170,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2000,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,98
104414,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2000,8,Male,8,Per 100 000 population,3,WHO / GHO,21.94
104415,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2000,9,Female,8,Per 100 000 population,3,WHO / GHO,4.99
109168,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2000,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,13.27
120748,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2000,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,24
120988,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2000,8,Male,8,Per 100 000 population,3,WHO / GHO,24.2
121228,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2000,9,Female,8,Per 100 000 population,3,WHO / GHO,23.8
69379,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2000,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,21.5
92067,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2000,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,53.02
97472,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2000,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,19.61
113758,3,ANGOLA,Total Health Expenditure (constant US$),AFR0349,2000,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,825.3
114218,3,ANGOLA,Total Health Expenditure (International US$),AFR0348,2000,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,213.12
106164,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2000,999,Not Applicable,14,Per Capita,3,WHO / GHO,12.96
106983,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2000,999,Not Applicable,14,Per Capita,42,WDI,0.36
107801,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2000,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.06
114695,3,ANGOLA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2000,999,Not Applicable,14,Per Capita,4,WB Database,71.8
115169,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2000,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,19.61
127862,3,ANGOLA,Life expectancy at birth (years),AFR0381,2000,28,Both sexes (male and female),17,years,4,WB Database,46.52
213219,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2000,28,Both sexes (male and female),23,Numeric,75,WHO/GHO_2021,42.9
213407,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2000,8,Male,23,Numeric,75,WHO/GHO_2021,41.2
213595,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2000,9,Female,23,Numeric,75,WHO/GHO_2021,44.7
183736,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2000,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,12.9
187200,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2000,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.06
190176,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2000,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,3.54
194469,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2000,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,5.36
186334,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2000,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,0.37
191908,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2000,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,19.7
193603,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2000,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,29.84
207296,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2000-2001,28,Both sexes (male and female),1,Percentage,5,UNICEF,37.8
122224,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2000-2005,28,Both sexes (male and female),1,Percentage,17,UN Population,14.2
122512,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2000-2005,8,Male,1,Percentage,17,UN Population,13.32
122800,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2000-2005,9,Female,1,Percentage,17,UN Population,14.86
130579,3,ANGOLA,Total fertility rate,AFR0130,2000-2005,9,Female,1,Percentage,17,UN Population,6.55
11482,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2001,9,Female,1,Percentage,3,WHO / GHO,766
50570,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2001,8,Male,1,Percentage,3,WHO / GHO,5.5
50571,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2001,9,Female,1,Percentage,3,WHO / GHO,5.3
50572,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.4
67577,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2001,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,26
68432,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2001,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
84241,3,ANGOLA,TB case detection rate,AFR0176,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,42
89608,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2001,8,Male,1,Percentage,3,WHO / GHO,30.7
89609,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2001,9,Female,1,Percentage,3,WHO / GHO,30.6
89610,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.7
92960,3,ANGOLA,GDP growth (annual %),AFR0388,2001,999,Not Applicable,1,Percentage,22,UN DESA,-0.21
93716,3,ANGOLA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2001,999,Not Applicable,1,Percentage,3,WHO / GHO,83.13
96471,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2001,999,Not Applicable,1,Percentage,4,WB Database,3.83
103526,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2001,999,Not Applicable,1,Percentage,3,WHO / GHO,5.82
104964,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2001,999,Not Applicable,1,Percentage,3,WHO / GHO,38.45
110412,3,ANGOLA,TB case detection rate,AFR0176,2001,29,Total,1,Percentage,3,WHO / GHO,59
111260,3,ANGOLA,TB treatment success rate,AFR0216,2001,29,Total,1,Percentage,3,WHO / GHO,68
112800,3,ANGOLA,TB treatment coverage,AFR0173,2001,29,Total,1,Percentage,3,WHO / GHO,68
115972,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
117001,3,ANGOLA,TB treatment success rate,AFR0216,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,36
123547,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2001,28,Both sexes (male and female),1,Percentage,35,IHME,0.82
124987,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2001,8,Male,1,Percentage,35,IHME,0.76
126427,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2001,9,Female,1,Percentage,35,IHME,0.88
136490,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2001,29,Total,1,Percentage,36,WHO/UNICEF,42
138395,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2001,29,Total,1,Percentage,3,WHO / GHO,68
138396,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,36
156277,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2001,999,Not Applicable,1,Percentage,3,WHO / GHO,38.45
177165,3,ANGOLA,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,2001,999,Not Applicable,1,Percentage,40,National Health Account Report,0
178678,3,ANGOLA,Access to electricity (% of population),AFR0380,2001,999,Not Applicable,1,Percentage,4,WB Database,20
182049,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,52.92
182915,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,4.48
184647,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,98.5
185513,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,1.43
188184,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,5.96
189050,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,5.96
191087,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,45
192801,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2001,999,Not Applicable,1,Percentage,10,WHO / GHED,7.83
195649,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2001,28,Both sexes (male and female),1,Percentage,35,IHME,1.16
196965,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.8
198811,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2001,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,15.8
200636,3,ANGOLA,Contraceptive prevalence rate,AFR0208,2001,9,Female,1,Percentage,22,UN DESA,6.27
139,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,5.48
140,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2001,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,28.85
141,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2001,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,157.39
3632,3,ANGOLA,Civil registration coverage of births (%),AFR0062,2001,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,35.6
12439,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2001,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,49.4
14005,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2001,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,199.72
18591,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2001,9,Female,2,Per 1000 live births,3,WHO / GHO,312.31
18592,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2001,8,Male,2,Per 1000 live births,3,WHO / GHO,364.97
28155,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2001,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,64.88
29847,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2001,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,128
30917,3,ANGOLA,TB case detection rate,AFR0176,2001,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,42
33200,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2001,12,Urban,2,Per 1000 live births,1,WHO/AFRO,66.91
33201,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2001,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.77
33202,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2001,29,Total,2,Per 1000 live births,1,WHO/AFRO,38.07
35041,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2001,12,Urban,2,Per 1000 live births,3,WHO / GHO,48.5
35042,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2001,11,Rural,2,Per 1000 live births,3,WHO / GHO,8.46
35043,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2001,29,Total,2,Per 1000 live births,3,WHO / GHO,21.73
37692,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2001,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.14
38560,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2001,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,15.45
39753,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2001,999,Not Applicable,2,Per 1000 live births,19,OECD,30.54
46900,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
46945,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,51,Polio,2,Per 1000 live births,1,WHO/AFRO,1
46992,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,740
47028,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,311
47080,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
63097,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2001,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,199.7
140126,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2001,12,Urban,2,Per 1000 live births,7,DHS,66.91
140127,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2001,11,Rural,2,Per 1000 live births,7,DHS,23.77
140128,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2001,29,Total,2,Per 1000 live births,7,DHS,38.07
82718,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2001,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
82763,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2001,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,1
82810,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2001,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,740
82846,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2001,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,311
82898,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2001,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
119610,3,ANGOLA,Number of road traffic injuries,AFR0140,2001,29,Total,5,Count (Numeric Integer),35,IHME,13645
137920,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2001,29,Total,5,Count (Numeric Integer),35,IHME,25837
141739,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2001,125,Biological,5,Count (Numeric Integer),35,IHME,30
142130,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2001,126,Hydrological,5,Count (Numeric Integer),35,IHME,9
142630,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2001,128,Climatological,5,Count (Numeric Integer),35,IHME,58
144753,3,ANGOLA,Number of people living with HIV,AFR0019,2001,29,Total,5,Count (Numeric Integer),16,UNAIDS,86000
143138,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2001,29,Total,6,Per 1000 population,16,UNAIDS,1.01
144458,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2001,8,Male,6,Per 1000 population,16,UNAIDS,0.7
62266,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2001,9,Female,7,per 100 000 live births,23,MMEIG,766
83171,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2001,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,128
69425,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2001,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,64.8
92068,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2001,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,30.54
97471,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2001,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,78.47
106163,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2001,999,Not Applicable,14,Per Capita,3,WHO / GHO,28.85
106982,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2001,999,Not Applicable,14,Per Capita,42,WDI,2.48
107800,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2001,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.41
115168,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2001,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,78.47
183781,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2001,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,28.9
187245,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2001,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.41
190221,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2001,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,13
194514,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2001,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,15.3
186379,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2001,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,2.5
191953,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2001,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,78.9
193648,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2001,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,92.62
207297,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2001-2007,28,Both sexes (male and female),1,Percentage,5,UNICEF,47.3
11483,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2002,9,Female,1,Percentage,3,WHO / GHO,690
50710,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2002,8,Male,1,Percentage,3,WHO / GHO,5.7
50711,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2002,9,Female,1,Percentage,3,WHO / GHO,5.5
50712,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.6
67623,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2002,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,27
68459,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2002,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
84242,3,ANGOLA,TB case detection rate,AFR0176,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,53
89746,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2002,8,Male,1,Percentage,3,WHO / GHO,30.7
89747,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2002,9,Female,1,Percentage,3,WHO / GHO,30.6
89748,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.7
92961,3,ANGOLA,GDP growth (annual %),AFR0388,2002,999,Not Applicable,1,Percentage,22,UN DESA,10.78
93804,3,ANGOLA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2002,999,Not Applicable,1,Percentage,3,WHO / GHO,80.12
96517,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2002,999,Not Applicable,1,Percentage,4,WB Database,3.87
103525,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2002,999,Not Applicable,1,Percentage,3,WHO / GHO,7.75
104963,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2002,999,Not Applicable,1,Percentage,3,WHO / GHO,40.05
110453,3,ANGOLA,TB case detection rate,AFR0176,2002,29,Total,1,Percentage,3,WHO / GHO,78
111301,3,ANGOLA,TB treatment success rate,AFR0216,2002,29,Total,1,Percentage,3,WHO / GHO,74
112842,3,ANGOLA,TB treatment coverage,AFR0173,2002,29,Total,1,Percentage,3,WHO / GHO,74
115973,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
117000,3,ANGOLA,TB treatment success rate,AFR0216,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,44.4
123595,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2002,28,Both sexes (male and female),1,Percentage,35,IHME,0.82
125035,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2002,8,Male,1,Percentage,35,IHME,0.76
126475,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2002,9,Female,1,Percentage,35,IHME,0.88
136537,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2002,29,Total,1,Percentage,36,WHO/UNICEF,47
138397,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2002,29,Total,1,Percentage,3,WHO / GHO,74
138398,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,44.4
156276,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2002,999,Not Applicable,1,Percentage,3,WHO / GHO,40.05
177199,3,ANGOLA,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,2002,999,Not Applicable,1,Percentage,40,National Health Account Report,0
178715,3,ANGOLA,Access to electricity (% of population),AFR0380,2002,999,Not Applicable,1,Percentage,4,WB Database,25
182094,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,59.41
182960,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,3.32
184692,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,98.7
185558,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,1.27
188229,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,4.19
189095,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,4.19
191132,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,49.6
192845,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2002,999,Not Applicable,1,Percentage,10,WHO / GHED,9.75
195650,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2002,28,Both sexes (male and female),1,Percentage,35,IHME,1.23
196966,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.1
198812,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2002,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,16.3
274,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2002,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,4.07
275,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2002,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,28.96
276,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2002,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,106.73
12440,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2002,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,48.23
14006,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2002,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,192.6
18593,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2002,9,Female,2,Per 1000 live births,3,WHO / GHO,291.19
18594,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2002,8,Male,2,Per 1000 live births,3,WHO / GHO,336.58
28199,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2002,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,18.79
29848,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2002,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,171
30918,3,ANGOLA,TB case detection rate,AFR0176,2002,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,53
33333,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2002,12,Urban,2,Per 1000 live births,1,WHO/AFRO,66.91
33334,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2002,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.75
33335,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2002,29,Total,2,Per 1000 live births,1,WHO/AFRO,38.38
35174,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2002,12,Urban,2,Per 1000 live births,3,WHO / GHO,49.49
35175,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2002,11,Rural,2,Per 1000 live births,3,WHO / GHO,9.38
35176,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2002,29,Total,2,Per 1000 live births,3,WHO / GHO,22.98
37693,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2002,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.27
38561,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2002,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,15.45
39754,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2002,999,Not Applicable,2,Per 1000 live births,19,OECD,33.55
46623,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
46651,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,0
46669,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
46715,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,0
46752,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,173
46796,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,0
46810,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,46,Measles,2,Per 1000 live births,1,WHO/AFRO,11945
46853,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
46883,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2002,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,0
63098,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2002,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,192.5
140129,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2002,12,Urban,2,Per 1000 live births,7,DHS,66.91
140130,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2002,11,Rural,2,Per 1000 live births,7,DHS,23.75
140131,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2002,29,Total,2,Per 1000 live births,7,DHS,38.38
128468,3,ANGOLA,Sex ratio at birth,AFR0428,2002,28,Both sexes (male and female),4,Ratio,4,WB Database,1.02
82441,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2002,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
82469,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2002,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,0
82487,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2002,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
82533,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2002,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,0
82570,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2002,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,173
82614,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2002,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,0
82628,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2002,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,11945
82671,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2002,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
82701,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2002,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,0
119657,3,ANGOLA,Number of road traffic injuries,AFR0140,2002,29,Total,5,Count (Numeric Integer),35,IHME,14204
137968,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2002,29,Total,5,Count (Numeric Integer),35,IHME,26886
142150,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2002,126,Hydrological,5,Count (Numeric Integer),35,IHME,8
144799,3,ANGOLA,Number of people living with HIV,AFR0019,2002,29,Total,5,Count (Numeric Integer),16,UNAIDS,99000
143182,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2002,29,Total,6,Per 1000 population,16,UNAIDS,1.07
144502,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2002,8,Male,6,Per 1000 population,16,UNAIDS,0.75
62267,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2002,9,Female,7,per 100 000 live births,23,MMEIG,690
83172,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2002,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,171
69471,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2002,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,18.7
92069,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2002,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,33.54
97470,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2002,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,58.53
106162,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2002,999,Not Applicable,14,Per Capita,3,WHO / GHO,28.96
106981,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2002,999,Not Applicable,14,Per Capita,42,WDI,1.5
107799,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2002,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.37
115167,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2002,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,58.53
183826,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2002,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,29
187290,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2002,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.37
190266,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2002,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,14.4
194559,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2002,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,17.2
186424,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2002,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,1.51
191998,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2002,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,58.9
193693,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2002,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,70.5
11484,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2003,9,Female,1,Percentage,3,WHO / GHO,628
50849,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2003,8,Male,1,Percentage,3,WHO / GHO,5.9
50850,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2003,9,Female,1,Percentage,3,WHO / GHO,5.7
50851,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.8
67669,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2003,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,22
68486,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2003,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
84243,3,ANGOLA,TB case detection rate,AFR0176,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,60
89884,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2003,8,Male,1,Percentage,3,WHO / GHO,30.6
89885,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2003,9,Female,1,Percentage,3,WHO / GHO,30.6
89886,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.7
92962,3,ANGOLA,GDP growth (annual %),AFR0388,2003,999,Not Applicable,1,Percentage,22,UN DESA,-0.43
93893,3,ANGOLA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2003,999,Not Applicable,1,Percentage,3,WHO / GHO,82.06
96563,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2003,999,Not Applicable,1,Percentage,4,WB Database,3.87
103524,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2003,999,Not Applicable,1,Percentage,3,WHO / GHO,2.31
104962,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2003,999,Not Applicable,1,Percentage,3,WHO / GHO,42.27
110497,3,ANGOLA,TB case detection rate,AFR0176,2003,29,Total,1,Percentage,3,WHO / GHO,88
111344,3,ANGOLA,TB treatment success rate,AFR0216,2003,29,Total,1,Percentage,3,WHO / GHO,71
112886,3,ANGOLA,TB treatment coverage,AFR0173,2003,29,Total,1,Percentage,3,WHO / GHO,71
115974,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116999,3,ANGOLA,TB treatment success rate,AFR0216,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,38.3
123643,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2003,28,Both sexes (male and female),1,Percentage,35,IHME,0.82
125083,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2003,8,Male,1,Percentage,35,IHME,0.76
126523,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2003,9,Female,1,Percentage,35,IHME,0.87
136584,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2003,29,Total,1,Percentage,36,WHO/UNICEF,46
138399,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2003,29,Total,1,Percentage,3,WHO / GHO,71
138400,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,38.3
156275,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2003,999,Not Applicable,1,Percentage,3,WHO / GHO,42.27
177233,3,ANGOLA,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,2003,999,Not Applicable,1,Percentage,40,National Health Account Report,0
178753,3,ANGOLA,Access to electricity (% of population),AFR0380,2003,999,Not Applicable,1,Percentage,4,WB Database,26.1
182139,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,57.65
183005,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,3.54
184737,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,98.9
185603,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,1.03
188274,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,4.26
189140,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,4.26
191177,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,48.5
192889,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2003,999,Not Applicable,1,Percentage,10,WHO / GHED,9.14
195651,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2003,28,Both sexes (male and female),1,Percentage,35,IHME,1.3
196967,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.3
198813,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2003,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,16.8
409,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2003,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,4.45
410,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2003,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,34.72
411,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2003,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,120.97
12441,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2003,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,46.91
14007,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2003,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,184.75
18595,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2003,9,Female,2,Per 1000 live births,3,WHO / GHO,272.81
18596,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2003,8,Male,2,Per 1000 live births,3,WHO / GHO,320.95
25491,3,ANGOLA,Adolescent birth rate [SDG 3.7.2],AFR0293,2003,9,Female,2,Per 1000 live births,1,WHO/AFRO,151
28243,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2003,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,24.44
29849,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2003,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,199
30919,3,ANGOLA,TB case detection rate,AFR0176,2003,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,60
33466,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2003,12,Urban,2,Per 1000 live births,1,WHO/AFRO,66.63
33467,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2003,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.73
33468,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2003,29,Total,2,Per 1000 live births,1,WHO/AFRO,38.59
35307,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2003,12,Urban,2,Per 1000 live births,3,WHO / GHO,50.48
35308,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2003,11,Rural,2,Per 1000 live births,3,WHO / GHO,10.3
35309,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2003,29,Total,2,Per 1000 live births,3,WHO / GHO,24.22
37694,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2003,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.37
38562,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2003,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,15.45
39755,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2003,999,Not Applicable,2,Per 1000 live births,19,OECD,31.16
46344,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
46376,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,22
46401,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
46447,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,2654
46479,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,117
46534,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,46,Measles,2,Per 1000 live births,1,WHO/AFRO,1196
46577,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2003,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,16
63099,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2003,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,184.7
140132,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2003,12,Urban,2,Per 1000 live births,7,DHS,66.63
140133,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2003,11,Rural,2,Per 1000 live births,7,DHS,23.73
140134,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2003,29,Total,2,Per 1000 live births,7,DHS,38.59
82162,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2003,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
82194,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2003,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,22
82219,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2003,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
82265,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2003,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,2654
82297,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2003,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,117
82352,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2003,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,1196
82395,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2003,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,16
119704,3,ANGOLA,Number of road traffic injuries,AFR0140,2003,29,Total,5,Count (Numeric Integer),35,IHME,14791
138016,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2003,29,Total,5,Count (Numeric Integer),35,IHME,28332
142164,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2003,126,Hydrological,5,Count (Numeric Integer),35,IHME,9
144845,3,ANGOLA,Number of people living with HIV,AFR0019,2003,29,Total,5,Count (Numeric Integer),16,UNAIDS,110000
143226,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2003,29,Total,6,Per 1000 population,16,UNAIDS,1.13
144546,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2003,8,Male,6,Per 1000 population,16,UNAIDS,0.79
62268,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2003,9,Female,7,per 100 000 live births,23,MMEIG,628
83173,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2003,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,199
70263,3,ANGOLA,Adolescent birth rate [SDG 3.7.2],AFR0293,2003,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,151
69517,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2003,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,24.4
92070,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2003,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,31.15
97469,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2003,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,61.78
106161,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2003,999,Not Applicable,14,Per Capita,3,WHO / GHO,34.72
106980,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2003,999,Not Applicable,14,Per Capita,42,WDI,1.32
107798,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2003,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.36
115166,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2003,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,61.78
183871,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2003,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,34.8
187335,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2003,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.36
190311,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2003,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,16.9
194604,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2003,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,20.1
186469,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2003,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,1.33
192043,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2003,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,62.2
193738,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2003,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,73.93
11485,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2004,9,Female,1,Percentage,3,WHO / GHO,574
50989,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2004,8,Male,1,Percentage,3,WHO / GHO,6.1
50990,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2004,9,Female,1,Percentage,3,WHO / GHO,5.9
50991,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6
67715,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2004,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,19
68513,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2004,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
84244,3,ANGOLA,TB case detection rate,AFR0176,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,54
90022,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2004,8,Male,1,Percentage,3,WHO / GHO,30.6
90023,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2004,9,Female,1,Percentage,3,WHO / GHO,30.6
90024,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.7
92963,3,ANGOLA,GDP growth (annual %),AFR0388,2004,999,Not Applicable,1,Percentage,22,UN DESA,7.19
93984,3,ANGOLA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2004,999,Not Applicable,1,Percentage,3,WHO / GHO,81.16
96609,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2004,999,Not Applicable,1,Percentage,4,WB Database,3.84
103523,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2004,999,Not Applicable,1,Percentage,3,WHO / GHO,3.55
104961,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2004,999,Not Applicable,1,Percentage,3,WHO / GHO,38.27
110541,3,ANGOLA,TB case detection rate,AFR0176,2004,29,Total,1,Percentage,3,WHO / GHO,82
111388,3,ANGOLA,TB treatment success rate,AFR0216,2004,29,Total,1,Percentage,3,WHO / GHO,69
112931,3,ANGOLA,TB treatment coverage,AFR0173,2004,29,Total,1,Percentage,3,WHO / GHO,69
115975,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116998,3,ANGOLA,TB treatment success rate,AFR0216,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,35.9
123691,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2004,28,Both sexes (male and female),1,Percentage,35,IHME,0.82
125131,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2004,8,Male,1,Percentage,35,IHME,0.76
126571,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2004,9,Female,1,Percentage,35,IHME,0.87
136631,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2004,29,Total,1,Percentage,36,WHO/UNICEF,47
138401,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2004,29,Total,1,Percentage,3,WHO / GHO,69
138402,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,35.9
156274,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2004,999,Not Applicable,1,Percentage,3,WHO / GHO,38.27
178791,3,ANGOLA,Access to electricity (% of population),AFR0380,2004,999,Not Applicable,1,Percentage,4,WB Database,27.1
182184,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,55.55
183050,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,3.96
184782,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,98
185648,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,1.92
188319,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,5.65
189185,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,5.65
191222,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,46.8
192933,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2004,999,Not Applicable,1,Percentage,10,WHO / GHED,8.66
195652,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2004,28,Both sexes (male and female),1,Percentage,35,IHME,1.39
196968,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.5
198814,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2004,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,17.2
544,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,4.76
545,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2004,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,49.53
546,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2004,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,142.03
3771,3,ANGOLA,Physicians density (per 1000 population),AFR0287,2004,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.07
4020,3,ANGOLA,Other health workers density (per 1000 population),AFR0066,2004,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.02
4189,3,ANGOLA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2004,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1.07
12442,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2004,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,45.4
14008,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2004,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,176.17
18597,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2004,9,Female,2,Per 1000 live births,3,WHO / GHO,261.37
18598,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2004,8,Male,2,Per 1000 live births,3,WHO / GHO,309.71
28287,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2004,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,11.15
29850,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2004,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,189
30920,3,ANGOLA,TB case detection rate,AFR0176,2004,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,54
33599,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2004,12,Urban,2,Per 1000 live births,1,WHO/AFRO,66.35
33600,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2004,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.71
33601,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2004,29,Total,2,Per 1000 live births,1,WHO/AFRO,38.81
35440,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2004,12,Urban,2,Per 1000 live births,3,WHO / GHO,51.47
35441,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2004,11,Rural,2,Per 1000 live births,3,WHO / GHO,11.23
35442,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2004,29,Total,2,Per 1000 live births,3,WHO / GHO,25.47
37695,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2004,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.47
38563,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2004,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,15.45
39756,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2004,999,Not Applicable,2,Per 1000 live births,19,OECD,38.62
46060,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
46095,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,43
46122,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
46168,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,1675
46199,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,100
46242,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,23
46254,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,46,Measles,2,Per 1000 live births,1,WHO/AFRO,29
46298,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
46326,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2004,26,25-64 years,2,Per 1000 live births,1,WHO/AFRO,0
63100,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2004,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,176.1
140135,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2004,12,Urban,2,Per 1000 live births,7,DHS,66.35
140136,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2004,11,Rural,2,Per 1000 live births,7,DHS,23.71
140137,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2004,29,Total,2,Per 1000 live births,7,DHS,38.81
81878,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2004,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
81913,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2004,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,43
81940,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2004,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
81986,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2004,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,1675
82017,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2004,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,100
82060,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2004,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,23
82072,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2004,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,29
82116,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2004,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
82144,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2004,54,Congenital Rubella Syndrome,5,Count (Numeric Integer),3,WHO / GHO,0
119751,3,ANGOLA,Number of road traffic injuries,AFR0140,2004,29,Total,5,Count (Numeric Integer),35,IHME,15399
138064,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2004,29,Total,5,Count (Numeric Integer),35,IHME,30321
141799,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2004,125,Biological,5,Count (Numeric Integer),35,IHME,329
142182,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2004,126,Hydrological,5,Count (Numeric Integer),35,IHME,27
144891,3,ANGOLA,Number of people living with HIV,AFR0019,2004,29,Total,5,Count (Numeric Integer),16,UNAIDS,130000
179018,3,ANGOLA,Number of medical doctors,AFR0469,2004,29,Total,5,Count (Numeric Integer),3,WHO / GHO,1165
76282,3,ANGOLA,Pharmaceutical personnel density (per 1000 population),AFR0284,2004,28,Both sexes (male and female),6,Per 1000 population,38,Global Health Workforce Statistics,4.9
76466,3,ANGOLA,Dentistry personnel density (per 1000 population),AFR0285,2004,28,Both sexes (male and female),6,Per 1000 population,38,Global Health Workforce Statistics,1.18
95117,3,ANGOLA,Laboratory health workers density (per 1000 population),AFR0283,2004,999,Not Applicable,6,Per 1000 population,3,WHO / GHO,0.14
121494,3,ANGOLA,Other health workers density (per 1000 population),AFR0066,2004,29,Total,6,Per 1000 population,3,WHO / GHO,0.02
143270,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2004,29,Total,6,Per 1000 population,16,UNAIDS,1.17
144590,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2004,8,Male,6,Per 1000 population,16,UNAIDS,0.82
62269,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2004,9,Female,7,per 100 000 live births,23,MMEIG,574
83174,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2004,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,189
69563,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2004,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,11.1
92071,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2004,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,38.62
97468,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2004,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,73.45
109021,3,ANGOLA,"Pharmacists (per 10,000 population)",AFR0253,2004,28,Both sexes (male and female),13,Per 10 000 population,38,Global Health Workforce Statistics,0.49
151444,3,ANGOLA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2004,1000,Dentists,13,Per 10 000 population,3,WHO / GHO,0.11
151445,3,ANGOLA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2004,1002,Nursing and midwifery personnel,13,Per 10 000 population,3,WHO / GHO,9.85
151446,3,ANGOLA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2004,1003,Pharmacists,13,Per 10 000 population,3,WHO / GHO,0.49
151447,3,ANGOLA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2004,1001,Medical doctors,13,Per 10 000 population,3,WHO / GHO,0.62
106160,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2004,999,Not Applicable,14,Per Capita,3,WHO / GHO,49.53
106979,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2004,999,Not Applicable,14,Per Capita,42,WDI,3.02
107797,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2004,999,Not Applicable,14,Per Capita,3,WHO / GHO,0.96
115165,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2004,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,73.45
183916,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2004,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,49.8
187380,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2004,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,0.96
190356,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2004,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,23.3
194649,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2004,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,27.6
186514,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2004,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,3.04
192088,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2004,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,74
193783,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2004,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,87.69
11486,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2005,9,Female,1,Percentage,3,WHO / GHO,519
51128,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2005,8,Male,1,Percentage,3,WHO / GHO,6.4
51129,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2005,9,Female,1,Percentage,3,WHO / GHO,6.1
51130,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.2
67761,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2005,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,15
68540,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2005,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
84245,3,ANGOLA,TB case detection rate,AFR0176,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,52
90160,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2005,8,Male,1,Percentage,3,WHO / GHO,30.6
90161,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2005,9,Female,1,Percentage,3,WHO / GHO,30.6
90162,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.7
92964,3,ANGOLA,GDP growth (annual %),AFR0388,2005,999,Not Applicable,1,Percentage,22,UN DESA,11.03
94074,3,ANGOLA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2005,999,Not Applicable,1,Percentage,3,WHO / GHO,76.18
96655,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2005,999,Not Applicable,1,Percentage,4,WB Database,3.79
98502,3,ANGOLA,Immunization coverage against Tetanus,AFR0189,2005,28,Both sexes (male and female),1,Percentage,4,WB Database,47
102384,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2005,999,Not Applicable,1,Percentage,4,WB Database,42.33
103522,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2005,999,Not Applicable,1,Percentage,3,WHO / GHO,3.7
109784,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2005,999,Not Applicable,1,Percentage,3,WHO / GHO,38.6
110587,3,ANGOLA,TB case detection rate,AFR0176,2005,29,Total,1,Percentage,3,WHO / GHO,82
111433,3,ANGOLA,TB treatment success rate,AFR0216,2005,29,Total,1,Percentage,3,WHO / GHO,72
112977,3,ANGOLA,TB treatment coverage,AFR0173,2005,29,Total,1,Percentage,3,WHO / GHO,72
115976,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116997,3,ANGOLA,TB treatment success rate,AFR0216,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,47.5
123739,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2005,28,Both sexes (male and female),1,Percentage,35,IHME,0.82
125179,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2005,8,Male,1,Percentage,35,IHME,0.76
126619,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2005,9,Female,1,Percentage,35,IHME,0.87
131283,3,ANGOLA,Proportion of urban population living in slums (%),AFR0118,2005,28,Both sexes (male and female),1,Percentage,4,WB Database,86.5
133665,3,ANGOLA,"Proportion of total government spending on essential services (education, health and social protection[SDG1.a.2]",AFR0419,2005,999,Not Applicable,1,Percentage,51,UNESCO/IMF,7.99
136678,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2005,29,Total,1,Percentage,36,WHO/UNICEF,47
138403,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2005,29,Total,1,Percentage,3,WHO / GHO,72
138404,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,47.5
156273,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2005,999,Not Applicable,1,Percentage,3,WHO / GHO,38.6
178830,3,ANGOLA,Access to electricity (% of population),AFR0380,2005,999,Not Applicable,1,Percentage,4,WB Database,28.2
182229,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,52.12
183095,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,2.85
184827,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,96.9
185693,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,3.03
188364,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,4.82
189230,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,4.82
191267,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,42.3
192977,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2005,999,Not Applicable,1,Percentage,10,WHO / GHED,9.79
195653,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2005,28,Both sexes (male and female),1,Percentage,35,IHME,1.45
196969,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.8
198815,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2005,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,17.7
679,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.73
680,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2005,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,53.93
681,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2005,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,131.33
3187,3,ANGOLA,Hospital bed density (per 10 000 population),AFR0231,2005,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,8
12443,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,43.77
14009,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,166.79
15926,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2005,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,7.2
16166,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2005,8,Male,2,Per 1000 live births,3,WHO / GHO,11
16406,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2005,9,Female,2,Per 1000 live births,3,WHO / GHO,3.7
16646,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,7.2
16930,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,17
18299,3,ANGOLA,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,21.3
18599,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2005,9,Female,2,Per 1000 live births,3,WHO / GHO,243.95
18600,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2005,8,Male,2,Per 1000 live births,3,WHO / GHO,291.79
21184,3,ANGOLA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,210.66
22637,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2005,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.4
25490,3,ANGOLA,Adolescent birth rate [SDG 3.7.2],AFR0293,2005,9,Female,2,Per 1000 live births,1,WHO/AFRO,165.6
25838,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2005,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,4.3
25839,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2005,9,Female,2,Per 1000 live births,20,ITU,3.2
25840,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2005,8,Male,2,Per 1000 live births,20,ITU,5.5
28332,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2005,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,42.68
29851,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2005,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,191
30921,3,ANGOLA,TB case detection rate,AFR0176,2005,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,52
33732,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2005,12,Urban,2,Per 1000 live births,1,WHO/AFRO,66.07
33733,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2005,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.69
33734,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2005,29,Total,2,Per 1000 live births,1,WHO/AFRO,39.02
35573,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2005,12,Urban,2,Per 1000 live births,3,WHO / GHO,52.46
35574,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2005,11,Rural,2,Per 1000 live births,3,WHO / GHO,12.15
35575,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2005,29,Total,2,Per 1000 live births,3,WHO / GHO,26.73
37696,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2005,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,1.14
38564,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2005,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,15
39757,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2005,999,Not Applicable,2,Per 1000 live births,19,OECD,41.54
45780,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
45814,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,10
45843,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,51,Polio,2,Per 1000 live births,1,WHO/AFRO,10
45889,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,0
45918,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,89
45971,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,46,Measles,2,Per 1000 live births,1,WHO/AFRO,258
46012,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2005,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
63101,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2005,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,166.7
140138,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2005,12,Urban,2,Per 1000 live births,7,DHS,66.07
140139,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2005,11,Rural,2,Per 1000 live births,7,DHS,23.69
140140,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2005,29,Total,2,Per 1000 live births,7,DHS,39.02
64734,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2005,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,17
81598,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2005,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
81632,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2005,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,10
81661,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2005,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,10
81707,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2005,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,0
81736,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2005,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,89
81789,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2005,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,258
81830,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2005,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
119798,3,ANGOLA,Number of road traffic injuries,AFR0140,2005,29,Total,5,Count (Numeric Integer),35,IHME,16033
138112,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2005,29,Total,5,Count (Numeric Integer),35,IHME,31198
144937,3,ANGOLA,Number of people living with HIV,AFR0019,2005,29,Total,5,Count (Numeric Integer),16,UNAIDS,140000
152660,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,70,0-4 years,5,Count (Numeric Integer),17,UN Population,3676787
152893,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,71,5-9 years,5,Count (Numeric Integer),17,UN Population,2941129
153126,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,72,10-14 years,5,Count (Numeric Integer),17,UN Population,2493337
153357,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,73,15-19 years,5,Count (Numeric Integer),17,UN Population,2126694
153588,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,74,20-24 years,5,Count (Numeric Integer),17,UN Population,1748847
153821,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,75,25-29 years,5,Count (Numeric Integer),17,UN Population,1418630
154052,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,76,30-34 years,5,Count (Numeric Integer),17,UN Population,1176042
154284,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,77,35-39 years,5,Count (Numeric Integer),17,UN Population,879930
154517,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,78,40-44 years,5,Count (Numeric Integer),17,UN Population,796441
154748,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,79,45-49 years,5,Count (Numeric Integer),17,UN Population,608881
154980,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,80,50-54 years,5,Count (Numeric Integer),17,UN Population,432547
155214,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,81,55-59 years,5,Count (Numeric Integer),17,UN Population,365854
155446,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,82,60-64 years,5,Count (Numeric Integer),17,UN Population,277520
155676,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,83,65-69 years,5,Count (Numeric Integer),17,UN Population,221725
155907,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,84,70-74 years,5,Count (Numeric Integer),17,UN Population,146189
156139,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,85,75-79 years,5,Count (Numeric Integer),17,UN Population,79932
177480,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,86,80-84 years,5,Count (Numeric Integer),17,UN Population,30683
177711,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,1010,85-89 years,5,Count (Numeric Integer),17,UN Population,10164
178023,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,1011,90-94 years,5,Count (Numeric Integer),17,UN Population,1974
178258,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,1012,95-99 years,5,Count (Numeric Integer),17,UN Population,279
178493,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2005,1009,100+ years,5,Count (Numeric Integer),17,UN Population,19
143314,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2005,29,Total,6,Per 1000 population,16,UNAIDS,1.18
144634,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2005,8,Male,6,Per 1000 population,16,UNAIDS,0.83
62270,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2005,9,Female,7,per 100 000 live births,23,MMEIG,519
70609,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2005,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,4.3
70610,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2005,9,Female,8,Per 100 000 population,13,UNStat,3.2
70611,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2005,8,Male,8,Per 100 000 population,13,UNStat,5.5
83175,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2005,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,191
104412,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2005,8,Male,8,Per 100 000 population,3,WHO / GHO,19.91
104413,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2005,9,Female,8,Per 100 000 population,3,WHO / GHO,4.43
109167,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2005,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,12
120796,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2005,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,21.3
121036,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2005,8,Male,8,Per 100 000 population,3,WHO / GHO,21.5
121276,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2005,9,Female,8,Per 100 000 population,3,WHO / GHO,21.2
70262,3,ANGOLA,Adolescent birth rate [SDG 3.7.2],AFR0293,2005,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,165.6
69609,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2005,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,42.6
92072,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2005,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,41.54
97467,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2005,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,54.62
113759,3,ANGOLA,Total Health Expenditure (constant US$),AFR0349,2005,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,1920.13
114219,3,ANGOLA,Total Health Expenditure (International US$),AFR0348,2005,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,1054.48
97392,3,ANGOLA,Hospital bed density (per 10 000 population),AFR0231,2005,999,Not Applicable,13,Per 10 000 population,3,WHO / GHO,8
106159,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2005,999,Not Applicable,14,Per Capita,3,WHO / GHO,53.93
106978,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2005,999,Not Applicable,14,Per Capita,42,WDI,3.91
107796,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2005,999,Not Applicable,14,Per Capita,3,WHO / GHO,1.64
114694,3,ANGOLA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2005,999,Not Applicable,14,Per Capita,4,WB Database,129.01
115164,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2005,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,54.62
127863,3,ANGOLA,Life expectancy at birth (years),AFR0381,2005,28,Both sexes (male and female),17,years,4,WB Database,50.17
183961,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2005,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,54.2
187425,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2005,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,1.64
190401,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2005,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,22.9
194694,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2005,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,28.2
186559,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2005,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,3.94
192133,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2005,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,54.9
193828,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2005,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,67.72
122272,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2005-2010,28,Both sexes (male and female),1,Percentage,17,UN Population,14.55
122560,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2005-2010,8,Male,1,Percentage,17,UN Population,13.53
122848,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2005-2010,9,Female,1,Percentage,17,UN Population,15.37
130580,3,ANGOLA,Total fertility rate,AFR0130,2005-2010,9,Female,1,Percentage,17,UN Population,6.35
11487,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2006,9,Female,1,Percentage,3,WHO / GHO,473
51268,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2006,8,Male,1,Percentage,3,WHO / GHO,6.6
51269,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2006,9,Female,1,Percentage,3,WHO / GHO,6.3
51270,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.4
67807,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2006,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,8
68567,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2006,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
84246,3,ANGOLA,TB case detection rate,AFR0176,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,66
90298,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2006,8,Male,1,Percentage,3,WHO / GHO,30.5
90299,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2006,9,Female,1,Percentage,3,WHO / GHO,30.6
90300,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.7
92965,3,ANGOLA,GDP growth (annual %),AFR0388,2006,999,Not Applicable,1,Percentage,22,UN DESA,7.68
94166,3,ANGOLA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2006,999,Not Applicable,1,Percentage,3,WHO / GHO,67.91
96701,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2006,999,Not Applicable,1,Percentage,4,WB Database,3.71
103521,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2006,999,Not Applicable,1,Percentage,3,WHO / GHO,5.17
104960,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2006,999,Not Applicable,1,Percentage,3,WHO / GHO,22.72
110632,3,ANGOLA,TB case detection rate,AFR0176,2006,29,Total,1,Percentage,3,WHO / GHO,100
111476,3,ANGOLA,TB treatment success rate,AFR0216,2006,29,Total,1,Percentage,3,WHO / GHO,18
113021,3,ANGOLA,TB treatment coverage,AFR0173,2006,29,Total,1,Percentage,3,WHO / GHO,18
115977,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116996,3,ANGOLA,TB treatment success rate,AFR0216,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9.4
123787,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2006,28,Both sexes (male and female),1,Percentage,35,IHME,0.81
125227,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2006,8,Male,1,Percentage,35,IHME,0.76
126667,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2006,9,Female,1,Percentage,35,IHME,0.87
131609,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,2006,28,Both sexes (male and female),1,Percentage,4,WB Database,98.97
133666,3,ANGOLA,"Proportion of total government spending on essential services (education, health and social protection[SDG1.a.2]",AFR0419,2006,999,Not Applicable,1,Percentage,51,UNESCO/IMF,7.45
136725,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2006,29,Total,1,Percentage,36,WHO/UNICEF,44
138405,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2006,29,Total,1,Percentage,3,WHO / GHO,18
138406,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9.4
156272,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2006,999,Not Applicable,1,Percentage,3,WHO / GHO,22.72
178870,3,ANGOLA,Access to electricity (% of population),AFR0380,2006,999,Not Applicable,1,Percentage,4,WB Database,29.2
180263,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,1015,<12 months,1,Percentage,30,MIS,22.6
180264,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,1018,12-23 months,1,Percentage,30,MIS,19.8
180265,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,1019,24-35 months,1,Percentage,30,MIS,19
180266,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,1020,36-47 months,1,Percentage,30,MIS,12.9
180267,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,1021,48-59 months,1,Percentage,30,MIS,14.3
180843,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,29,Total,1,Percentage,30,MIS,17.7
180844,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,8,Male,1,Percentage,30,MIS,18
180845,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,9,Female,1,Percentage,30,MIS,17.5
180846,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,12,Urban,1,Percentage,30,MIS,16.7
180847,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,11,Rural,1,Percentage,30,MIS,18.7
181423,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,1022,Lowest,1,Percentage,30,MIS,17.2
181424,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,20,Second Quintile,1,Percentage,30,MIS,16.3
181425,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,1023,Middle,1,Percentage,30,MIS,22
181426,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,22,Fourth Quintile,1,Percentage,30,MIS,17.1
181427,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2006,1024,Highest,1,Percentage,30,MIS,14.3
182274,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,40.36
183140,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,2.68
184872,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,94.1
185738,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,5.85
188409,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,4.71
189275,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,4.71
191312,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,30.6
193021,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2006,999,Not Applicable,1,Percentage,10,WHO / GHED,9.7
195654,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2006,28,Both sexes (male and female),1,Percentage,35,IHME,1.51
196970,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5
198816,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2006,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,18.2
814,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.37
815,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2006,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,69.42
816,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2006,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,142.14
12444,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2006,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,42.13
14010,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2006,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,157.25
16931,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2006,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,48
18601,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2006,9,Female,2,Per 1000 live births,3,WHO / GHO,230.88
18602,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2006,8,Male,2,Per 1000 live births,3,WHO / GHO,280.95
28377,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2006,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,25.81
29852,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2006,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,250
30922,3,ANGOLA,TB case detection rate,AFR0176,2006,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,66
33865,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2006,12,Urban,2,Per 1000 live births,1,WHO/AFRO,65.79
33866,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2006,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.67
33867,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2006,29,Total,2,Per 1000 live births,1,WHO/AFRO,39.23
35706,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2006,12,Urban,2,Per 1000 live births,3,WHO / GHO,53.45
35707,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2006,11,Rural,2,Per 1000 live births,3,WHO / GHO,13.07
35708,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2006,29,Total,2,Per 1000 live births,3,WHO / GHO,27.99
37697,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2006,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,1.5
38565,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2006,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,15
39758,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2006,999,Not Applicable,2,Per 1000 live births,19,OECD,35.22
45467,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
45502,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,14
45541,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,51,Polio,2,Per 1000 live births,1,WHO/AFRO,2
45587,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,1328
45615,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,60
45674,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,46,Measles,2,Per 1000 live births,1,WHO/AFRO,765
45717,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2006,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
63102,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2006,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,157.2
140141,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2006,12,Urban,2,Per 1000 live births,7,DHS,65.79
140142,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2006,11,Rural,2,Per 1000 live births,7,DHS,23.67
140143,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2006,29,Total,2,Per 1000 live births,7,DHS,39.23
64735,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2006,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,48
81285,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2006,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
81320,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2006,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,14
81359,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2006,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,2
81405,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2006,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,1328
81433,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2006,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,60
81492,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2006,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,765
81535,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2006,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
119845,3,ANGOLA,Number of road traffic injuries,AFR0140,2006,29,Total,5,Count (Numeric Integer),35,IHME,16701
138160,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2006,29,Total,5,Count (Numeric Integer),35,IHME,32325
141839,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2006,125,Biological,5,Count (Numeric Integer),35,IHME,2354
144983,3,ANGOLA,Number of people living with HIV,AFR0019,2006,29,Total,5,Count (Numeric Integer),16,UNAIDS,150000
143358,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2006,29,Total,6,Per 1000 population,16,UNAIDS,1.2
144678,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2006,8,Male,6,Per 1000 population,16,UNAIDS,0.84
62271,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2006,9,Female,7,per 100 000 live births,23,MMEIG,473
83176,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2006,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,250
69655,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2006,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,25.8
92073,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2006,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,35.21
97466,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2006,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,41.33
106158,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2006,999,Not Applicable,14,Per Capita,3,WHO / GHO,69.42
106977,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2006,999,Not Applicable,14,Per Capita,42,WDI,7.89
107795,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2006,999,Not Applicable,14,Per Capita,3,WHO / GHO,4.07
115163,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2006,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,41.33
184006,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2006,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,69.8
187470,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2006,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,4.08
190446,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2006,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,21.4
194739,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2006,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,28.1
186604,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2006,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,7.94
192178,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2006,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,41.5
193873,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2006,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,54.73
99388,3,ANGOLA,Indoor residual spraying (IRS) coverage,AFR0165,2006-2007,28,Both sexes (male and female),1,Percentage,39,National Malaria Control Programme,95
200873,3,ANGOLA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2006-2007,29,Total,1,Percentage,36,WHO/UNICEF,79.8
200874,3,ANGOLA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2006-2007,12,Urban,1,Percentage,36,WHO/UNICEF,92.4
200875,3,ANGOLA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2006-2007,11,Rural,1,Percentage,36,WHO/UNICEF,68.2
200903,3,ANGOLA,Institutional deliveries,AFR0200,2006-2007,29,Total,1,Percentage,36,WHO/UNICEF,45.8
200904,3,ANGOLA,Institutional deliveries,AFR0200,2006-2007,12,Urban,1,Percentage,36,WHO/UNICEF,72.1
200905,3,ANGOLA,Institutional deliveries,AFR0200,2006-2007,11,Rural,1,Percentage,36,WHO/UNICEF,21.7
11488,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2007,9,Female,1,Percentage,3,WHO / GHO,431
51407,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2007,8,Male,1,Percentage,3,WHO / GHO,6.9
51408,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2007,9,Female,1,Percentage,3,WHO / GHO,6.5
51409,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.7
67853,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2007,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,43
68594,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2007,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
84247,3,ANGOLA,TB case detection rate,AFR0176,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,52
85695,3,ANGOLA,Children under 5 years who are stunted [SDG 2.2.1],AFR0303,2007,28,Both sexes (male and female),1,Percentage,5,UNICEF,29.2
85721,3,ANGOLA,Proportion of children moderately or severely stunted (%),AFR0100,2007,28,Both sexes (male and female),1,Percentage,5,UNICEF,29.2
90436,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2007,8,Male,1,Percentage,3,WHO / GHO,30.5
90437,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2007,9,Female,1,Percentage,3,WHO / GHO,30.6
90438,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.6
92966,3,ANGOLA,GDP growth (annual %),AFR0388,2007,999,Not Applicable,1,Percentage,22,UN DESA,9.89
94257,3,ANGOLA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2007,999,Not Applicable,1,Percentage,3,WHO / GHO,77.95
96747,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2007,999,Not Applicable,1,Percentage,4,WB Database,3.63
103520,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2007,999,Not Applicable,1,Percentage,3,WHO / GHO,2.88
104959,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2007,999,Not Applicable,1,Percentage,3,WHO / GHO,26.94
110675,3,ANGOLA,TB case detection rate,AFR0176,2007,29,Total,1,Percentage,3,WHO / GHO,81
111516,3,ANGOLA,TB treatment success rate,AFR0216,2007,29,Total,1,Percentage,3,WHO / GHO,74
112224,3,ANGOLA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2007,9,Female,1,Percentage,44,DHS/MICS,79.8
113062,3,ANGOLA,TB treatment coverage,AFR0173,2007,29,Total,1,Percentage,3,WHO / GHO,74
115978,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116995,3,ANGOLA,TB treatment success rate,AFR0216,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,40
123835,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2007,28,Both sexes (male and female),1,Percentage,35,IHME,0.81
125275,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2007,8,Male,1,Percentage,35,IHME,0.75
126715,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2007,9,Female,1,Percentage,35,IHME,0.86
131610,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,2007,28,Both sexes (male and female),1,Percentage,4,WB Database,105.18
136772,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2007,29,Total,1,Percentage,36,WHO/UNICEF,48
138407,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2007,29,Total,1,Percentage,3,WHO / GHO,74
138408,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,40
149548,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,9,Female,1,Percentage,7,DHS,47.3
156271,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2007,999,Not Applicable,1,Percentage,3,WHO / GHO,26.94
178912,3,ANGOLA,Access to electricity (% of population),AFR0380,2007,999,Not Applicable,1,Percentage,4,WB Database,37.5
182319,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,39.4
183185,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,2.97
184917,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,97.3
185783,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,2.69
188454,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,4.51
189320,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,4.51
191357,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,28.3
193066,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2007,999,Not Applicable,1,Percentage,10,WHO / GHED,11
195655,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2007,28,Both sexes (male and female),1,Percentage,35,IHME,1.61
196971,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.3
198817,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2007,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,18.8
949,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2007,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.21
950,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2007,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,92.45
951,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2007,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,164.69
12445,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2007,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,40.57
14011,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2007,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,147.74
16932,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2007,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,439
18603,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2007,9,Female,2,Per 1000 live births,3,WHO / GHO,217.99
18604,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2007,8,Male,2,Per 1000 live births,3,WHO / GHO,270.31
24128,3,ANGOLA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2007,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,8.2
28421,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2007,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,47.93
29853,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2007,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,198
30923,3,ANGOLA,TB case detection rate,AFR0176,2007,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,52
32440,3,ANGOLA,Prevalence of stunting in children under 5 u (%),AFR0154,2007,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,29.2
32672,3,ANGOLA,Prevalence of wasting in children under 5 u (%),AFR0155,2007,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,8.2
33998,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2007,12,Urban,2,Per 1000 live births,1,WHO/AFRO,65.51
33999,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2007,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.65
34000,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2007,29,Total,2,Per 1000 live births,1,WHO/AFRO,39.44
35839,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2007,12,Urban,2,Per 1000 live births,3,WHO / GHO,54.44
35840,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2007,11,Rural,2,Per 1000 live births,3,WHO / GHO,14
35841,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2007,29,Total,2,Per 1000 live births,3,WHO / GHO,29.25
37698,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2007,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,1.7
38566,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2007,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,15
39759,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2007,999,Not Applicable,2,Per 1000 live births,19,OECD,53.17
45138,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
45174,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,25
45212,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,51,Polio,2,Per 1000 live births,1,WHO/AFRO,8
45258,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,921
45290,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,70
45351,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,46,Measles,2,Per 1000 live births,1,WHO/AFRO,1014
45413,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,4
63103,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2007,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,147.7
140144,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2007,12,Urban,2,Per 1000 live births,7,DHS,65.51
140145,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2007,11,Rural,2,Per 1000 live births,7,DHS,23.65
140146,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2007,29,Total,2,Per 1000 live births,7,DHS,39.44
128467,3,ANGOLA,Sex ratio at birth,AFR0428,2007,28,Both sexes (male and female),4,Ratio,4,WB Database,1.02
64736,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2007,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,439
80956,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2007,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
80992,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2007,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,25
81030,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2007,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,8
81076,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2007,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,921
81108,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2007,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,70
81169,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2007,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,1014
81231,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2007,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,4
119892,3,ANGOLA,Number of road traffic injuries,AFR0140,2007,29,Total,5,Count (Numeric Integer),35,IHME,17410
138208,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2007,29,Total,5,Count (Numeric Integer),35,IHME,33414
141859,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2007,125,Biological,5,Count (Numeric Integer),35,IHME,515
142218,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2007,126,Hydrological,5,Count (Numeric Integer),35,IHME,105
145029,3,ANGOLA,Number of people living with HIV,AFR0019,2007,29,Total,5,Count (Numeric Integer),16,UNAIDS,170000
143402,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2007,29,Total,6,Per 1000 population,16,UNAIDS,1.21
62272,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2007,9,Female,7,per 100 000 live births,23,MMEIG,431
83177,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2007,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,198
69701,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2007,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,47.9
92074,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2007,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,53.16
97465,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2007,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,47.85
106157,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2007,999,Not Applicable,14,Per Capita,3,WHO / GHO,92.45
106976,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2007,999,Not Applicable,14,Per Capita,42,WDI,4.54
107794,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2007,999,Not Applicable,14,Per Capita,3,WHO / GHO,2.49
115162,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2007,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,47.85
184051,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2007,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,92.8
187515,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2007,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,2.5
190491,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2007,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,26.3
194784,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2007,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,36.5
186649,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2007,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,4.57
192223,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2007,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,48
193918,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2007,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,66.78
207298,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2007-2009,28,Both sexes (male and female),1,Percentage,5,UNICEF,49.4
11489,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2008,9,Female,1,Percentage,3,WHO / GHO,395
51547,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2008,8,Male,1,Percentage,3,WHO / GHO,7.1
51548,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2008,9,Female,1,Percentage,3,WHO / GHO,6.7
51549,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.9
67899,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2008,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,41
68621,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2008,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
68918,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2008,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
71351,3,ANGOLA,Proportion of population with large household expenditures on health (greater than 10%) as a share of total household expenditure or income (%),AFR0107,2008,29,Total,1,Percentage,13,UNStat,12.38
71400,3,ANGOLA,Proportion of population with large household expenditures on health (greater than 10%) as a share of total household expenditure or income (%),AFR0107,2008,12,Urban,1,Percentage,13,UNStat,11.9
71442,3,ANGOLA,Proportion of population with large household expenditures on health (greater than 10%) as a share of total household expenditure or income (%),AFR0107,2008,11,Rural,1,Percentage,13,UNStat,12.81
84248,3,ANGOLA,TB case detection rate,AFR0176,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,54
90574,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2008,8,Male,1,Percentage,3,WHO / GHO,30.4
90575,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2008,9,Female,1,Percentage,3,WHO / GHO,30.5
90576,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.6
92967,3,ANGOLA,GDP growth (annual %),AFR0388,2008,999,Not Applicable,1,Percentage,22,UN DESA,7.12
94349,3,ANGOLA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2008,999,Not Applicable,1,Percentage,3,WHO / GHO,67.05
96793,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2008,999,Not Applicable,1,Percentage,4,WB Database,3.61
103519,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2008,999,Not Applicable,1,Percentage,3,WHO / GHO,2.38
104958,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2008,999,Not Applicable,1,Percentage,3,WHO / GHO,19.68
110715,3,ANGOLA,TB case detection rate,AFR0176,2008,29,Total,1,Percentage,3,WHO / GHO,83
111559,3,ANGOLA,TB treatment success rate,AFR0216,2008,29,Total,1,Percentage,3,WHO / GHO,37
113106,3,ANGOLA,TB treatment coverage,AFR0173,2008,29,Total,1,Percentage,3,WHO / GHO,37
115979,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116994,3,ANGOLA,TB treatment success rate,AFR0216,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,17.8
123883,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2008,28,Both sexes (male and female),1,Percentage,35,IHME,0.81
125323,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2008,8,Male,1,Percentage,35,IHME,0.75
126763,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2008,9,Female,1,Percentage,35,IHME,0.86
131611,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,2008,28,Both sexes (male and female),1,Percentage,4,WB Database,104.13
134224,3,ANGOLA,School dropout rate,AFR0160,2008,28,Both sexes (male and female),1,Percentage,42,WDI,17.55
136819,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2008,29,Total,1,Percentage,36,WHO/UNICEF,49
138409,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2008,29,Total,1,Percentage,3,WHO / GHO,37
138410,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,17.8
146864,3,ANGOLA,Proportion of population with large household expenditures on health (greater than 25%) as a share of total household expenditure or income (%),AFR0441,2008,29,Total,1,Percentage,13,UNStat,4.54
146916,3,ANGOLA,Proportion of the population with large household expenditure on health as a share of total household consumption or income [SDG 3.8.2],AFR0052,2008,29,Total,1,Percentage,13,UNStat,12.38
146917,3,ANGOLA,Proportion of the population with large household expenditure on health as a share of total household consumption or income [SDG 3.8.2],AFR0052,2008,12,Urban,1,Percentage,13,UNStat,11.9
146918,3,ANGOLA,Proportion of the population with large household expenditure on health as a share of total household consumption or income [SDG 3.8.2],AFR0052,2008,11,Rural,1,Percentage,13,UNStat,12.81
156270,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2008,999,Not Applicable,1,Percentage,3,WHO / GHO,19.68
179348,3,ANGOLA,Access to electricity (% of population),AFR0380,2008,999,Not Applicable,1,Percentage,4,WB Database,31.2
182364,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,33.15
183230,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,3.32
184962,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,97.5
185828,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,2.48
188499,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,4.06
189365,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,4.06
191402,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,21.6
193110,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2008,999,Not Applicable,1,Percentage,10,WHO / GHED,11.5
195656,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2008,28,Both sexes (male and female),1,Percentage,35,IHME,1.73
196972,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.6
198818,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2008,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,19.3
1084,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2008,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.5
1085,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2008,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,135.21
1086,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2008,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,200.72
12446,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2008,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,39.11
14012,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2008,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,138.25
16933,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2008,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,227
18605,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2008,9,Female,2,Per 1000 live births,3,WHO / GHO,204.65
18606,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2008,8,Male,2,Per 1000 live births,3,WHO / GHO,258.33
23365,3,ANGOLA,Proportion of population with large household expenditures on health (greater than 10%) as a share of total household expenditure or income (%),AFR0107,2008,29,Total,2,Per 1000 live births,3,WHO / GHO,12.38
23414,3,ANGOLA,Proportion of population with large household expenditures on health (greater than 10%) as a share of total household expenditure or income (%),AFR0107,2008,12,Urban,2,Per 1000 live births,3,WHO / GHO,11.9
23456,3,ANGOLA,Proportion of population with large household expenditures on health (greater than 10%) as a share of total household expenditure or income (%),AFR0107,2008,11,Rural,2,Per 1000 live births,3,WHO / GHO,12.81
25489,3,ANGOLA,Adolescent birth rate [SDG 3.7.2],AFR0293,2008,9,Female,2,Per 1000 live births,1,WHO/AFRO,188
28465,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2008,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,69.18
29854,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2008,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,205
30924,3,ANGOLA,TB case detection rate,AFR0176,2008,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,54
34131,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2008,12,Urban,2,Per 1000 live births,1,WHO/AFRO,65.23
34132,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2008,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.63
34133,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2008,29,Total,2,Per 1000 live births,1,WHO/AFRO,39.65
35972,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2008,12,Urban,2,Per 1000 live births,3,WHO / GHO,55.43
35973,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2008,11,Rural,2,Per 1000 live births,3,WHO / GHO,14.92
35974,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2008,29,Total,2,Per 1000 live births,3,WHO / GHO,30.52
37699,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2008,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,1.9
38567,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2008,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,15
39760,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2008,999,Not Applicable,2,Per 1000 live births,19,OECD,31.23
44851,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,28
44891,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,51,Polio,2,Per 1000 live births,1,WHO/AFRO,29
44937,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,1148
44968,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,89
45031,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,46,Measles,2,Per 1000 live births,1,WHO/AFRO,265
45092,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2008,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,69
63104,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2008,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,138.2
140147,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2008,12,Urban,2,Per 1000 live births,7,DHS,65.23
140148,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2008,11,Rural,2,Per 1000 live births,7,DHS,23.63
140149,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2008,29,Total,2,Per 1000 live births,7,DHS,39.65
128466,3,ANGOLA,Sex ratio at birth,AFR0428,2008,28,Both sexes (male and female),4,Ratio,4,WB Database,1.02
64737,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2008,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,227
80669,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2008,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,28
80709,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2008,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,29
80755,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2008,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,1148
80786,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2008,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,89
80849,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2008,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,265
80910,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2008,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,69
119939,3,ANGOLA,Number of road traffic injuries,AFR0140,2008,29,Total,5,Count (Numeric Integer),35,IHME,18148
138256,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2008,29,Total,5,Count (Numeric Integer),35,IHME,34972
141873,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2008,125,Biological,5,Count (Numeric Integer),35,IHME,229
142245,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2008,126,Hydrological,5,Count (Numeric Integer),35,IHME,7
145075,3,ANGOLA,Number of people living with HIV,AFR0019,2008,29,Total,5,Count (Numeric Integer),16,UNAIDS,180000
102095,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2008,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,13.08
143446,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2008,29,Total,6,Per 1000 population,16,UNAIDS,1.19
62273,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2008,9,Female,7,per 100 000 live births,23,MMEIG,395
83178,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2008,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,205
70261,3,ANGOLA,Adolescent birth rate [SDG 3.7.2],AFR0293,2008,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,188
69747,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2008,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,69.1
92075,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2008,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,31.23
97464,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2008,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,44.61
106156,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2008,999,Not Applicable,14,Per Capita,3,WHO / GHO,135.2
106975,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2008,999,Not Applicable,14,Per Capita,42,WDI,5.12
107793,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2008,999,Not Applicable,14,Per Capita,3,WHO / GHO,3.37
115161,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2008,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,44.61
184096,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2008,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,135
187560,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2008,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,3.37
190536,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2008,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,29.3
194829,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2008,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,44.9
186694,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2008,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,5.14
192268,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2008,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,44.7
193963,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2008,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,68.54
200637,3,ANGOLA,Contraceptive prevalence rate,AFR0208,2008-2009,9,Female,1,Percentage,22,UN DESA,20
11490,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2009,9,Female,1,Percentage,3,WHO / GHO,359
51686,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2009,8,Male,1,Percentage,3,WHO / GHO,7.4
51687,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2009,9,Female,1,Percentage,3,WHO / GHO,6.9
51688,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.1
67945,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2009,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,34
68648,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2009,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
68959,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2009,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
84249,3,ANGOLA,TB case detection rate,AFR0176,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,48
90712,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2009,8,Male,1,Percentage,3,WHO / GHO,30.3
90713,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2009,9,Female,1,Percentage,3,WHO / GHO,30.4
90714,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.5
92968,3,ANGOLA,GDP growth (annual %),AFR0388,2009,999,Not Applicable,1,Percentage,22,UN DESA,-2.81
94443,3,ANGOLA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2009,999,Not Applicable,1,Percentage,3,WHO / GHO,75.37
96839,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2009,999,Not Applicable,1,Percentage,4,WB Database,3.78
103518,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2009,999,Not Applicable,1,Percentage,3,WHO / GHO,3.02
104957,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2009,999,Not Applicable,1,Percentage,3,WHO / GHO,29.45
110761,3,ANGOLA,TB case detection rate,AFR0176,2009,29,Total,1,Percentage,3,WHO / GHO,73
111604,3,ANGOLA,TB treatment success rate,AFR0216,2009,29,Total,1,Percentage,3,WHO / GHO,41
113152,3,ANGOLA,TB treatment coverage,AFR0173,2009,29,Total,1,Percentage,3,WHO / GHO,41
115980,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116993,3,ANGOLA,TB treatment success rate,AFR0216,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,20.5
123931,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2009,28,Both sexes (male and female),1,Percentage,35,IHME,0.8
125371,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2009,8,Male,1,Percentage,35,IHME,0.75
126811,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2009,9,Female,1,Percentage,35,IHME,0.85
131612,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,2009,28,Both sexes (male and female),1,Percentage,4,WB Database,105.78
134225,3,ANGOLA,School dropout rate,AFR0160,2009,28,Both sexes (male and female),1,Percentage,42,WDI,18.74
136866,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2009,29,Total,1,Percentage,36,WHO/UNICEF,50
138411,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2009,29,Total,1,Percentage,3,WHO / GHO,41
138412,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,20.5
156269,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2009,999,Not Applicable,1,Percentage,3,WHO / GHO,29.45
179349,3,ANGOLA,Access to electricity (% of population),AFR0380,2009,999,Not Applicable,1,Percentage,4,WB Database,32.3
182409,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,28.49
183275,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,3.84
185007,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,96.1
185873,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,3.82
188544,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,5.77
189410,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,5.77
191447,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,15.5
193154,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2009,999,Not Applicable,1,Percentage,10,WHO / GHED,12.9
195657,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2009,28,Both sexes (male and female),1,Percentage,35,IHME,1.85
196973,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.9
198819,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2009,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,19.8
1219,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,3.58
1220,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2009,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,119.81
1221,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2009,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,204.65
3869,3,ANGOLA,Physicians density (per 1000 population),AFR0287,2009,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0.14
4109,3,ANGOLA,Other health workers density (per 1000 population),AFR0066,2009,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.27
4286,3,ANGOLA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2009,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,1.44
12447,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2009,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,37.72
14013,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2009,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,129.02
16934,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2009,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,73
18607,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2009,9,Female,2,Per 1000 live births,3,WHO / GHO,190.96
18608,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2009,8,Male,2,Per 1000 live births,3,WHO / GHO,246.34
25488,3,ANGOLA,Adolescent birth rate [SDG 3.7.2],AFR0293,2009,9,Female,2,Per 1000 live births,1,WHO/AFRO,190.9
28508,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2009,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,52.02
29855,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2009,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,183
30925,3,ANGOLA,TB case detection rate,AFR0176,2009,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,48
34264,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2009,12,Urban,2,Per 1000 live births,1,WHO/AFRO,64.94
34265,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2009,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.61
34266,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2009,29,Total,2,Per 1000 live births,1,WHO/AFRO,39.85
36105,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2009,12,Urban,2,Per 1000 live births,3,WHO / GHO,56.41
36106,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2009,11,Rural,2,Per 1000 live births,3,WHO / GHO,15.84
36107,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2009,29,Total,2,Per 1000 live births,3,WHO / GHO,31.79
37700,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2009,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,2.3
38568,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2009,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,37.27
39761,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2009,999,Not Applicable,2,Per 1000 live births,19,OECD,39.2
44524,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,10
44562,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,51,Polio,2,Per 1000 live births,1,WHO/AFRO,29
44608,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,1127
44639,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,66
44684,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,0
44701,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2009,46,Measles,2,Per 1000 live births,1,WHO/AFRO,2807
63105,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2009,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,129
140150,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2009,12,Urban,2,Per 1000 live births,7,DHS,64.94
140151,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2009,11,Rural,2,Per 1000 live births,7,DHS,23.61
140152,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2009,29,Total,2,Per 1000 live births,7,DHS,39.85
128465,3,ANGOLA,Sex ratio at birth,AFR0428,2009,28,Both sexes (male and female),4,Ratio,4,WB Database,1.02
64738,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2009,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,73
80342,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2009,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,10
80380,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2009,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,29
80426,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2009,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,1127
80457,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2009,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,66
80502,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2009,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,0
80519,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2009,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,2807
119986,3,ANGOLA,Number of road traffic injuries,AFR0140,2009,29,Total,5,Count (Numeric Integer),35,IHME,18899
138304,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2009,29,Total,5,Count (Numeric Integer),35,IHME,36580
141895,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2009,125,Biological,5,Count (Numeric Integer),35,IHME,9
142265,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2009,126,Hydrological,5,Count (Numeric Integer),35,IHME,2
145121,3,ANGOLA,Number of people living with HIV,AFR0019,2009,29,Total,5,Count (Numeric Integer),16,UNAIDS,200000
179017,3,ANGOLA,Number of medical doctors,AFR0469,2009,29,Total,5,Count (Numeric Integer),3,WHO / GHO,2956
76637,3,ANGOLA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2009,999,Not Applicable,6,Per 1000 population,38,Global Health Workforce Statistics,131.44
102096,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2009,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,12.36
121584,3,ANGOLA,Other health workers density (per 1000 population),AFR0066,2009,29,Total,6,Per 1000 population,3,WHO / GHO,0.31
143490,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2009,29,Total,6,Per 1000 population,16,UNAIDS,1.18
62274,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2009,9,Female,7,per 100 000 live births,23,MMEIG,359
83179,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2009,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,183
70260,3,ANGOLA,Adolescent birth rate [SDG 3.7.2],AFR0293,2009,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,190.9
69793,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2009,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,52
92076,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2009,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,39.19
97463,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2009,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,36.23
151817,3,ANGOLA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2009,1002,Nursing and midwifery personnel,13,Per 10 000 population,3,WHO / GHO,13.1
151818,3,ANGOLA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2009,1001,Medical doctors,13,Per 10 000 population,3,WHO / GHO,1.31
106155,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2009,999,Not Applicable,14,Per Capita,3,WHO / GHO,119.8
106974,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2009,999,Not Applicable,14,Per Capita,42,WDI,8.94
107792,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2009,999,Not Applicable,14,Per Capita,3,WHO / GHO,4.59
115160,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2009,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,36.23
184141,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2009,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,119
187605,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2009,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,4.59
190581,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2009,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,18.6
194874,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2009,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,34.1
186739,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2009,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,8.96
192313,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2009,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,36.3
194008,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2009,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,66.72
10577,3,ANGOLA,Number of people living with HIV,AFR0019,2010,28,Both sexes (male and female),1,Percentage,16,UNAIDS,220000
11491,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2010,9,Female,1,Percentage,3,WHO / GHO,326
51826,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2010,8,Male,1,Percentage,3,WHO / GHO,7.6
51827,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2010,9,Female,1,Percentage,3,WHO / GHO,7.1
51828,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.3
67991,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2010,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,52
68675,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2010,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
69000,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2010,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
71956,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2010,28,Both sexes (male and female),1,Percentage,16,UNAIDS,10
72424,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2010,9,Female,1,Percentage,16,UNAIDS,19
73412,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,62
75765,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,79
75782,3,ANGOLA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2010,999,Not Applicable,1,Percentage,3,WHO / GHO,71.03
84250,3,ANGOLA,TB case detection rate,AFR0176,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,50
91868,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,52
95699,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2010,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,52
96885,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2010,999,Not Applicable,1,Percentage,4,WB Database,9.43
98503,3,ANGOLA,Immunization coverage against Tetanus,AFR0189,2010,28,Both sexes (male and female),1,Percentage,4,WB Database,51
102385,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2010,999,Not Applicable,1,Percentage,4,WB Database,19.34
103517,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2010,999,Not Applicable,1,Percentage,3,WHO / GHO,2.35
109783,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2010,999,Not Applicable,1,Percentage,3,WHO / GHO,27.75
110807,3,ANGOLA,TB case detection rate,AFR0176,2010,29,Total,1,Percentage,3,WHO / GHO,75
111648,3,ANGOLA,TB treatment success rate,AFR0216,2010,29,Total,1,Percentage,3,WHO / GHO,48
113197,3,ANGOLA,TB treatment coverage,AFR0173,2010,29,Total,1,Percentage,3,WHO / GHO,48
115981,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116992,3,ANGOLA,TB treatment success rate,AFR0216,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,24.5
123979,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2010,28,Both sexes (male and female),1,Percentage,35,IHME,0.8
125419,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2010,8,Male,1,Percentage,35,IHME,0.74
126859,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2010,9,Female,1,Percentage,35,IHME,0.85
131613,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,2010,28,Both sexes (male and female),1,Percentage,4,WB Database,119.53
133450,3,ANGOLA,Proportion of urban population living in slums (%),AFR0118,2010,28,Both sexes (male and female),1,Percentage,4,WB Database,65.8
133667,3,ANGOLA,"Proportion of total government spending on essential services (education, health and social protection[SDG1.a.2]",AFR0419,2010,999,Not Applicable,1,Percentage,51,UNESCO/IMF,8.68
134226,3,ANGOLA,School dropout rate,AFR0160,2010,28,Both sexes (male and female),1,Percentage,42,WDI,18.09
136913,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2010,29,Total,1,Percentage,36,WHO/UNICEF,51
138413,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2010,29,Total,1,Percentage,3,WHO / GHO,48
138414,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,24.5
141109,3,ANGOLA,Effective PMTCT coverage,AFR0213,2010,9,Female,1,Percentage,16,UNAIDS,19
148182,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2010,107,Female (10-14 years),1,Percentage,35,IHME,140.57
149912,3,ANGOLA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2010,9,Female,1,Percentage,16,UNAIDS,31.26
150924,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2010,66,Female (15-49 years),1,Percentage,35,IHME,51.6
156268,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2010,999,Not Applicable,1,Percentage,3,WHO / GHO,27.75
179350,3,ANGOLA,Access to electricity (% of population),AFR0380,2010,999,Not Applicable,1,Percentage,4,WB Database,33.3
182454,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,34.63
183320,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,2.69
185052,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,96.7
185918,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,3.24
188589,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,4.24
189455,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,4.24
191492,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,19.3
193198,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2010,999,Not Applicable,1,Percentage,10,WHO / GHED,15.2
195334,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2010,28,Both sexes (male and female),1,Percentage,37,IDF,3.5
195658,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2010,28,Both sexes (male and female),1,Percentage,35,IHME,1.98
196974,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.2
198820,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2010,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,20.4
207918,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2010,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,62
1354,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,2.74
1355,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2010,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,96.64
1356,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2010,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,158.17
2623,3,ANGOLA,Total density per million population: Magnetic Resonance Imaging,AFR0081,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.05
2693,3,ANGOLA,Total density per million population: Computed tomography units,AFR0078,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.47
2767,3,ANGOLA,Total density per million population: Positron Emission tomography,AFR0082,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
2830,3,ANGOLA,Total density per million population: Gamma camera or Nuclear medicine,AFR0079,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
2898,3,ANGOLA,Total density per million population: Linear Accelerator (numeric),AFR0080,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
2970,3,ANGOLA,Total density per million population: Telecobalt Unit,AFR0084,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.05
3043,3,ANGOLA,Total density per million population: Radiotherapy units,AFR0083,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.05
3116,3,ANGOLA,Total density per million females aged from 50 to 69 years old: Mammography units,AFR0077,2010,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,6.98
3498,3,ANGOLA,Total density per 100 000 population: Provincial hospitals,AFR0075,2010,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0
3562,3,ANGOLA,Total density per 100 000 population: Specialized hospitals,AFR0076,2010,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,0
4531,3,ANGOLA,GDP growth (annual %),AFR0388,2010,999,Not Applicable,2,Per 1000 live births,22,UN DESA,1.18
5203,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,270
5532,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,233
5861,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,307
6291,3,ANGOLA,TB mortality rate (per 100 000 population),AFR0013,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,74
6655,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,57.13
6742,3,ANGOLA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,1.7
7622,3,ANGOLA,Life expectancy at birth (years),AFR0381,2010,8,Male,2,Per 1000 live births,1,WHO/AFRO,56.1
7951,3,ANGOLA,Life expectancy at birth (years),AFR0381,2010,9,Female,2,Per 1000 live births,1,WHO/AFRO,60.7
8280,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,16.7
8609,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2010,8,Male,2,Per 1000 live births,1,WHO/AFRO,15.8
8938,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2010,9,Female,2,Per 1000 live births,1,WHO/AFRO,17.4
9259,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,51.8
9400,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,49.9
9541,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,53.7
9682,3,ANGOLA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,12.8
9823,3,ANGOLA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,12.1
9964,3,ANGOLA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,13.4
10163,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.9
11025,3,ANGOLA,Population size (in thousands) total,AFR0004,2010,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,23356.25
12448,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,36.36
14014,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,120.49
15974,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2010,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,5.7
16214,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,8.7
16454,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,2.8
16694,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,5.7
16935,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,86
17200,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,58.4
17529,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,56.1
17858,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,60.7
18191,3,ANGOLA,Malaria mortality rate (per 100 000 population),AFR0015,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,57.13
18298,3,ANGOLA,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,18.1
18609,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,178.21
18610,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,234.75
20410,3,ANGOLA,TB incidence rate [SDG 3.3.2],AFR0334,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,384
21139,3,ANGOLA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,133.76
21324,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2010,8,Male,2,Per 1000 live births,3,WHO / GHO,30.2
21325,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2010,9,Female,2,Per 1000 live births,3,WHO / GHO,30.3
21326,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,30.4
22594,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.7
23239,3,ANGOLA,Anaemia prevalence in children,AFR0300,2010,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,54.8
23648,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2010,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,15879207
25204,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,79
25976,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2010,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,3.5
25977,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2010,9,Female,2,Per 1000 live births,20,ITU,2.6
25978,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2010,8,Male,2,Per 1000 live births,20,ITU,4.4
26854,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,62
27284,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,56
27615,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,52
28046,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2010,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,85
28551,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2010,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,57.39
29195,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2010,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,19
29405,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,10
29856,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,191
30664,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,513
30926,3,ANGOLA,TB case detection rate,AFR0176,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,50
31767,3,ANGOLA,HIV test results for registered new and relapse TB patients,AFR0171,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,2434
34397,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2010,12,Urban,2,Per 1000 live births,1,WHO/AFRO,64.66
34398,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2010,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.59
34399,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2010,29,Total,2,Per 1000 live births,1,WHO/AFRO,40.06
36238,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2010,12,Urban,2,Per 1000 live births,3,WHO / GHO,57.4
36239,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2010,11,Rural,2,Per 1000 live births,3,WHO / GHO,16.77
36240,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2010,29,Total,2,Per 1000 live births,3,WHO / GHO,33.06
37701,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2010,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,2.8
38569,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2010,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,38.64
39762,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2010,999,Not Applicable,2,Per 1000 live births,19,OECD,24.83
41057,3,ANGOLA,DTP dropout rate (DTP1 -DPT3),AFR0226,2010,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,33
44167,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
44202,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,38
44238,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,51,Polio,2,Per 1000 live births,1,WHO/AFRO,33
44282,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,2539
44313,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,13
44357,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,47,Mumps,2,Per 1000 live births,1,WHO/AFRO,0
44375,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010,46,Measles,2,Per 1000 live births,1,WHO/AFRO,1190
63106,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2010,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,120.4
140153,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2010,12,Urban,2,Per 1000 live births,7,DHS,64.66
140154,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2010,11,Rural,2,Per 1000 live births,7,DHS,23.59
140155,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2010,29,Total,2,Per 1000 live births,7,DHS,40.06
141110,3,ANGOLA,Effective PMTCT coverage,AFR0213,2010,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,19
94765,3,ANGOLA,Availability of national list of approved medical devices for procurement or reimbursement,AFR0059,2010,999,Not Applicable,3,String,3,WHO / GHO,\N
94847,3,ANGOLA,Availability of national standards or recommended lists of medical devices,AFR0060,2010,999,Not Applicable,3,String,3,WHO / GHO,\N
94926,3,ANGOLA,Availability of technical specifications of medical devices to support procurement or donations,AFR0061,2010,999,Not Applicable,3,String,3,WHO / GHO,\N
95008,3,ANGOLA,Types of lists recommending health technology for high burden diseases,AFR0085,2010,999,Not Applicable,3,String,3,WHO / GHO,\N
118694,3,ANGOLA,Presence and quality of national M&E plan / HIS strategic plan / digital health strategy,AFR0234,2010,29,Total,3,String,20,ITU,\N
128464,3,ANGOLA,Sex ratio at birth,AFR0428,2010,28,Both sexes (male and female),4,Ratio,4,WB Database,1.03
64739,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2010,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,86
71540,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2010,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,15879207
79985,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2010,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
80020,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2010,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,38
80056,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2010,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,33
80100,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2010,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,2539
80131,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2010,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,13
80175,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2010,58,Mumps,5,Count (Numeric Integer),3,WHO / GHO,0
80193,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2010,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,1190
85091,3,ANGOLA,HIV test results for registered new and relapse TB patients,AFR0171,2010,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,2434
120033,3,ANGOLA,Number of road traffic injuries,AFR0140,2010,29,Total,5,Count (Numeric Integer),35,IHME,19652
138352,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2010,29,Total,5,Count (Numeric Integer),35,IHME,38486
142287,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2010,126,Hydrological,5,Count (Numeric Integer),35,IHME,7
145167,3,ANGOLA,Number of people living with HIV,AFR0019,2010,29,Total,5,Count (Numeric Integer),16,UNAIDS,220000
152661,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,70,0-4 years,5,Count (Numeric Integer),17,UN Population,4472076
152894,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,71,5-9 years,5,Count (Numeric Integer),17,UN Population,3579519
153127,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,72,10-14 years,5,Count (Numeric Integer),17,UN Population,2935562
153358,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,73,15-19 years,5,Count (Numeric Integer),17,UN Population,2490136
153589,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,74,20-24 years,5,Count (Numeric Integer),17,UN Population,2110233
153822,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,75,25-29 years,5,Count (Numeric Integer),17,UN Population,1725665
154053,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,76,30-34 years,5,Count (Numeric Integer),17,UN Population,1397912
154285,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,77,35-39 years,5,Count (Numeric Integer),17,UN Population,1154723
154518,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,78,40-44 years,5,Count (Numeric Integer),17,UN Population,859934
154749,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,79,45-49 years,5,Count (Numeric Integer),17,UN Population,769515
154981,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,80,50-54 years,5,Count (Numeric Integer),17,UN Population,580175
155215,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,81,55-59 years,5,Count (Numeric Integer),17,UN Population,402447
155447,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,82,60-64 years,5,Count (Numeric Integer),17,UN Population,326965
155677,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,83,65-69 years,5,Count (Numeric Integer),17,UN Population,233124
155908,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,84,70-74 years,5,Count (Numeric Integer),17,UN Population,168002
156140,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,85,75-79 years,5,Count (Numeric Integer),17,UN Population,94605
177481,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,86,80-84 years,5,Count (Numeric Integer),17,UN Population,41344
177712,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,1010,85-89 years,5,Count (Numeric Integer),17,UN Population,11426
178024,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,1011,90-94 years,5,Count (Numeric Integer),17,UN Population,2554
178259,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,1012,95-99 years,5,Count (Numeric Integer),17,UN Population,305
178494,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2010,1009,100+ years,5,Count (Numeric Integer),17,UN Population,25
195468,3,ANGOLA,Number of deaths attributable to diabetes,AFR0474,2010,28,Both sexes (male and female),5,Count (Numeric Integer),37,IDF,4791
47247,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2010,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,10.4
98446,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2010,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,11.68
99628,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2010,6,Adult (15+ Years),6,Per 1000 population,16,UNAIDS,1.5
100056,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2010,45,Male (15+ years),6,Per 1000 population,16,UNAIDS,1
100484,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2010,42,Female (15+ years),6,Per 1000 population,16,UNAIDS,2.1
100912,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2010,37,Both sexes (15-24 years),6,Per 1000 population,16,UNAIDS,0.9
101302,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2010,35,Male (15-24 years),6,Per 1000 population,16,UNAIDS,0.4
101692,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2010,36,Female (15-24 years),6,Per 1000 population,16,UNAIDS,1.4
143534,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2010,29,Total,6,Per 1000 population,16,UNAIDS,1.16
62275,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2010,9,Female,7,per 100 000 live births,23,MMEIG,326
47474,3,ANGOLA,AIDS-related mortality rate (per 100 000 population),AFR0014,2010,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,42.81
70747,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2010,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,3.5
70748,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2010,9,Female,8,Per 100 000 population,13,UNStat,2.6
70749,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2010,8,Male,8,Per 100 000 population,13,UNStat,4.4
83180,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2010,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,191
83988,3,ANGOLA,"TB prevalence rate per 100,000 population per year",AFR0332,2010,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,513
104410,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2010,8,Male,8,Per 100 000 population,3,WHO / GHO,18.1
104411,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2010,9,Female,8,Per 100 000 population,3,WHO / GHO,3.8
108604,3,ANGOLA,Malaria mortality rate (per 100 000 population),AFR0015,2010,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,57.31
109166,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2010,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,10.8
120844,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2010,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,18.1
121084,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2010,8,Male,8,Per 100 000 population,3,WHO / GHO,18.6
121324,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2010,9,Female,8,Per 100 000 population,3,WHO / GHO,17.8
69839,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2010,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,57.3
92077,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2010,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,24.83
97462,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2010,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,32.46
113760,3,ANGOLA,Total Health Expenditure (constant US$),AFR0349,2010,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,2712.83
114220,3,ANGOLA,Total Health Expenditure (International US$),AFR0348,2010,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,2258.47
106154,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2010,999,Not Applicable,14,Per Capita,3,WHO / GHO,96.64
106973,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2010,999,Not Applicable,14,Per Capita,42,WDI,5.44
107791,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2010,999,Not Applicable,14,Per Capita,3,WHO / GHO,3.14
114693,3,ANGOLA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2010,999,Not Applicable,14,Per Capita,4,WB Database,167.82
115159,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2010,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,32.46
127864,3,ANGOLA,Life expectancy at birth (years),AFR0381,2010,28,Both sexes (male and female),17,years,4,WB Database,55.35
213172,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2010,28,Both sexes (male and female),23,Numeric,75,WHO/GHO_2021,50.6
213360,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2010,8,Male,23,Numeric,75,WHO/GHO_2021,49.3
213548,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2010,9,Female,23,Numeric,75,WHO/GHO_2021,52
184186,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2010,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,96.6
187650,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2010,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,3.13
190626,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2010,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,18.7
194919,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2010,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,33.4
186784,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2010,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,5.45
192358,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2010,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,32.4
194053,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2010,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,58.16
122320,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2010-2015,28,Both sexes (male and female),1,Percentage,17,UN Population,15.07
122608,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2010-2015,8,Male,1,Percentage,17,UN Population,13.89
122896,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2010-2015,9,Female,1,Percentage,17,UN Population,16.06
130581,3,ANGOLA,Total fertility rate,AFR0130,2010-2015,9,Female,1,Percentage,17,UN Population,6
149503,3,ANGOLA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2010-2016,9,Female,1,Percentage,7,DHS,3.7
207299,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010-2016,28,Both sexes (male and female),1,Percentage,5,UNICEF,46.6
131195,3,ANGOLA,Proportion of women aged 20-24 years who were married or in a union by age 18 (%),AFR0102,2010-2017,9,Female,1,Percentage,3,WHO / GHO,30
131239,3,ANGOLA,Proportion of women aged 20-24 years who were married or in a union before age 15 (%),AFR0382,2010-2017,9,Female,1,Percentage,3,WHO / GHO,8
135466,3,ANGOLA,"Proportion of ever-partnered women and girls subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months, by age (%)",AFR0101,2010-2017,9,Female,1,Percentage,3,WHO / GHO,26
130045,3,ANGOLA,Proportion of population with large household expenditures on health (greater than 10%) as a share of total household expenditure or income (%),AFR0107,2010-2018,999,Not Applicable,1,Percentage,3,WHO / GHO,\N
130093,3,ANGOLA,Proportion of the population with large household expenditure on health as a share of total household consumption or income [SDG 3.8.2],AFR0052,2010-2018,999,Not Applicable,1,Percentage,3,WHO / GHO,\N
22723,3,ANGOLA,Prevalence of exclusive breastfeeding in infants aged six months or less (Exclusive BF),AFR0306,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,37.4
22770,3,ANGOLA,Early initiation of breastfeeding (%),AFR0305,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,48.3
22816,3,ANGOLA,Children under 5 years who are stunted [SDG 2.2.1],AFR0303,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,37.6
22864,3,ANGOLA,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,3.4
22911,3,ANGOLA,Incidence of low birth weight among newborns,AFR0304,2010-2018,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,12.2
130509,3,ANGOLA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2010-2018,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,0.41
129949,3,ANGOLA,"Adolescent birth rate (per 1,000 women aged 15-19 years)",AFR0106,2010-2018,28,Both sexes (male and female),9,Per 1000 women aged 15-19 years,3,WHO / GHO,163
130461,3,ANGOLA,Density of medical doctors (per 10 000 population),AFR0434,2010-2018,28,Both sexes (male and female),13,Per 10 000 population,3,WHO / GHO,2.1
135258,3,ANGOLA,"Pharmacists (per 10,000 population)",AFR0253,2010-2018,28,Both sexes (male and female),13,Per 10 000 population,3,WHO / GHO,\N
129796,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2010-2019,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,47
129901,3,ANGOLA,Proportion of women married or in a union of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (% of women aged 15-49 years),AFR0105,2010-2019,9,Female,1,Percentage,3,WHO / GHO,29.8
130423,3,ANGOLA,Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis [SDG 3.b.3],AFR0399,2010-2019,999,Not Applicable,1,Percentage,3,WHO / GHO,\N
135274,3,ANGOLA,Prevalence of wasting in children under 5 u (%),AFR0155,2010-2019,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.9
135322,3,ANGOLA,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2010-2019,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.4
135370,3,ANGOLA,Prevalence of stunting in children under 5 u (%),AFR0154,2010-2019,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,37.6
135211,3,ANGOLA,Density of dentists (per 10 000 population ),AFR0435,2010-2019,28,Both sexes (male and female),13,Per 10 000 population,3,WHO / GHO,\N
10623,3,ANGOLA,Number of people living with HIV,AFR0019,2011,28,Both sexes (male and female),1,Percentage,16,UNAIDS,230000
11492,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2011,9,Female,1,Percentage,3,WHO / GHO,300
51966,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2011,8,Male,1,Percentage,3,WHO / GHO,7.8
51967,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2011,9,Female,1,Percentage,3,WHO / GHO,7.3
51968,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.5
68037,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2011,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,46
68702,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2011,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
69041,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2011,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
72001,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2011,28,Both sexes (male and female),1,Percentage,16,UNAIDS,11
72465,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2011,9,Female,1,Percentage,16,UNAIDS,13
73365,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,57
74236,3,ANGOLA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2011,999,Not Applicable,1,Percentage,3,WHO / GHO,41
75751,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,74
75870,3,ANGOLA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2011,999,Not Applicable,1,Percentage,3,WHO / GHO,70.08
84251,3,ANGOLA,TB case detection rate,AFR0176,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,51
91821,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,46
95654,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2011,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,46
96931,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2011,999,Not Applicable,1,Percentage,4,WB Database,7.36
98504,3,ANGOLA,Immunization coverage against Tetanus,AFR0189,2011,28,Both sexes (male and female),1,Percentage,4,WB Database,52
102386,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2011,999,Not Applicable,1,Percentage,4,WB Database,17.99
103516,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2011,999,Not Applicable,1,Percentage,3,WHO / GHO,2.42
109782,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2011,999,Not Applicable,1,Percentage,3,WHO / GHO,24.99
110852,3,ANGOLA,TB case detection rate,AFR0176,2011,29,Total,1,Percentage,3,WHO / GHO,76
111693,3,ANGOLA,TB treatment success rate,AFR0216,2011,29,Total,1,Percentage,3,WHO / GHO,27
113242,3,ANGOLA,TB treatment coverage,AFR0173,2011,29,Total,1,Percentage,3,WHO / GHO,27
115982,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116991,3,ANGOLA,TB treatment success rate,AFR0216,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,14.6
124027,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2011,28,Both sexes (male and female),1,Percentage,35,IHME,0.8
125467,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2011,8,Male,1,Percentage,35,IHME,0.74
126907,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2011,9,Female,1,Percentage,35,IHME,0.86
134227,3,ANGOLA,School dropout rate,AFR0160,2011,28,Both sexes (male and female),1,Percentage,42,WDI,18.4
136960,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2011,29,Total,1,Percentage,36,WHO/UNICEF,52
138415,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2011,29,Total,1,Percentage,3,WHO / GHO,27
138416,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,14.6
141111,3,ANGOLA,Effective PMTCT coverage,AFR0213,2011,9,Female,1,Percentage,16,UNAIDS,13
148183,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2011,107,Female (10-14 years),1,Percentage,35,IHME,136.71
149913,3,ANGOLA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2011,9,Female,1,Percentage,16,UNAIDS,31.55
150925,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2011,66,Female (15-49 years),1,Percentage,35,IHME,48.21
156267,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2011,999,Not Applicable,1,Percentage,3,WHO / GHO,24.99
177267,3,ANGOLA,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,2011,999,Not Applicable,1,Percentage,40,National Health Account Report,0
179351,3,ANGOLA,Access to electricity (% of population),AFR0380,2011,999,Not Applicable,1,Percentage,4,WB Database,34.6
180268,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,1015,<12 months,1,Percentage,30,MIS,37.8
180269,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,1018,12-23 months,1,Percentage,30,MIS,29.6
180270,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,1019,24-35 months,1,Percentage,30,MIS,26.6
180271,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,1020,36-47 months,1,Percentage,30,MIS,20
180272,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,1021,48-59 months,1,Percentage,30,MIS,16.7
180848,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,29,Total,1,Percentage,30,MIS,25.9
180849,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,8,Male,1,Percentage,30,MIS,25.4
180850,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,9,Female,1,Percentage,30,MIS,26.4
180851,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,12,Urban,1,Percentage,30,MIS,28.9
180852,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,11,Rural,1,Percentage,30,MIS,24.4
181428,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,1022,Lowest,1,Percentage,30,MIS,13.3
181429,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,20,Second Quintile,1,Percentage,30,MIS,22.7
181430,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,1023,Middle,1,Percentage,30,MIS,34.6
181431,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,22,Fourth Quintile,1,Percentage,30,MIS,33.5
181432,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2011,1024,Highest,1,Percentage,30,MIS,27.3
182500,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,32.38
183366,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,2.64
185098,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,97.1
185964,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,2.86
188635,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,4.58
189501,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,4.58
191538,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,17.9
193243,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2011,999,Not Applicable,1,Percentage,10,WHO / GHED,14.3
195659,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2011,28,Both sexes (male and female),1,Percentage,35,IHME,2.13
196975,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.5
198821,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2011,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,21
207919,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2011,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,57
1492,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,2.84
1493,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2011,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,122.12
1494,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2011,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,167.92
4578,3,ANGOLA,GDP growth (annual %),AFR0388,2011,999,Not Applicable,2,Per 1000 live births,22,UN DESA,-0.16
5202,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,260
5531,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2011,9,Female,2,Per 1000 live births,3,WHO / GHO,224
5860,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2011,8,Male,2,Per 1000 live births,3,WHO / GHO,298
6290,3,ANGOLA,TB mortality rate (per 100 000 population),AFR0013,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,72
6788,3,ANGOLA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,1.8
7621,3,ANGOLA,Life expectancy at birth (years),AFR0381,2011,8,Male,2,Per 1000 live births,1,WHO/AFRO,57.2
7950,3,ANGOLA,Life expectancy at birth (years),AFR0381,2011,9,Female,2,Per 1000 live births,1,WHO/AFRO,61.8
8279,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,16.9
8608,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2011,8,Male,2,Per 1000 live births,1,WHO/AFRO,16
8937,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2011,9,Female,2,Per 1000 live births,1,WHO/AFRO,17.6
10209,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.9
11073,3,ANGOLA,Population size (in thousands) total,AFR0004,2011,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,24220.66
12449,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,35.03
14015,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,112.5
15502,3,ANGOLA,AIDS-related mortality rate (per 100 000 population),AFR0014,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,45.41
16936,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,245
17199,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,59.5
17528,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2011,8,Male,2,Per 1000 live births,3,WHO / GHO,57.2
17857,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2011,9,Female,2,Per 1000 live births,3,WHO / GHO,61.8
18611,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2011,9,Female,2,Per 1000 live births,3,WHO / GHO,167.08
18612,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2011,8,Male,2,Per 1000 live births,3,WHO / GHO,224.61
20411,3,ANGOLA,TB incidence rate [SDG 3.3.2],AFR0334,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,383
21094,3,ANGOLA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,125.54
21462,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2011,8,Male,2,Per 1000 live births,3,WHO / GHO,30.1
21463,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2011,9,Female,2,Per 1000 live births,3,WHO / GHO,30.2
21464,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,30.2
23192,3,ANGOLA,Anaemia prevalence in children,AFR0300,2011,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,54
23649,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2011,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,16066272
25157,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,74
26807,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,57
27237,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,50
27568,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,46
27999,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2011,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,79
28594,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2011,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,38.89
29236,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2011,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,13
29450,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,11
29857,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,195
30710,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,510
30927,3,ANGOLA,TB case detection rate,AFR0176,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,51
31768,3,ANGOLA,HIV test results for registered new and relapse TB patients,AFR0171,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,5107
34530,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2011,12,Urban,2,Per 1000 live births,1,WHO/AFRO,64.38
34531,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2011,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.57
34532,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2011,29,Total,2,Per 1000 live births,1,WHO/AFRO,40.26
36371,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2011,12,Urban,2,Per 1000 live births,3,WHO / GHO,58.39
36372,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2011,11,Rural,2,Per 1000 live births,3,WHO / GHO,17.69
36373,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2011,29,Total,2,Per 1000 live births,3,WHO / GHO,34.34
37702,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2011,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,3.1
38570,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2011,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,38.64
39763,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2011,999,Not Applicable,2,Per 1000 live births,19,OECD,25.02
41010,3,ANGOLA,DTP dropout rate (DTP1 -DPT3),AFR0226,2011,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,21
43834,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
43872,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,24
43911,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,51,Polio,2,Per 1000 live births,1,WHO/AFRO,5
43958,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,1554
43989,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,75
44050,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,46,Measles,2,Per 1000 live births,1,WHO/AFRO,1449
44095,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
44112,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2011,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,0
63107,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2011,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,112.5
140156,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2011,12,Urban,2,Per 1000 live births,7,DHS,64.38
140157,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2011,11,Rural,2,Per 1000 live births,7,DHS,23.57
140158,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2011,29,Total,2,Per 1000 live births,7,DHS,40.26
141112,3,ANGOLA,Effective PMTCT coverage,AFR0213,2011,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,13
128463,3,ANGOLA,Sex ratio at birth,AFR0428,2011,28,Both sexes (male and female),4,Ratio,4,WB Database,1.03
64740,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2011,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,245
71541,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2011,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,16066272
79652,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2011,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
79690,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2011,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,24
79729,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2011,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,5
79776,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2011,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,1554
79807,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2011,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,75
79868,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2011,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,1449
79913,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2011,56,Japanese encephalitis,5,Count (Numeric Integer),3,WHO / GHO,0
79930,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2011,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,0
85092,3,ANGOLA,HIV test results for registered new and relapse TB patients,AFR0171,2011,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,5107
120080,3,ANGOLA,Number of road traffic injuries,AFR0140,2011,29,Total,5,Count (Numeric Integer),35,IHME,20401
139670,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2011,29,Total,5,Count (Numeric Integer),35,IHME,40162
142312,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2011,126,Hydrological,5,Count (Numeric Integer),35,IHME,17
145213,3,ANGOLA,Number of people living with HIV,AFR0019,2011,29,Total,5,Count (Numeric Integer),16,UNAIDS,230000
47294,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2011,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,9.94
99670,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2011,6,Adult (15+ Years),6,Per 1000 population,16,UNAIDS,1.6
100098,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2011,45,Male (15+ years),6,Per 1000 population,16,UNAIDS,1
100526,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2011,42,Female (15+ years),6,Per 1000 population,16,UNAIDS,2.2
100951,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2011,37,Both sexes (15-24 years),6,Per 1000 population,16,UNAIDS,0.9
101341,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2011,35,Male (15-24 years),6,Per 1000 population,16,UNAIDS,0.4
101732,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2011,36,Female (15-24 years),6,Per 1000 population,16,UNAIDS,1.4
102097,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2011,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,11.03
143578,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2011,29,Total,6,Per 1000 population,16,UNAIDS,1.15
62276,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2011,9,Female,7,per 100 000 live births,23,MMEIG,300
83181,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2011,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,195
84034,3,ANGOLA,"TB prevalence rate per 100,000 population per year",AFR0332,2011,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,510
108605,3,ANGOLA,Malaria mortality rate (per 100 000 population),AFR0015,2011,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,52.85
69885,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2011,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,38.8
92078,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2011,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,25.01
97461,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2011,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,30.21
113761,3,ANGOLA,Total Health Expenditure (constant US$),AFR0349,2011,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,2755.48
114221,3,ANGOLA,Total Health Expenditure (International US$),AFR0348,2011,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,2957.51
106153,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2011,999,Not Applicable,14,Per Capita,3,WHO / GHO,122.1
106972,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2011,999,Not Applicable,14,Per Capita,42,WDI,4.8
107790,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2011,999,Not Applicable,14,Per Capita,3,WHO / GHO,3.49
114692,3,ANGOLA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2011,999,Not Applicable,14,Per Capita,4,WB Database,167.91
115158,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2011,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,30.21
127865,3,ANGOLA,Life expectancy at birth (years),AFR0381,2011,28,Both sexes (male and female),17,years,4,WB Database,56.33
184232,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2011,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,122
187696,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2011,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,3.49
190672,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2011,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,21.9
194965,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2011,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,39.5
186830,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2011,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,4.8
192404,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2011,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,30.2
194099,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2011,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,54.36
37633,3,ANGOLA,Average death rate due to natural disasters y (per 100 000 population),AFR0027,2011-2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,0.1
72988,3,ANGOLA,Average death rate due to natural disasters y (per 100 000 population),AFR0027,2011-2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,0.1
73467,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2011-2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,0
13840,3,ANGOLA,Demand for family planning satisfied with modern methods [SDG 3.7.1],AFR0207,2011-2017,9,Female,1,Percentage,3,WHO / GHO,30
76084,3,ANGOLA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2011-2017,9,Female,1,Percentage,1,WHO/AFRO,61
140990,3,ANGOLA,Proportion of women married or in a union of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (% of women aged 15-49 years),AFR0105,2011-2017,9,Female,1,Percentage,3,WHO / GHO,30
24017,3,ANGOLA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2011-2017,9,Female,2,Per 1000 live births,3,WHO / GHO,61
10669,3,ANGOLA,Number of people living with HIV,AFR0019,2012,28,Both sexes (male and female),1,Percentage,16,UNAIDS,250000
11493,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2012,9,Female,1,Percentage,3,WHO / GHO,281
52105,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2012,8,Male,1,Percentage,3,WHO / GHO,8.1
52106,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2012,9,Female,1,Percentage,3,WHO / GHO,7.4
52107,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.7
68083,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2012,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,52
68729,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2012,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
69082,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2012,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
72046,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2012,28,Both sexes (male and female),1,Percentage,16,UNAIDS,13
72506,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2012,9,Female,1,Percentage,16,UNAIDS,15
73318,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,65
75737,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,73
75957,3,ANGOLA,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2012,999,Not Applicable,1,Percentage,3,WHO / GHO,70.52
84252,3,ANGOLA,TB case detection rate,AFR0176,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,54
91774,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,52
95609,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2012,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,52
96977,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2012,999,Not Applicable,1,Percentage,4,WB Database,7.37
98505,3,ANGOLA,Immunization coverage against Tetanus,AFR0189,2012,28,Both sexes (male and female),1,Percentage,4,WB Database,53
102387,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2012,999,Not Applicable,1,Percentage,4,WB Database,17.61
103515,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2012,999,Not Applicable,1,Percentage,3,WHO / GHO,1.78
109781,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2012,999,Not Applicable,1,Percentage,3,WHO / GHO,23.98
110899,3,ANGOLA,TB case detection rate,AFR0176,2012,29,Total,1,Percentage,3,WHO / GHO,79
111738,3,ANGOLA,TB treatment success rate,AFR0216,2012,29,Total,1,Percentage,3,WHO / GHO,45
112631,3,ANGOLA,TB preventive therapy for HIV-positive people newly enrolled in HIV care,AFR0170,2012,29,Total,1,Percentage,3,WHO / GHO,6
113288,3,ANGOLA,TB treatment coverage,AFR0173,2012,29,Total,1,Percentage,3,WHO / GHO,45
115983,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116990,3,ANGOLA,TB treatment success rate,AFR0216,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27
124075,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2012,28,Both sexes (male and female),1,Percentage,35,IHME,0.81
125515,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2012,8,Male,1,Percentage,35,IHME,0.75
126955,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2012,9,Female,1,Percentage,35,IHME,0.86
137008,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2012,29,Total,1,Percentage,36,WHO/UNICEF,53
138417,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2012,29,Total,1,Percentage,3,WHO / GHO,45
138418,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27
141113,3,ANGOLA,Effective PMTCT coverage,AFR0213,2012,9,Female,1,Percentage,16,UNAIDS,15
148184,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2012,107,Female (10-14 years),1,Percentage,35,IHME,125.74
149914,3,ANGOLA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2012,9,Female,1,Percentage,16,UNAIDS,30.62
150926,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2012,66,Female (15-49 years),1,Percentage,35,IHME,46.13
156266,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2012,999,Not Applicable,1,Percentage,3,WHO / GHO,23.98
179352,3,ANGOLA,Access to electricity (% of population),AFR0380,2012,999,Not Applicable,1,Percentage,4,WB Database,35.6
182546,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,32.57
183412,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,2.39
185144,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,97.8
186010,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,2.17
188681,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,4.2
189547,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,4.2
191584,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,17.6
193286,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2012,999,Not Applicable,1,Percentage,10,WHO / GHED,14.9
195660,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2012,28,Both sexes (male and female),1,Percentage,35,IHME,2.29
196976,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,6.8
198822,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2012,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,21.5
207920,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2012,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,65
1630,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2012,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,2.69
1631,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2012,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,122.24
1632,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2012,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,162.49
4625,3,ANGOLA,GDP growth (annual %),AFR0388,2012,999,Not Applicable,2,Per 1000 live births,22,UN DESA,4.75
5201,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,253
5530,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2012,9,Female,2,Per 1000 live births,3,WHO / GHO,217
5859,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2012,8,Male,2,Per 1000 live births,3,WHO / GHO,290
6289,3,ANGOLA,TB mortality rate (per 100 000 population),AFR0013,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,67
6834,3,ANGOLA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,1.8
7620,3,ANGOLA,Life expectancy at birth (years),AFR0381,2012,8,Male,2,Per 1000 live births,1,WHO/AFRO,58.1
7949,3,ANGOLA,Life expectancy at birth (years),AFR0381,2012,9,Female,2,Per 1000 live births,1,WHO/AFRO,62.6
8278,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,17
8607,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2012,8,Male,2,Per 1000 live births,1,WHO/AFRO,16.2
8936,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2012,9,Female,2,Per 1000 live births,1,WHO/AFRO,17.8
10255,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.9
11121,3,ANGOLA,Population size (in thousands) total,AFR0004,2012,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,25107.93
12450,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,33.85
14016,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,104.95
15344,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2012,28,Both sexes (male and female),2,Per 1000 live births,4,WB Database,9.53
15549,3,ANGOLA,AIDS-related mortality rate (per 100 000 population),AFR0014,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,43.81
16937,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,72
17198,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,60.4
17527,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2012,8,Male,2,Per 1000 live births,3,WHO / GHO,58.1
17856,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2012,9,Female,2,Per 1000 live births,3,WHO / GHO,62.6
18613,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2012,9,Female,2,Per 1000 live births,3,WHO / GHO,156.59
18614,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2012,8,Male,2,Per 1000 live births,3,WHO / GHO,213.93
20412,3,ANGOLA,TB incidence rate [SDG 3.3.2],AFR0334,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,380
21049,3,ANGOLA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,123.99
21600,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2012,8,Male,2,Per 1000 live births,3,WHO / GHO,30
21601,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2012,9,Female,2,Per 1000 live births,3,WHO / GHO,30
21602,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,30.1
23145,3,ANGOLA,Anaemia prevalence in children,AFR0300,2012,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,53.2
23650,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2012,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,16421331
25110,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,73
26760,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,65
27190,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,54
27521,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,52
27952,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2012,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,73
28640,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2012,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,69.64
29277,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2012,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,15
29495,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,13
29858,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,206
30757,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,504
30928,3,ANGOLA,TB case detection rate,AFR0176,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,54
31769,3,ANGOLA,HIV test results for registered new and relapse TB patients,AFR0171,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,12022
31991,3,ANGOLA,TB preventive therapy for HIV-positive people newly enrolled in HIV care,AFR0170,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,1100
34666,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2012,12,Urban,2,Per 1000 live births,1,WHO/AFRO,64.1
34667,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2012,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.55
34668,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2012,29,Total,2,Per 1000 live births,1,WHO/AFRO,40.46
36507,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2012,12,Urban,2,Per 1000 live births,3,WHO / GHO,59.38
36508,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2012,11,Rural,2,Per 1000 live births,3,WHO / GHO,18.62
36509,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2012,29,Total,2,Per 1000 live births,3,WHO / GHO,35.61
37703,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2012,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,6.5
38571,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2012,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,38.18
39764,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2012,999,Not Applicable,2,Per 1000 live births,19,OECD,23.2
40963,3,ANGOLA,DTP dropout rate (DTP1 -DPT3),AFR0226,2012,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,21
43500,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
43539,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,65
43579,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
43625,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,1259
43655,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,6
43715,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,46,Measles,2,Per 1000 live births,1,WHO/AFRO,4458
43774,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2012,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,15
63108,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2012,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,104.9
140159,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2012,12,Urban,2,Per 1000 live births,7,DHS,64.1
140160,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2012,11,Rural,2,Per 1000 live births,7,DHS,23.55
140161,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2012,29,Total,2,Per 1000 live births,7,DHS,40.46
141114,3,ANGOLA,Effective PMTCT coverage,AFR0213,2012,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,15
128462,3,ANGOLA,Sex ratio at birth,AFR0428,2012,28,Both sexes (male and female),4,Ratio,4,WB Database,1.03
64741,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2012,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,72
71542,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2012,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,16421331
79318,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2012,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
79357,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2012,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,65
79397,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2012,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
79443,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2012,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,1259
79473,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2012,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,6
79533,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2012,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,4458
79592,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2012,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,15
85093,3,ANGOLA,HIV test results for registered new and relapse TB patients,AFR0171,2012,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,12022
85315,3,ANGOLA,TB preventive therapy for HIV-positive people newly enrolled in HIV care,AFR0170,2012,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,1100
120127,3,ANGOLA,Number of road traffic injuries,AFR0140,2012,29,Total,5,Count (Numeric Integer),35,IHME,21153
139718,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2012,29,Total,5,Count (Numeric Integer),35,IHME,41804
145259,3,ANGOLA,Number of people living with HIV,AFR0019,2012,29,Total,5,Count (Numeric Integer),16,UNAIDS,250000
62072,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2012,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,9.52
99712,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2012,6,Adult (15+ Years),6,Per 1000 population,16,UNAIDS,1.6
100140,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2012,45,Male (15+ years),6,Per 1000 population,16,UNAIDS,1
100568,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2012,42,Female (15+ years),6,Per 1000 population,16,UNAIDS,2.2
100990,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2012,37,Both sexes (15-24 years),6,Per 1000 population,16,UNAIDS,0.9
101380,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2012,35,Male (15-24 years),6,Per 1000 population,16,UNAIDS,0.4
101771,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2012,36,Female (15-24 years),6,Per 1000 population,16,UNAIDS,1.4
143622,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2012,29,Total,6,Per 1000 population,16,UNAIDS,1.12
62277,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2012,9,Female,7,per 100 000 live births,23,MMEIG,281
83182,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2012,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,206
84081,3,ANGOLA,"TB prevalence rate per 100,000 population per year",AFR0332,2012,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,504
108606,3,ANGOLA,Malaria mortality rate (per 100 000 population),AFR0015,2012,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,49.41
69931,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2012,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,69.6
92079,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2012,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,23.2
97460,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2012,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,28.6
113762,3,ANGOLA,Total Health Expenditure (constant US$),AFR0349,2012,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,2708.39
114222,3,ANGOLA,Total Health Expenditure (International US$),AFR0348,2012,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,3067.82
106152,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2012,999,Not Applicable,14,Per Capita,3,WHO / GHO,122.2
106971,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2012,999,Not Applicable,14,Per Capita,42,WDI,3.53
107789,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2012,999,Not Applicable,14,Per Capita,3,WHO / GHO,2.66
114691,3,ANGOLA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2012,999,Not Applicable,14,Per Capita,4,WB Database,162.32
115157,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2012,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,28.6
127866,3,ANGOLA,Life expectancy at birth (years),AFR0381,2012,28,Both sexes (male and female),17,years,4,WB Database,57.24
184278,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2012,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,122
187742,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2012,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,2.65
190718,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2012,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,21.5
195011,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2012,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,39.7
186876,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2012,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,3.52
192450,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2012,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,28.5
194145,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2012,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,52.84
118583,3,ANGOLA,Existence of national health sector policy/strategy/plan,AFR0250,2012-2025,999,Not Applicable,3,String,1,WHO/AFRO,\N
10715,3,ANGOLA,Number of people living with HIV,AFR0019,2013,28,Both sexes (male and female),1,Percentage,16,UNAIDS,260000
11494,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2013,9,Female,1,Percentage,3,WHO / GHO,269
52245,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2013,8,Male,1,Percentage,3,WHO / GHO,8.3
52246,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2013,9,Female,1,Percentage,3,WHO / GHO,7.6
52247,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.9
68129,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,54
68756,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
69123,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,9
72091,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2013,28,Both sexes (male and female),1,Percentage,16,UNAIDS,19
72547,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2013,9,Female,1,Percentage,16,UNAIDS,26
73271,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,59
74296,3,ANGOLA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2013,999,Not Applicable,1,Percentage,3,WHO / GHO,41
75723,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,71
84253,3,ANGOLA,TB case detection rate,AFR0176,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,60
91727,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,54
95564,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,54
95937,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2013,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,45
97023,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2013,999,Not Applicable,1,Percentage,4,WB Database,7.4
98506,3,ANGOLA,Immunization coverage against Tetanus,AFR0189,2013,28,Both sexes (male and female),1,Percentage,4,WB Database,54
102388,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2013,999,Not Applicable,1,Percentage,4,WB Database,21.34
103514,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2013,999,Not Applicable,1,Percentage,3,WHO / GHO,1.86
109598,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2013,999,Not Applicable,1,Percentage,3,WHO / GHO,18.59
110945,3,ANGOLA,TB case detection rate,AFR0176,2013,29,Total,1,Percentage,3,WHO / GHO,60
111784,3,ANGOLA,TB treatment success rate,AFR0216,2013,29,Total,1,Percentage,3,WHO / GHO,23
112375,3,ANGOLA,Pneumococcal vaccination coverage,AFR0186,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,9
113335,3,ANGOLA,TB treatment coverage,AFR0173,2013,29,Total,1,Percentage,3,WHO / GHO,23
115984,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116989,3,ANGOLA,TB treatment success rate,AFR0216,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,12.4
121884,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2013,29,Total,1,Percentage,36,WHO/UNICEF,9
124123,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2013,28,Both sexes (male and female),1,Percentage,35,IHME,0.81
125563,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2013,8,Male,1,Percentage,35,IHME,0.75
127003,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2013,9,Female,1,Percentage,35,IHME,0.87
137056,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2013,29,Total,1,Percentage,36,WHO/UNICEF,54
138419,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2013,29,Total,1,Percentage,3,WHO / GHO,23
138420,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,12.4
141115,3,ANGOLA,Effective PMTCT coverage,AFR0213,2013,9,Female,1,Percentage,16,UNAIDS,26
148185,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2013,107,Female (10-14 years),1,Percentage,35,IHME,123.19
149915,3,ANGOLA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2013,9,Female,1,Percentage,16,UNAIDS,27.32
150927,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2013,66,Female (15-49 years),1,Percentage,35,IHME,43.83
156265,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2013,999,Not Applicable,1,Percentage,3,WHO / GHO,18.59
179353,3,ANGOLA,Access to electricity (% of population),AFR0380,2013,999,Not Applicable,1,Percentage,4,WB Database,36.8
182592,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,35.4
183458,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,2.73
185190,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,97.4
186056,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,2.56
188727,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,4.57
189593,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,4.57
191630,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,21.3
193331,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2013,999,Not Applicable,1,Percentage,10,WHO / GHED,14
195661,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2013,28,Both sexes (male and female),1,Percentage,35,IHME,2.45
196977,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.1
198823,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2013,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,22.1
207921,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2013,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,59
1768,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,2.99
1769,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2013,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,143.7
1770,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2013,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,191.44
2658,3,ANGOLA,Total density per million population: Magnetic Resonance Imaging,AFR0081,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.05
2730,3,ANGOLA,Total density per million population: Computed tomography units,AFR0078,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.42
2799,3,ANGOLA,Total density per million population: Positron Emission tomography,AFR0082,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
2864,3,ANGOLA,Total density per million population: Gamma camera or Nuclear medicine,AFR0079,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
2936,3,ANGOLA,Total density per million population: Linear Accelerator (numeric),AFR0080,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0
3008,3,ANGOLA,Total density per million population: Telecobalt Unit,AFR0084,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.05
3081,3,ANGOLA,Total density per million population: Radiotherapy units,AFR0083,2013,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,0.05
4672,3,ANGOLA,GDP growth (annual %),AFR0388,2013,999,Not Applicable,2,Per 1000 live births,22,UN DESA,1.31
5200,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,249
5529,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2013,9,Female,2,Per 1000 live births,3,WHO / GHO,214
5858,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2013,8,Male,2,Per 1000 live births,3,WHO / GHO,286
6288,3,ANGOLA,TB mortality rate (per 100 000 population),AFR0013,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,59
6880,3,ANGOLA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,1.9
7619,3,ANGOLA,Life expectancy at birth (years),AFR0381,2013,8,Male,2,Per 1000 live births,1,WHO/AFRO,58.8
7948,3,ANGOLA,Life expectancy at birth (years),AFR0381,2013,9,Female,2,Per 1000 live births,1,WHO/AFRO,63.3
8277,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,17.1
8606,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2013,8,Male,2,Per 1000 live births,1,WHO/AFRO,16.2
8935,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2013,9,Female,2,Per 1000 live births,1,WHO/AFRO,17.9
10301,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.9
11169,3,ANGOLA,Population size (in thousands) total,AFR0004,2013,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,26015.78
12451,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,32.75
14017,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,98.4
15391,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2013,28,Both sexes (male and female),2,Per 1000 live births,4,WB Database,9.18
15596,3,ANGOLA,AIDS-related mortality rate (per 100 000 population),AFR0014,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,46.12
16838,3,ANGOLA,Death rate due to road traffic injuries (per 100 000 population) [SDG 3.6.1],AFR0017,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,26.9
16938,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,50
17197,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,61
17526,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2013,8,Male,2,Per 1000 live births,3,WHO / GHO,58.8
17855,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2013,9,Female,2,Per 1000 live births,3,WHO / GHO,63.3
18615,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2013,9,Female,2,Per 1000 live births,3,WHO / GHO,150.59
18616,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2013,8,Male,2,Per 1000 live births,3,WHO / GHO,208.07
20413,3,ANGOLA,TB incidence rate [SDG 3.3.2],AFR0334,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,376
21004,3,ANGOLA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,130.2
21738,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2013,8,Male,2,Per 1000 live births,3,WHO / GHO,29.9
21739,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2013,9,Female,2,Per 1000 live births,3,WHO / GHO,29.9
21740,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,30
23098,3,ANGOLA,Anaemia prevalence in children,AFR0300,2013,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,52.4
23651,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2013,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,17149903
25063,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,71
26713,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,59
27143,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,48
27474,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,54
27905,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2013,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,67
28686,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2013,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,69.97
29318,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2013,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,26
29540,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,19
29859,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,225
30804,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,498
30929,3,ANGOLA,TB case detection rate,AFR0176,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,60
31770,3,ANGOLA,HIV test results for registered new and relapse TB patients,AFR0171,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,24445
34802,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2013,12,Urban,2,Per 1000 live births,1,WHO/AFRO,63.82
34803,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2013,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.53
34804,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2013,29,Total,2,Per 1000 live births,1,WHO/AFRO,40.65
36643,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2013,12,Urban,2,Per 1000 live births,3,WHO / GHO,60.37
36644,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2013,11,Rural,2,Per 1000 live births,3,WHO / GHO,19.54
36645,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2013,29,Total,2,Per 1000 live births,3,WHO / GHO,36.89
37704,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2013,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,8.9
38572,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2013,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,34.09
39765,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2013,999,Not Applicable,2,Per 1000 live births,19,OECD,21.74
40916,3,ANGOLA,DTP dropout rate (DTP1 -DPT3),AFR0226,2013,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,13
43166,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
43203,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,36
43245,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
43292,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,0
43323,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,33
43384,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,46,Measles,2,Per 1000 live births,1,WHO/AFRO,8523
43444,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013,27,65+ years,2,Per 1000 live births,1,WHO/AFRO,20
63109,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2013,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,98.4
140162,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2013,12,Urban,2,Per 1000 live births,7,DHS,63.82
140163,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2013,11,Rural,2,Per 1000 live births,7,DHS,23.53
140164,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2013,29,Total,2,Per 1000 live births,7,DHS,40.65
141116,3,ANGOLA,Effective PMTCT coverage,AFR0213,2013,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,26
94764,3,ANGOLA,Availability of national list of approved medical devices for procurement or reimbursement,AFR0059,2013,999,Not Applicable,3,String,3,WHO / GHO,\N
94846,3,ANGOLA,Availability of national standards or recommended lists of medical devices,AFR0060,2013,999,Not Applicable,3,String,3,WHO / GHO,\N
94925,3,ANGOLA,Availability of technical specifications of medical devices to support procurement or donations,AFR0061,2013,999,Not Applicable,3,String,3,WHO / GHO,\N
95007,3,ANGOLA,Types of lists recommending health technology for high burden diseases,AFR0085,2013,999,Not Applicable,3,String,3,WHO / GHO,\N
128461,3,ANGOLA,Sex ratio at birth,AFR0428,2013,28,Both sexes (male and female),4,Ratio,4,WB Database,1.03
64742,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2013,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,50
71543,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2013,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,17149903
78984,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2013,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
79021,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2013,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,36
79063,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2013,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
79110,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2013,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,0
79141,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2013,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,33
79202,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2013,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,8523
79262,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2013,55,Diphteria,5,Count (Numeric Integer),3,WHO / GHO,20
85094,3,ANGOLA,HIV test results for registered new and relapse TB patients,AFR0171,2013,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,24445
120174,3,ANGOLA,Number of road traffic injuries,AFR0140,2013,29,Total,5,Count (Numeric Integer),35,IHME,21905
142346,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2013,126,Hydrological,5,Count (Numeric Integer),35,IHME,9
145305,3,ANGOLA,Number of people living with HIV,AFR0019,2013,29,Total,5,Count (Numeric Integer),16,UNAIDS,260000
147394,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2013,29,Total,5,Count (Numeric Integer),35,IHME,43106
62119,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2013,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,9.17
76636,3,ANGOLA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2013,999,Not Applicable,6,Per 1000 population,38,Global Health Workforce Statistics,0.12
99755,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2013,6,Adult (15+ Years),6,Per 1000 population,16,UNAIDS,1.7
100183,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2013,45,Male (15+ years),6,Per 1000 population,16,UNAIDS,1
100610,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2013,42,Female (15+ years),6,Per 1000 population,16,UNAIDS,2.3
101029,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2013,37,Both sexes (15-24 years),6,Per 1000 population,16,UNAIDS,0.9
101419,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2013,35,Male (15-24 years),6,Per 1000 population,16,UNAIDS,0.4
101810,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2013,36,Female (15-24 years),6,Per 1000 population,16,UNAIDS,1.3
143666,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2013,29,Total,6,Per 1000 population,16,UNAIDS,1.06
62278,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2013,9,Female,7,per 100 000 live births,23,MMEIG,269
83183,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2013,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,225
84128,3,ANGOLA,"TB prevalence rate per 100,000 population per year",AFR0332,2013,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,498
108607,3,ANGOLA,Malaria mortality rate (per 100 000 population),AFR0015,2013,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,47
69977,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2013,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,69.9
92080,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2013,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,21.73
97459,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2013,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,40.75
113763,3,ANGOLA,Total Health Expenditure (constant US$),AFR0349,2013,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,3242.52
114223,3,ANGOLA,Total Health Expenditure (International US$),AFR0348,2013,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,3736.04
152126,3,ANGOLA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2013,1002,Nursing and midwifery personnel,13,Per 10 000 population,3,WHO / GHO,0.01
106151,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2013,999,Not Applicable,14,Per Capita,3,WHO / GHO,143.7
106970,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2013,999,Not Applicable,14,Per Capita,42,WDI,4.89
107788,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2013,999,Not Applicable,14,Per Capita,3,WHO / GHO,3.69
114690,3,ANGOLA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2013,999,Not Applicable,14,Per Capita,4,WB Database,190.89
115156,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2013,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,40.75
127867,3,ANGOLA,Life expectancy at birth (years),AFR0381,2013,28,Both sexes (male and female),17,years,4,WB Database,58.05
184324,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2013,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,143
187788,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2013,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,3.68
190764,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2013,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,30.6
195057,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2013,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,50.8
186922,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2013,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,4.89
192496,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2013,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,40.7
194191,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2013,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,67.53
71485,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013-2018,9,Female,1,Percentage,13,UNStat,46.6
13792,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2013-2018,9,Female,2,Per 1000 live births,3,WHO / GHO,46.6
10761,3,ANGOLA,Number of people living with HIV,AFR0019,2014,28,Both sexes (male and female),1,Percentage,16,UNAIDS,280000
11495,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2014,9,Female,1,Percentage,3,WHO / GHO,258
52384,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2014,8,Male,1,Percentage,3,WHO / GHO,8.5
52385,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2014,9,Female,1,Percentage,3,WHO / GHO,7.8
52386,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8.2
68175,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,55
68783,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,\N
69164,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,45
72136,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2014,28,Both sexes (male and female),1,Percentage,16,UNAIDS,23
72588,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2014,9,Female,1,Percentage,16,UNAIDS,39
73224,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,56
74332,3,ANGOLA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2014,999,Not Applicable,1,Percentage,3,WHO / GHO,18
75709,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,72
84254,3,ANGOLA,TB case detection rate,AFR0176,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,54
85970,3,ANGOLA,Immunization coverage against Rotavirus vaccine,AFR0187,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,18
91680,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,55
95519,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,55
95905,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2014,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,45
97069,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2014,999,Not Applicable,1,Percentage,4,WB Database,7.33
98507,3,ANGOLA,Immunization coverage against Tetanus,AFR0189,2014,28,Both sexes (male and female),1,Percentage,4,WB Database,55
102389,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2014,999,Not Applicable,1,Percentage,4,WB Database,26.87
102843,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2014,999,Not Applicable,1,Percentage,4,WB Database,26.87
103513,3,ANGOLA,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2014,999,Not Applicable,1,Percentage,3,WHO / GHO,2.63
109597,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2014,999,Not Applicable,1,Percentage,3,WHO / GHO,23.96
110991,3,ANGOLA,TB case detection rate,AFR0176,2014,29,Total,1,Percentage,3,WHO / GHO,54
111830,3,ANGOLA,TB treatment success rate,AFR0216,2014,29,Total,1,Percentage,3,WHO / GHO,34
112398,3,ANGOLA,Pneumococcal vaccination coverage,AFR0186,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,45
113382,3,ANGOLA,TB treatment coverage,AFR0173,2014,29,Total,1,Percentage,3,WHO / GHO,34
115985,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116988,3,ANGOLA,TB treatment success rate,AFR0216,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,19.7
121906,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2014,29,Total,1,Percentage,36,WHO/UNICEF,45
124171,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2014,28,Both sexes (male and female),1,Percentage,35,IHME,0.82
125611,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2014,8,Male,1,Percentage,35,IHME,0.76
127051,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2014,9,Female,1,Percentage,35,IHME,0.88
131284,3,ANGOLA,Proportion of urban population living in slums (%),AFR0118,2014,28,Both sexes (male and female),1,Percentage,4,WB Database,55.5
131614,3,ANGOLA,"School enrolment, primary (% gross)",AFR0391,2014,28,Both sexes (male and female),1,Percentage,4,WB Database,113.48
137104,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2014,29,Total,1,Percentage,36,WHO/UNICEF,55
138421,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2014,29,Total,1,Percentage,3,WHO / GHO,34
138422,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,19.7
141117,3,ANGOLA,Effective PMTCT coverage,AFR0213,2014,9,Female,1,Percentage,16,UNAIDS,39
148186,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2014,107,Female (10-14 years),1,Percentage,35,IHME,119.68
149916,3,ANGOLA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2014,9,Female,1,Percentage,16,UNAIDS,23.88
150928,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2014,66,Female (15-49 years),1,Percentage,35,IHME,43.94
156264,3,ANGOLA,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2014,999,Not Applicable,1,Percentage,3,WHO / GHO,23.96
179603,3,ANGOLA,Access to electricity (% of population),AFR0380,2014,999,Not Applicable,1,Percentage,4,WB Database,32
182638,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,42.67
183504,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,2.43
185236,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,96.8
186102,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,3.17
188773,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,3.61
189639,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,3.61
191676,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,26.8
193376,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2014,999,Not Applicable,1,Percentage,10,WHO / GHED,15.8
195662,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2014,28,Both sexes (male and female),1,Percentage,35,IHME,2.6
196978,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.5
198824,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2014,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,22.7
207922,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2014,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,56
1906,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,2.8
1907,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2014,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,131.75
1908,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2014,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,184.5
3150,3,ANGOLA,Total density per million females aged from 50 to 69 years old: Mammography units,AFR0077,2014,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,6.33
4719,3,ANGOLA,GDP growth (annual %),AFR0388,2014,999,Not Applicable,2,Per 1000 live births,22,UN DESA,1.23
5199,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,244
5528,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2014,9,Female,2,Per 1000 live births,3,WHO / GHO,207
5857,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2014,8,Male,2,Per 1000 live births,3,WHO / GHO,282
6287,3,ANGOLA,TB mortality rate (per 100 000 population),AFR0013,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,66
6926,3,ANGOLA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,1.9
7618,3,ANGOLA,Life expectancy at birth (years),AFR0381,2014,8,Male,2,Per 1000 live births,1,WHO/AFRO,59.4
7947,3,ANGOLA,Life expectancy at birth (years),AFR0381,2014,9,Female,2,Per 1000 live births,1,WHO/AFRO,64
8276,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,17.2
8605,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2014,8,Male,2,Per 1000 live births,1,WHO/AFRO,16.3
8934,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2014,9,Female,2,Per 1000 live births,1,WHO/AFRO,18
10347,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.8
11217,3,ANGOLA,Population size (in thousands) total,AFR0004,2014,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,26941.78
12452,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,31.67
14018,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,92.94
15438,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2014,28,Both sexes (male and female),2,Per 1000 live births,4,WB Database,8.9
15643,3,ANGOLA,AIDS-related mortality rate (per 100 000 population),AFR0014,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,37.11
16939,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,155
17196,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,61.7
17525,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2014,8,Male,2,Per 1000 live births,3,WHO / GHO,59.4
17854,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2014,9,Female,2,Per 1000 live births,3,WHO / GHO,64
18617,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2014,9,Female,2,Per 1000 live births,3,WHO / GHO,143.92
18618,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2014,8,Male,2,Per 1000 live births,3,WHO / GHO,201.29
20414,3,ANGOLA,TB incidence rate [SDG 3.3.2],AFR0334,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,370
20959,3,ANGOLA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,139.97
22015,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2014,8,Male,2,Per 1000 live births,3,WHO / GHO,29.8
22016,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2014,9,Female,2,Per 1000 live births,3,WHO / GHO,29.7
22017,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,29.8
23051,3,ANGOLA,Anaemia prevalence in children,AFR0300,2014,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,51.8
23652,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2014,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,17666908
25016,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,72
25385,3,ANGOLA,Immunization coverage against Rotavirus vaccine,AFR0187,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,18
25487,3,ANGOLA,Adolescent birth rate [SDG 3.7.2],AFR0293,2014,9,Female,2,Per 1000 live births,1,WHO/AFRO,163
26666,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,56
27096,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,55
27427,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,55
27858,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2014,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,69
28732,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2014,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,48.01
29359,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2014,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,39
29585,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,23
29860,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,199
30851,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,490
30930,3,ANGOLA,TB case detection rate,AFR0176,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,54
31771,3,ANGOLA,HIV test results for registered new and relapse TB patients,AFR0171,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,27699
36818,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2014,12,Urban,2,Per 1000 live births,3,WHO / GHO,61.36
36819,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2014,11,Rural,2,Per 1000 live births,3,WHO / GHO,20.46
36820,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2014,29,Total,2,Per 1000 live births,3,WHO / GHO,38.16
37587,3,ANGOLA,Annual mean concentrations of fine particulate matter (PM2.5) in urban areas(g/m3),AFR0026,2014,29,Total,2,Per 1000 live births,3,WHO / GHO,42.8
37705,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2014,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,21.4
38573,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2014,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,36.82
39766,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2014,999,Not Applicable,2,Per 1000 live births,19,OECD,29.57
40869,3,ANGOLA,DTP dropout rate (DTP1 -DPT3),AFR0226,2014,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,14
42836,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
42872,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,112
42915,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
42962,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,0
42992,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,19
43052,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2014,46,Measles,2,Per 1000 live births,1,WHO/AFRO,11699
63110,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2014,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,92.93
141118,3,ANGOLA,Effective PMTCT coverage,AFR0213,2014,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,39
128460,3,ANGOLA,Sex ratio at birth,AFR0428,2014,28,Both sexes (male and female),4,Ratio,4,WB Database,1.03
64743,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2014,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,155
71544,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2014,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,17666908
78654,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2014,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
78690,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2014,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,112
78733,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2014,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
78780,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2014,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,0
78810,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2014,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,19
78870,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2014,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,11699
85095,3,ANGOLA,HIV test results for registered new and relapse TB patients,AFR0171,2014,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,27699
120221,3,ANGOLA,Number of road traffic injuries,AFR0140,2014,29,Total,5,Count (Numeric Integer),35,IHME,22660
145351,3,ANGOLA,Number of people living with HIV,AFR0019,2014,29,Total,5,Count (Numeric Integer),16,UNAIDS,280000
147442,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2014,29,Total,5,Count (Numeric Integer),35,IHME,44041
62166,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2014,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,8.89
99798,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2014,6,Adult (15+ Years),6,Per 1000 population,16,UNAIDS,1.7
100226,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2014,45,Male (15+ years),6,Per 1000 population,16,UNAIDS,1.1
100653,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2014,42,Female (15+ years),6,Per 1000 population,16,UNAIDS,2.3
101068,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2014,37,Both sexes (15-24 years),6,Per 1000 population,16,UNAIDS,0.9
101458,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2014,35,Male (15-24 years),6,Per 1000 population,16,UNAIDS,0.4
101849,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2014,36,Female (15-24 years),6,Per 1000 population,16,UNAIDS,1.3
143710,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2014,29,Total,6,Per 1000 population,16,UNAIDS,0.99
62279,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2014,9,Female,7,per 100 000 live births,23,MMEIG,258
83184,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2014,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,199
84175,3,ANGOLA,"TB prevalence rate per 100,000 population per year",AFR0332,2014,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,490
108608,3,ANGOLA,Malaria mortality rate (per 100 000 population),AFR0015,2014,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,46.33
70259,3,ANGOLA,Adolescent birth rate [SDG 3.7.2],AFR0293,2014,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,163
70023,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2014,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,48
92081,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2014,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,29.56
97458,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2014,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,47.13
113764,3,ANGOLA,Total Health Expenditure (constant US$),AFR0349,2014,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,3027.4
114224,3,ANGOLA,Total Health Expenditure (International US$),AFR0348,2014,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,3546.82
91923,3,ANGOLA,"Annual mean levels of fine particulate matter in cities, urban population (micrograms per cubic meter)",AFR0121,2014,29,Total,11,micrograms per cubic meter,3,WHO / GHO,42.8
74955,3,ANGOLA,Gender development index score,AFR0347,2014,28,Both sexes (male and female),12,Index,14,UNDP,0.83
106150,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2014,999,Not Applicable,14,Per Capita,3,WHO / GHO,131.8
106969,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2014,999,Not Applicable,14,Per Capita,42,WDI,5.55
107787,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2014,999,Not Applicable,14,Per Capita,3,WHO / GHO,4.18
114689,3,ANGOLA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2014,999,Not Applicable,14,Per Capita,4,WB Database,175.37
115155,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2014,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,47.13
127868,3,ANGOLA,Life expectancy at birth (years),AFR0381,2014,28,Both sexes (male and female),17,years,4,WB Database,58.78
184370,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2014,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,131
187834,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2014,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,4.17
190810,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2014,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,35.3
195103,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2014,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,56.1
186968,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2014,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,5.55
192542,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2014,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,47
194237,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2014,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,74.78
10807,3,ANGOLA,Number of people living with HIV,AFR0019,2015,28,Both sexes (male and female),1,Percentage,16,UNAIDS,290000
11496,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2015,9,Female,1,Percentage,3,WHO / GHO,251
68221,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,55
68810,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,26
69205,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,58
71304,3,ANGOLA,Coverage of essential health services,AFR0128,2015,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,38
72181,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2015,28,Both sexes (male and female),1,Percentage,16,UNAIDS,25
72406,3,ANGOLA,People living with HIV who know their status,AFR0181,2015,28,Both sexes (male and female),1,Percentage,16,UNAIDS,51
72629,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2015,9,Female,1,Percentage,16,UNAIDS,36
72759,3,ANGOLA,Children aged under 5 years who are overweight [SDG 2.2.2],AFR0301,2015,28,Both sexes (male and female),1,Percentage,5,UNICEF,3.4
73177,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,51
73963,3,ANGOLA,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2015,28,Both sexes (male and female),1,Percentage,15,UNESCO,36.48
73972,3,ANGOLA,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2015,9,Female,1,Percentage,15,UNESCO,31.9
73981,3,ANGOLA,"Lower secondary completion rate, total (% of relevant age group)",AFR0158,2015,8,Male,1,Percentage,15,UNESCO,41.73
75398,3,ANGOLA,Contraceptive prevalence rate,AFR0208,2015,9,Female,1,Percentage,1,WHO/AFRO,14.2
75695,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,69
84255,3,ANGOLA,TB case detection rate,AFR0176,2015,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,58
85942,3,ANGOLA,Immunization coverage against Rotavirus vaccine,AFR0187,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,55
91396,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,57
91633,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,55
95474,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,55
95869,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2015,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,58
97115,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2015,999,Not Applicable,1,Percentage,4,WB Database,7.28
98508,3,ANGOLA,Immunization coverage against Tetanus,AFR0189,2015,28,Both sexes (male and female),1,Percentage,4,WB Database,59
102390,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2015,999,Not Applicable,1,Percentage,4,WB Database,33.52
102842,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2015,999,Not Applicable,1,Percentage,4,WB Database,33.52
103055,3,ANGOLA,Service availability index (%) (high-level indicator),AFR0229,2015,999,Not Applicable,1,Percentage,4,WB Database,38
103196,3,ANGOLA,Service availability index (%),AFR0049,2015,999,Not Applicable,1,Percentage,4,WB Database,38
105500,3,ANGOLA,Immunization coverage,AFR0405,2015,999,Not Applicable,1,Percentage,3,WHO / GHO,16.4
105501,3,ANGOLA,Immunization coverage,AFR0405,2015,15,Primary Education,1,Percentage,3,WHO / GHO,24.44
105502,3,ANGOLA,Immunization coverage,AFR0405,2015,68,Secondary or Higher Education,1,Percentage,3,WHO / GHO,52.19
111038,3,ANGOLA,TB case detection rate,AFR0176,2015,29,Total,1,Percentage,3,WHO / GHO,58
112430,3,ANGOLA,Pneumococcal vaccination coverage,AFR0186,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,55
115986,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2015,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
121937,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2015,29,Total,1,Percentage,36,WHO/UNICEF,55
124219,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2015,28,Both sexes (male and female),1,Percentage,35,IHME,0.83
125659,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2015,8,Male,1,Percentage,35,IHME,0.76
127099,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2015,9,Female,1,Percentage,35,IHME,0.89
127539,3,ANGOLA,Timing of first ANC visit,AFR0202,2015,29,Total,1,Percentage,7,DHS,38.9
127681,3,ANGOLA,Timing of first ANC visit,AFR0202,2015,12,Urban,1,Percentage,7,DHS,46.7
127823,3,ANGOLA,Timing of first ANC visit,AFR0202,2015,11,Rural,1,Percentage,7,DHS,26.3
137152,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2015,29,Total,1,Percentage,36,WHO/UNICEF,59
141119,3,ANGOLA,Effective PMTCT coverage,AFR0213,2015,9,Female,1,Percentage,16,UNAIDS,36
147206,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2015,29,Total,1,Percentage,36,WHO/UNICEF,26
148187,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2015,107,Female (10-14 years),1,Percentage,35,IHME,117.53
148681,3,ANGOLA,Contraceptive prevalence rate,AFR0208,2015,9,Female,1,Percentage,7,DHS,12.5
148828,3,ANGOLA,Contraceptive prevalence rate,AFR0208,2015,129,Married women,1,Percentage,7,DHS,12.5
148977,3,ANGOLA,Comprehensive correct knowledge about AIDS,AFR0458,2015,8,Male,1,Percentage,7,DHS,35.5
149064,3,ANGOLA,Comprehensive correct knowledge about AIDS,AFR0458,2015,9,Female,1,Percentage,7,DHS,31.7
149917,3,ANGOLA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2015,9,Female,1,Percentage,16,UNAIDS,23.71
150312,3,ANGOLA,"Proportion of ever-partnered women and girls subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months, by age (%)",AFR0101,2015,66,Female (15-49 years),1,Percentage,7,DHS,4.8
150366,3,ANGOLA,Unmet need for family planning,AFR0462,2015,129,Married women,1,Percentage,7,DHS,38
150929,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2015,66,Female (15-49 years),1,Percentage,35,IHME,41.47
179604,3,ANGOLA,Access to electricity (% of population),AFR0380,2015,999,Not Applicable,1,Percentage,4,WB Database,42
180273,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,1015,<12 months,1,Percentage,7,DHS,27.9
180274,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,1018,12-23 months,1,Percentage,7,DHS,24.3
180275,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,1019,24-35 months,1,Percentage,7,DHS,19.9
180276,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,1020,36-47 months,1,Percentage,7,DHS,18.8
180277,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,1021,48-59 months,1,Percentage,7,DHS,16.8
180853,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,29,Total,1,Percentage,7,DHS,21.7
180854,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,8,Male,1,Percentage,7,DHS,21.1
180855,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,9,Female,1,Percentage,7,DHS,22.2
180856,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,12,Urban,1,Percentage,7,DHS,23
180857,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,11,Rural,1,Percentage,7,DHS,19.7
181433,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,1022,Lowest,1,Percentage,7,DHS,16.8
181434,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,20,Second Quintile,1,Percentage,7,DHS,23.1
181435,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,1023,Middle,1,Percentage,7,DHS,23.9
181436,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,22,Fourth Quintile,1,Percentage,7,DHS,23
181437,3,ANGOLA,Percentage of children under age five who slept under an insecticide treated net (ITN) the night before the survey,AFR0471,2015,1024,Highest,1,Percentage,7,DHS,22
182684,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,49.96
183550,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,2.6
185282,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,97.3
186148,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,2.67
188819,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,4.56
189685,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,4.56
191722,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,33.5
193421,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2015,999,Not Applicable,1,Percentage,10,WHO / GHED,16.4
195663,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2015,28,Both sexes (male and female),1,Percentage,35,IHME,2.8
196979,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2015,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,7.9
198825,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2015,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,23.3
200901,3,ANGOLA,Demand for family planning satisfied with modern methods [SDG 3.7.1],AFR0207,2015,29,Total,1,Percentage,36,WHO/UNICEF,29.8
207923,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2015,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,51
2044,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2015,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,2.95
2045,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2015,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,108.68
2046,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2015,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,195.76
4766,3,ANGOLA,GDP growth (annual %),AFR0388,2015,999,Not Applicable,2,Per 1000 live births,22,UN DESA,-2.46
4907,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2015,12,Urban,2,Per 1000 live births,1,WHO/AFRO,63.3
4954,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2015,11,Rural,2,Per 1000 live births,1,WHO/AFRO,23.5
5001,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2015,29,Total,2,Per 1000 live births,1,WHO/AFRO,41
5049,3,ANGOLA,Population using safely managed sanitation services [SDG 6.2.1a/6.2.1b],AFR0291,2015,12,Urban,2,Per 1000 live births,3,WHO / GHO,62.3
5096,3,ANGOLA,Population using safely managed sanitation services [SDG 6.2.1a/6.2.1b],AFR0291,2015,11,Rural,2,Per 1000 live births,3,WHO / GHO,21.4
5143,3,ANGOLA,Population using safely managed sanitation services [SDG 6.2.1a/6.2.1b],AFR0291,2015,29,Total,2,Per 1000 live births,3,WHO / GHO,39.4
5198,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,240
5527,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,203
5856,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,278
6286,3,ANGOLA,TB mortality rate (per 100 000 population),AFR0013,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,61
6972,3,ANGOLA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,1.9
7617,3,ANGOLA,Life expectancy at birth (years),AFR0381,2015,8,Male,2,Per 1000 live births,1,WHO/AFRO,59.9
7946,3,ANGOLA,Life expectancy at birth (years),AFR0381,2015,9,Female,2,Per 1000 live births,1,WHO/AFRO,64.5
8275,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,17.3
8604,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2015,8,Male,2,Per 1000 live births,1,WHO/AFRO,16.4
8933,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2015,9,Female,2,Per 1000 live births,1,WHO/AFRO,18.1
9258,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,55.3
9399,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,53.3
9540,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,57.3
9681,3,ANGOLA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,13.5
9822,3,ANGOLA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,12.8
9963,3,ANGOLA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,14.2
10393,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.7
11265,3,ANGOLA,Population size (in thousands) total,AFR0004,2015,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,27884.38
12453,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,30.77
14019,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,88.13
15485,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2015,28,Both sexes (male and female),2,Per 1000 live births,4,WB Database,8.68
15690,3,ANGOLA,AIDS-related mortality rate (per 100 000 population),AFR0014,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,35.86
16022,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2015,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,5
16262,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,7.5
16502,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,2.6
16742,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,5
16940,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,439
17195,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,62.2
17524,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,59.9
17853,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,64.5
18297,3,ANGOLA,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,16.9
18619,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,139.06
18620,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,196.35
20415,3,ANGOLA,TB incidence rate [SDG 3.3.2],AFR0334,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,366
20914,3,ANGOLA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,154.48
21876,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2015,8,Male,2,Per 1000 live births,3,WHO / GHO,29.6
21877,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,29.6
21878,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,29.7
23004,3,ANGOLA,Anaemia prevalence in children,AFR0300,2015,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,51.3
23546,3,ANGOLA,Coverage of essential health services,AFR0128,2015,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,38
23638,3,ANGOLA,Stillbirth rate (per 1000 total births),AFR0011,2015,28,Both sexes (male and female),2,Per 1000 live births,7,DHS,27.3
23653,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2015,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,18534219
24228,3,ANGOLA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2015,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,4.9
24427,3,ANGOLA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2015,9,Female,2,Per 1000 live births,5,UNICEF,4.3
24623,3,ANGOLA,Children under 5 years who are wasted [SDG 2.2.2],AFR0302,2015,8,Male,2,Per 1000 live births,5,UNICEF,5.6
24663,3,ANGOLA,Contraceptive prevalence rate,AFR0208,2015,9,Female,2,Per 1000 live births,3,WHO / GHO,14.2
24969,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,69
25357,3,ANGOLA,Immunization coverage against Rotavirus vaccine,AFR0187,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,55
26114,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2015,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,2.9
26115,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2015,9,Female,2,Per 1000 live births,20,ITU,2.2
26116,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2015,8,Male,2,Per 1000 live births,20,ITU,3.7
26619,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,51
27049,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,57
27380,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,55
27811,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2015,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,65
28778,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2015,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,52.96
29400,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2015,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,36
29703,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,25
29861,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,214
30931,3,ANGOLA,TB case detection rate,AFR0176,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,58
32441,3,ANGOLA,Prevalence of stunting in children under 5 u (%),AFR0154,2015,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,37.57
32673,3,ANGOLA,Prevalence of wasting in children under 5 u (%),AFR0155,2015,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,4.92
32910,3,ANGOLA,Prevalence of overweight in children under 5 u (%),AFR0156,2015,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,3.4
37706,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2015,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,12.4
38574,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2015,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,36.82
39598,3,ANGOLA,"Children in employment, total (% of children ages 7-14)",AFR0030,2015,28,Both sexes (male and female),2,Per 1000 live births,21,ILO,18.72
39599,3,ANGOLA,"Children in employment, total (% of children ages 7-14)",AFR0030,2015,9,Female,2,Per 1000 live births,21,ILO,19.87
39600,3,ANGOLA,"Children in employment, total (% of children ages 7-14)",AFR0030,2015,8,Male,2,Per 1000 live births,21,ILO,16.6
39767,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2015,999,Not Applicable,2,Per 1000 live births,19,OECD,256.93
40672,3,ANGOLA,Hepatitis B surface antigen prevalence (%),AFR0326,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,4.9
40822,3,ANGOLA,DTP dropout rate (DTP1 -DPT3),AFR0226,2015,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,10
42482,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,3
42520,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,230
42563,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
42610,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,0
42643,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,36
42707,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2015,46,Measles,2,Per 1000 live births,1,WHO/AFRO,119
63111,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2015,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,88.12
85792,3,ANGOLA,Stillbirth rate (per 1000 total births),AFR0011,2015,9,Female,2,Per 1000 live births,7,DHS,27.3
140165,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2015,12,Urban,2,Per 1000 live births,7,DHS,63.3
140166,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2015,11,Rural,2,Per 1000 live births,7,DHS,23.5
140167,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2015,29,Total,2,Per 1000 live births,7,DHS,41
141120,3,ANGOLA,Effective PMTCT coverage,AFR0213,2015,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,36
67056,3,ANGOLA,Existence of national screening program for cervical cancer,AFR0418,2015,999,Not Applicable,3,String,3,WHO / GHO,\N
67197,3,ANGOLA,Most widely used screening method in national cervical cancer screening program,AFR0415,2015,999,Not Applicable,3,String,3,WHO / GHO,\N
67338,3,ANGOLA,Type of national cervical cancer screening program,AFR0416,2015,999,Not Applicable,3,String,3,WHO / GHO,\N
67429,3,ANGOLA,Coverage of national cervical cancer screening program (%),AFR0417,2015,999,Not Applicable,3,String,3,WHO / GHO,\N
129458,3,ANGOLA,Existence of national screening program for cervical cancer,AFR0418,2015,9,Female,3,String,3,WHO / GHO,\N
128459,3,ANGOLA,Sex ratio at birth,AFR0428,2015,28,Both sexes (male and female),4,Ratio,4,WB Database,1.03
64744,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2015,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,439
71545,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2015,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,18534219
78300,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2015,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,3
78338,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2015,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,230
78381,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2015,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
78428,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2015,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,0
78461,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2015,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,36
78525,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2015,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,119
99160,3,ANGOLA,"Pre-primary education, duration (years)",AFR0392,2015,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,1
120268,3,ANGOLA,Number of road traffic injuries,AFR0140,2015,29,Total,5,Count (Numeric Integer),35,IHME,23417
141971,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2015,125,Biological,5,Count (Numeric Integer),35,IHME,384
142372,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2015,126,Hydrological,5,Count (Numeric Integer),35,IHME,1
145397,3,ANGOLA,Number of people living with HIV,AFR0019,2015,29,Total,5,Count (Numeric Integer),16,UNAIDS,290000
147490,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2015,29,Total,5,Count (Numeric Integer),35,IHME,46047
152662,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,70,0-4 years,5,Count (Numeric Integer),17,UN Population,5192358
152895,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,71,5-9 years,5,Count (Numeric Integer),17,UN Population,4381416
153128,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,72,10-14 years,5,Count (Numeric Integer),17,UN Population,3562269
153359,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,73,15-19 years,5,Count (Numeric Integer),17,UN Population,2920715
153590,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,74,20-24 years,5,Count (Numeric Integer),17,UN Population,2463585
154054,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,76,30-34 years,5,Count (Numeric Integer),17,UN Population,1696733
154286,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,77,35-39 years,5,Count (Numeric Integer),17,UN Population,1369482
154519,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,78,40-44 years,5,Count (Numeric Integer),17,UN Population,1124113
154750,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,79,45-49 years,5,Count (Numeric Integer),17,UN Population,829929
154982,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,80,50-54 years,5,Count (Numeric Integer),17,UN Population,730901
155216,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,81,55-59 years,5,Count (Numeric Integer),17,UN Population,538940
155448,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,82,60-64 years,5,Count (Numeric Integer),17,UN Population,360183
155678,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,83,65-69 years,5,Count (Numeric Integer),17,UN Population,275747
155909,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,84,70-74 years,5,Count (Numeric Integer),17,UN Population,178566
156141,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,85,75-79 years,5,Count (Numeric Integer),17,UN Population,110936
177482,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,86,80-84 years,5,Count (Numeric Integer),17,UN Population,50024
177713,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,1010,85-89 years,5,Count (Numeric Integer),17,UN Population,15952
178025,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,1011,90-94 years,5,Count (Numeric Integer),17,UN Population,2953
178260,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,1012,95-99 years,5,Count (Numeric Integer),17,UN Population,406
178495,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2015,1009,100+ years,5,Count (Numeric Integer),17,UN Population,28
62213,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2015,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,8.68
99841,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2015,6,Adult (15+ Years),6,Per 1000 population,16,UNAIDS,1.7
100269,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2015,45,Male (15+ years),6,Per 1000 population,16,UNAIDS,1.1
100697,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2015,42,Female (15+ years),6,Per 1000 population,16,UNAIDS,2.4
101107,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2015,37,Both sexes (15-24 years),6,Per 1000 population,16,UNAIDS,0.9
101497,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2015,35,Male (15-24 years),6,Per 1000 population,16,UNAIDS,0.4
101888,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2015,36,Female (15-24 years),6,Per 1000 population,16,UNAIDS,1.3
143754,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2015,29,Total,6,Per 1000 population,16,UNAIDS,0.95
62280,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2015,9,Female,7,per 100 000 live births,23,MMEIG,251
70885,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2015,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,2.9
70886,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2015,9,Female,8,Per 100 000 population,13,UNStat,2.2
70887,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2015,8,Male,8,Per 100 000 population,13,UNStat,3.7
71947,3,ANGOLA,Hepatitis B surface antigen prevalence (%),AFR0326,2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,4900
83185,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,214
104408,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2015,8,Male,8,Per 100 000 population,3,WHO / GHO,16.92
104409,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2015,9,Female,8,Per 100 000 population,3,WHO / GHO,3.47
108609,3,ANGOLA,Malaria mortality rate (per 100 000 population),AFR0015,2015,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,47.04
109165,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,10.06
120892,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2015,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,16.9
121132,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2015,8,Male,8,Per 100 000 population,3,WHO / GHO,17.6
121372,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2015,9,Female,8,Per 100 000 population,3,WHO / GHO,16.3
70069,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2015,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,52.9
92082,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2015,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,256.93
97457,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2015,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,62.05
113765,3,ANGOLA,Total Health Expenditure (constant US$),AFR0349,2015,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,3271.49
114225,3,ANGOLA,Total Health Expenditure (International US$),AFR0348,2015,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,3027.76
74999,3,ANGOLA,Gender development index score,AFR0347,2015,28,Both sexes (male and female),12,Index,14,UNDP,0.83
106149,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2015,999,Not Applicable,14,Per Capita,3,WHO / GHO,108.7
106968,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2015,999,Not Applicable,14,Per Capita,42,WDI,4.94
107786,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2015,999,Not Applicable,14,Per Capita,3,WHO / GHO,2.9
114688,3,ANGOLA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2015,999,Not Applicable,14,Per Capita,4,WB Database,185.08
115154,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2015,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,62.05
127869,3,ANGOLA,Life expectancy at birth (years),AFR0381,2015,28,Both sexes (male and female),17,years,4,WB Database,59.4
213125,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2015,28,Both sexes (male and female),23,Numeric,75,WHO/GHO_2021,53.7
213313,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2015,8,Male,23,Numeric,75,WHO/GHO_2021,52.2
213501,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2015,9,Female,23,Numeric,75,WHO/GHO_2021,55.3
213688,3,ANGOLA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2015,28,Both sexes (male and female),23,Numeric,75,WHO/GHO_2021,12.4
184416,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2015,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,108
187880,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2015,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,2.89
190856,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2015,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,36.4
195149,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2015,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,54.2
187014,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2015,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,4.93
192588,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2015,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,61.9
194283,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2015,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,92.39
65042,3,ANGOLA,Intimate partner violence prevalence [SDG 5.2.1],AFR0297,2015-2016,9,Female,1,Percentage,13,UNStat,25.9
72706,3,ANGOLA,Use of insecticide treated nets (ITNs),AFR0167,2015-2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,21.7
75563,3,ANGOLA,Completeness of birth registration (%),AFR0245,2015-2016,28,Both sexes (male and female),1,Percentage,13,UNStat,25
75608,3,ANGOLA,Civil registration coverage of births (%),AFR0062,2015-2016,28,Both sexes (male and female),1,Percentage,13,UNStat,25
83115,3,ANGOLA,Indoor residual spraying (IRS) coverage,AFR0165,2015-2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.6
103027,3,ANGOLA,Intermittent preventive therapy for malaria during pregnancy (IPTp),AFR0168,2015-2016,9,Female,1,Percentage,7,DHS,20
108567,3,ANGOLA,Intimate partner violence and injuries,AFR0055,2015-2016,9,Female,1,Percentage,13,UNStat,25.9
200638,3,ANGOLA,Contraceptive prevalence rate,AFR0208,2015-2016,9,Female,1,Percentage,22,UN DESA,13.66
200876,3,ANGOLA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2015-2016,29,Total,1,Percentage,36,WHO/UNICEF,81.6
200877,3,ANGOLA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2015-2016,12,Urban,1,Percentage,36,WHO/UNICEF,92.2
200878,3,ANGOLA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2015-2016,11,Rural,1,Percentage,36,WHO/UNICEF,62.7
200879,3,ANGOLA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2015-2016,19,First Quintile,1,Percentage,36,WHO/UNICEF,55.6
200880,3,ANGOLA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2015-2016,20,Second Quintile,1,Percentage,36,WHO/UNICEF,71.4
200881,3,ANGOLA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2015-2016,1023,Middle,1,Percentage,36,WHO/UNICEF,89.7
200882,3,ANGOLA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2015-2016,22,Fourth Quintile,1,Percentage,36,WHO/UNICEF,96.3
200883,3,ANGOLA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2015-2016,23,Fifth Quintile,1,Percentage,36,WHO/UNICEF,97.7
200885,3,ANGOLA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2015-2016,29,Total,1,Percentage,36,WHO/UNICEF,61.4
200886,3,ANGOLA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2015-2016,12,Urban,1,Percentage,36,WHO/UNICEF,73.8
200887,3,ANGOLA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2015-2016,11,Rural,1,Percentage,36,WHO/UNICEF,39.4
200888,3,ANGOLA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2015-2016,19,First Quintile,1,Percentage,36,WHO/UNICEF,34
200889,3,ANGOLA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2015-2016,20,Second Quintile,1,Percentage,36,WHO/UNICEF,44.8
200890,3,ANGOLA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2015-2016,1023,Middle,1,Percentage,36,WHO/UNICEF,64
200891,3,ANGOLA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2015-2016,22,Fourth Quintile,1,Percentage,36,WHO/UNICEF,81.5
200892,3,ANGOLA,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,2015-2016,23,Fifth Quintile,1,Percentage,36,WHO/UNICEF,88.2
200893,3,ANGOLA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2015-2016,29,Total,1,Percentage,36,WHO/UNICEF,3.7
200894,3,ANGOLA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2015-2016,12,Urban,1,Percentage,36,WHO/UNICEF,5.4
200895,3,ANGOLA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2015-2016,11,Rural,1,Percentage,36,WHO/UNICEF,1.1
200896,3,ANGOLA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2015-2016,19,First Quintile,1,Percentage,36,WHO/UNICEF,0.7
200897,3,ANGOLA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2015-2016,20,Second Quintile,1,Percentage,36,WHO/UNICEF,1.7
200898,3,ANGOLA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2015-2016,1023,Middle,1,Percentage,36,WHO/UNICEF,3.2
200899,3,ANGOLA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2015-2016,22,Fourth Quintile,1,Percentage,36,WHO/UNICEF,5.3
200900,3,ANGOLA,Percentage of deliveries in health facilities by caesarean section,AFR0455,2015-2016,23,Fifth Quintile,1,Percentage,36,WHO/UNICEF,10.5
200906,3,ANGOLA,Institutional deliveries,AFR0200,2015-2016,29,Total,1,Percentage,36,WHO/UNICEF,45.6
200907,3,ANGOLA,Institutional deliveries,AFR0200,2015-2016,12,Urban,1,Percentage,36,WHO/UNICEF,64.5
200908,3,ANGOLA,Institutional deliveries,AFR0200,2015-2016,11,Rural,1,Percentage,36,WHO/UNICEF,16.8
200909,3,ANGOLA,Institutional deliveries,AFR0200,2015-2016,19,First Quintile,1,Percentage,36,WHO/UNICEF,12
200910,3,ANGOLA,Institutional deliveries,AFR0200,2015-2016,20,Second Quintile,1,Percentage,36,WHO/UNICEF,24.4
200911,3,ANGOLA,Institutional deliveries,AFR0200,2015-2016,1023,Middle,1,Percentage,36,WHO/UNICEF,54.9
200912,3,ANGOLA,Institutional deliveries,AFR0200,2015-2016,22,Fourth Quintile,1,Percentage,36,WHO/UNICEF,72
200913,3,ANGOLA,Institutional deliveries,AFR0200,2015-2016,23,Fifth Quintile,1,Percentage,36,WHO/UNICEF,85.9
200914,3,ANGOLA,Percentage of women who received postnatal (postpartum care) within two days of child birth,AFR0314,2015-2016,29,Total,1,Percentage,36,WHO/UNICEF,23.3
200915,3,ANGOLA,Percentage of women who received postnatal (postpartum care) within two days of child birth,AFR0314,2015-2016,12,Urban,1,Percentage,36,WHO/UNICEF,31
200916,3,ANGOLA,Percentage of women who received postnatal (postpartum care) within two days of child birth,AFR0314,2015-2016,11,Rural,1,Percentage,36,WHO/UNICEF,11.5
200917,3,ANGOLA,Percentage of women who received postnatal (postpartum care) within two days of child birth,AFR0314,2015-2016,19,First Quintile,1,Percentage,36,WHO/UNICEF,9
200918,3,ANGOLA,Percentage of women who received postnatal (postpartum care) within two days of child birth,AFR0314,2015-2016,20,Second Quintile,1,Percentage,36,WHO/UNICEF,12.8
200919,3,ANGOLA,Percentage of women who received postnatal (postpartum care) within two days of child birth,AFR0314,2015-2016,1023,Middle,1,Percentage,36,WHO/UNICEF,27.2
200920,3,ANGOLA,Percentage of women who received postnatal (postpartum care) within two days of child birth,AFR0314,2015-2016,22,Fourth Quintile,1,Percentage,36,WHO/UNICEF,35.6
200921,3,ANGOLA,Percentage of women who received postnatal (postpartum care) within two days of child birth,AFR0314,2015-2016,23,Fifth Quintile,1,Percentage,36,WHO/UNICEF,40.9
200922,3,ANGOLA,Postnatal care coverage: Percentage of newborn babies who have postnatal care contact within two days following birth,AFR0199,2015-2016,29,Total,1,Percentage,36,WHO/UNICEF,20.9
200923,3,ANGOLA,Postnatal care coverage: Percentage of newborn babies who have postnatal care contact within two days following birth,AFR0199,2015-2016,12,Urban,1,Percentage,36,WHO/UNICEF,27.9
200924,3,ANGOLA,Postnatal care coverage: Percentage of newborn babies who have postnatal care contact within two days following birth,AFR0199,2015-2016,11,Rural,1,Percentage,36,WHO/UNICEF,10.3
200925,3,ANGOLA,Postnatal care coverage: Percentage of newborn babies who have postnatal care contact within two days following birth,AFR0199,2015-2016,19,First Quintile,1,Percentage,36,WHO/UNICEF,8.5
200926,3,ANGOLA,Postnatal care coverage: Percentage of newborn babies who have postnatal care contact within two days following birth,AFR0199,2015-2016,20,Second Quintile,1,Percentage,36,WHO/UNICEF,10.7
200927,3,ANGOLA,Postnatal care coverage: Percentage of newborn babies who have postnatal care contact within two days following birth,AFR0199,2015-2016,1023,Middle,1,Percentage,36,WHO/UNICEF,24.1
200928,3,ANGOLA,Postnatal care coverage: Percentage of newborn babies who have postnatal care contact within two days following birth,AFR0199,2015-2016,22,Fourth Quintile,1,Percentage,36,WHO/UNICEF,30.2
200929,3,ANGOLA,Postnatal care coverage: Percentage of newborn babies who have postnatal care contact within two days following birth,AFR0199,2015-2016,23,Fifth Quintile,1,Percentage,36,WHO/UNICEF,40
3633,3,ANGOLA,Civil registration coverage of births (%),AFR0062,2015-2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,25
23337,3,ANGOLA,Intimate partner violence prevalence [SDG 5.2.1],AFR0297,2015-2016,9,Female,2,Per 1000 live births,20,ITU,25.9
32316,3,ANGOLA,Use of insecticide treated nets (ITNs),AFR0167,2015-2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,21.7
32344,3,ANGOLA,Indoor residual spraying (IRS) coverage,AFR0165,2015-2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,1.6
122368,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2015-2020,28,Both sexes (male and female),1,Percentage,17,UN Population,15.4
122656,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2015-2020,8,Male,1,Percentage,17,UN Population,14.06
122944,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2015-2020,9,Female,1,Percentage,17,UN Population,16.57
130582,3,ANGOLA,Total fertility rate,AFR0130,2015-2020,9,Female,1,Percentage,17,UN Population,5.55
10853,3,ANGOLA,Number of people living with HIV,AFR0019,2016,28,Both sexes (male and female),1,Percentage,16,UNAIDS,310000
11497,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2016,9,Female,1,Percentage,3,WHO / GHO,246
65206,3,ANGOLA,Age-standardized prevalence of insufficiently physically active persons aged 18+ years,AFR0308,2016,8,Male,1,Percentage,3,WHO / GHO,\N
65207,3,ANGOLA,Age-standardized prevalence of insufficiently physically active persons aged 18+ years,AFR0308,2016,9,Female,1,Percentage,3,WHO / GHO,\N
65208,3,ANGOLA,Age-standardized prevalence of insufficiently physically active persons aged 18+ years,AFR0308,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,\N
68267,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,55
68837,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,26
69246,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,59
72226,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2016,28,Both sexes (male and female),1,Percentage,16,UNAIDS,23
73130,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,45
75681,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,49
84256,3,ANGOLA,TB case detection rate,AFR0176,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,57
85911,3,ANGOLA,Immunization coverage against Rotavirus vaccine,AFR0187,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,59
91349,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,53
91586,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,55
95429,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,55
95831,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2016,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,59
97161,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2016,999,Not Applicable,1,Percentage,4,WB Database,7.22
98509,3,ANGOLA,Immunization coverage against Tetanus,AFR0189,2016,28,Both sexes (male and female),1,Percentage,4,WB Database,59
102391,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2016,999,Not Applicable,1,Percentage,4,WB Database,35.2
102841,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2016,999,Not Applicable,1,Percentage,4,WB Database,35.2
109922,3,ANGOLA,"Proportion of ever-partnered women and girls subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months, by age (%)",AFR0101,2016,9,Female,1,Percentage,13,UNStat,25.9
111084,3,ANGOLA,TB case detection rate,AFR0176,2016,29,Total,1,Percentage,3,WHO / GHO,57
111921,3,ANGOLA,TB treatment success rate,AFR0216,2016,29,Total,1,Percentage,3,WHO / GHO,27
112122,3,ANGOLA,Percentage of pregnant women that made four or more ANC visits,AFR0135,2016,9,Female,1,Percentage,44,DHS/MICS,61.4
112306,3,ANGOLA,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,2016,9,Female,1,Percentage,44,DHS/MICS,81.6
112467,3,ANGOLA,Pneumococcal vaccination coverage,AFR0186,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,55
113475,3,ANGOLA,TB treatment coverage,AFR0173,2016,29,Total,1,Percentage,3,WHO / GHO,27
113734,3,ANGOLA,Sexual violence against children [SDG 16.2.3],AFR0295,2016,9,Female,1,Percentage,7,DHS,3.5
115987,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116987,3,ANGOLA,TB treatment success rate,AFR0216,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,13.8
121973,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2016,29,Total,1,Percentage,36,WHO/UNICEF,55
123007,3,ANGOLA,Non-partner sexual violence prevalence [SDG 5.2.2],AFR0296,2016,66,Female (15-49 years),1,Percentage,7,DHS,2.3
124267,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2016,28,Both sexes (male and female),1,Percentage,35,IHME,0.83
125707,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2016,8,Male,1,Percentage,35,IHME,0.76
127147,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2016,9,Female,1,Percentage,35,IHME,0.89
133451,3,ANGOLA,Proportion of urban population living in slums (%),AFR0118,2016,28,Both sexes (male and female),1,Percentage,4,WB Database,48.8
135418,3,ANGOLA,"Prevalence of anaemia in women aged 15-49, by age and pregnancy status",AFR0299,2016,9,Female,1,Percentage,3,WHO / GHO,47.7
135754,3,ANGOLA,Annual mean concentrations of fine particulate matter (PM2.5) in urban areas(g/m3),AFR0026,2016,999,Not Applicable,1,Percentage,3,WHO / GHO,28.4
135898,3,ANGOLA,Prevalence of obesity among children and adolescents (5-19 years)(%),AFR0439,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.4
135946,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8.2
137200,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2016,29,Total,1,Percentage,36,WHO/UNICEF,59
138423,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2016,29,Total,1,Percentage,3,WHO / GHO,27
138424,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,13.8
147230,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2016,29,Total,1,Percentage,36,WHO/UNICEF,26
148188,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2016,107,Female (10-14 years),1,Percentage,35,IHME,117.97
149184,3,ANGOLA,Percentage condom use with last high- risk sex amongst AGYW,AFR0453,2016,9,Female,1,Percentage,7,DHS,32.9
149549,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,9,Female,1,Percentage,12,UNICEF / MICS,49.6
149918,3,ANGOLA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2016,9,Female,1,Percentage,16,UNAIDS,24.59
150930,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2016,66,Female (15-49 years),1,Percentage,35,IHME,40.26
179605,3,ANGOLA,Access to electricity (% of population),AFR0380,2016,999,Not Applicable,1,Percentage,4,WB Database,40.6
180100,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2016,9,Female,1,Percentage,16,UNAIDS,32
182730,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,52.22
183596,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,2.71
185328,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,96.3
186194,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,3.64
188865,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,5.43
189731,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,5.43
191768,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,35.2
193466,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2016,999,Not Applicable,1,Percentage,10,WHO / GHED,17
195664,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2016,28,Both sexes (male and female),1,Percentage,35,IHME,3.01
198826,3,ANGOLA,Prevalence of overweight in persons aged 18+years,AFR0383,2016,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,23.9
207924,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2016,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,45
2182,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2016,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,2.88
2183,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2016,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,95.22
2184,3,ANGOLA,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2016,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,185.82
4813,3,ANGOLA,GDP growth (annual %),AFR0388,2016,999,Not Applicable,2,Per 1000 live births,22,UN DESA,-5.81
5197,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,238
5526,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,202
5855,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,275
6285,3,ANGOLA,TB mortality rate (per 100 000 population),AFR0013,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,64
7018,3,ANGOLA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,1.9
7616,3,ANGOLA,Life expectancy at birth (years),AFR0381,2016,8,Male,2,Per 1000 live births,1,WHO/AFRO,60.3
7945,3,ANGOLA,Life expectancy at birth (years),AFR0381,2016,9,Female,2,Per 1000 live births,1,WHO/AFRO,64.9
8274,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,17.3
8603,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2016,8,Male,2,Per 1000 live births,1,WHO/AFRO,16.5
8932,3,ANGOLA,Life expectancy at age 60 years,AFR0003,2016,9,Female,2,Per 1000 live births,1,WHO/AFRO,18.1
9257,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,55.8
9398,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,53.8
9539,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,57.7
9680,3,ANGOLA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,13.6
9821,3,ANGOLA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,12.9
9962,3,ANGOLA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,14.3
10439,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.7
11313,3,ANGOLA,Population size (in thousands) total,AFR0004,2016,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,28842.49
12454,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,29.91
14020,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,84.01
15737,3,ANGOLA,AIDS-related mortality rate (per 100 000 population),AFR0014,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,34.67
16070,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2016,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,4.7
16310,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,7
16550,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,2.5
16790,3,ANGOLA,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,4.7
16885,3,ANGOLA,Death rate due to road traffic injuries (per 100 000 population) [SDG 3.6.1],AFR0017,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,23.6
16941,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,343
17194,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,62.6
17523,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,60.3
17852,3,ANGOLA,Average life expectancy at birth (in years),AFR0001,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,64.9
18296,3,ANGOLA,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,16.5
18621,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,135.01
18622,3,ANGOLA,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,191.95
20258,3,ANGOLA,"Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (deaths per 100,000 population)",AFR0109,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,48.8
20306,3,ANGOLA,"Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (deaths per 100,000 population)",AFR0109,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,52.6
20354,3,ANGOLA,"Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (deaths per 100,000 population)",AFR0109,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,45.2
20416,3,ANGOLA,TB incidence rate [SDG 3.3.2],AFR0334,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,362
20869,3,ANGOLA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,155.66
21274,3,ANGOLA,Hepatitis B surface antigen prevalence (%),AFR0326,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,9.4
22171,3,ANGOLA,Total alcohol per capita (age 15+ years) consumption [SDG 3.5.2],AFR0310,2016,8,Male,2,Per 1000 live births,3,WHO / GHO,17.7
22172,3,ANGOLA,Total alcohol per capita (age 15+ years) consumption [SDG 3.5.2],AFR0310,2016,9,Female,2,Per 1000 live births,3,WHO / GHO,6.7
22173,3,ANGOLA,Total alcohol per capita (age 15+ years) consumption [SDG 3.5.2],AFR0310,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,13.7
22957,3,ANGOLA,Anaemia prevalence in children,AFR0300,2016,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,50.9
23654,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2016,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,14419092
24922,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,49
25326,3,ANGOLA,Immunization coverage against Rotavirus vaccine,AFR0187,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,59
26252,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,2.7
26253,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,9,Female,2,Per 1000 live births,20,ITU,2
26254,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,8,Male,2,Per 1000 live births,20,ITU,3.4
26388,3,ANGOLA,Mortality rate attributed to household and ambient air pollution [SDG 3.9.1],AFR0132,2016,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,119
26572,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,45
27002,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,53
27333,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,55
27764,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2016,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,67
28824,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2016,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,47.83
29025,3,ANGOLA,People living with HIV who know their status,AFR0181,2016,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,55
29748,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,23
29862,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,206
30932,3,ANGOLA,TB case detection rate,AFR0176,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,57
36961,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2016,29,Total,2,Per 1000 live births,3,WHO / GHO,48.63
36962,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2016,11,Rural,2,Per 1000 live births,3,WHO / GHO,22.31
36965,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2016,12,Urban,2,Per 1000 live births,3,WHO / GHO,63.34
37498,3,ANGOLA,Annual mean concentrations of fine particulate matter (PM2.5) in urban areas(g/m3),AFR0026,2016,29,Total,2,Per 1000 live births,3,WHO / GHO,27.95
37514,3,ANGOLA,Annual mean concentrations of fine particulate matter (PM2.5) in urban areas(g/m3),AFR0026,2016,12,Urban,2,Per 1000 live births,3,WHO / GHO,28.41
37707,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2016,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,13
38575,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2016,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,36.82
39768,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2016,999,Not Applicable,2,Per 1000 live births,19,OECD,475.89
40775,3,ANGOLA,DTP dropout rate (DTP1 -DPT3),AFR0226,2016,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,12
42153,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,881
42190,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,12
42233,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
42280,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,0
42369,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2016,46,Measles,2,Per 1000 live births,1,WHO/AFRO,53
63112,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2016,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,84.01
128458,3,ANGOLA,Sex ratio at birth,AFR0428,2016,28,Both sexes (male and female),4,Ratio,4,WB Database,1.03
64745,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2016,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,343
71546,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2016,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,14419092
77971,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2016,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,881
78008,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2016,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,12
78051,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2016,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
78098,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2016,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,0
78187,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2016,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,53
99159,3,ANGOLA,"Pre-primary education, duration (years)",AFR0392,2016,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,5
120315,3,ANGOLA,Number of road traffic injuries,AFR0140,2016,29,Total,5,Count (Numeric Integer),35,IHME,24039
142390,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2016,126,Hydrological,5,Count (Numeric Integer),35,IHME,54
145443,3,ANGOLA,Number of people living with HIV,AFR0019,2016,29,Total,5,Count (Numeric Integer),16,UNAIDS,300000
147538,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2016,29,Total,5,Count (Numeric Integer),35,IHME,47986
47329,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2016,28,Both sexes (male and female),6,Per 1000 population,3,WHO / GHO,8.51
99884,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2016,6,Adult (15+ Years),6,Per 1000 population,16,UNAIDS,1.8
100312,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2016,45,Male (15+ years),6,Per 1000 population,16,UNAIDS,1.1
100740,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2016,42,Female (15+ years),6,Per 1000 population,16,UNAIDS,2.4
101146,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2016,37,Both sexes (15-24 years),6,Per 1000 population,16,UNAIDS,0.8
101536,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2016,35,Male (15-24 years),6,Per 1000 population,16,UNAIDS,0.4
101927,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2016,36,Female (15-24 years),6,Per 1000 population,16,UNAIDS,1.3
102098,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2016,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,8.71
143798,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2016,29,Total,6,Per 1000 population,16,UNAIDS,0.94
62281,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2016,9,Female,7,per 100 000 live births,23,MMEIG,246
47520,3,ANGOLA,Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2),AFR0096,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,48.8
47568,3,ANGOLA,Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2),AFR0096,2016,8,Male,8,Per 100 000 population,3,WHO / GHO,52.6
47616,3,ANGOLA,Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2),AFR0096,2016,9,Female,8,Per 100 000 population,3,WHO / GHO,45.2
71023,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,2.7
71024,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,9,Female,8,Per 100 000 population,13,UNStat,2
71025,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,8,Male,8,Per 100 000 population,13,UNStat,3.4
71160,3,ANGOLA,Mortality rate attributed to household and ambient air pollution [SDG 3.9.1],AFR0132,2016,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,119
83186,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,206
103352,3,ANGOLA,Mortality attributable to joint effects of household and ambient air pollution,AFR0129,2016,29,Total,8,Per 100 000 population,3,WHO / GHO,118.5
103399,3,ANGOLA,Mortality attributable to joint effects of household and ambient air pollution,AFR0129,2016,9,Female,8,Per 100 000 population,3,WHO / GHO,117
103446,3,ANGOLA,Mortality attributable to joint effects of household and ambient air pollution,AFR0129,2016,8,Male,8,Per 100 000 population,3,WHO / GHO,120
104406,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2016,8,Male,8,Per 100 000 population,3,WHO / GHO,16.5
104407,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2016,9,Female,8,Per 100 000 population,3,WHO / GHO,3.41
108610,3,ANGOLA,Malaria mortality rate (per 100 000 population),AFR0015,2016,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,45.94
109164,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,9.83
120503,3,ANGOLA,"Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (deaths per 100,000 population)",AFR0109,2016,29,Total,8,Per 100 000 population,3,WHO / GHO,48.8
120940,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,16.5
121180,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2016,8,Male,8,Per 100 000 population,3,WHO / GHO,17.2
121420,3,ANGOLA,"Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease [SDG 3.4.1]",AFR0397,2016,9,Female,8,Per 100 000 population,3,WHO / GHO,16
130141,3,ANGOLA,Mortality rate attributed to household and ambient air pollution [SDG 3.9.1],AFR0132,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,118.5
130189,3,ANGOLA,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2016,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,2.7
141035,3,ANGOLA,"Mortality rate attributed to household air pollution (deaths per 100,000 population)",AFR0108,2016,28,Both sexes (male and female),8,Per 100 000 population,13,UNStat,119
70115,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2016,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,47.8
92083,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2016,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,475.89
97456,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2016,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,64.61
105995,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2016,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,1.57
113766,3,ANGOLA,Total Health Expenditure (constant US$),AFR0349,2016,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,3318.39
114226,3,ANGOLA,Total Health Expenditure (International US$),AFR0348,2016,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,2743.64
116833,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2016,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,1.57
75043,3,ANGOLA,Gender development index score,AFR0347,2016,28,Both sexes (male and female),12,Index,14,UNDP,0.9
106148,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2016,999,Not Applicable,14,Per Capita,3,WHO / GHO,95.22
106967,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2016,999,Not Applicable,14,Per Capita,42,WDI,6.68
107785,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2016,999,Not Applicable,14,Per Capita,3,WHO / GHO,3.47
114687,3,ANGOLA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2016,999,Not Applicable,14,Per Capita,4,WB Database,183.51
115153,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2016,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,64.61
127870,3,ANGOLA,Life expectancy at birth (years),AFR0381,2016,28,Both sexes (male and female),17,years,4,WB Database,59.93
184462,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2016,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,95.1
187926,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2016,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,3.46
190902,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2016,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,33.4
195195,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2016,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,49.6
187060,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2016,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,6.67
192634,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2016,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,64.5
194329,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2016,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,95.73
10899,3,ANGOLA,Number of people living with HIV,AFR0019,2017,28,Both sexes (male and female),1,Percentage,16,UNAIDS,320000
11498,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2017,9,Female,1,Percentage,3,WHO / GHO,241
65221,3,ANGOLA,Tobacco use among persons aged 15+ years - [SDG 3.a.1] (Also: adolescents),AFR0307,2017,8,Male,1,Percentage,3,WHO / GHO,\N
65231,3,ANGOLA,Tobacco use among persons aged 15+ years - [SDG 3.a.1] (Also: adolescents),AFR0307,2017,9,Female,1,Percentage,3,WHO / GHO,\N
68313,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,52
68864,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,30
69287,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,59
71257,3,ANGOLA,Coverage of essential health services,AFR0128,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,40
72271,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2017,28,Both sexes (male and female),1,Percentage,16,UNAIDS,25
73083,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,42
74412,3,ANGOLA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2017,999,Not Applicable,1,Percentage,3,WHO / GHO,75
75667,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,83
84257,3,ANGOLA,TB case detection rate,AFR0176,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,51
85652,3,ANGOLA,Vitamin A supplementation coverage,AFR0185,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,3
85878,3,ANGOLA,Immunization coverage against Rotavirus vaccine,AFR0187,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,58
91302,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,47
91539,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,52
95384,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,52
95792,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2017,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,59
97207,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2017,999,Not Applicable,1,Percentage,4,WB Database,7.11
98510,3,ANGOLA,Immunization coverage against Tetanus,AFR0189,2017,28,Both sexes (male and female),1,Percentage,4,WB Database,56
102392,3,ANGOLA,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2017,999,Not Applicable,1,Percentage,4,WB Database,34.12
102840,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2017,999,Not Applicable,1,Percentage,4,WB Database,34.12
103054,3,ANGOLA,Service availability index (%) (high-level indicator),AFR0229,2017,999,Not Applicable,1,Percentage,4,WB Database,40
103195,3,ANGOLA,Service availability index (%),AFR0049,2017,999,Not Applicable,1,Percentage,4,WB Database,40
109115,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2017,28,Both sexes (male and female),1,Percentage,4,WB Database,14
111131,3,ANGOLA,TB case detection rate,AFR0176,2017,29,Total,1,Percentage,3,WHO / GHO,51
111968,3,ANGOLA,TB treatment success rate,AFR0216,2017,29,Total,1,Percentage,3,WHO / GHO,25
112506,3,ANGOLA,Pneumococcal vaccination coverage,AFR0186,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,52
112708,3,ANGOLA,TB preventive therapy for HIV-positive people newly enrolled in HIV care,AFR0170,2017,29,Total,1,Percentage,3,WHO / GHO,13
113523,3,ANGOLA,TB treatment coverage,AFR0173,2017,29,Total,1,Percentage,3,WHO / GHO,25
115988,3,ANGOLA,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,0
116986,3,ANGOLA,TB treatment success rate,AFR0216,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,15.3
122011,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2017,29,Total,1,Percentage,36,WHO/UNICEF,52
124315,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2017,28,Both sexes (male and female),1,Percentage,35,IHME,0.83
125755,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2017,8,Male,1,Percentage,35,IHME,0.77
127195,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2017,9,Female,1,Percentage,35,IHME,0.89
134228,3,ANGOLA,School dropout rate,AFR0160,2017,28,Both sexes (male and female),1,Percentage,42,WDI,4.33
135269,3,ANGOLA,General Government Health Expenditure (GGHE) as % of Total health expenditure (GGE),AFR0272,2017,999,Not Applicable,1,Percentage,3,WHO / GHO,5.4
135514,3,ANGOLA,"Proportion of population using safely managed drinking water services, by urban/rural (%)",AFR0115,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,\N
135562,3,ANGOLA,Population using safely managed drinking-water services [SDG 6.1.1],AFR0292,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,\N
135610,3,ANGOLA,Proportion of population using a hand-washing facility with soap and water (%),AFR0437,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27
137248,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2017,29,Total,1,Percentage,36,WHO/UNICEF,56
138425,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2017,29,Total,1,Percentage,3,WHO / GHO,25
138426,3,ANGOLA,Tuberculosis treatment success rate,AFR0335,2017,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,15.3
147256,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2017,29,Total,1,Percentage,36,WHO/UNICEF,30
148189,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2017,107,Female (10-14 years),1,Percentage,35,IHME,107.19
149919,3,ANGOLA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2017,9,Female,1,Percentage,16,UNAIDS,25.45
150931,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2017,66,Female (15-49 years),1,Percentage,35,IHME,39.21
179606,3,ANGOLA,Access to electricity (% of population),AFR0380,2017,999,Not Applicable,1,Percentage,4,WB Database,41.9
180141,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2017,9,Female,1,Percentage,16,UNAIDS,30
182776,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,50.6
183642,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,2.79
185374,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,96.8
186240,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,3.11
188911,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,5.42
189777,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,5.42
191814,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,34.1
193511,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2017,999,Not Applicable,1,Percentage,10,WHO / GHED,16.4
195665,3,ANGOLA,Share of premature deaths attributed to high body mass index,AFR0475,2017,28,Both sexes (male and female),1,Percentage,35,IHME,3.23
207925,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2017,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,42
4860,3,ANGOLA,GDP growth (annual %),AFR0388,2017,999,Not Applicable,2,Per 1000 live births,22,UN DESA,-5.68
6177,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2017,8,Male,2,Per 1000 live births,3,WHO / GHO,273.44
6224,3,ANGOLA,Adult mortality rate between 15 and 60 years of age (per 1000 population),AFR0007,2017,9,Female,2,Per 1000 live births,3,WHO / GHO,199.98
6607,3,ANGOLA,TB mortality rate (per 100 000 population),AFR0013,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,67
6656,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,44.7
7064,3,ANGOLA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,2
10485,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.6
11360,3,ANGOLA,Population size (in thousands) total,AFR0004,2017,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,29816.77
12455,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,29.17
14021,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,80.44
15784,3,ANGOLA,AIDS-related mortality rate (per 100 000 population),AFR0014,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,40.24
16942,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,73
18192,3,ANGOLA,Malaria mortality rate (per 100 000 population),AFR0015,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,44.7
20155,3,ANGOLA,Infant mortality rate (per 1 000 live births),AFR0009,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,53.8
20417,3,ANGOLA,TB incidence rate [SDG 3.3.2],AFR0334,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,359
20824,3,ANGOLA,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,154.97
22507,3,ANGOLA,Tobacco use among persons aged 15+ years - [SDG 3.a.1] (Also: adolescents),AFR0307,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,0
23499,3,ANGOLA,Coverage of essential health services,AFR0128,2017,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,40
23655,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2017,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,14739913
24875,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,83
25293,3,ANGOLA,Immunization coverage against Rotavirus vaccine,AFR0187,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,58
26434,3,ANGOLA,Vitamin A supplementation coverage,AFR0185,2017,28,Both sexes (male and female),2,Per 1000 live births,5,UNICEF,3
26525,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,42
26955,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,47
27717,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2017,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,61
28870,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2017,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,64.64
29067,3,ANGOLA,People living with HIV who know their status,AFR0181,2017,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,57
29793,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,25
29863,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,182
30933,3,ANGOLA,TB case detection rate,AFR0176,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,51
31992,3,ANGOLA,TB preventive therapy for HIV-positive people newly enrolled in HIV care,AFR0170,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,2842
32131,3,ANGOLA,HIV-positive new and relapse TB patients on ART during TB treatment,AFR0169,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,1401
36960,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2017,29,Total,2,Per 1000 live births,3,WHO / GHO,49.88
36963,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2017,11,Rural,2,Per 1000 live births,3,WHO / GHO,23.23
36964,3,ANGOLA,Proportion of population using improved sanitation (%),AFR0024,2017,12,Urban,2,Per 1000 live births,3,WHO / GHO,64.33
37708,3,ANGOLA,Individuals using the Internet (% of population),AFR0033,2017,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,14.34
38576,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2017,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,38.18
39769,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2017,999,Not Applicable,2,Per 1000 live births,19,OECD,49.51
40728,3,ANGOLA,DTP dropout rate (DTP1 -DPT3),AFR0226,2017,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,9
41799,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
41842,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,20
41885,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
41962,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,18
42028,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2017,46,Measles,2,Per 1000 live births,1,WHO/AFRO,29
63113,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2017,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,80.44
67009,3,ANGOLA,Existence of national screening program for cervical cancer,AFR0418,2017,999,Not Applicable,3,String,3,WHO / GHO,\N
67150,3,ANGOLA,Most widely used screening method in national cervical cancer screening program,AFR0415,2017,999,Not Applicable,3,String,3,WHO / GHO,\N
67291,3,ANGOLA,Type of national cervical cancer screening program,AFR0416,2017,999,Not Applicable,3,String,3,WHO / GHO,\N
67407,3,ANGOLA,Coverage of national cervical cancer screening program (%),AFR0417,2017,999,Not Applicable,3,String,3,WHO / GHO,\N
129463,3,ANGOLA,Existence of national screening program for cervical cancer,AFR0418,2017,9,Female,3,String,3,WHO / GHO,\N
128457,3,ANGOLA,Sex ratio at birth,AFR0428,2017,28,Both sexes (male and female),4,Ratio,4,WB Database,1.03
64746,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2017,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,73
71547,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2017,28,Both sexes (male and female),5,Count (Numeric Integer),13,UNStat,14739913
77617,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2017,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
77660,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2017,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,20
77703,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2017,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
77780,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2017,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,18
77846,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2017,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,29
85316,3,ANGOLA,TB preventive therapy for HIV-positive people newly enrolled in HIV care,AFR0170,2017,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,2842
85455,3,ANGOLA,HIV-positive new and relapse TB patients on ART during TB treatment,AFR0169,2017,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,1401
98308,3,ANGOLA,"Secondary education, duration (years)",AFR0393,2017,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,6
99158,3,ANGOLA,"Pre-primary education, duration (years)",AFR0392,2017,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,5
120362,3,ANGOLA,Number of road traffic injuries,AFR0140,2017,29,Total,5,Count (Numeric Integer),35,IHME,24737
129997,3,ANGOLA,Coverage of essential health services,AFR0128,2017,999,Not Applicable,5,Count (Numeric Integer),3,WHO / GHO,40
142407,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2017,126,Hydrological,5,Count (Numeric Integer),35,IHME,11
145489,3,ANGOLA,Number of people living with HIV,AFR0019,2017,29,Total,5,Count (Numeric Integer),16,UNAIDS,320000
147586,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2017,29,Total,5,Count (Numeric Integer),35,IHME,50882
179016,3,ANGOLA,Number of medical doctors,AFR0469,2017,29,Total,5,Count (Numeric Integer),3,WHO / GHO,6400
99927,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2017,6,Adult (15+ Years),6,Per 1000 population,16,UNAIDS,1.8
100355,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2017,45,Male (15+ years),6,Per 1000 population,16,UNAIDS,1.1
100783,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2017,42,Female (15+ years),6,Per 1000 population,16,UNAIDS,2.4
101185,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2017,37,Both sexes (15-24 years),6,Per 1000 population,16,UNAIDS,0.8
101575,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2017,35,Male (15-24 years),6,Per 1000 population,16,UNAIDS,0.4
101966,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2017,36,Female (15-24 years),6,Per 1000 population,16,UNAIDS,1.2
102099,3,ANGOLA,Crude death rate (per 1 000 mid-year population),AFR0005,2017,28,Both sexes (male and female),6,Per 1000 population,4,WB Database,8.43
143842,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2017,29,Total,6,Per 1000 population,16,UNAIDS,0.94
62282,3,ANGOLA,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2017,9,Female,7,per 100 000 live births,23,MMEIG,241
83187,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2017,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,182
104404,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2017,8,Male,8,Per 100 000 population,3,WHO / GHO,15.88
104405,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2017,9,Female,8,Per 100 000 population,3,WHO / GHO,3.35
108611,3,ANGOLA,Malaria mortality rate (per 100 000 population),AFR0015,2017,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,44.75
109163,3,ANGOLA,Estimated direct deaths from major conflicts (per 100 000 population),AFR0029,2017,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,9.55
135802,3,ANGOLA,Number of victims of intentional homicide per 100 000 population,AFR0028,2017,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,9.5
70161,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2017,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,64.6
92084,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2017,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,49.5
97455,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2017,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,63.42
105996,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2017,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,2.09
113767,3,ANGOLA,Total Health Expenditure (constant US$),AFR0349,2017,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,3409.08
114227,3,ANGOLA,Total Health Expenditure (International US$),AFR0348,2017,999,Not Applicable,10,Millions of constant 2018 United States dollars,4,WB Database,3409.08
116832,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2017,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,2.09
75087,3,ANGOLA,Gender development index score,AFR0347,2017,28,Both sexes (male and female),12,Index,14,UNDP,0.9
152428,3,ANGOLA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2017,1001,Medical doctors,13,Per 10 000 population,3,WHO / GHO,2.14
106147,3,ANGOLA,Total Health Expenditure (THE) per Capita in US$,AFR0267,2017,999,Not Applicable,14,Per Capita,3,WHO / GHO,114.5
106966,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2017,999,Not Applicable,14,Per Capita,42,WDI,5.78
107784,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2017,999,Not Applicable,14,Per Capita,3,WHO / GHO,3.57
114686,3,ANGOLA,Total Health Expenditure (THE) per Capita in Int$ (Purchasing Power Parity),AFR0266,2017,999,Not Applicable,14,Per Capita,4,WB Database,185.85
115152,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2017,28,Both sexes (male and female),14,Per Capita,3,WHO / GHO,63.42
127871,3,ANGOLA,Life expectancy at birth (years),AFR0381,2017,28,Both sexes (male and female),17,years,4,WB Database,60.38
184508,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2017,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,114
187972,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2017,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,3.56
190948,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2017,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,39
195241,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2017,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,57.8
187106,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2017,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,5.78
192680,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2017,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,63.3
194375,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2017,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,93.95
10945,3,ANGOLA,Number of people living with HIV,AFR0019,2018,28,Both sexes (male and female),1,Percentage,16,UNAIDS,330000
13934,3,ANGOLA,Proportion of women aged 20-24 years who were married or in a union by age 18 (%),AFR0102,2018,9,Female,1,Percentage,1,WHO/AFRO,30
68359,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,59
68891,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,35
69328,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,67
72316,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2018,28,Both sexes (male and female),1,Percentage,16,UNAIDS,27
73036,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,50
74460,3,ANGOLA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2018,999,Not Applicable,1,Percentage,3,WHO / GHO,59
74558,3,ANGOLA,"IHR Coordination, Communication and Advocacy",AFR0035,2018,999,Not Applicable,1,Percentage,3,WHO / GHO,80
75653,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,86
84258,3,ANGOLA,TB case detection rate,AFR0176,2018,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,61
85843,3,ANGOLA,Immunization coverage against Rotavirus vaccine,AFR0187,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,65
91255,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,56
91492,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 3,AFR0191,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,59
92969,3,ANGOLA,GDP growth (annual %),AFR0388,2018,999,Not Applicable,1,Percentage,22,UN DESA,-4.38
95339,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,59
95752,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2018,28,Both sexes (male and female),1,Percentage,1,WHO/AFRO,67
97253,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2018,999,Not Applicable,1,Percentage,4,WB Database,7.01
98511,3,ANGOLA,Immunization coverage against Tetanus,AFR0189,2018,28,Both sexes (male and female),1,Percentage,4,WB Database,63
111178,3,ANGOLA,TB case detection rate,AFR0176,2018,29,Total,1,Percentage,3,WHO / GHO,61
112545,3,ANGOLA,Pneumococcal vaccination coverage,AFR0186,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,59
112728,3,ANGOLA,TB preventive therapy for HIV-positive people newly enrolled in HIV care,AFR0170,2018,29,Total,1,Percentage,3,WHO / GHO,42
122049,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2018,29,Total,1,Percentage,36,WHO/UNICEF,59
124363,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2018,28,Both sexes (male and female),1,Percentage,35,IHME,0.84
125803,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2018,8,Male,1,Percentage,35,IHME,0.78
127243,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2018,9,Female,1,Percentage,35,IHME,0.9
130238,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2018,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,59
130286,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2018,999,Not Applicable,1,Percentage,3,WHO / GHO,35
130334,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2018,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,67
130382,3,ANGOLA,Immunization coverage against HPV,AFR0188,2018,9,Female,1,Percentage,3,WHO / GHO,\N
133452,3,ANGOLA,Proportion of urban population living in slums (%),AFR0118,2018,28,Both sexes (male and female),1,Percentage,4,WB Database,48.6
134229,3,ANGOLA,School dropout rate,AFR0160,2018,28,Both sexes (male and female),1,Percentage,42,WDI,6.39
135658,3,ANGOLA,Amount of water and sanitation-related official development assistance that is part of a government coordinated spending plan (constant 2017 US $ millions),AFR0438,2018,999,Not Applicable,1,Percentage,3,WHO / GHO,23.09
135706,3,ANGOLA,Proportion of population with primary reliance on clean fuels (%) -[SDG 7.1.2],AFR0126,2018,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,48
137296,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2018,29,Total,1,Percentage,36,WHO/UNICEF,63
147283,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2018,29,Total,1,Percentage,36,WHO/UNICEF,35
148190,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2018,107,Female (10-14 years),1,Percentage,35,IHME,108.02
148245,3,ANGOLA,Antenatal care attendees who were positive for syphilis (%),AFR0457,2018,9,Female,1,Percentage,59,GARPR,3.4
148388,3,ANGOLA,Antenatal client syphilis screening,AFR0454,2018,9,Female,1,Percentage,59,GARPR,1.7
149803,3,ANGOLA,Percentage of women accessing antenatal care services who tested positive for syphilis and were treated,AFR0448,2018,9,Female,1,Percentage,59,GARPR,98.4
149920,3,ANGOLA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2018,9,Female,1,Percentage,16,UNAIDS,23.52
150932,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2018,66,Female (15-49 years),1,Percentage,35,IHME,39.07
179607,3,ANGOLA,Access to electricity (% of population),AFR0380,2018,999,Not Applicable,1,Percentage,4,WB Database,43.2
180182,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2018,9,Female,1,Percentage,16,UNAIDS,41
182823,3,ANGOLA,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,54.74
183689,3,ANGOLA,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,2.54
185421,3,ANGOLA,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,96.6
186287,3,ANGOLA,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,3.32
188958,3,ANGOLA,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,5.42
189824,3,ANGOLA,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,5.42
191861,3,ANGOLA,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,36.7
193557,3,ANGOLA,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2018,999,Not Applicable,1,Percentage,10,WHO / GHED,17.9
207926,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2018,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,50
7110,3,ANGOLA,HIV prevalence among adults aged 15-49 years (%),AFR0377,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,2
10531,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.6
11393,3,ANGOLA,Population size (in thousands) total,AFR0004,2018,28,Both sexes (male and female),2,Per 1000 live births,17,UN Population,30774.21
12456,3,ANGOLA,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,28.48
13886,3,ANGOLA,"Adolescent birth rate (per 1,000 women aged 15-19 years)",AFR0106,2018,9,Female,2,Per 1000 live births,3,WHO / GHO,190.9
14022,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,77.16
15831,3,ANGOLA,AIDS-related mortality rate (per 100 000 population),AFR0014,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,45.44
16943,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,89
20202,3,ANGOLA,HIV incidence rate per 1000 uninfected population [SDG 3.3.1],AFR0395,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.6
20418,3,ANGOLA,TB incidence rate [SDG 3.3.2],AFR0334,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,355
22551,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,2
23293,3,ANGOLA,Early marriage,AFR0315,2018,9,Female,2,Per 1000 live births,3,WHO / GHO,30.3
24828,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - BCG,AFR0197,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,86
25258,3,ANGOLA,Immunization coverage against Rotavirus vaccine,AFR0187,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,65
25433,3,ANGOLA,Adolescent birth rate [SDG 3.7.2],AFR0293,2018,9,Female,2,Per 1000 live births,20,ITU,190.9
26478,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,50
26908,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 3,AFR0194,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,56
27670,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2018,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,67
28916,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2018,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,45.39
29109,3,ANGOLA,People living with HIV who know their status,AFR0181,2018,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,60
29864,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,215
30934,3,ANGOLA,TB case detection rate,AFR0176,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,61
31993,3,ANGOLA,TB preventive therapy for HIV-positive people newly enrolled in HIV care,AFR0170,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,9567
32132,3,ANGOLA,HIV-positive new and relapse TB patients on ART during TB treatment,AFR0169,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,2101
38577,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2018,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,30.45
39770,3,ANGOLA,Net official development assistance received (current US$),AFR0031,2018,999,Not Applicable,2,Per 1000 live births,19,OECD,45.62
40681,3,ANGOLA,DTP dropout rate (DTP1 -DPT3),AFR0226,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,8
41504,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,31
41548,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,51,Polio,2,Per 1000 live births,1,WHO/AFRO,0
41593,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,0
41624,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,48,Neonatal tetanus,2,Per 1000 live births,1,WHO/AFRO,86
41685,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2018,46,Measles,2,Per 1000 live births,1,WHO/AFRO,57
47201,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2018,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,15220708
63114,3,ANGOLA,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2018,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,77.16
128456,3,ANGOLA,Sex ratio at birth,AFR0428,2018,28,Both sexes (male and female),4,Ratio,4,WB Database,1.03
64747,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2018,28,Both sexes (male and female),5,Count (Numeric Integer),25,UNISDR,89
77322,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2018,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,31
77366,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2018,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,0
77411,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2018,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,0
77442,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2018,59,Neonatal tetanus,5,Count (Numeric Integer),3,WHO / GHO,86
77503,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2018,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,57
85317,3,ANGOLA,TB preventive therapy for HIV-positive people newly enrolled in HIV care,AFR0170,2018,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,9567
85456,3,ANGOLA,HIV-positive new and relapse TB patients on ART during TB treatment,AFR0169,2018,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,2101
98307,3,ANGOLA,"Secondary education, duration (years)",AFR0393,2018,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,6
99157,3,ANGOLA,"Pre-primary education, duration (years)",AFR0392,2018,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,5
120409,3,ANGOLA,Number of road traffic injuries,AFR0140,2018,29,Total,5,Count (Numeric Integer),35,IHME,25710
129850,3,ANGOLA,Number of people requiring interventions against neglected tropical diseases [SDG 3.3.5],AFR0327,2018,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,15220708
141997,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2018,125,Biological,5,Count (Numeric Integer),35,IHME,2
142421,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2018,126,Hydrological,5,Count (Numeric Integer),35,IHME,8
145535,3,ANGOLA,Number of people living with HIV,AFR0019,2018,29,Total,5,Count (Numeric Integer),16,UNAIDS,330000
147634,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2018,29,Total,5,Count (Numeric Integer),35,IHME,53793
76635,3,ANGOLA,Nursing and midwifery personnel density (per 1000 population),AFR0286,2018,999,Not Applicable,6,Per 1000 population,38,Global Health Workforce Statistics,40.75
99970,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2018,6,Adult (15+ Years),6,Per 1000 population,16,UNAIDS,1.8
100398,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2018,45,Male (15+ years),6,Per 1000 population,16,UNAIDS,1.1
100826,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2018,42,Female (15+ years),6,Per 1000 population,16,UNAIDS,2.5
101224,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2018,37,Both sexes (15-24 years),6,Per 1000 population,16,UNAIDS,0.8
101614,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2018,35,Male (15-24 years),6,Per 1000 population,16,UNAIDS,0.4
102005,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2018,36,Female (15-24 years),6,Per 1000 population,16,UNAIDS,1.2
143886,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2018,29,Total,6,Per 1000 population,16,UNAIDS,0.9
83188,3,ANGOLA,Tuberculosis (TB) notification rate (per 100 000 population),AFR0333,2018,28,Both sexes (male and female),8,Per 100 000 population,3,WHO / GHO,215
108612,3,ANGOLA,Malaria mortality rate (per 100 000 population),AFR0015,2018,999,Not Applicable,8,Per 100 000 population,3,WHO / GHO,43.57
120655,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 1,AFR0196,2018,29,Total,8,Per 100 000 population,36,WHO/UNICEF,40
64995,3,ANGOLA,Adolescent birth rate [SDG 3.7.2],AFR0293,2018,9,Female,9,Per 1000 women aged 15-19 years,3,WHO / GHO,190.9
71209,3,ANGOLA,Adolescent birth rate [SDG 3.7.2],AFR0293,2018,9,Female,9,Per 1000 women aged 15-19 years,13,UNStat,190.9
70207,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2018,28,Both sexes (male and female),10,Millions of constant 2018 United States dollars,13,UNStat,45.3
92085,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2018,999,Not Applicable,10,Millions of constant 2018 United States dollars,19,OECD,45.61
105997,3,ANGOLA,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2018,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,1.47
116831,3,ANGOLA,"Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2016 United States dollars)",AFR0113,2018,999,Not Applicable,10,Millions of constant 2018 United States dollars,3,WHO / GHO,1.47
75131,3,ANGOLA,Gender development index score,AFR0347,2018,28,Both sexes (male and female),12,Index,14,UNDP,0.9
131010,3,ANGOLA,Radiation Emergencies,AFR0414,2018,999,Not Applicable,12,Index,3,WHO / GHO,60
131103,3,ANGOLA,Risk Communication,AFR0039,2018,999,Not Applicable,12,Index,3,WHO / GHO,80
152494,3,ANGOLA,"Health worker density, by type of occupation (per 10,000 population)",AFR0114,2018,1002,Nursing and midwifery personnel,13,Per 10 000 population,3,WHO / GHO,4.07
127872,3,ANGOLA,Life expectancy at birth (years),AFR0381,2018,28,Both sexes (male and female),17,years,4,WB Database,60.78
129473,3,ANGOLA,Population size (in thousands) total,AFR0004,2018,8,Male,18,in thousands,50,World Health Statistics,15241
129519,3,ANGOLA,Population size (in thousands) total,AFR0004,2018,9,Female,18,in thousands,50,World Health Statistics,15568
129565,3,ANGOLA,Population size (in thousands) total,AFR0004,2018,28,Both sexes (male and female),18,in thousands,50,World Health Statistics,30810
129611,3,ANGOLA,Population size (in thousands) total,AFR0004,2018,8,Male,18,in thousands,3,WHO / GHO,15241
129658,3,ANGOLA,Population size (in thousands) total,AFR0004,2018,9,Female,18,in thousands,3,WHO / GHO,15568
129705,3,ANGOLA,Population size (in thousands) total,AFR0004,2018,28,Both sexes (male and female),18,in thousands,3,WHO / GHO,30810
184555,3,ANGOLA,Current health expenditure (CHE) per capita in US$,AFR0263,2018,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,87.6
188019,3,ANGOLA,External Health Expenditure (EXT) per Capita in US$,AFR0095,2018,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,2.91
190995,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in US$,AFR0258,2018,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,32.2
195288,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in US$,AFR0092,2018,999,Not Applicable,24,Per capita in US$,10,WHO / GHED,47.9
187153,3,ANGOLA,External Health Expenditure (EXT) per Capita in PPP Int$,AFR0094,2018,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,5.47
192727,3,ANGOLA,Out-of-Pocket expenditure (OOP) per capita in PPP int$,AFR0257,2018,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,60.6
194422,3,ANGOLA,Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$,AFR0091,2018,999,Not Applicable,28,per capita in PPP int$,10,WHO / GHED,90.17
72361,3,ANGOLA,Coverage of antiretroviral therapy (ART) (also effective ART treatment coverage),AFR0179,2019,28,Both sexes (male and female),1,Percentage,16,UNAIDS,27
74508,3,ANGOLA,International Health Regulations (IHR) core capacities index - [SDG 3.d.1],AFR0251,2019,999,Not Applicable,1,Percentage,3,WHO / GHO,63
74557,3,ANGOLA,"IHR Coordination, Communication and Advocacy",AFR0035,2019,999,Not Applicable,1,Percentage,3,WHO / GHO,90
97299,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2019,999,Not Applicable,1,Percentage,4,WB Database,6.88
98512,3,ANGOLA,Immunization coverage against Tetanus,AFR0189,2019,28,Both sexes (male and female),1,Percentage,4,WB Database,57
103147,3,ANGOLA,Service availability index (%) (high-level indicator),AFR0229,2019,999,Not Applicable,1,Percentage,4,WB Database,40
103288,3,ANGOLA,Service availability index (%),AFR0049,2019,999,Not Applicable,1,Percentage,4,WB Database,40
105957,3,ANGOLA,Immunization coverage against Rotavirus vaccine,AFR0187,2019,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,58
112585,3,ANGOLA,Pneumococcal vaccination coverage,AFR0186,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,53
112742,3,ANGOLA,TB preventive therapy for HIV-positive people newly enrolled in HIV care,AFR0170,2019,29,Total,1,Percentage,3,WHO / GHO,3
122088,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2019,29,Total,1,Percentage,36,WHO/UNICEF,53
124411,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2019,28,Both sexes (male and female),1,Percentage,35,IHME,0.87
125851,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2019,8,Male,1,Percentage,35,IHME,0.8
127291,3,ANGOLA,Prevalence chronic obstructive pulmonary diseases,AFR0319,2019,9,Female,1,Percentage,35,IHME,0.93
134230,3,ANGOLA,School dropout rate,AFR0160,2019,28,Both sexes (male and female),1,Percentage,42,WDI,7.58
137344,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2019,29,Total,1,Percentage,36,WHO/UNICEF,57
147310,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2019,29,Total,1,Percentage,36,WHO/UNICEF,45
148191,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2019,107,Female (10-14 years),1,Percentage,35,IHME,100.77
148246,3,ANGOLA,Antenatal care attendees who were positive for syphilis (%),AFR0457,2019,9,Female,1,Percentage,59,GARPR,2.5
148389,3,ANGOLA,Antenatal client syphilis screening,AFR0454,2019,9,Female,1,Percentage,59,GARPR,15.3
149804,3,ANGOLA,Percentage of women accessing antenatal care services who tested positive for syphilis and were treated,AFR0448,2019,9,Female,1,Percentage,59,GARPR,88.8
149921,3,ANGOLA,Prevention of mother-to-child transmission (PMTCT) of HIV,AFR0050,2019,9,Female,1,Percentage,16,UNAIDS,19.3
150933,3,ANGOLA,Percentage of maternal deaths due to unsafe abortion,AFR0447,2019,66,Female (15-49 years),1,Percentage,35,IHME,38.6
180223,3,ANGOLA,Coverage of prevention of mother-to-child transmission (also effective PMTCT coverage),AFR0180,2019,9,Female,1,Percentage,16,UNAIDS,63
195378,3,ANGOLA,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2019,28,Both sexes (male and female),1,Percentage,37,IDF,4.5
195423,3,ANGOLA,Proportion of people with undiagnosed diabetes,AFR0473,2019,28,Both sexes (male and female),1,Percentage,37,IDF,52.4
207652,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,57
207761,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,45
207823,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,53
207927,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2019,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,51
29151,3,ANGOLA,People living with HIV who know their status,AFR0181,2019,28,Both sexes (male and female),2,Per 1000 live births,16,UNAIDS,62
38578,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2019,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,30
41123,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,53,Yellow fever,2,Per 1000 live births,1,WHO/AFRO,0
41162,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,52,Rubella,2,Per 1000 live births,1,WHO/AFRO,69
41206,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,51,Polio,2,Per 1000 live births,1,WHO/AFRO,130
41252,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,50,Pertussis,2,Per 1000 live births,1,WHO/AFRO,0
41344,3,ANGOLA,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,2019,46,Measles,2,Per 1000 live births,1,WHO/AFRO,2987
66962,3,ANGOLA,Existence of national screening program for cervical cancer,AFR0418,2019,999,Not Applicable,3,String,3,WHO / GHO,\N
67103,3,ANGOLA,Most widely used screening method in national cervical cancer screening program,AFR0415,2019,999,Not Applicable,3,String,3,WHO / GHO,\N
67244,3,ANGOLA,Type of national cervical cancer screening program,AFR0416,2019,999,Not Applicable,3,String,3,WHO / GHO,\N
67385,3,ANGOLA,Coverage of national cervical cancer screening program (%),AFR0417,2019,999,Not Applicable,3,String,3,WHO / GHO,\N
129468,3,ANGOLA,Existence of national screening program for cervical cancer,AFR0418,2019,9,Female,3,String,3,WHO / GHO,\N
76941,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2019,53,Yellow fever,5,Count (Numeric Integer),3,WHO / GHO,0
76980,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2019,52,Rubella,5,Count (Numeric Integer),3,WHO / GHO,69
77024,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2019,51,Polio,5,Count (Numeric Integer),3,WHO / GHO,130
77070,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2019,61,Pertussis,5,Count (Numeric Integer),3,WHO / GHO,0
77162,3,ANGOLA,New cases of vaccine-preventable diseases,AFR0324,2019,57,Measles,5,Count (Numeric Integer),3,WHO / GHO,2987
98306,3,ANGOLA,"Secondary education, duration (years)",AFR0393,2019,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,6
99156,3,ANGOLA,"Pre-primary education, duration (years)",AFR0392,2019,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,5
120456,3,ANGOLA,Number of road traffic injuries,AFR0140,2019,29,Total,5,Count (Numeric Integer),35,IHME,26820
135850,3,ANGOLA,Number of cases of poliomyelitis caused by wild poliovirus (WPV),AFR0425,2019,28,Both sexes (male and female),5,Count (Numeric Integer),3,WHO / GHO,0
142434,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2019,126,Hydrological,5,Count (Numeric Integer),35,IHME,11
145581,3,ANGOLA,Number of people living with HIV,AFR0019,2019,29,Total,5,Count (Numeric Integer),16,UNAIDS,340000
147682,3,ANGOLA,Number of cancer cases (all cause),AFR0321,2019,29,Total,5,Count (Numeric Integer),35,IHME,56741
195512,3,ANGOLA,Number of deaths attributable to diabetes,AFR0474,2019,28,Both sexes (male and female),5,Count (Numeric Integer),37,IDF,6988
100013,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2019,6,Adult (15+ Years),6,Per 1000 population,16,UNAIDS,1.8
100441,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2019,45,Male (15+ years),6,Per 1000 population,16,UNAIDS,1.1
100869,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2019,42,Female (15+ years),6,Per 1000 population,16,UNAIDS,2.5
101263,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2019,37,Both sexes (15-24 years),6,Per 1000 population,16,UNAIDS,0.8
101653,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2019,35,Male (15-24 years),6,Per 1000 population,16,UNAIDS,0.4
102045,3,ANGOLA,HIV prevalence rate (per 1000 population),AFR0020,2019,36,Female (15-24 years),6,Per 1000 population,16,UNAIDS,1.2
143930,3,ANGOLA,"Number of new HIV infections per 1,000 uninfected population",AFR0104,2019,29,Total,6,Per 1000 population,16,UNAIDS,0.84
120700,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Polio 1,AFR0196,2019,29,Total,8,Per 100 000 population,36,WHO/UNICEF,43
131009,3,ANGOLA,Radiation Emergencies,AFR0414,2019,999,Not Applicable,12,Index,3,WHO / GHO,60
131102,3,ANGOLA,Risk Communication,AFR0039,2019,999,Not Applicable,12,Index,3,WHO / GHO,80
213078,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2019,28,Both sexes (male and female),23,Numeric,75,WHO/GHO_2021,54.8
213266,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2019,8,Male,23,Numeric,75,WHO/GHO_2021,53.6
213454,3,ANGOLA,Healthy life expectancy at birth (in years),AFR0002,2019,9,Female,23,Numeric,75,WHO/GHO_2021,56.2
213642,3,ANGOLA,Healthy life expectancy (HALE) at age 60 (years),AFR0086,2019,28,Both sexes (male and female),23,Numeric,75,WHO/GHO_2021,12.6
97345,3,ANGOLA,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2020,999,Not Applicable,1,Percentage,4,WB Database,6.77
195564,3,ANGOLA,Prevalence of obesity in persons aged 18+years,AFR0021,2020,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8.2
207653,3,ANGOLA,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2020,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,51
207762,3,ANGOLA,Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%),AFR0112,2020,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,41
207824,3,ANGOLA,PCV3 immunization coverage among 1-year-olds (%),AFR0125,2020,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,47
207928,3,ANGOLA,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Measles,AFR0190,2020,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,44
28963,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2020,8,Male,2,Per 1000 live births,3,WHO / GHO,28.3
28964,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2020,9,Female,2,Per 1000 live births,3,WHO / GHO,25.6
28965,3,ANGOLA,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2020,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,27
38579,3,ANGOLA,Proportion of seats held by women in national parliaments (%),AFR0034,2020,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,30
98257,3,ANGOLA,"Secondary education, duration (years)",AFR0393,2020,28,Both sexes (male and female),5,Count (Numeric Integer),4,WB Database,6
142459,3,ANGOLA,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,2020,126,Hydrological,5,Count (Numeric Integer),35,IHME,11
152663,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,70,0-4 years,5,Count (Numeric Integer),17,UN Population,5795004
152896,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,71,5-9 years,5,Count (Numeric Integer),17,UN Population,5104164
153129,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,72,10-14 years,5,Count (Numeric Integer),17,UN Population,4349261
153360,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,73,15-19 years,5,Count (Numeric Integer),17,UN Population,3532518
153591,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,74,20-24 years,5,Count (Numeric Integer),17,UN Population,2882566
153823,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,75,25-29 years,5,Count (Numeric Integer),17,UN Population,2423471
154055,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,76,30-34 years,5,Count (Numeric Integer),17,UN Population,2040757
154287,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,77,35-39 years,5,Count (Numeric Integer),17,UN Population,1658972
154520,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,78,40-44 years,5,Count (Numeric Integer),17,UN Population,1330695
154751,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,79,45-49 years,5,Count (Numeric Integer),17,UN Population,1082040
154983,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,80,50-54 years,5,Count (Numeric Integer),17,UN Population,787212
155217,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,81,55-59 years,5,Count (Numeric Integer),17,UN Population,677390
155449,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,82,60-64 years,5,Count (Numeric Integer),17,UN Population,481968
155679,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,83,65-69 years,5,Count (Numeric Integer),17,UN Population,303929
155910,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,84,70-74 years,5,Count (Numeric Integer),17,UN Population,212513
156142,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,85,75-79 years,5,Count (Numeric Integer),17,UN Population,119216
177483,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,86,80-84 years,5,Count (Numeric Integer),17,UN Population,59937
177714,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,1010,85-89 years,5,Count (Numeric Integer),17,UN Population,19878
178026,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,1011,90-94 years,5,Count (Numeric Integer),17,UN Population,4259
178261,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,1012,95-99 years,5,Count (Numeric Integer),17,UN Population,480
178496,3,ANGOLA,Population by age (under 1; 1-5; 6-12; 13-25; 26-49; 50-64; over 65 years),AFR0018,2020,1009,100+ years,5,Count (Numeric Integer),17,UN Population,38
130583,4,BENIN,Total fertility rate,AFR0130,1950-1955,9,Female,1,Percentage,17,UN Population,5.86
131337,4,BENIN,Total fertility rate,AFR0130,1955-1960,9,Female,1,Percentage,17,UN Population,6.13
131338,4,BENIN,Total fertility rate,AFR0130,1960-1965,9,Female,1,Percentage,17,UN Population,6.42
128499,4,BENIN,Sex ratio at birth,AFR0428,1962,28,Both sexes (male and female),4,Ratio,4,WB Database,1.04
131339,4,BENIN,Total fertility rate,AFR0130,1965-1970,9,Female,1,Percentage,17,UN Population,6.65
128498,4,BENIN,Sex ratio at birth,AFR0428,1967,28,Both sexes (male and female),4,Ratio,4,WB Database,1.04
127873,4,BENIN,Life expectancy at birth (years),AFR0381,1970,28,Both sexes (male and female),17,years,4,WB Database,42.15
131340,4,BENIN,Total fertility rate,AFR0130,1970-1975,9,Female,1,Percentage,17,UN Population,6.83
131615,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1971,28,Both sexes (male and female),1,Percentage,4,WB Database,34.76
131616,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1972,28,Both sexes (male and female),1,Percentage,4,WB Database,37.7
128497,4,BENIN,Sex ratio at birth,AFR0428,1972,28,Both sexes (male and female),4,Ratio,4,WB Database,1.04
131617,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1973,28,Both sexes (male and female),1,Percentage,4,WB Database,41.49
131618,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1974,28,Both sexes (male and female),1,Percentage,4,WB Database,39.69
86023,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1975,8,Male,1,Percentage,3,WHO / GHO,29.1
86024,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1975,9,Female,1,Percentage,3,WHO / GHO,25.3
86025,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1975,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.1
131619,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1975,28,Both sexes (male and female),1,Percentage,4,WB Database,46.19
196980,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1975,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.1
198827,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1975,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,8.7
131341,4,BENIN,Total fertility rate,AFR0130,1975-1980,9,Female,1,Percentage,17,UN Population,7
86161,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1976,8,Male,1,Percentage,3,WHO / GHO,29.4
86162,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1976,9,Female,1,Percentage,3,WHO / GHO,25.7
86163,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1976,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.4
131620,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1976,28,Both sexes (male and female),1,Percentage,4,WB Database,47.99
196981,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1976,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.2
198828,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1976,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9
86299,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1977,8,Male,1,Percentage,3,WHO / GHO,29.6
86300,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1977,9,Female,1,Percentage,3,WHO / GHO,26
86301,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1977,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,27.8
131621,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1977,28,Both sexes (male and female),1,Percentage,4,WB Database,49.99
196982,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1977,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.3
198829,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1977,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9.3
128496,4,BENIN,Sex ratio at birth,AFR0428,1977,28,Both sexes (male and female),4,Ratio,4,WB Database,1.04
86437,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1978,8,Male,1,Percentage,3,WHO / GHO,29.9
86438,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1978,9,Female,1,Percentage,3,WHO / GHO,26.4
86439,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1978,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.1
131622,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1978,28,Both sexes (male and female),1,Percentage,4,WB Database,50.81
196983,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1978,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.4
198830,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1978,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,9.7
86575,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1979,8,Male,1,Percentage,3,WHO / GHO,30.2
86576,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1979,9,Female,1,Percentage,3,WHO / GHO,26.8
86577,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1979,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.4
131623,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1979,28,Both sexes (male and female),1,Percentage,4,WB Database,56.86
196984,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1979,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.5
198831,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1979,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,10
47669,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1980,8,Male,1,Percentage,3,WHO / GHO,3.1
47670,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1980,9,Female,1,Percentage,3,WHO / GHO,2.7
47671,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1980,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.9
86713,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1980,8,Male,1,Percentage,3,WHO / GHO,30.4
86714,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1980,9,Female,1,Percentage,3,WHO / GHO,27.2
86715,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1980,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,28.8
131624,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1980,28,Both sexes (male and female),1,Percentage,4,WB Database,58.26
196985,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1980,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.6
198832,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1980,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,10.4
131342,4,BENIN,Total fertility rate,AFR0130,1980-1985,9,Female,1,Percentage,17,UN Population,7.01
47807,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1981,8,Male,1,Percentage,3,WHO / GHO,3.2
47808,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1981,9,Female,1,Percentage,3,WHO / GHO,2.8
47809,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1981,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3
86851,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1981,8,Male,1,Percentage,3,WHO / GHO,30.6
86852,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1981,9,Female,1,Percentage,3,WHO / GHO,27.5
86853,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1981,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29.1
131625,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1981,28,Both sexes (male and female),1,Percentage,4,WB Database,60.35
196986,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1981,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.7
198833,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1981,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,10.8
47945,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1982,8,Male,1,Percentage,3,WHO / GHO,3.3
47946,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1982,9,Female,1,Percentage,3,WHO / GHO,2.9
47947,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1982,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3
86989,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1982,8,Male,1,Percentage,3,WHO / GHO,30.8
86990,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1982,9,Female,1,Percentage,3,WHO / GHO,27.8
86991,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1982,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29.3
131626,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1982,28,Both sexes (male and female),1,Percentage,4,WB Database,64.68
196987,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1982,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.8
198834,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1982,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.1
128495,4,BENIN,Sex ratio at birth,AFR0428,1982,28,Both sexes (male and female),4,Ratio,4,WB Database,1.04
48083,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1983,8,Male,1,Percentage,3,WHO / GHO,3.4
48084,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1983,9,Female,1,Percentage,3,WHO / GHO,2.9
48085,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1983,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.1
87127,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,8,Male,1,Percentage,3,WHO / GHO,31
87128,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,9,Female,1,Percentage,3,WHO / GHO,28.2
87129,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1983,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29.6
131193,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1983,28,Both sexes (male and female),1,Percentage,4,WB Database,66.25
196988,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1983,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2
198835,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1983,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.5
48221,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1984,8,Male,1,Percentage,3,WHO / GHO,3.5
48222,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1984,9,Female,1,Percentage,3,WHO / GHO,3
48223,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1984,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.2
87265,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,8,Male,1,Percentage,3,WHO / GHO,31.1
87266,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,9,Female,1,Percentage,3,WHO / GHO,28.4
87267,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1984,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,29.8
131627,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1984,28,Both sexes (male and female),1,Percentage,4,WB Database,64.2
134231,4,BENIN,School dropout rate,AFR0160,1984,28,Both sexes (male and female),1,Percentage,42,WDI,49.9
196989,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1984,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.1
198836,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1984,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,11.9
48359,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1985,8,Male,1,Percentage,3,WHO / GHO,3.6
48360,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1985,9,Female,1,Percentage,3,WHO / GHO,3.1
48361,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1985,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.3
87403,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,8,Male,1,Percentage,3,WHO / GHO,31.3
87404,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,9,Female,1,Percentage,3,WHO / GHO,28.7
87405,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1985,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30
131628,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1985,28,Both sexes (male and female),1,Percentage,4,WB Database,64.31
134232,4,BENIN,School dropout rate,AFR0160,1985,28,Both sexes (male and female),1,Percentage,42,WDI,49.16
196990,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1985,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.3
198837,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1985,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,12.2
142030,4,BENIN,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1985,126,Hydrological,5,Count (Numeric Integer),35,IHME,61
131343,4,BENIN,Total fertility rate,AFR0130,1985-1990,9,Female,1,Percentage,17,UN Population,6.88
48497,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1986,8,Male,1,Percentage,3,WHO / GHO,3.7
48498,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1986,9,Female,1,Percentage,3,WHO / GHO,3.2
48499,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1986,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.4
87541,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,8,Male,1,Percentage,3,WHO / GHO,31.4
87542,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,9,Female,1,Percentage,3,WHO / GHO,29
87543,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1986,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.2
131629,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1986,28,Both sexes (male and female),1,Percentage,4,WB Database,62.37
134233,4,BENIN,School dropout rate,AFR0160,1986,28,Both sexes (male and female),1,Percentage,42,WDI,51.1
196991,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1986,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.4
198838,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1986,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,12.6
48635,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1987,8,Male,1,Percentage,3,WHO / GHO,3.8
48636,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1987,9,Female,1,Percentage,3,WHO / GHO,3.3
48637,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1987,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.5
87679,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,8,Male,1,Percentage,3,WHO / GHO,31.5
87680,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,9,Female,1,Percentage,3,WHO / GHO,29.2
87681,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1987,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.4
131630,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1987,28,Both sexes (male and female),1,Percentage,4,WB Database,62.69
196992,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1987,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.6
198839,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1987,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,13
128494,4,BENIN,Sex ratio at birth,AFR0428,1987,28,Both sexes (male and female),4,Ratio,4,WB Database,1.04
141573,4,BENIN,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1987,125,Biological,5,Count (Numeric Integer),35,IHME,24
48773,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1988,8,Male,1,Percentage,3,WHO / GHO,3.9
48774,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1988,9,Female,1,Percentage,3,WHO / GHO,3.4
48775,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1988,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.6
87817,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,8,Male,1,Percentage,3,WHO / GHO,31.5
87818,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,9,Female,1,Percentage,3,WHO / GHO,29.4
87819,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1988,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.6
131631,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1988,28,Both sexes (male and female),1,Percentage,4,WB Database,61.63
134234,4,BENIN,School dropout rate,AFR0160,1988,28,Both sexes (male and female),1,Percentage,42,WDI,51.56
196993,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1988,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.7
198840,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1988,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,13.4
48911,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1989,8,Male,1,Percentage,3,WHO / GHO,4.1
48912,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1989,9,Female,1,Percentage,3,WHO / GHO,3.5
48913,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1989,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.8
87955,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,8,Male,1,Percentage,3,WHO / GHO,31.6
87956,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,9,Female,1,Percentage,3,WHO / GHO,29.6
87957,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1989,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.7
131632,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1989,28,Both sexes (male and female),1,Percentage,4,WB Database,61.1
134235,4,BENIN,School dropout rate,AFR0160,1989,28,Both sexes (male and female),1,Percentage,42,WDI,51.07
196994,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1989,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,2.9
198841,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1989,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,13.8
141591,4,BENIN,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1989,125,Biological,5,Count (Numeric Integer),35,IHME,228
11499,4,BENIN,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,1990,9,Female,1,Percentage,3,WHO / GHO,576
49049,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1990,8,Male,1,Percentage,3,WHO / GHO,4.2
49050,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1990,9,Female,1,Percentage,3,WHO / GHO,3.6
49051,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1990,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.9
88093,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1990,8,Male,1,Percentage,3,WHO / GHO,31.6
88094,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1990,9,Female,1,Percentage,3,WHO / GHO,29.8
88095,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1990,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.8
98513,4,BENIN,Immunization coverage against Tetanus,AFR0189,1990,28,Both sexes (male and female),1,Percentage,4,WB Database,74
109994,4,BENIN,TB case detection rate,AFR0176,1990,29,Total,1,Percentage,3,WHO / GHO,32
123020,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1990,28,Both sexes (male and female),1,Percentage,35,IHME,0.97
124460,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1990,8,Male,1,Percentage,35,IHME,0.96
125900,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1990,9,Female,1,Percentage,35,IHME,0.98
131633,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1990,28,Both sexes (male and female),1,Percentage,4,WB Database,51.25
133453,4,BENIN,Proportion of urban population living in slums (%),AFR0118,1990,28,Both sexes (male and female),1,Percentage,4,WB Database,79.3
134236,4,BENIN,School dropout rate,AFR0160,1990,28,Both sexes (male and female),1,Percentage,42,WDI,60.49
135996,4,BENIN,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1990,29,Total,1,Percentage,36,WHO/UNICEF,74
195666,4,BENIN,Share of premature deaths attributed to high body mass index,AFR0475,1990,28,Both sexes (male and female),1,Percentage,35,IHME,1.21
196995,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1990,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.1
198842,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1990,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,14.2
12457,4,BENIN,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1990,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,45.84
14023,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1990,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,175.38
63115,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1990,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,175.3
128493,4,BENIN,Sex ratio at birth,AFR0428,1990,28,Both sexes (male and female),4,Ratio,4,WB Database,1.04
119094,4,BENIN,Number of road traffic injuries,AFR0140,1990,29,Total,5,Count (Numeric Integer),35,IHME,6281
137393,4,BENIN,Number of cancer cases (all cause),AFR0321,1990,29,Total,5,Count (Numeric Integer),35,IHME,6856
142655,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1990,29,Total,6,Per 1000 population,16,UNAIDS,0.39
143975,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1990,8,Male,6,Per 1000 population,16,UNAIDS,0.4
127874,4,BENIN,Life expectancy at birth (years),AFR0381,1990,28,Both sexes (male and female),17,years,4,WB Database,53.81
122129,4,BENIN,Life expectancy at age 60 years,AFR0003,1990-1995,28,Both sexes (male and female),1,Percentage,17,UN Population,16.84
122417,4,BENIN,Life expectancy at age 60 years,AFR0003,1990-1995,8,Male,1,Percentage,17,UN Population,16.12
122705,4,BENIN,Life expectancy at age 60 years,AFR0003,1990-1995,9,Female,1,Percentage,17,UN Population,17.39
131344,4,BENIN,Total fertility rate,AFR0130,1990-1995,9,Female,1,Percentage,17,UN Population,6.56
49187,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1991,8,Male,1,Percentage,3,WHO / GHO,4.3
49188,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1991,9,Female,1,Percentage,3,WHO / GHO,3.8
49189,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1991,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4
88231,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1991,8,Male,1,Percentage,3,WHO / GHO,31.6
88232,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1991,9,Female,1,Percentage,3,WHO / GHO,29.9
88233,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1991,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.9
96013,4,BENIN,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1991,999,Not Applicable,1,Percentage,4,WB Database,1.48
110034,4,BENIN,TB case detection rate,AFR0176,1991,29,Total,1,Percentage,3,WHO / GHO,35
123068,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1991,28,Both sexes (male and female),1,Percentage,35,IHME,0.97
124508,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1991,8,Male,1,Percentage,35,IHME,0.96
125948,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1991,9,Female,1,Percentage,35,IHME,0.98
131634,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1991,28,Both sexes (male and female),1,Percentage,4,WB Database,58.22
136039,4,BENIN,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1991,29,Total,1,Percentage,36,WHO/UNICEF,69
195667,4,BENIN,Share of premature deaths attributed to high body mass index,AFR0475,1991,28,Both sexes (male and female),1,Percentage,35,IHME,1.3
196996,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1991,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.2
198843,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1991,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,14.6
12458,4,BENIN,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1991,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,45.11
14024,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1991,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,171.26
63116,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1991,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,171.2
119141,4,BENIN,Number of road traffic injuries,AFR0140,1991,29,Total,5,Count (Numeric Integer),35,IHME,6441
137441,4,BENIN,Number of cancer cases (all cause),AFR0321,1991,29,Total,5,Count (Numeric Integer),35,IHME,7072
142055,4,BENIN,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1991,126,Hydrological,5,Count (Numeric Integer),35,IHME,3
142699,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1991,29,Total,6,Per 1000 population,16,UNAIDS,0.58
144019,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1991,8,Male,6,Per 1000 population,16,UNAIDS,0.58
49325,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1992,8,Male,1,Percentage,3,WHO / GHO,4.5
49326,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1992,9,Female,1,Percentage,3,WHO / GHO,3.9
49327,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1992,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.2
88369,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1992,8,Male,1,Percentage,3,WHO / GHO,31.6
88370,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1992,9,Female,1,Percentage,3,WHO / GHO,30
88371,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1992,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.9
96059,4,BENIN,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1992,999,Not Applicable,1,Percentage,4,WB Database,1.5
110070,4,BENIN,TB case detection rate,AFR0176,1992,29,Total,1,Percentage,3,WHO / GHO,40
123116,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1992,28,Both sexes (male and female),1,Percentage,35,IHME,0.97
124556,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1992,8,Male,1,Percentage,35,IHME,0.95
125996,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1992,9,Female,1,Percentage,35,IHME,0.98
131635,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1992,28,Both sexes (male and female),1,Percentage,4,WB Database,61.41
134237,4,BENIN,School dropout rate,AFR0160,1992,28,Both sexes (male and female),1,Percentage,42,WDI,50.79
136083,4,BENIN,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1992,29,Total,1,Percentage,36,WHO/UNICEF,73
195668,4,BENIN,Share of premature deaths attributed to high body mass index,AFR0475,1992,28,Both sexes (male and female),1,Percentage,35,IHME,1.39
196997,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1992,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.4
198844,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1992,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,15
12459,4,BENIN,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1992,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,44.4
14025,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1992,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,167.17
63117,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1992,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,167.1
128492,4,BENIN,Sex ratio at birth,AFR0428,1992,28,Both sexes (male and female),4,Ratio,4,WB Database,1.04
119188,4,BENIN,Number of road traffic injuries,AFR0140,1992,29,Total,5,Count (Numeric Integer),35,IHME,6608
137489,4,BENIN,Number of cancer cases (all cause),AFR0321,1992,29,Total,5,Count (Numeric Integer),35,IHME,7294
142743,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1992,29,Total,6,Per 1000 population,16,UNAIDS,0.8
144063,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1992,8,Male,6,Per 1000 population,16,UNAIDS,0.77
49463,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1993,8,Male,1,Percentage,3,WHO / GHO,4.6
49464,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1993,9,Female,1,Percentage,3,WHO / GHO,4
49465,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1993,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.3
88507,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1993,8,Male,1,Percentage,3,WHO / GHO,31.5
88508,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1993,9,Female,1,Percentage,3,WHO / GHO,30.1
88509,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1993,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.9
96105,4,BENIN,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1993,999,Not Applicable,1,Percentage,4,WB Database,1.46
110104,4,BENIN,TB case detection rate,AFR0176,1993,29,Total,1,Percentage,3,WHO / GHO,39
123164,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1993,28,Both sexes (male and female),1,Percentage,35,IHME,0.97
124604,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1993,8,Male,1,Percentage,35,IHME,0.95
126044,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1993,9,Female,1,Percentage,35,IHME,0.98
131636,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1993,28,Both sexes (male and female),1,Percentage,4,WB Database,66.5
134238,4,BENIN,School dropout rate,AFR0160,1993,28,Both sexes (male and female),1,Percentage,42,WDI,46.79
136127,4,BENIN,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1993,29,Total,1,Percentage,36,WHO/UNICEF,75
195669,4,BENIN,Share of premature deaths attributed to high body mass index,AFR0475,1993,28,Both sexes (male and female),1,Percentage,35,IHME,1.48
196998,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1993,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.6
198845,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1993,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,15.4
12460,4,BENIN,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1993,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,43.76
14026,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1993,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,163.18
63118,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1993,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,163.1
119235,4,BENIN,Number of road traffic injuries,AFR0140,1993,29,Total,5,Count (Numeric Integer),35,IHME,6788
137537,4,BENIN,Number of cancer cases (all cause),AFR0321,1993,29,Total,5,Count (Numeric Integer),35,IHME,7542
142787,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1993,29,Total,6,Per 1000 population,16,UNAIDS,1
144107,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1993,8,Male,6,Per 1000 population,16,UNAIDS,0.95
207304,4,BENIN,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,1993-1996,28,Both sexes (male and female),1,Percentage,5,UNICEF,59.8
49601,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1994,8,Male,1,Percentage,3,WHO / GHO,4.8
49602,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1994,9,Female,1,Percentage,3,WHO / GHO,4.1
49603,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1994,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.4
88645,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1994,8,Male,1,Percentage,3,WHO / GHO,31.5
88646,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1994,9,Female,1,Percentage,3,WHO / GHO,30.1
88647,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1994,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.9
96151,4,BENIN,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1994,999,Not Applicable,1,Percentage,4,WB Database,1.36
110141,4,BENIN,TB case detection rate,AFR0176,1994,29,Total,1,Percentage,3,WHO / GHO,36
123212,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1994,28,Both sexes (male and female),1,Percentage,35,IHME,0.96
124652,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1994,8,Male,1,Percentage,35,IHME,0.95
126092,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1994,9,Female,1,Percentage,35,IHME,0.98
131637,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1994,28,Both sexes (male and female),1,Percentage,4,WB Database,66.89
134239,4,BENIN,School dropout rate,AFR0160,1994,28,Both sexes (male and female),1,Percentage,42,WDI,45.52
136172,4,BENIN,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1994,29,Total,1,Percentage,36,WHO/UNICEF,81
195670,4,BENIN,Share of premature deaths attributed to high body mass index,AFR0475,1994,28,Both sexes (male and female),1,Percentage,35,IHME,1.58
196999,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1994,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,3.8
198846,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1994,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,15.8
12461,4,BENIN,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1994,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,43.21
14027,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1994,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,159.37
63119,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1994,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,159.3
119282,4,BENIN,Number of road traffic injuries,AFR0140,1994,29,Total,5,Count (Numeric Integer),35,IHME,6976
137585,4,BENIN,Number of cancer cases (all cause),AFR0321,1994,29,Total,5,Count (Numeric Integer),35,IHME,7867
142831,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1994,29,Total,6,Per 1000 population,16,UNAIDS,1.15
144151,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1994,8,Male,6,Per 1000 population,16,UNAIDS,1.07
11500,4,BENIN,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,1995,9,Female,1,Percentage,3,WHO / GHO,550
49739,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1995,8,Male,1,Percentage,3,WHO / GHO,4.9
49740,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1995,9,Female,1,Percentage,3,WHO / GHO,4.3
49741,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1995,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.6
88783,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1995,8,Male,1,Percentage,3,WHO / GHO,31.4
88784,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1995,9,Female,1,Percentage,3,WHO / GHO,30.1
88785,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1995,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.9
96197,4,BENIN,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1995,999,Not Applicable,1,Percentage,4,WB Database,1.26
103552,4,BENIN,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1995,999,Not Applicable,1,Percentage,3,WHO / GHO,19.59
104982,4,BENIN,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1995,999,Not Applicable,1,Percentage,3,WHO / GHO,54.94
110176,4,BENIN,TB case detection rate,AFR0176,1995,29,Total,1,Percentage,3,WHO / GHO,40
123260,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1995,28,Both sexes (male and female),1,Percentage,35,IHME,0.96
124700,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1995,8,Male,1,Percentage,35,IHME,0.94
126140,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1995,9,Female,1,Percentage,35,IHME,0.98
131638,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1995,28,Both sexes (male and female),1,Percentage,4,WB Database,70.24
133454,4,BENIN,Proportion of urban population living in slums (%),AFR0118,1995,28,Both sexes (male and female),1,Percentage,4,WB Database,76.8
134240,4,BENIN,School dropout rate,AFR0160,1995,28,Both sexes (male and female),1,Percentage,42,WDI,43.11
136217,4,BENIN,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1995,29,Total,1,Percentage,36,WHO/UNICEF,67
156303,4,BENIN,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1995,999,Not Applicable,1,Percentage,3,WHO / GHO,54.94
195671,4,BENIN,Share of premature deaths attributed to high body mass index,AFR0475,1995,28,Both sexes (male and female),1,Percentage,35,IHME,1.68
197000,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1995,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4
198847,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1995,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,16.2
12462,4,BENIN,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1995,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,42.7
14028,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1995,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,155.77
63120,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1995,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,155.7
119329,4,BENIN,Number of road traffic injuries,AFR0140,1995,29,Total,5,Count (Numeric Integer),35,IHME,7167
137633,4,BENIN,Number of cancer cases (all cause),AFR0321,1995,29,Total,5,Count (Numeric Integer),35,IHME,8187
142073,4,BENIN,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1995,126,Hydrological,5,Count (Numeric Integer),35,IHME,20
142875,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1995,29,Total,6,Per 1000 population,16,UNAIDS,1.23
144195,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1995,8,Male,6,Per 1000 population,16,UNAIDS,1.12
74678,4,BENIN,Gender development index score,AFR0347,1995,28,Both sexes (male and female),12,Index,14,UNDP,0.72
122177,4,BENIN,Life expectancy at age 60 years,AFR0003,1995-2000,28,Both sexes (male and female),1,Percentage,17,UN Population,16.41
122465,4,BENIN,Life expectancy at age 60 years,AFR0003,1995-2000,8,Male,1,Percentage,17,UN Population,15.66
122753,4,BENIN,Life expectancy at age 60 years,AFR0003,1995-2000,9,Female,1,Percentage,17,UN Population,16.98
131345,4,BENIN,Total fertility rate,AFR0130,1995-2000,9,Female,1,Percentage,17,UN Population,6.16
49877,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1996,8,Male,1,Percentage,3,WHO / GHO,5.1
49878,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1996,9,Female,1,Percentage,3,WHO / GHO,4.4
49879,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1996,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.7
75402,4,BENIN,Contraceptive prevalence rate,AFR0208,1996,9,Female,1,Percentage,1,WHO/AFRO,17
88921,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1996,8,Male,1,Percentage,3,WHO / GHO,31.2
88922,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1996,9,Female,1,Percentage,3,WHO / GHO,30.1
88923,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1996,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.8
96243,4,BENIN,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1996,999,Not Applicable,1,Percentage,4,WB Database,1.17
103551,4,BENIN,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1996,999,Not Applicable,1,Percentage,3,WHO / GHO,12
104981,4,BENIN,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1996,999,Not Applicable,1,Percentage,3,WHO / GHO,55.65
105518,4,BENIN,Immunization coverage,AFR0405,1996,999,Not Applicable,1,Percentage,3,WHO / GHO,51.23
105519,4,BENIN,Immunization coverage,AFR0405,1996,15,Primary Education,1,Percentage,3,WHO / GHO,66.52
105520,4,BENIN,Immunization coverage,AFR0405,1996,68,Secondary or Higher Education,1,Percentage,3,WHO / GHO,90.71
110217,4,BENIN,TB case detection rate,AFR0176,1996,29,Total,1,Percentage,3,WHO / GHO,40
123308,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1996,28,Both sexes (male and female),1,Percentage,35,IHME,0.96
124748,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1996,8,Male,1,Percentage,35,IHME,0.94
126188,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1996,9,Female,1,Percentage,35,IHME,0.97
127439,4,BENIN,Timing of first ANC visit,AFR0202,1996,29,Total,1,Percentage,7,DHS,23.8
127581,4,BENIN,Timing of first ANC visit,AFR0202,1996,12,Urban,1,Percentage,7,DHS,33.8
127723,4,BENIN,Timing of first ANC visit,AFR0202,1996,11,Rural,1,Percentage,7,DHS,19
131639,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1996,28,Both sexes (male and female),1,Percentage,4,WB Database,72.65
134241,4,BENIN,School dropout rate,AFR0160,1996,28,Both sexes (male and female),1,Percentage,42,WDI,40.88
136262,4,BENIN,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1996,29,Total,1,Percentage,36,WHO/UNICEF,66
148682,4,BENIN,Contraceptive prevalence rate,AFR0208,1996,9,Female,1,Percentage,7,DHS,3.4
148829,4,BENIN,Contraceptive prevalence rate,AFR0208,1996,129,Married women,1,Percentage,7,DHS,3.4
150367,4,BENIN,Unmet need for family planning,AFR0462,1996,129,Married women,1,Percentage,7,DHS,27.7
156302,4,BENIN,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1996,999,Not Applicable,1,Percentage,3,WHO / GHO,55.65
188065,4,BENIN,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,1996,9,Female,1,Percentage,7,DHS,63.9
188068,4,BENIN,Demand for family planning satisfied with modern methods [SDG 3.7.1],AFR0207,1996,9,Female,1,Percentage,7,DHS,7.8
188087,4,BENIN,Proportion of women aged 20-24 years who were married or in a union before age 15 (%),AFR0382,1996,9,Female,1,Percentage,7,DHS,10.8
188098,4,BENIN,Access to electricity (% of population),AFR0380,1996,28,Both sexes (male and female),1,Percentage,7,DHS,14.3
188104,4,BENIN,Proportion of population with primary reliance on clean fuels (%) -[SDG 7.1.2],AFR0126,1996,28,Both sexes (male and female),1,Percentage,7,DHS,0.4
188132,4,BENIN,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1996,28,Both sexes (male and female),1,Percentage,7,DHS,66.9
195672,4,BENIN,Share of premature deaths attributed to high body mass index,AFR0475,1996,28,Both sexes (male and female),1,Percentage,35,IHME,1.78
197001,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1996,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.2
198848,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1996,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,16.6
201045,4,BENIN,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,1996,29,Total,1,Percentage,36,WHO/UNICEF,77.8
201046,4,BENIN,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,1996,12,Urban,1,Percentage,36,WHO/UNICEF,87.3
201047,4,BENIN,Percentage of pregnant women that made at least one ANC visit (first ANC visit),AFR0206,1996,11,Rural,1,Percentage,36,WHO/UNICEF,73.4
201076,4,BENIN,Percentage of pregnant women that made four ANC visits (Fourth ANC visit),AFR0203,1996,29,Total,1,Percentage,36,WHO/UNICEF,53.7
201107,4,BENIN,Percentage of deliveries in health facilities by caesarean section,AFR0455,1996,29,Total,1,Percentage,36,WHO/UNICEF,2.2
201108,4,BENIN,Percentage of deliveries in health facilities by caesarean section,AFR0455,1996,12,Urban,1,Percentage,36,WHO/UNICEF,4.1
201109,4,BENIN,Percentage of deliveries in health facilities by caesarean section,AFR0455,1996,11,Rural,1,Percentage,36,WHO/UNICEF,1.3
201139,4,BENIN,Institutional deliveries,AFR0200,1996,29,Total,1,Percentage,36,WHO/UNICEF,63.9
201140,4,BENIN,Institutional deliveries,AFR0200,1996,12,Urban,1,Percentage,36,WHO/UNICEF,79.4
201141,4,BENIN,Institutional deliveries,AFR0200,1996,11,Rural,1,Percentage,36,WHO/UNICEF,56.7
12463,4,BENIN,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1996,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,42.25
14029,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1996,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,152.45
24667,4,BENIN,Contraceptive prevalence rate,AFR0208,1996,9,Female,2,Per 1000 live births,3,WHO / GHO,17
63121,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1996,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,152.4
188110,4,BENIN,Infant mortality rate (per 1 000 live births),AFR0009,1996,28,Both sexes (male and female),2,Per 1000 live births,7,DHS,166
188115,4,BENIN,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1996,28,Both sexes (male and female),2,Per 1000 live births,7,DHS,38
119376,4,BENIN,Number of road traffic injuries,AFR0140,1996,29,Total,5,Count (Numeric Integer),35,IHME,7372
137681,4,BENIN,Number of cancer cases (all cause),AFR0321,1996,29,Total,5,Count (Numeric Integer),35,IHME,8501
141636,4,BENIN,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1996,125,Biological,5,Count (Numeric Integer),35,IHME,65
142083,4,BENIN,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1996,126,Hydrological,5,Count (Numeric Integer),35,IHME,11
142919,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1996,29,Total,6,Per 1000 population,16,UNAIDS,1.24
144239,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1996,8,Male,6,Per 1000 population,16,UNAIDS,1.11
188120,4,BENIN,Maternal Mortality Ratio,AFR0467,1996,9,Female,7,per 100 000 live births,7,DHS,498
188127,4,BENIN,Total fertility rate,AFR0130,1996,109,Female (15-19 years),9,Per 1000 women aged 15-19 years,7,DHS,119
207305,4,BENIN,Proportion of births attended by skilled health personnel [SDG 3.1.2],AFR0201,1996-2001,28,Both sexes (male and female),1,Percentage,5,UNICEF,65.5
50015,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1997,8,Male,1,Percentage,3,WHO / GHO,5.2
50016,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1997,9,Female,1,Percentage,3,WHO / GHO,4.6
50017,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1997,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.9
89059,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1997,8,Male,1,Percentage,3,WHO / GHO,31.1
89060,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1997,9,Female,1,Percentage,3,WHO / GHO,30.1
89061,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1997,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.8
96289,4,BENIN,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1997,999,Not Applicable,1,Percentage,4,WB Database,1.07
103550,4,BENIN,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1997,999,Not Applicable,1,Percentage,3,WHO / GHO,18.33
104980,4,BENIN,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1997,999,Not Applicable,1,Percentage,3,WHO / GHO,57.86
110257,4,BENIN,TB case detection rate,AFR0176,1997,29,Total,1,Percentage,3,WHO / GHO,38
123356,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1997,28,Both sexes (male and female),1,Percentage,35,IHME,0.95
124796,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1997,8,Male,1,Percentage,35,IHME,0.93
126236,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1997,9,Female,1,Percentage,35,IHME,0.97
131640,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1997,28,Both sexes (male and female),1,Percentage,4,WB Database,76.38
134242,4,BENIN,School dropout rate,AFR0160,1997,28,Both sexes (male and female),1,Percentage,42,WDI,37.52
136307,4,BENIN,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1997,29,Total,1,Percentage,36,WHO/UNICEF,66
156301,4,BENIN,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1997,999,Not Applicable,1,Percentage,3,WHO / GHO,57.86
195673,4,BENIN,Share of premature deaths attributed to high body mass index,AFR0475,1997,28,Both sexes (male and female),1,Percentage,35,IHME,1.87
197002,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1997,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.4
198849,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1997,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,17
12464,4,BENIN,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1997,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,41.74
14030,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1997,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,149.19
63122,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1997,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,149.1
128491,4,BENIN,Sex ratio at birth,AFR0428,1997,28,Both sexes (male and female),4,Ratio,4,WB Database,1.04
119423,4,BENIN,Number of road traffic injuries,AFR0140,1997,29,Total,5,Count (Numeric Integer),35,IHME,7579
137729,4,BENIN,Number of cancer cases (all cause),AFR0321,1997,29,Total,5,Count (Numeric Integer),35,IHME,8772
141655,4,BENIN,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1997,125,Biological,5,Count (Numeric Integer),35,IHME,47
142963,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1997,29,Total,6,Per 1000 population,16,UNAIDS,1.18
144283,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1997,8,Male,6,Per 1000 population,16,UNAIDS,1.06
50155,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1998,8,Male,1,Percentage,3,WHO / GHO,5.4
50156,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1998,9,Female,1,Percentage,3,WHO / GHO,4.7
50157,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1998,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5
89197,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1998,8,Male,1,Percentage,3,WHO / GHO,31
89198,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1998,9,Female,1,Percentage,3,WHO / GHO,30
89199,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1998,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.7
96335,4,BENIN,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1998,999,Not Applicable,1,Percentage,4,WB Database,0.98
103549,4,BENIN,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1998,999,Not Applicable,1,Percentage,3,WHO / GHO,14.45
104979,4,BENIN,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1998,999,Not Applicable,1,Percentage,3,WHO / GHO,55.71
110295,4,BENIN,TB case detection rate,AFR0176,1998,29,Total,1,Percentage,3,WHO / GHO,40
123404,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1998,28,Both sexes (male and female),1,Percentage,35,IHME,0.94
124844,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1998,8,Male,1,Percentage,35,IHME,0.92
126284,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1998,9,Female,1,Percentage,35,IHME,0.97
131641,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1998,28,Both sexes (male and female),1,Percentage,4,WB Database,79.43
136352,4,BENIN,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1998,29,Total,1,Percentage,36,WHO/UNICEF,70
156300,4,BENIN,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1998,999,Not Applicable,1,Percentage,3,WHO / GHO,55.71
195674,4,BENIN,Share of premature deaths attributed to high body mass index,AFR0475,1998,28,Both sexes (male and female),1,Percentage,35,IHME,1.97
197003,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1998,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.6
198850,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1998,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,17.5
12465,4,BENIN,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1998,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,41.24
14031,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1998,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,145.92
63123,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1998,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,145.9
119470,4,BENIN,Number of road traffic injuries,AFR0140,1998,29,Total,5,Count (Numeric Integer),35,IHME,7796
137777,4,BENIN,Number of cancer cases (all cause),AFR0321,1998,29,Total,5,Count (Numeric Integer),35,IHME,9073
141672,4,BENIN,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1998,125,Biological,5,Count (Numeric Integer),35,IHME,78
143007,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1998,29,Total,6,Per 1000 population,16,UNAIDS,1.11
144327,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1998,8,Male,6,Per 1000 population,16,UNAIDS,0.99
50294,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1999,8,Male,1,Percentage,3,WHO / GHO,5.5
50295,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1999,9,Female,1,Percentage,3,WHO / GHO,4.8
50296,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,1999,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.2
89335,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1999,8,Male,1,Percentage,3,WHO / GHO,30.8
89336,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1999,9,Female,1,Percentage,3,WHO / GHO,30
89337,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,1999,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.6
96381,4,BENIN,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,1999,999,Not Applicable,1,Percentage,4,WB Database,0.91
103548,4,BENIN,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,1999,999,Not Applicable,1,Percentage,3,WHO / GHO,13.08
104978,4,BENIN,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,1999,999,Not Applicable,1,Percentage,3,WHO / GHO,53.94
110336,4,BENIN,TB case detection rate,AFR0176,1999,29,Total,1,Percentage,3,WHO / GHO,44
123452,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1999,28,Both sexes (male and female),1,Percentage,35,IHME,0.94
124892,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1999,8,Male,1,Percentage,35,IHME,0.92
126332,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,1999,9,Female,1,Percentage,35,IHME,0.96
131642,4,BENIN,"School enrolment, primary (% gross)",AFR0391,1999,28,Both sexes (male and female),1,Percentage,4,WB Database,79.58
136397,4,BENIN,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,1999,29,Total,1,Percentage,36,WHO/UNICEF,74
156299,4,BENIN,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,1999,999,Not Applicable,1,Percentage,3,WHO / GHO,53.94
177090,4,BENIN,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,1999,999,Not Applicable,1,Percentage,40,National Health Account Report,8.4
195675,4,BENIN,Share of premature deaths attributed to high body mass index,AFR0475,1999,28,Both sexes (male and female),1,Percentage,35,IHME,2.07
197004,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,1999,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,4.8
198851,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,1999,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,17.9
12466,4,BENIN,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,1999,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,40.59
14032,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1999,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,142.65
63124,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,1999,28,Both sexes (male and female),2,Per 1000 live births,24,UN IGME,142.6
119517,4,BENIN,Number of road traffic injuries,AFR0140,1999,29,Total,5,Count (Numeric Integer),35,IHME,8026
137825,4,BENIN,Number of cancer cases (all cause),AFR0321,1999,29,Total,5,Count (Numeric Integer),35,IHME,9370
141691,4,BENIN,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1999,125,Biological,5,Count (Numeric Integer),35,IHME,9
142105,4,BENIN,"Number of deaths and missing persons attributed to disasters, by hazard type (number)",AFR0119,1999,126,Hydrological,5,Count (Numeric Integer),35,IHME,3
143051,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1999,29,Total,6,Per 1000 population,16,UNAIDS,1.04
144371,4,BENIN,"Number of new HIV infections per 1,000 uninfected population",AFR0104,1999,8,Male,6,Per 1000 population,16,UNAIDS,0.92
11501,4,BENIN,"Maternal mortality ratio (per 100,000 live births) [SDG 3.1.1]",AFR0012,2000,9,Female,1,Percentage,3,WHO / GHO,520
50434,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2000,8,Male,1,Percentage,3,WHO / GHO,5.7
50435,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2000,9,Female,1,Percentage,3,WHO / GHO,5
50436,4,BENIN,Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose,AFR0313,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5.3
67532,4,BENIN,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2000,28,Both sexes (male and female),1,Percentage,36,WHO/UNICEF,78
84259,4,BENIN,TB case detection rate,AFR0176,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,45
89473,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2000,8,Male,1,Percentage,3,WHO / GHO,30.7
89474,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2000,9,Female,1,Percentage,3,WHO / GHO,29.9
89475,4,BENIN,Age-standardized prevalence of raised blood pressure among persons aged 18+ years,AFR0311,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,30.5
92970,4,BENIN,GDP growth (annual %),AFR0388,2000,999,Not Applicable,1,Percentage,22,UN DESA,2.75
93625,4,BENIN,Out-of-pocket (OOPS) as % of Private health expenditure (PvtHE),AFR0068,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,99.88
94555,4,BENIN,Social security funds as % of General government health expenditure (GGHE),AFR0294,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,0.52
96427,4,BENIN,"Unemployment, total (% of total labor force) (modelled ILO estimate)",AFR0032,2000,999,Not Applicable,1,Percentage,4,WB Database,0.82
98514,4,BENIN,Immunization coverage against Tetanus,AFR0189,2000,28,Both sexes (male and female),1,Percentage,4,WB Database,78
102393,4,BENIN,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2000,999,Not Applicable,1,Percentage,4,WB Database,52.49
103547,4,BENIN,External Resources on Health as % of Total Health Expenditure (THE),AFR0271,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,17.04
109791,4,BENIN,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%),AFR0259,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,55.74
110373,4,BENIN,TB case detection rate,AFR0176,2000,29,Total,1,Percentage,3,WHO / GHO,45
111225,4,BENIN,TB treatment success rate,AFR0216,2000,29,Total,1,Percentage,3,WHO / GHO,78
112764,4,BENIN,TB treatment coverage,AFR0173,2000,29,Total,1,Percentage,3,WHO / GHO,78
115989,4,BENIN,Social Health Insurance (SHI) as % of Current Health Expenditure (CHE),AFR0270,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,1.13
117020,4,BENIN,TB treatment success rate,AFR0216,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,35.1
123500,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,2000,28,Both sexes (male and female),1,Percentage,35,IHME,0.93
124940,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,2000,8,Male,1,Percentage,35,IHME,0.91
126380,4,BENIN,Prevalence chronic obstructive pulmonary diseases,AFR0319,2000,9,Female,1,Percentage,35,IHME,0.96
131643,4,BENIN,"School enrolment, primary (% gross)",AFR0391,2000,28,Both sexes (male and female),1,Percentage,4,WB Database,82.53
133455,4,BENIN,Proportion of urban population living in slums (%),AFR0118,2000,28,Both sexes (male and female),1,Percentage,4,WB Database,74.3
133668,4,BENIN,"Proportion of total government spending on essential services (education, health and social protection[SDG1.a.2]",AFR0419,2000,999,Not Applicable,1,Percentage,51,UNESCO/IMF,13.51
136444,4,BENIN,Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%),AFR0111,2000,29,Total,1,Percentage,36,WHO/UNICEF,78
138427,4,BENIN,Tuberculosis treatment success rate,AFR0335,2000,29,Total,1,Percentage,3,WHO / GHO,78
138428,4,BENIN,Tuberculosis treatment success rate,AFR0335,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,35.1
151367,4,BENIN,Other Private Health Expenditure (OTHER) as % Current Health Expenditure (CHE),AFR0067,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,4.81
156298,4,BENIN,Out of Pocket Expenditure (OOPS) as % of Total Health Expenditure (THE),AFR0269,2000,999,Not Applicable,1,Percentage,3,WHO / GHO,55.74
177124,4,BENIN,Private Insurance as % of Private Health Expenditure (PvtHE),AFR0058,2000,999,Not Applicable,1,Percentage,40,National Health Account Report,8.4
178645,4,BENIN,Access to electricity (% of population),AFR0380,2000,999,Not Applicable,1,Percentage,4,WB Database,21.3
182005,4,BENIN,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%),AFR0261,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,57.25
182871,4,BENIN,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,3.09
184603,4,BENIN,Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE),AFR0097,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,83.2
185469,4,BENIN,External Health Expenditure (EXT) as % of Current Health Expenditure (CHE),AFR0093,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,16.7
188140,4,BENIN,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%),AFR0260,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,5.15
189006,4,BENIN,Domestic general government health expenditure as percentage of GGE (%) - [SDG 1.a.2],AFR0127,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,5.15
191043,4,BENIN,Out-of-pocket (OOPS) as % of Current Health Expenditure (CHE),AFR0268,2000,999,Not Applicable,1,Percentage,10,WHO / GHED,52.4
195676,4,BENIN,Share of premature deaths attributed to high body mass index,AFR0475,2000,28,Both sexes (male and female),1,Percentage,35,IHME,2.17
197005,4,BENIN,Prevalence of obesity in persons aged 18+years,AFR0021,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,5
198852,4,BENIN,Prevalence of overweight in persons aged 18+years,AFR0383,2000,28,Both sexes (male and female),1,Percentage,3,WHO / GHO,18.4
7,4,BENIN,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%),AFR0087,2000,999,Not Applicable,2,Per 1000 live births,1,WHO/AFRO,4.23
8,4,BENIN,Current health expenditure (CHE) per capita in US$,AFR0263,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,15.83
9,4,BENIN,Current health expenditure (CHE) per capita in PPP int$,AFR0262,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,55.87
12467,4,BENIN,Neonatal mortality rate (per 1 000 live births)-[SDG 3.2.2],AFR0010,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,39.86
14033,4,BENIN,Under-five mortality rate (per 1 000 live births)-[SDG 3.2.1],AFR0008,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,139.26
15879,4,BENIN,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,999,Not Applicable,2,Per 1000 live births,3,WHO / GHO,9.5
16119,4,BENIN,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,8,Male,2,Per 1000 live births,3,WHO / GHO,13.2
16359,4,BENIN,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,9,Female,2,Per 1000 live births,3,WHO / GHO,6
16599,4,BENIN,Suicide rate (per 100 000 population) - [SDG 3.4.2],AFR0016,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,9.5
18305,4,BENIN,Premature noncommunicable disease (NCD) mortality [SDG 3.4.1],AFR0394,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,20
18623,4,BENIN,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2000,9,Female,2,Per 1000 live births,3,WHO / GHO,254.36
18624,4,BENIN,Adolescent mortality rate (per 100 000 adolescent population),AFR0006,2000,8,Male,2,Per 1000 live births,3,WHO / GHO,290.29
21230,4,BENIN,Malaria incidence rate (per 1000 population at risk) [SDG 3.3.3],AFR0331,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,368.65
22681,4,BENIN,HIV prevalence rate (per 1000 population),AFR0020,2000,28,Both sexes (male and female),2,Per 1000 live births,3,WHO / GHO,1.3
25495,4,BENIN,Adolescent birth rate [SDG 3.7.2],AFR0293,2000,9,Female,2,Per 1000 live births,1,WHO/AFRO,109.4
25703,4,BENIN,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,3.6
25704,4,BENIN,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,9,Female,2,Per 1000 live births,20,ITU,2.6
25705,4,BENIN,Mortality rate attributed to unintentional poisoning [SDG 3.9.3],AFR0110,2000,8,Male,2,Per 1000 live births,20,ITU,4.6
28113,4,BENIN,Total net official development assistance to medical research and basic health sectors [SDG 3.b.2],AFR0134,2000,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,23.14
29865,4,BENIN,Immunization coverage rate by vaccine for each vaccine in the national schedule [SDG 3.b.1] - Penta 1,AFR0193,2000,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,39
30935,4,BENIN,TB case detection rate,AFR0176,2000,28,Both sexes (male and female),2,Per 1000 live births,1,WHO/AFRO,45
37286,4,BENIN,People practicing open defecation (%) of population),AFR0025,2000,29,Total,2,Per 1000 live births,5,UNICEF,67.61
37287,4,BENIN,People practicing open defecation (%) of population),AFR0025,2000,11,Rural,2,Per 1000 live births,5,UNICEF,75.41
37709,4,BENIN,Individuals using the Internet (% of population),AFR0033,2000,28,Both sexes (male and female),2,Per 1000 live births,20,ITU,0.23
38580,4,BENIN,Proportion of seats held by women in national parliaments (%),AFR0034,2000,9,Female,2,Per 1000 live births,18,Inter-Parliamentary Union,6.02
